data_1u38_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u38 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.359 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.3 m-85 -69.45 150.96 46.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.21 127.9 3.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.793 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.6 104.64 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.407 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 13.8 t -82.78 142.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HE1' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.96 104.34 6.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.234 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -106.63 99.67 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.451 . . . . 0.0 111.263 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' CG ' ' CD ' ' A' ' 98' ' ' ARG . 1.9 mp0 -85.72 109.89 18.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.262 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -166.61 2.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 111.069 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.99 163.56 18.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -58.07 161.64 3.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.64 11.48 62.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' LEU . 48.2 mt-10 -126.45 34.39 4.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.853 0.326 . . . . 0.0 110.406 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.467 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 14.11 -78.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.083 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' GLU . 31.7 tp 176.51 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.819 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 83.34 62.62 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.575 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.98 157.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.05 0.452 . . . . 0.0 111.935 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' -1' ' ' TYR . 43.9 t -122.34 129.25 75.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.369 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.82 152.85 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.959 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 27.1 m -146.27 166.67 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.072 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.85 132.06 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.4 p -72.74 83.81 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.451 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.81 -4.73 90.24 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.961 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.51 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.67 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.668 0.27 . . . . 0.0 110.515 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.59 -25.21 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.825 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.407 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 81.79 48.03 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.486 0.66 . . . . 0.0 111.248 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.51 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 65.9 mt -63.55 -35.99 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.536 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -149.34 110.3 3.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.797 178.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.7 Cg_endo -56.47 84.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.188 1.925 . . . . 0.0 112.483 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -135.24 -154.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.386 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -109.0 163.59 6.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.682 0.277 . . . . 0.0 110.907 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -122.2 130.34 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' CG2' HD11 ' A' ' 66' ' ' ILE . 59.3 mt -70.0 90.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.02 -14.45 47.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.476 ' CA ' HD12 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -157.64 159.65 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.063 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -151.92 139.28 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.481 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.457 ' HG3' ' CD2' ' B' ' -1' ' ' TYR . 6.7 mtm -74.97 96.13 3.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.371 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -62.46 79.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.42 -29.49 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.218 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.65 -166.34 15.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.171 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.12 -16.46 40.26 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.569 2.179 . . . . 0.0 112.422 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.07 50.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.028 0.442 . . . . 0.0 110.705 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -34.89 56.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.532 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -58.99 -47.25 85.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 t -62.5 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.46 -28.18 12.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.884 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.9 mtpp -58.17 -26.28 62.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.418 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 21.3 mt -101.92 126.28 48.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.487 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.75 140.26 33.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.476 HD12 ' CA ' ' A' ' 51' ' ' ASN . 27.2 mm -48.72 146.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.54 59.57 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 2.9 m-20 -105.2 152.64 22.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.797 0.332 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.0 mm100 -107.48 115.54 30.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 2.8 mt -86.42 125.07 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.065 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.03 -63.24 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.299 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.8 p -139.47 145.77 39.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.376 . . . . 0.0 111.417 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.41 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.0 mt -115.42 116.26 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 55.25 27.65 10.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.346 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.57 -28.2 12.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.804 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -65.95 99.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -67.69 125.23 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.218 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 17.6 mt -105.19 -20.72 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -57.98 85.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.498 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.91 -41.84 1.1 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.117 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -77.45 159.86 76.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.419 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.81 -168.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.884 2.389 . . . . 0.0 112.687 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.23 -49.94 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.284 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.0 t -52.74 -39.98 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.526 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HG12 ' A' ' 89' ' ' ILE . 97.6 m -63.15 -49.48 74.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.552 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.2 m -57.84 -48.19 80.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -50.38 -44.16 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.079 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.484 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 25.5 m -60.97 -37.41 82.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.534 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 85' ' ' THR . 14.1 mm -58.51 -49.67 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.769 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.481 ' CG2' HD13 ' B' ' 0' ' ' ILE . 22.8 mt -73.94 -50.52 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.484 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.19 -23.98 38.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -40.12 90.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.208 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.4 pp -93.74 48.19 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 110.92 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' CG ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.46 -7.07 51.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.555 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -120.2 34.32 5.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.315 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -92.43 155.92 17.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.239 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 t -108.04 -9.71 15.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.126 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.9 tpp85 -154.42 114.31 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.374 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.31 104.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.558 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -92.66 97.66 10.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -107.02 154.57 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 111.155 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -124.12 86.85 2.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 70' ' ' ILE . 4.0 pt -111.74 169.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.304 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.438 HG22 ' CG ' ' A' ' 18' ' ' PHE . 27.3 t -118.05 111.08 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.909 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.647 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . 0.418 ' HD2' ' CE1' ' B' ' -1' ' ' TYR . 89.1 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 N-CA-C 112.784 0.263 . . . . 0.0 112.784 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 54.6 99.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.799 0.333 . . . . 0.0 111.426 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.458 ' CE2' HG21 ' A' ' 34' ' ' VAL . 49.0 m-85 -90.76 137.99 31.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.526 ' CD1' HG23 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.78 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.461 ' CZ ' ' HG3' ' A' ' 71' ' ' MET . 4.0 m-85 -58.25 143.87 42.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 125.63 3.35 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 111.487 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.27 104.65 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.466 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -85.76 141.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.103 0.477 . . . . 0.0 111.435 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CZ ' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -132.28 104.7 6.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.323 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.66 99.68 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.353 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.54 109.87 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.93 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 4.9 pttm -133.13 -170.4 2.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.968 0.414 . . . . 0.0 111.38 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -121.26 170.32 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.231 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.51 162.07 16.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.937 0.398 . . . . 0.0 110.74 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.52 20.09 50.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.302 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 31' ' ' LEU . 51.3 mt-10 -132.14 31.94 4.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.249 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 14.11 -81.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.307 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' GLU . 20.4 tp 177.75 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.221 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 59.45 2.1 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.575 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' B' ' 0' ' ' ILE . 0.9 OUTLIER -147.9 156.97 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.471 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 39.2 t -125.22 123.75 65.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.109 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.9 pt -114.02 145.66 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.28 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -138.11 166.76 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.87 133.76 51.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.454 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 23.2 p -76.16 83.57 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.463 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -80.34 -7.26 88.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.036 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.36 -162.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.499 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.29 8.24 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.871 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.68 49.25 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.643 0.735 . . . . 0.0 111.19 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 82.5 mt -59.56 -40.6 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.771 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD12 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.61 87.87 4.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.004 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 1.9 Cg_endo -42.66 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.163 2.575 . . . . 0.0 113.63 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -139.86 -92.87 0.17 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.953 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.14 167.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.61 129.93 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.052 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 66.7 mt -68.5 94.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.43 -2.42 54.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.33 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.539 ' CA ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -169.88 159.94 8.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.6 mtm -158.94 138.61 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.433 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.433 ' HG3' ' CD2' ' B' ' -1' ' ' TYR . 19.7 mtm -72.95 105.16 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.17 74.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.91 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.53 -33.56 0.17 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.946 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.95 -179.19 32.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.941 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 31.4 Cg_exo -58.93 -16.47 32.3 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.464 2.11 . . . . 0.0 112.601 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.01 53.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 110.813 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -36.98 55.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.497 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -57.73 -46.85 83.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -65.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.19 29.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.387 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -35.52 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.61 118.06 33.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -129.09 141.06 51.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.539 HD11 ' CA ' ' A' ' 51' ' ' ASN . 48.2 mm -47.57 143.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 111.832 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.66 11.38 58.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.592 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 64.9 m-20 -101.59 161.38 13.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB2' HG21 ' A' ' 104' ' ' VAL . 1.9 mm100 -119.99 97.99 5.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.47 ' O ' ' OG1' ' A' ' 46' ' ' THR . 3.4 mt -67.6 143.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.574 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.461 ' HG3' ' CZ ' ' A' ' 18' ' ' PHE . 12.3 mmt -111.94 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -125.61 138.35 53.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 111.445 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -112.79 108.32 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 59.69 21.17 9.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.96 -34.45 4.47 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -66.69 104.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.747 0.308 . . . . 0.0 111.116 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 p -68.13 146.59 53.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.02 -28.41 5.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.308 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.72 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.56 -21.87 2.71 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.305 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.86 162.41 20.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.983 0.391 . . . . 0.0 111.543 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 44.9 Cg_endo -66.8 -171.65 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.045 2.496 . . . . 0.0 112.584 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.413 HD22 ' NE2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -78.45 -50.47 11.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.37 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 p -52.99 -36.51 60.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.713 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.589 ' O ' HG12 ' A' ' 89' ' ' ILE . 77.5 m -66.87 -50.81 61.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.56 -49.75 73.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 110.707 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.413 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.4 mt-30 -50.33 -49.48 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.452 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 3.2 t -55.04 -37.95 67.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 85' ' ' THR . 23.5 mm -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.175 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 0' ' ' ILE . 22.5 mt -67.68 -50.23 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.452 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.03 -20.0 62.01 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.85 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.46 -19.18 70.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.485 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.2 pp -116.33 51.83 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 110.948 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.48 -30.74 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -97.75 32.6 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -95.9 155.88 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.016 0.436 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -104.26 -12.84 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 tpp85 -148.5 126.75 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.9 t -110.42 104.79 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -91.28 127.69 36.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.583 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.36 154.81 46.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.026 0.441 . . . . 0.0 111.211 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 91.4 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.431 HG23 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -114.9 172.61 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.125 0.488 . . . . 0.0 112.309 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -113.23 119.02 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.979 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.914 0.297 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.57 -10.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.46 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 34' ' ' VAL . 26.2 m-85 62.78 167.13 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.376 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.791 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CE1' ' CG2' ' A' ' 104' ' ' VAL . 1.6 m-85 -62.81 153.22 33.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.994 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.69 124.45 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.0 111.517 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.91 102.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.185 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 37.3 t -88.15 112.32 23.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.787 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -106.3 113.52 27.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -111.37 99.85 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.468 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.87 124.64 29.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.09 -172.07 3.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.255 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -111.47 176.83 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.655 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -72.99 157.03 38.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.742 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.52 11.05 67.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.615 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 31' ' ' LEU . 16.9 mt-10 -124.32 32.84 5.4 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.285 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.492 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 14.4 -80.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.994 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 29' ' ' GLU . 5.1 tp 174.43 -49.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.297 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.406 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.37 69.79 1.12 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.79 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.9 OUTLIER -154.06 155.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 117.01 0.405 . . . . 0.0 111.656 178.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' B' ' -1' ' ' TYR . 55.1 t -118.72 128.94 75.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.505 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -119.7 141.82 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.34 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 48' ' ' ILE . 32.7 m -136.51 163.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -50.96 134.81 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 110.956 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.1 p -78.17 83.66 4.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.596 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.09 -7.65 88.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.946 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.536 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.63 -161.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.429 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.75 -25.98 7.52 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.717 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.423 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.76 33.58 0.07 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.536 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 70.7 mt -47.34 -40.86 6.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.034 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 1.3 mt -146.72 97.2 4.29 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.08 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 12.2 Cg_endo -56.11 91.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.551 2.167 . . . . 0.0 113.097 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -138.61 -91.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.063 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -160.3 167.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.787 0.327 . . . . 0.0 111.362 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -128.9 130.52 68.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.789 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' A' ' 66' ' ' ILE . 49.5 mt -69.16 88.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.52 -13.0 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.785 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CA ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -159.83 160.31 33.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.751 0.31 . . . . 0.0 110.888 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 ttp -147.82 134.1 19.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.03 0.443 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -70.48 83.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.569 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.455 ' CG ' ' HG2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -56.24 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 163.32 -28.21 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.409 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.74 -165.36 39.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.08 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.11 -16.31 40.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.506 2.137 . . . . 0.0 112.477 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -49.39 73.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.727 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HG2' ' CG ' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -77.76 -37.09 49.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -63.69 -41.37 98.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.23 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.45 -71.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.254 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.05 15.72 10.45 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.802 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.37 -32.1 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.918 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.435 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 21.5 mt -85.61 126.9 34.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.65 129.92 23.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.462 HD11 ' CA ' ' A' ' 51' ' ' ASN . 24.9 mm -45.02 143.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.944 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 11.94 55.01 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -107.03 159.83 16.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 1.2 mm100 -113.85 114.55 26.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.449 ' O ' ' OG1' ' A' ' 46' ' ' THR . 1.7 mt -84.9 136.02 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.445 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 30.6 mmt -96.06 -69.12 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 24.3 p -132.39 146.68 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.69 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.41 ' CG2' HD23 ' A' ' 101' ' ' LEU . 2.7 mp -120.17 120.1 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.776 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 61.01 19.42 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.332 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 -27.47 10.85 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.792 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -71.23 111.6 6.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.943 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 22.1 p -76.17 142.48 41.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.311 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.12 -20.65 12.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.161 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 t -59.98 92.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.409 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.98 -22.15 3.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.469 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -102.04 161.05 24.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 111.481 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 57.8 Cg_endo -69.16 -167.49 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.0 112.572 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -78.1 -50.15 12.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.268 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -52.4 -38.22 58.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.584 ' O ' HG12 ' A' ' 89' ' ' ILE . 36.3 m -64.39 -49.16 72.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.519 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.29 -51.6 69.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.771 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' NE2' HD23 ' A' ' 83' ' ' LEU . 56.8 mt-30 -49.63 -39.88 37.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.484 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 2.8 m -64.96 -37.95 89.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.659 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 85' ' ' THR . 23.9 mm -58.65 -49.97 80.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' B' ' 0' ' ' ILE . 38.1 mt -72.94 -49.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.484 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -57.4 -22.82 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.452 . . . . 0.0 110.741 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.51 -39.33 61.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.171 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -94.83 46.16 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -76.73 -36.01 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.026 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -88.79 51.57 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.123 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -111.24 172.37 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.393 0.616 . . . . 0.0 111.573 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.6 p -113.99 -7.1 13.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.656 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.787 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.2 ttm180 -161.94 150.43 15.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -133.09 113.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.513 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.65 130.96 38.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -140.06 154.92 47.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.3 90.72 3.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.431 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -113.63 172.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.45 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 24.3 t -111.73 119.93 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 CA-C-O 120.724 0.218 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.4 t -59.55 136.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.5 ' CE1' HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -120.31 138.68 53.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.841 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 2.2 m-85 -58.94 151.57 21.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.815 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 129.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.95 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.8 122.73 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.744 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' HG ' ' A' ' 64' ' ' LEU . 44.3 t -106.68 111.48 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -107.84 114.91 29.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.443 ' HB ' HG11 ' A' ' 99' ' ' VAL . 19.9 mm -114.16 99.25 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 112.48 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.949 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 -170.81 2.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.336 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -117.46 158.23 24.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.522 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -58.38 145.89 36.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.947 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.51 18.45 79.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.382 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -129.19 29.1 5.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.137 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 19.17 -82.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.123 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . 15.3 tp 179.24 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.916 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.45 62.53 1.63 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.598 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.22 155.9 7.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.966 0.413 . . . . 0.0 111.433 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.482 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 30.7 t -123.67 116.35 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.791 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -104.46 146.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.259 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 30.0 m -135.66 167.3 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.08 131.19 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.458 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 51.4 p -74.25 84.49 1.89 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.539 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -82.7 -6.7 88.26 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.11 -163.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.714 0.292 . . . . 0.0 110.287 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.38 -26.38 6.92 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.798 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 p 80.0 51.7 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.801 0.81 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 82.3 mt -61.18 -41.75 90.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.774 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 0.4 OUTLIER -149.2 81.53 7.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.103 178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.35 90.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.536 2.824 . . . . 0.0 114.136 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -136.41 -96.43 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.149 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -156.14 167.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-O 120.687 0.279 . . . . 0.0 111.05 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.14 128.68 62.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 66' ' ' ILE . 52.4 mt -67.78 90.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.45 -8.88 55.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.158 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.52 ' CA ' HD11 ' A' ' 66' ' ' ILE . 1.4 t-20 -162.01 159.81 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.006 0.431 . . . . 0.0 111.405 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 13.4 ttm -152.0 148.11 27.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.429 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 8.7 mtt -56.07 -22.41 27.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 61.09 47.26 7.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.63 -34.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.134 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.63 -171.18 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.11 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.02 -24.83 34.01 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.428 2.085 . . . . 0.0 112.408 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.71 70.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.001 0.429 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -39.38 44.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.709 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -53.26 -47.23 69.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.44 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -56.32 5.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.06 -16.8 53.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.066 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 25.1 mmmt -57.3 -30.08 64.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.368 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.454 ' HG ' HG13 ' A' ' 21' ' ' VAL . 26.0 mt -103.12 134.68 46.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -144.15 128.19 17.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.52 HD11 ' CA ' ' A' ' 51' ' ' ASN . 30.5 mm -44.1 142.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.125 0.488 . . . . 0.0 111.891 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.31 18.37 46.22 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.464 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -112.31 164.8 12.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.449 ' NE2' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -118.65 116.49 26.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.176 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.6 mt -85.87 143.99 10.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.219 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.468 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 8.3 mmt -112.17 -67.52 0.99 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 132.11 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 111.692 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.3 mt -115.96 114.18 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 58.51 23.86 11.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.4 -35.5 4.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.672 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 m -68.63 117.1 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.356 . . . . 0.0 110.943 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.54 154.17 34.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' MET . 61.9 mt -121.49 -37.58 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.23 91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.303 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.32 -24.84 2.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.117 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -103.6 160.95 24.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 111.406 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.37 -169.6 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.859 2.372 . . . . 0.0 112.726 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.18 -47.74 17.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 83' ' ' LEU . 17.8 m -53.15 -42.06 65.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.451 . . . . 0.0 110.446 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.9 m -65.05 -49.28 70.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.764 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 90.2 m -55.76 -56.2 23.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.324 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.425 ' NE2' HD23 ' A' ' 83' ' ' LEU . 27.9 mt-30 -48.88 -46.11 42.13 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 110.14 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.93 -36.93 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.556 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 85' ' ' THR . 24.8 mm -57.99 -49.95 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' B' ' 0' ' ' ILE . 44.0 mt -71.25 -43.71 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -54.96 -24.86 25.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.88 -45.43 42.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.337 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -85.95 58.86 5.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.912 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -87.37 -31.34 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -113.8 65.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.337 . . . . 0.0 111.595 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.506 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.4 mm100 -118.95 -28.45 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t 75.44 5.87 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.994 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.659 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.9 ttm180 -165.07 127.48 2.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.062 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.443 HG11 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.01 126.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 0.0 111.932 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -108.71 108.87 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.414 ' HG ' HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.37 117.58 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.228 0.537 . . . . 0.0 112.356 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 90.77 8.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.977 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 70' ' ' ILE . 1.4 pt -109.02 171.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.068 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 69' ' ' GLN . 3.4 p -115.38 131.6 67.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.725 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.755 0.231 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.3 t -58.41 150.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.855 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -117.86 138.06 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.327 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.488 ' CD1' HG21 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.596 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.996 0.426 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 71' ' ' MET . 2.8 m-85 -67.73 154.28 41.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.83 126.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.512 . . . . 0.0 112.13 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 106.44 3.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.062 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -93.29 104.25 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.128 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.87 104.78 15.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.663 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -102.55 99.29 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.29 109.82 9.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -177.23 4.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.595 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -113.86 168.88 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.82 155.09 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.923 0.392 . . . . 0.0 110.698 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.6 15.14 73.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.469 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -129.45 32.8 4.6 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.942 0.401 . . . . 0.0 110.248 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.496 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.2 OUTLIER 13.74 -80.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.273 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' GLU . 13.6 tp 175.67 -45.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.789 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 85.38 63.63 1.56 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.609 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 ' CD1' ' B' ' 0' ' ' ILE . 1.0 OUTLIER -153.28 155.81 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 111.323 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.507 HG22 ' CE1' ' B' ' -1' ' ' TYR . 46.5 t -123.5 129.02 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.5 pt -114.53 144.22 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 48' ' ' ILE . 27.1 m -137.13 165.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.47 133.83 45.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 48' ' ' ILE . 52.4 p -76.28 83.08 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.451 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.68 -4.45 90.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.707 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.535 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.75 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.22 -26.66 6.7 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.667 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.78 44.98 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.501 0.667 . . . . 0.0 111.56 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.535 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 70.1 mt -59.15 -35.02 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.49 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' CE ' ' A' ' 71' ' ' MET . 85.0 mt -155.65 96.32 2.4 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.029 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.3 91.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.653 2.235 . . . . 0.0 113.497 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.11 -90.15 0.33 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.69 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.66 167.58 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.879 0.371 . . . . 0.0 111.463 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.84 129.56 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.629 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' CG2' HD12 ' A' ' 66' ' ' ILE . 66.6 mt -68.57 89.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.4 -15.77 45.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.049 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.1 m-20 -154.38 158.99 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.729 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.8 ttp -149.2 137.45 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.534 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -53.42 -24.63 13.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.351 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m80 60.61 46.4 9.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.494 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.63 -38.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.051 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -174.01 2.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.942 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.78 -24.07 29.24 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.357 2.038 . . . . 0.0 112.313 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.12 69.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 110.733 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.2 -39.0 50.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.524 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -55.8 -47.15 77.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 t -65.15 -64.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.783 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.9 -24.34 19.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -58.15 -25.53 61.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 22.6 mt -103.41 131.61 50.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -144.06 133.93 23.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.419 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.487 HD13 ' CA ' ' A' ' 51' ' ' ASN . 26.7 mm -44.91 142.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.004 0.431 . . . . 0.0 111.924 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.56 13.53 47.36 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.662 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 66.4 m-20 -102.88 162.43 12.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.434 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 2.3 mm100 -119.24 98.11 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 46' ' ' THR . 3.5 mt -71.97 143.84 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.618 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mmt -108.97 -69.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.849 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.84 142.03 51.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.337 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mt -115.35 106.95 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.78 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 58.15 26.39 13.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.06 -36.43 3.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -67.78 107.74 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.9 t -72.71 148.7 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.081 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.6 mt -118.49 -12.44 9.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.99 101.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.677 0.275 . . . . 0.0 111.522 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.28 6.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.29 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.4 158.12 32.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.011 0.405 . . . . 0.0 111.421 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.69 -172.07 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.945 2.43 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' NE2' ' A' ' 87' ' ' GLN . 12.1 tp -78.12 -44.34 26.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -41.1 65.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.083 0.468 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.542 ' O ' HG12 ' A' ' 89' ' ' ILE . 56.6 m -64.26 -52.77 57.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 58.2 m -56.58 -50.03 73.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.834 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.4 ' NE2' ' HG ' ' A' ' 83' ' ' LEU . 9.9 mt-30 -50.19 -42.87 52.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 109.962 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.496 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -61.12 -37.21 81.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 85' ' ' THR . 17.6 mm -58.83 -49.84 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.61 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.673 HG21 ' HB ' ' B' ' 0' ' ' ILE . 22.3 mt -68.98 -50.32 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.4 -25.1 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.996 0.427 . . . . 0.0 110.765 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.83 -46.27 90.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.969 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -88.79 66.92 8.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 110.659 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -40.88 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.357 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -88.87 50.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.292 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.72 150.4 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 111.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 p -92.32 -8.14 45.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.459 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.28 145.49 5.86 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.778 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.48 104.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 0.0 111.915 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -85.1 121.14 27.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.886 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 154.36 48.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 111.128 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.97 89.89 3.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 70' ' ' ILE . 1.5 pt -107.9 171.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 0.0 112.282 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.443 HG21 ' CE1' ' A' ' 18' ' ' PHE . 5.1 t -122.82 113.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . 0.433 ' HG2' ' CG2' ' A' ' 34' ' ' VAL . 78.6 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 CA-C-O 120.744 0.227 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.9 t 69.12 -67.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.507 ' CE1' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER 68.14 99.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.308 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.673 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.2 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.82 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 9.7 m-85 -62.89 146.79 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.985 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 124.01 2.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.974 0.416 . . . . 0.0 111.48 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.51 131.47 42.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.278 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.423 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 29.9 t -112.89 132.81 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.37 106.26 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -110.86 99.3 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.89 109.73 14.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.19 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 6.0 pttm -131.59 -169.01 2.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.211 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.5 177.74 4.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.245 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 95' ' ' ASN . 12.6 mmtm -79.86 162.16 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.96 13.92 28.76 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.905 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -123.04 33.69 5.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 109.972 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER 14.51 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.43 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 174.12 -42.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.005 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.08 1.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.621 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -150.34 155.83 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.952 0.406 . . . . 0.0 111.299 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 22.3 t -120.58 131.36 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.157 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -116.6 156.96 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.495 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 m -148.71 169.46 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -62.14 130.62 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.871 0.367 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.466 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 59.0 p -69.94 84.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.619 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.99 -3.96 88.81 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.896 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.1 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 110.462 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.74 -26.2 7.72 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.875 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.41 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.82 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.426 0.631 . . . . 0.0 111.244 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.49 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 72.9 mt -60.87 -40.17 84.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.567 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HB2' ' CE ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -149.38 117.03 3.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.574 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.21 102.58 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.199 1.933 . . . . 0.0 113.234 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 70' ' ' ILE . 1.3 p -153.54 -154.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.123 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -109.32 158.1 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.646 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -119.22 133.34 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.111 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 54.5 mt -69.74 95.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.67 -1.88 52.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.67 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.526 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.3 m-20 -170.57 159.52 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.71 144.67 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.914 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.4 mtt -55.9 -22.6 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 61.95 50.51 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.682 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.53 -36.05 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.054 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 -171.8 1.54 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.111 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 49.3 Cg_exo -55.74 -23.64 42.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.544 2.162 . . . . 0.0 112.493 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 110.715 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.06 -38.4 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -57.36 -47.12 82.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -57.24 -74.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 15.18 8.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.444 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 61.5 mtpt -108.56 -24.75 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.404 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 mt -103.0 118.66 37.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -131.62 140.72 49.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.741 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.526 HD13 ' CA ' ' A' ' 51' ' ' ASN . 47.0 mm -47.33 145.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.554 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.01 7.17 59.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.85 157.27 16.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 0.268 . . . . 0.0 110.558 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -117.32 112.23 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.881 0.372 . . . . 0.0 110.684 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 103' ' ' ILE . 5.8 mt -78.94 138.76 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.502 ' CE ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mmm -103.57 -67.49 0.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.211 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 p -131.2 133.51 45.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.56 117.07 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 56.64 27.32 12.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.1 -30.4 9.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -61.73 100.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.05 114.92 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 25.15 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.71 87.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.587 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.09 4.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.509 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.49 157.07 73.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.618 0.246 . . . . 0.0 110.775 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -175.05 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.519 2.146 . . . . 0.0 111.972 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.11 -46.43 20.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 p -53.63 -40.87 66.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.608 ' O ' HG12 ' A' ' 89' ' ' ILE . 69.8 m -66.14 -50.9 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -55.79 -57.02 13.76 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.66 0.267 . . . . 0.0 111.283 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.09 -40.22 44.93 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -63.78 -33.82 76.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.252 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 85' ' ' THR . 5.8 mm -58.93 -49.4 83.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' B' ' 0' ' ' ILE . 35.5 mt -71.06 -47.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.125 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -23.61 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.05 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -33.91 48.84 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.193 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -104.25 46.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.402 . . . . 0.0 110.704 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.23 -23.55 35.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.245 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 6.8 p30 -91.95 42.42 1.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.4 135.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.41 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 t -78.53 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.183 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 ttm180 -145.51 127.5 15.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.02 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.6 t -112.93 104.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -87.73 126.47 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.7 117.83 13.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.273 0.559 . . . . 0.0 112.302 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 71' ' ' MET . 1.1 m120 -89.37 97.69 11.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.445 HG22 HG12 ' A' ' 70' ' ' ILE . 2.7 pt -121.33 172.64 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.131 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 t -115.97 110.76 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.412 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.029 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.79 0.246 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.64 154.06 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' A' ' 34' ' ' VAL . 3.7 m-85 -127.43 123.38 35.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.95 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.83 0.347 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.43 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 1.2 m-85 -58.85 144.27 44.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.329 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.85 128.47 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.306 0.574 . . . . 0.0 112.11 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.43 101.64 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.019 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.455 HG13 ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -82.27 115.84 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CD1' ' CE ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -116.53 104.52 11.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.27 99.53 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.39 109.89 11.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -170.91 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.36 154.09 25.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -56.67 153.95 9.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.27 12.12 79.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.597 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' LEU . 38.0 mt-10 -124.93 31.68 5.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.204 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 18.49 -81.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' GLU . 14.7 tp 175.74 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.72 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.51 65.1 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.427 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.15 156.08 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 111.893 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 77.1 t -117.69 129.7 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.637 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -118.11 150.78 20.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 33.9 m -147.49 166.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.206 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -56.3 133.48 52.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 60.5 p -74.37 83.51 1.93 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.435 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.91 -3.87 90.28 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.512 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.95 -164.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.629 0.252 . . . . 0.0 110.541 179.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.06 -24.86 7.01 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.823 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.73 54.96 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.578 0.704 . . . . 0.0 111.217 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.512 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 60.3 mt -70.71 -36.33 64.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.624 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.43 HD21 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -150.04 110.14 3.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.782 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_endo -56.09 86.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.207 1.938 . . . . 0.0 112.62 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.18 -155.32 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.17 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.9 OUTLIER -107.71 161.87 6.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.625 0.25 . . . . 0.0 110.745 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -120.33 133.13 68.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.771 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 61.0 mt -73.62 91.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.73 -13.9 44.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.844 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -156.59 159.56 38.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 111.144 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.2 ttm -153.36 130.66 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' GLY . 8.2 mtm -64.95 93.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -57.86 80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.29 -28.74 0.27 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.743 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.07 18.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.844 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.52 -14.36 36.71 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.808 2.339 . . . . 0.0 113.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 -52.32 60.25 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 -40.21 30.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -50.81 -47.22 60.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.447 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.16 -70.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.62 16.72 6.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.345 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 1.3 mmmm -101.08 -28.5 12.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.691 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 ' HG ' HG13 ' A' ' 21' ' ' VAL . 63.4 mt -103.89 134.71 46.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -142.51 127.34 18.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.255 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.498 HD13 ' CA ' ' A' ' 51' ' ' ASN . 22.4 mm -43.31 142.56 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 112.078 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.3 45.29 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.428 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 89.5 m-20 -104.27 178.88 4.43 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.946 0.403 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 4.0 mm100 -134.33 114.92 13.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 103' ' ' ILE . 5.4 mt -87.89 125.07 41.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.056 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -87.63 -44.77 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.668 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 p -158.51 144.64 17.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 mp -118.7 126.4 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.015 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 53.84 26.92 6.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.358 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.9 -21.78 40.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.768 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -67.89 101.36 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 m -65.69 111.27 3.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.5 mt -90.99 -20.66 21.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 22.0 t -54.61 88.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.366 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.67 -25.94 4.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.691 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.52 152.68 81.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.99 -169.51 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 111.95 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.412 HD21 ' NE2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -78.31 -52.25 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.227 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -53.07 -40.72 64.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.5 m -65.05 -50.2 67.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -58.85 -50.44 73.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.682 0.277 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.412 ' NE2' HD21 ' A' ' 83' ' ' LEU . 6.2 mt-30 -49.4 -43.66 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.176 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.441 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 35.3 m -61.27 -38.83 88.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.657 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 85' ' ' THR . 24.1 mm -58.25 -50.13 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.761 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.602 HG23 ' HB ' ' B' ' 0' ' ' ILE . 24.1 mt -67.74 -50.23 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.08 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.63 -21.11 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.93 -39.05 55.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.25 45.77 1.18 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.902 0.382 . . . . 0.0 110.989 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -5.97 58.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -114.8 49.96 1.0 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.688 0.28 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.74 161.41 30.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.675 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 t -93.5 -11.5 31.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.538 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -141.26 138.88 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.771 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.03 103.74 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.448 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -90.83 118.57 30.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.445 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.03 117.44 12.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 95.25 9.73 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 ' HA ' ' A' ' 70' ' ' ILE . 1.2 pt -117.64 171.46 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.167 0.508 . . . . 0.0 111.999 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.427 HG21 ' CG ' ' A' ' 18' ' ' PHE . 40.5 t -124.62 128.1 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.647 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . 0.481 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 49.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.937 0.307 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.02 -23.26 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.806 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.438 ' CE1' HG23 ' A' ' 34' ' ' VAL . 10.8 m-85 63.59 136.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.602 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.666 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 2.4 m-85 -66.28 153.34 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.564 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.95 125.98 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 0.0 111.31 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.71 106.39 7.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.402 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.532 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CE2' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -129.06 104.33 7.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.035 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 mm -105.9 99.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.451 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' CG ' ' HD2' ' A' ' 98' ' ' ARG . 1.6 mp0 -82.92 109.29 16.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -132.08 -171.41 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.916 0.388 . . . . 0.0 111.359 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.57 156.57 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -59.93 154.43 18.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.011 0.434 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.52 13.13 74.15 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.416 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' LEU . 15.9 mt-10 -124.79 32.26 5.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.391 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 17.73 -80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.159 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . 14.7 tp 178.06 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.075 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.13 60.51 1.83 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.756 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.7 156.78 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 111.45 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 20.2 t -123.7 121.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.114 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 pt -111.75 149.21 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.189 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.2 168.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.06 130.85 48.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.681 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 49.6 p -71.41 83.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.544 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -5.36 87.14 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.713 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CZ2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.0 -162.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 110.948 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -53.17 -18.83 6.94 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.765 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.4 m 107.48 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.598 0.759 . . . . 0.0 111.082 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.507 ' HB ' ' CZ2' ' A' ' 40' ' ' TRP . 81.4 mt 57.71 -65.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.353 0.597 . . . . 0.0 111.399 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.649 ' N ' ' O ' ' A' ' 42' ' ' SER . 1.3 mt -138.54 81.66 23.83 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.798 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.57 93.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.641 2.227 . . . . 0.0 113.072 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -139.77 -87.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.29 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.3 167.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 120.661 0.267 . . . . 0.0 111.059 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.06 126.94 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG2' HD12 ' A' ' 66' ' ' ILE . 65.0 mt -66.18 91.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 -8.73 55.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.31 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.476 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.3 m-20 -163.68 162.06 23.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.441 . . . . 0.0 111.316 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.1 ttm -153.8 134.28 13.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.408 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 4.9 mtt -50.93 -26.07 5.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.247 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 57.6 56.44 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 110.686 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -35.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.07 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.5 -160.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.911 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.4 Cg_endo -69.13 -22.65 34.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 112.212 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.57 77.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.026 0.441 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -38.61 52.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -59.21 -29.96 67.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.241 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.413 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -73.42 -68.31 0.51 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.804 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.37 -32.82 5.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.369 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.69 -27.15 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.705 0.288 . . . . 0.0 110.983 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.6 mt -97.97 126.6 43.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.02 137.08 27.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.476 HD13 ' CA ' ' A' ' 51' ' ' ASN . 24.3 mm -46.0 145.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.13 14.09 58.0 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.428 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 83.6 m-20 -103.7 163.0 12.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.671 0.272 . . . . 0.0 110.899 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.42 106.44 11.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 103' ' ' ILE . 3.2 mt -78.72 139.68 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.518 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 20.7 mmt -104.38 -68.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.2 t -124.11 140.84 52.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.985 0.421 . . . . 0.0 111.579 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mt -117.56 109.79 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.717 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 59.09 25.94 14.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.186 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.8 -34.73 5.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.681 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.9 m -67.85 109.88 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.44 147.46 41.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -115.89 -22.06 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.241 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -62.88 102.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.411 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.24 -30.53 4.28 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.337 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.98 159.49 34.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.957 0.408 . . . . 0.0 111.387 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.94 -174.33 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.943 2.428 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -77.89 -43.39 30.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -41.53 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.156 0.503 . . . . 0.0 110.527 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 89' ' ' ILE . 63.7 m -64.79 -50.49 66.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.73 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.53 -57.2 12.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.328 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.14 -39.53 43.61 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.7 t -61.65 -38.06 86.33 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.208 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 85' ' ' THR . 24.3 mm -58.96 -49.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.739 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' B' ' 0' ' ' ILE . 29.0 mt -69.34 -50.42 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.825 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.73 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.9 -42.68 68.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.988 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -91.63 52.18 2.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.569 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -88.0 -20.75 25.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -99.85 49.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.738 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 1.3 pt20 -128.41 -179.14 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.564 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.1 m -123.68 -3.85 8.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.462 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.3 134.56 24.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 110.476 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -119.38 104.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -97.4 97.86 9.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.456 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.97 154.99 23.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.57 91.86 3.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -113.62 172.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' A' ' 18' ' ' PHE . 9.8 t -121.44 124.76 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.658 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.905 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.801 0.251 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.3 -15.89 7.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.712 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.434 ' CD2' HG22 ' A' ' 34' ' ' VAL . 50.0 m-85 64.79 170.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.03 0.443 . . . . 0.0 111.321 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.511 ' CD1' HG23 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.597 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.7 m-85 -58.63 154.1 15.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.45 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.33 125.93 1.9 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.183 0.516 . . . . 0.0 112.024 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 101.15 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.354 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 101' ' ' LEU . 22.7 t -82.73 108.23 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.56 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' CE1' ' CG ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.89 104.76 15.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.83 99.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' CG ' ' CD ' ' A' ' 98' ' ' ARG . 6.6 mp0 -82.31 117.23 22.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.01 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.74 -170.93 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -117.76 -179.54 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.47 161.7 30.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.36 15.17 58.69 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' ILE . 41.6 mt-10 -129.59 33.5 4.47 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 110.269 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 8.25 -78.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.225 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' GLU . 11.2 tp 176.27 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.822 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.07 63.67 1.44 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.515 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -152.78 156.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.195 179.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.457 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 45.9 t -126.45 123.95 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -109.51 148.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.74 167.58 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -54.56 135.16 46.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.377 . . . . 0.0 110.807 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.48 ' HA ' HG12 ' A' ' 48' ' ' ILE . 53.1 p -78.54 83.11 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.807 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.28 -4.87 87.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.604 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.09 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 122.338 0.255 . . . . 0.0 110.383 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.41 -26.63 7.22 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.689 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.424 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.75 40.31 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.402 0.62 . . . . 0.0 111.605 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.551 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 69.9 mt -54.21 -35.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.611 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 89.2 mt -155.09 96.55 2.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.147 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.2 Cg_endo -55.53 92.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.569 2.18 . . . . 0.0 113.45 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -138.65 -88.8 0.22 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.785 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.46 167.64 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.74 131.06 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' A' ' 66' ' ' ILE . 60.8 mt -68.9 92.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.3 -6.5 55.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.219 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.473 ' CA ' HD12 ' A' ' 66' ' ' ILE . 1.5 t-20 -163.53 157.72 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -154.82 133.96 12.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.529 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.468 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 10.8 mtm -75.07 96.75 3.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.31 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -62.97 78.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 170.71 -33.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.057 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.33 -168.1 18.52 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.927 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.8 Cg_endo -69.1 -16.33 40.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.456 2.104 . . . . 0.0 112.471 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.15 65.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.191 0.519 . . . . 0.0 110.607 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -77.22 -36.45 54.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.87 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -58.01 -47.27 83.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.85 -7.64 59.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.288 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 1.9 mmmt -72.86 -29.56 63.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.416 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 92.4 mt -101.45 120.06 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -132.49 133.6 43.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.426 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.473 HD12 ' CA ' ' A' ' 51' ' ' ASN . 28.1 mm -45.65 143.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.063 0.459 . . . . 0.0 111.7 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.53 57.54 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.564 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -105.34 172.01 7.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -128.37 112.34 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.357 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.475 ' O ' ' OG1' ' A' ' 46' ' ' THR . 3.3 mt -82.88 142.89 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.659 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.469 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 14.1 mmt -105.7 -70.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.36 131.8 52.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.435 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.439 HG21 HD22 ' A' ' 93' ' ' LEU . 3.4 mt -103.6 111.73 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 60.43 20.11 9.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.84 -33.46 5.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.743 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -68.71 100.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 110.985 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m -65.94 149.05 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.89 -22.82 8.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.367 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.6 t -50.44 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.348 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.33 1.65 20.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.985 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.13 151.24 41.28 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.954 0.377 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.91 168.02 25.04 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.59 2.193 . . . . 0.0 111.828 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.2 tp -62.01 -45.24 94.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.969 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -43.06 68.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.462 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.7 m -65.27 -51.31 61.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.0 m -55.73 -56.24 22.84 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 111.096 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -49.44 -41.13 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.105 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 44.8 m -61.53 -38.77 88.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.424 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 85' ' ' THR . 19.8 mm -58.26 -49.98 79.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.972 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 14.5 mt -75.67 -50.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.185 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -55.77 -23.89 32.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 110.911 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.32 -44.1 76.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.222 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 1.5 pp -85.82 62.62 7.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.068 0.461 . . . . 0.0 110.942 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' CG ' ' CG2' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -84.61 -23.54 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.13 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.8 38.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.257 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -96.73 162.2 13.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.191 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.6 p -118.52 -10.7 10.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.532 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 4.1 tpp85 -156.03 116.07 3.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.186 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 t -99.09 117.86 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.901 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.25 97.8 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.144 179.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -109.73 155.3 21.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.451 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.66 91.52 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.472 HG22 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -111.51 169.83 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 4.7 t -116.28 124.81 72.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.696 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.712 0.213 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.27 124.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.468 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 12.5 m-85 -102.33 113.16 26.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.487 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CE2' HD22 ' A' ' 44' ' ' LEU . 4.9 m-85 -58.93 153.11 18.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -166.91 125.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 112.065 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.3 103.37 2.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.99 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 63' ' ' LYS . 26.2 t -87.16 108.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.491 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.778 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -96.83 112.18 24.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.453 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.27 102.62 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.28 114.99 24.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -171.54 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.215 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -109.68 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.342 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -55.4 148.57 14.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.46 14.4 82.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.126 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 31' ' ' LEU . 3.2 mt-10 -128.02 31.21 5.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.494 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.2 OUTLIER 14.48 -79.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.348 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.57 -47.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.66 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 67.58 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.651 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -150.71 155.97 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.326 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 38.4 t -116.8 128.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.2 pt -116.03 149.85 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.609 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 48' ' ' ILE . 31.0 m -141.68 167.71 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.032 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.77 129.69 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.45 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 70.0 p -70.8 84.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.344 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.47 90.05 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.96 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.544 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.01 -163.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.663 0.268 . . . . 0.0 110.59 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.94 -25.38 7.33 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.788 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.413 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 4.7 p 80.43 44.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.694 0.759 . . . . 0.0 111.61 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.544 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 78.4 mt -58.64 -37.68 66.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -148.58 104.73 3.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.884 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' GLY . 51.6 Cg_exo -52.71 94.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.091 1.861 . . . . 0.0 112.612 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -145.02 -153.74 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -109.27 164.6 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.595 0.236 . . . . 0.0 110.634 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.54 129.3 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 71.2 mt -67.61 93.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.22 -6.15 51.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.287 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.515 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.3 m-20 -165.59 162.52 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -150.86 144.08 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.259 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 mtm -57.13 -28.56 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 61.47 61.02 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.82 -33.54 0.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.196 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -165.78 6.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.055 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.13 -16.93 40.56 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.443 2.095 . . . . 0.0 112.407 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.05 70.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.19 -34.21 56.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.748 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -59.62 -47.23 86.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.041 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 m -59.68 -52.19 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.55 64.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.076 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 2.3 mmmt -72.13 -31.56 66.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.0 mt -97.23 99.89 11.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -119.59 144.9 46.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.515 HD13 ' CA ' ' A' ' 51' ' ' ASN . 51.7 mm -47.22 142.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.722 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.464 ' N ' HG21 ' A' ' 66' ' ' ILE . . . 92.34 9.28 61.96 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 25.3 m-20 -96.97 154.5 17.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.682 0.277 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 6.2 mm100 -111.08 111.44 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.971 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 3.2 mt -86.57 113.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -77.6 -64.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.256 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.39 148.43 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.91 114.35 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 60.78 29.77 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.832 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.32 -20.0 52.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -69.86 95.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -71.87 121.06 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 pp -128.91 28.18 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.7 t -75.39 86.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 140.26 -50.26 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.684 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.413 HD11 ' CG2' ' A' ' 85' ' ' THR . 0.0 OUTLIER -51.02 163.82 0.48 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 111.116 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.59 -178.68 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.768 2.312 . . . . 0.0 112.829 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 tp -78.26 -45.04 23.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 p -53.41 -40.88 65.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.093 0.473 . . . . 0.0 110.69 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.7 m -66.08 -49.25 68.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 74.4 m -55.52 -56.28 22.15 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.286 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -49.18 -46.24 45.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.465 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 34.8 t -56.42 -35.18 67.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.345 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 85' ' ' THR . 6.5 mm -59.58 -47.28 91.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.494 HG22 ' HB ' ' B' ' 0' ' ' ILE . 44.6 mt -69.88 -50.63 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.161 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.465 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -63.24 -17.53 62.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.215 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.45 73.61 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.691 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.17 42.86 2.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 111.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -7.21 57.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.442 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.61 35.01 1.4 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.666 0.27 . . . . 0.0 111.591 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -126.12 134.67 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.836 0.35 . . . . 0.0 110.31 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -8.71 51.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.757 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.778 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.4 ttm105 -145.35 150.11 36.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 0.0 110.873 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.67 118.16 21.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 111.798 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.1 mtpt -97.73 97.84 9.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 153.44 19.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.969 0.414 . . . . 0.0 111.074 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.84 94.49 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' A' ' 70' ' ' ILE . 4.4 pt -120.52 171.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.45 117.83 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.552 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 C--O 1.23 0.123 0 CA-C-O 120.784 0.244 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.41 110.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.112 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -100.29 143.05 30.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.113 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.917 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 7.7 m-85 -62.33 154.32 28.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.236 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.64 125.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.342 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 101.53 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.42 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 23.8 t -83.89 116.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.75 104.56 12.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.488 179.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.25 99.74 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.098 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.53 109.99 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.969 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -131.51 -173.95 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.4 . . . . 0.0 111.492 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.49 159.34 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.9 156.96 13.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.17 18.03 62.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.355 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -130.23 31.7 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.891 0.377 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 14.31 -80.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.311 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' GLU . 11.9 tp 177.8 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.866 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.76 61.48 1.86 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.537 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -147.43 156.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 111.66 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' B' ' -1' ' ' TYR . 37.6 t -120.82 126.79 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.01 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.8 pt -116.74 144.15 25.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.206 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 48' ' ' ILE . 36.0 m -133.97 163.26 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 124.29 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' ' CG1' ' A' ' 48' ' ' ILE . 51.8 p -65.48 84.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.386 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.6 -3.97 90.49 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.754 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CZ2' ' HB ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -56.17 -162.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -52.94 -18.94 6.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.842 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.2 m 107.27 -86.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.486 0.714 . . . . 0.0 111.004 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.499 ' HB ' ' CZ2' ' A' ' 40' ' ' TRP . 84.4 mt 57.3 -64.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.387 0.613 . . . . 0.0 111.4 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 42' ' ' SER . 1.4 mt -135.87 73.39 60.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.625 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 87.1 Cg_exo -47.1 90.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.882 2.388 . . . . 0.0 113.359 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.76 -91.57 0.29 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.372 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -154.04 167.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 111.431 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.31 129.59 50.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.775 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 79.2 mt -66.41 94.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.01 0.91 55.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.4 m-20 -174.07 161.62 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 111.141 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 mtm -154.96 159.78 40.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.415 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 8.0 mtt -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 60.96 47.11 7.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.614 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -35.31 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.23 -171.97 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.173 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.11 -21.93 45.03 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.549 2.166 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.65 -49.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.961 0.41 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -39.36 41.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -52.8 -47.39 67.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.393 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -68.9 -61.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.78 -1.97 38.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.196 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 1.9 mmmm -76.97 -28.75 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.42 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 53.6 mt -107.04 113.97 27.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.042 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -130.92 141.41 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.395 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.487 HD13 ' CA ' ' A' ' 51' ' ' ASN . 42.0 mm -44.87 141.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 111.84 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 17.72 52.37 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.428 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 65.5 m-20 -102.83 158.49 16.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.622 0.249 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -117.57 106.99 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 1.4 mt -85.4 119.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -80.44 -65.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.66 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -133.64 146.97 51.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 111.473 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.409 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.2 mt -113.89 114.37 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.759 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 59.12 22.22 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.263 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.86 8.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -68.18 108.27 3.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 t -69.98 138.16 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 57.6 mt -111.07 -23.32 10.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.7 t -58.82 98.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.03 -29.47 3.71 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.413 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 159.8 31.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 111.609 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.74 178.68 2.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.003 2.469 . . . . 0.0 112.517 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.35 -39.45 68.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.091 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.5 t -53.32 -46.08 69.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.451 . . . . 0.0 110.393 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.593 ' O ' HG12 ' A' ' 89' ' ' ILE . 28.6 m -62.07 -50.5 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.992 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.8 m -55.39 -55.77 27.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -49.28 -40.48 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 110.289 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -63.57 -37.11 86.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.407 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 85' ' ' THR . 27.4 mm -58.15 -49.56 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.987 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.491 ' CG2' HD11 ' B' ' 0' ' ' ILE . 36.6 mt -71.83 -44.27 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -25.36 29.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.828 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.01 -51.05 48.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.091 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 1.6 pp -79.04 60.96 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 110.953 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -87.2 -26.07 23.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.358 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -108.51 51.95 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.33 . . . . 0.0 111.324 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.501 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 mt-30 -109.45 163.9 12.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 0.0 111.683 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.0 p -98.47 -10.92 22.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.36 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.56 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.69 150.4 10.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.279 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -119.91 119.19 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 112.054 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -97.6 117.81 32.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.9 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.37 117.95 13.9 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.994 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.99 96.22 9.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.418 ' CD1' ' HB3' ' A' ' 68' ' ' ASP . 2.0 pt -120.44 170.46 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.183 0.516 . . . . 0.0 112.229 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 18' ' ' PHE . 21.3 t -108.25 113.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.237 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.493 -179.416 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.881 0.284 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.53 161.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.47 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 5.5 m-85 -119.74 160.33 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.492 ' CD1' HG23 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.886 0.374 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.9 m-85 -59.38 154.28 17.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.49 125.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.105 0.478 . . . . 0.0 111.542 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.8 129.93 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.164 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 15.4 t -110.39 129.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.08 104.64 9.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -107.48 99.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.01 110.88 21.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.16 -167.75 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.0 111.307 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.48 172.81 6.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.489 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.93 158.82 34.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.696 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.68 16.62 56.24 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.389 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 31' ' ' LEU . 8.6 mt-10 -126.32 30.83 5.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.503 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 16.46 -80.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.966 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 29' ' ' GLU . 2.9 tp 177.58 -45.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.06 64.71 1.23 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.977 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -151.47 156.35 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 19.6 t -121.18 122.74 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 0.0 111.359 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 pt -111.47 142.37 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.0 m -135.18 170.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -60.57 135.22 57.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.46 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.0 p -75.52 83.57 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.432 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -8.47 83.33 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.82 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.539 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.45 -161.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.637 0.256 . . . . 0.0 110.468 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.43 -26.67 7.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.883 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.98 42.04 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.404 0.621 . . . . 0.0 111.384 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.539 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 89.0 mt -51.49 -42.46 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.887 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD13 ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.58 89.72 4.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.231 178.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 80' ' ' GLY . 85.4 Cg_exo -45.58 111.34 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.974 2.449 . . . . 0.0 113.841 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -156.54 -89.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.48 167.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.236 . . . . 0.0 111.015 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -133.68 129.41 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 78.9 mt -70.3 96.2 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.84 0.57 52.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.233 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.1 m-20 -169.46 161.2 9.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.451 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 14.4 mtm -155.23 134.93 12.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.42 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.428 ' HG2' ' CZ ' ' B' ' -1' ' ' TYR . 13.9 mtm -70.39 95.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.299 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -60.64 80.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.125 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 165.45 -31.45 0.22 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.59 -167.43 31.96 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.086 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 56.5 Cg_endo -69.28 -16.12 39.37 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.652 2.234 . . . . 0.0 112.529 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 33' ' ' VAL . . . -66.89 -49.6 65.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 110.83 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.57 -38.59 48.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.43 -47.21 82.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.193 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -59.34 -68.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.55 38.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.165 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -72.33 -30.01 64.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.51 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 53.6 mt -102.7 129.97 49.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.456 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 73.8 m-80 -142.75 138.12 30.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.726 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 6.2 mt -46.67 140.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.202 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.8 16.62 44.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.58 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.409 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 2.1 m-20 -111.87 157.22 20.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 110.739 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -112.79 117.75 33.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 103' ' ' ILE . 2.3 mt -91.8 108.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.464 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 21.6 mmt -66.94 -67.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 53.5 p -131.57 156.07 46.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.348 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.44 109.8 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.493 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 64.23 29.42 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.879 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.62 50.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.924 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 m -77.75 95.84 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.741 0.305 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 56.4 p -77.02 131.63 38.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.247 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' CA ' ' HG ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.98 19.26 7.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 23.5 t -60.39 88.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.848 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 133.07 -24.66 3.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.779 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HG ' ' CA ' ' A' ' 78' ' ' LEU . 1.3 mt -70.72 155.42 93.42 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 110.766 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.99 -173.75 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 tp -78.13 -47.21 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.008 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 p -53.37 -43.35 67.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.085 0.469 . . . . 0.0 110.263 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 89' ' ' ILE . 83.1 m -65.04 -52.23 57.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.852 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 85.9 m -56.56 -50.33 72.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -49.89 -45.1 50.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 110.07 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -60.26 -35.95 76.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.519 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 85' ' ' THR . 7.5 mm -58.21 -48.99 83.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.432 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' B' ' 0' ' ' ILE . 57.1 mt -73.08 -42.17 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.158 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -55.18 -25.83 35.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.5 69.21 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.397 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.2 mt -93.31 45.28 1.16 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.68 30.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.193 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.01 35.69 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.74 159.78 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.134 0.493 . . . . 0.0 111.635 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 p -114.24 -9.26 12.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.455 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 ttm180 -150.73 134.9 16.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.368 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.403 ' CG2' ' NZ ' ' A' ' 25' ' ' LYS . 13.1 t -122.59 104.84 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 0.0 111.723 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.99 100.48 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 123.33 48.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.458 . . . . 0.0 112.089 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.3 93.81 9.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.317 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 70' ' ' ILE . 2.0 pt -114.42 170.25 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.045 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.0 126.51 72.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.81 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . 0.47 ' HG2' ' CG2' ' A' ' 34' ' ' VAL . 64.9 Cg_endo . . . . . 0 CA--C 1.528 0.215 0 CA-C-O 120.626 0.178 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 23.0 t -45.11 -56.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.584 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' A' ' 34' ' ' VAL . 1.0 OUTLIER 64.16 149.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.07 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.946 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 5.9 m-85 -58.8 154.06 15.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.809 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.73 125.44 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 111.468 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -73.3 105.89 4.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.648 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' CG1' ' HG3' ' A' ' 63' ' ' LYS . 26.6 t -82.37 132.17 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.466 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -123.99 104.71 9.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -110.3 99.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.337 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.81 109.79 20.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.268 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.77 -172.07 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -106.86 163.36 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.42 155.94 27.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.35 16.13 64.49 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.425 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -126.38 30.51 5.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.508 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 19.36 -82.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.957 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 175.19 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.624 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 91.19 67.67 1.17 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.814 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.84 156.53 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.375 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 36.5 t -124.73 119.81 57.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 2.0 pt -110.41 145.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -136.4 165.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 131.62 51.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.025 0.441 . . . . 0.0 110.623 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.0 p -69.85 84.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.653 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.36 -4.31 89.53 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.832 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.528 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.73 -163.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.667 0.27 . . . . 0.0 110.302 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' OG ' ' A' ' 42' ' ' SER . . . -50.07 -25.68 7.99 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.77 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.434 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 8.9 p 82.21 63.04 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.001 0.905 . . . . 0.0 111.517 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.528 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 48.3 mt -78.91 -32.31 15.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.757 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' O ' ' CG2' ' A' ' 46' ' ' THR . 80.9 mt -156.13 89.74 2.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.286 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 Cg_exo -49.19 86.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.822 2.348 . . . . 0.0 113.515 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.81 -91.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.055 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 2.9 m -160.27 167.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 120.684 0.278 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -133.5 127.68 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.93 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 60.8 mt -67.74 93.39 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.25 55.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.137 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.561 ' CA ' HD12 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -165.95 156.82 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.301 . . . . 0.0 110.9 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 ttm -153.38 131.57 11.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.262 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.433 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 6.2 mtm -63.23 100.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.493 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -66.45 73.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.15 -34.13 0.15 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.126 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.3 -168.2 13.85 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.919 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.0 Cg_endo -69.32 -16.57 39.51 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.502 2.134 . . . . 0.0 112.424 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.48 71.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -40.39 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -58.12 -29.67 65.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.446 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -69.23 -66.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.11 -33.47 5.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.136 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HE3' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.4 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 15.4 mt -92.6 119.25 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.814 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -133.07 130.07 38.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.585 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 ' CA ' ' A' ' 51' ' ' ASN . 42.3 mm -45.74 142.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.87 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.418 ' N ' HG21 ' A' ' 66' ' ' ILE . . . 94.96 12.01 55.85 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.502 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -105.88 161.33 14.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.763 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' NE2' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -113.1 119.85 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.431 ' HA ' HG21 ' A' ' 103' ' ' ILE . 4.4 mt -89.7 97.82 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.434 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -57.81 -64.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.599 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.2 p -137.14 149.9 47.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.26 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.409 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.2 mt -117.59 118.24 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 56.08 29.09 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.28 11.98 56.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.796 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -100.65 95.91 7.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.09 126.7 28.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 23.5 mt -109.14 -23.62 11.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.3 t -56.03 88.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.464 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.16 -38.79 1.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.362 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.21 159.68 67.23 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.436 . . . . 0.0 111.464 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.19 -175.04 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.956 2.438 . . . . 0.0 112.659 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' CD1' ' NE2' ' A' ' 87' ' ' GLN . 1.6 tm? -78.25 -46.42 20.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.0 m -53.6 -42.61 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.996 0.427 . . . . 0.0 110.589 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.514 ' O ' HG12 ' A' ' 89' ' ' ILE . 71.0 m -62.01 -49.28 76.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.7 m -56.56 -46.5 80.69 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.811 0.339 . . . . 0.0 110.729 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' NE2' ' CD1' ' A' ' 83' ' ' LEU . 10.3 mt-30 -52.69 -43.11 65.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.049 0.452 . . . . 0.0 109.896 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.1 p -60.9 -37.23 81.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.422 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 85' ' ' THR . 21.0 mm -58.22 -49.44 81.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.963 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.612 HG21 ' HB ' ' B' ' 0' ' ' ILE . 52.7 mt -71.46 -45.04 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.224 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -58.48 -20.68 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -20.71 67.85 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.055 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.5 pp -100.53 43.88 1.04 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.001 0.401 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -5.89 58.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.291 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -122.55 54.21 1.22 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.871 0.367 . . . . 0.0 111.208 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -136.27 160.48 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -98.79 -15.84 19.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.828 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -139.68 143.87 37.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.749 0.309 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 104.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.064 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -95.92 97.6 9.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.225 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.83 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.927 0.394 . . . . 0.0 111.002 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.6 OUTLIER -118.94 97.58 5.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 70' ' ' ILE . 1.1 pt -118.77 170.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 111.681 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 69' ' ' GLN . 3.5 p -121.4 132.61 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.801 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.837 0.265 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.33 119.35 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' A' ' 34' ' ' VAL . 2.3 m-85 -100.21 132.17 45.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.612 ' HB ' HG21 ' A' ' 90' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.01 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.001 0.429 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 13.1 m-85 -60.21 151.94 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.878 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -162.35 124.51 2.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.137 0.494 . . . . 0.0 111.18 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 120.54 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 101' ' ' LEU . 16.4 t -103.16 147.2 9.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -140.34 104.79 4.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.825 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 57' ' ' PRO . 12.7 mm -107.4 99.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -83.99 109.87 17.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.405 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -132.27 -175.32 3.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -104.63 144.27 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.372 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG2' ' CB ' ' A' ' 95' ' ' ASN . 15.6 mttt -50.24 144.45 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.076 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 10.73 80.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.624 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 31' ' ' LEU . 26.9 mm-40 -124.86 31.05 5.75 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.499 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 25.5 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.089 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 29' ' ' GLU . 56.8 tp 177.56 -41.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.791 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.79 63.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.856 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG22 ' CD1' ' B' ' 0' ' ' ILE . 0.9 OUTLIER -151.11 156.12 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 111.216 178.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 51' ' ' ASN . 38.6 t -121.61 129.83 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.76 140.84 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.434 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 28.9 m -131.52 168.15 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.91 132.57 54.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.914 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.454 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.4 p -74.1 84.08 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -79.27 -7.74 88.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.074 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.59 -162.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 110.322 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.02 -26.5 6.01 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.445 -0.884 . . . . 0.0 111.816 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.31 45.74 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.544 0.688 . . . . 0.0 111.256 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 83.6 mt -59.01 -39.28 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.942 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' HB2' ' HE1' ' A' ' 71' ' ' MET . 2.0 mt -146.22 80.99 9.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.386 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 80' ' ' GLY . 94.8 Cg_exo -42.57 91.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.913 2.408 . . . . 0.0 113.581 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.13 -89.42 0.2 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.354 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.41 ' H ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.61 167.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.653 0.264 . . . . 0.0 111.205 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.43 129.44 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HD13 ' A' ' 66' ' ' ILE . 52.2 mt -68.21 91.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -13.26 41.46 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.764 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.532 ' CA ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -158.13 159.1 35.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.975 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.13 129.14 10.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.42 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 3.3 mtm -56.3 102.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.0 70.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.777 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.88 -34.26 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.066 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.09 -167.86 4.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.093 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.5 Cg_endo -69.27 -16.11 39.37 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.813 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.41 -49.69 58.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.856 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -36.87 50.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -56.73 -47.28 80.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -73.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.39 -4.05 23.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.309 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -75.93 -37.49 58.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.539 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 mt -91.81 126.53 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -132.15 128.13 37.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.496 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.532 HD11 ' CA ' ' A' ' 51' ' ' ASN . 43.8 mm -44.18 142.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.5 . . . . 0.0 111.937 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 66' ' ' ILE . . . 93.12 13.33 56.38 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.563 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 87.4 m-20 -102.37 166.93 10.29 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.761 0.315 . . . . 0.0 110.615 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 3.4 mm100 -120.32 105.71 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.467 ' HA ' HG21 ' A' ' 103' ' ' ILE . 4.9 mt -78.82 129.48 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -95.42 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 p -126.56 142.26 51.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.598 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.08 122.85 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.515 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.76 31.23 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.85 14.52 69.71 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.522 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 m -109.14 95.63 5.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -73.56 131.01 41.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.591 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 16.32 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.04 89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.999 0.428 . . . . 0.0 110.28 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 134.63 -22.04 3.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.1 167.71 33.04 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.276 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 85' ' ' THR . 9.7 Cg_exo -68.9 -177.27 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.751 2.301 . . . . 0.0 111.439 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -52.9 7.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 -38.84 65.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.723 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 89' ' ' ILE . 37.2 m -62.4 -43.12 99.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.79 -51.48 69.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -50.99 -44.05 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.276 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.5 m -60.42 -35.19 75.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.371 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 85' ' ' THR . 2.8 mm -58.35 -49.43 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' B' ' 0' ' ' ILE . 59.1 mt -71.45 -43.44 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.769 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.38 -24.44 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.84 -42.28 38.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.627 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.4 OUTLIER -89.19 51.15 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 111.142 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -23.84 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.421 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 56.6 m-80 -116.07 63.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.434 ' O ' ' CB ' ' A' ' 97' ' ' SER . 3.3 mm100 -124.19 -29.78 3.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.602 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 3.8 t 82.28 -2.16 1.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.247 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.1 ttm180 -154.93 134.02 12.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.73 0.3 . . . . 0.0 110.229 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.7 t -119.75 104.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.711 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -90.98 100.85 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.71 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.415 ' CD1' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -115.84 120.76 40.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -90.45 90.58 8.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 70' ' ' ILE . 1.7 pt -111.94 164.63 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.05 107.96 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.333 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.6 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . 0.434 ' CG ' HG23 ' A' ' 34' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.823 0.26 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.96 -42.51 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.365 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.453 ' CE1' HG21 ' A' ' 34' ' ' VAL . 1.5 m-85 64.97 90.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.609 ' HB ' HG22 ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.042 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 44' ' ' LEU . 5.4 m-85 -58.68 151.98 19.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.965 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -164.38 125.23 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 111.508 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.09 102.14 4.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.7 136.66 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -124.95 104.77 8.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -105.88 99.78 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -86.87 109.82 19.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -138.04 -171.15 2.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.995 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.54 169.38 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.59 156.99 31.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 18.84 61.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.292 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' C ' ' A' ' 30' ' ' ILE . 2.7 mm-40 -127.7 29.5 5.46 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.522 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.3 OUTLIER 10.29 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.326 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 172.75 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.77 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.01 66.65 1.26 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.467 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.9 OUTLIER -149.39 156.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 21.9 t -121.23 126.51 75.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.721 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -113.94 151.92 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.77 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 35.2 m -142.61 167.3 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.32 131.1 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.462 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 25.2 p -70.4 84.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.62 -5.82 89.21 Favored Glycine 0 C--N 1.328 0.135 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.967 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.517 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.24 -163.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.566 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.08 -24.49 6.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.409 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.76 36.52 0.08 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.233 0.54 . . . . 0.0 111.404 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.517 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 65.5 mt -52.45 -36.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.657 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -147.59 101.06 3.74 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.943 178.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 75.6 Cg_exo -51.76 83.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.398 2.065 . . . . 0.0 112.876 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -133.84 -152.35 0.48 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.214 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 15.8 m -111.28 166.1 5.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.634 0.254 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.04 131.33 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 73.1 mt -68.2 93.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.28 -9.58 44.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.238 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.541 ' CA ' HD12 ' A' ' 66' ' ' ILE . 1.2 m-20 -162.12 160.22 27.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 111.053 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -152.06 147.65 26.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.9 mtt -59.64 -27.86 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 60.61 60.85 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.697 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.96 -30.15 0.16 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.278 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.7 -170.68 29.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.043 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.403 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 29.7 Cg_endo -63.09 -17.21 59.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.301 2.001 . . . . 0.0 112.343 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -49.02 66.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -38.77 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -56.38 -45.95 80.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 p -56.04 -56.15 24.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -29.21 11.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.289 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -61.02 -29.3 69.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.69 125.96 48.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.14 147.75 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.541 HD12 ' CA ' ' A' ' 51' ' ' ASN . 50.8 mm -50.41 146.5 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.647 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.93 59.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.262 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.55 174.18 6.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.689 0.281 . . . . 0.0 110.658 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.5 mm100 -130.35 107.8 9.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.147 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 103' ' ' ILE . 7.5 mt -88.71 134.2 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -97.02 -69.91 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t -129.62 144.95 51.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.267 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.4 mt -113.88 110.95 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 57.69 22.77 8.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.94 -34.21 4.71 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.868 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -65.55 103.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.984 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 p -68.81 135.59 51.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.309 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 29.5 mt -112.58 -20.16 11.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.089 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.9 t -56.28 88.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.649 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.51 -49.69 0.86 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.361 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 159.88 55.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.554 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.67 -177.39 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.037 2.491 . . . . 0.0 112.654 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 36' ' ' VAL . 1.9 tm? -78.17 -49.91 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.712 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 m -53.15 -41.14 64.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.991 0.424 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.633 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.8 m -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.036 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.0 m -55.7 -54.1 48.41 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -49.03 -48.01 44.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.2 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 23.2 t -56.81 -35.26 68.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.556 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 85' ' ' THR . 7.0 mm -58.8 -48.58 85.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' B' ' 0' ' ' ILE . 23.7 mt -67.49 -50.55 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.17 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.27 -19.97 62.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.87 -23.22 69.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.583 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.4 pp -113.82 44.27 1.66 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -12.27 43.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.42 39.15 1.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 1.8 pt20 -126.02 147.98 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 110.677 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 t -83.13 -9.12 59.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.71 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 1.9 ttm180 -147.15 141.78 26.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.746 0.308 . . . . 0.0 110.725 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.7 104.89 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.36 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -88.68 97.91 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.28 154.55 18.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 111.297 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.4 OUTLIER -124.13 97.65 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 70' ' ' ILE . 1.7 pt -121.51 172.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.129 0.49 . . . . 0.0 112.295 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 69' ' ' GLN . 4.3 m -125.9 130.99 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.587 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . 0.409 ' HG2' ' CG2' ' A' ' 34' ' ' VAL . 68.1 Cg_endo . . . . . 0 N--CA 1.464 -0.243 0 N-CA-C 112.623 0.201 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.1 t 54.39 87.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -81.89 145.77 30.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.522 ' OXT' ' HB ' ' A' ' 30' ' ' ILE . 2.2 pp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.775 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.865 0.364 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 6.4 m-85 -64.71 154.44 36.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.784 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.59 125.32 2.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.233 0.539 . . . . 0.0 111.559 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.55 100.15 1.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.502 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.41 HG12 ' CD1' ' A' ' 101' ' ' LEU . 24.9 t -82.43 112.01 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.131 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -110.92 104.82 13.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CG2' ' HB2' ' A' ' 57' ' ' PRO . 4.1 mm -105.96 104.16 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.2 mp0 -84.05 110.3 18.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.5 -171.3 2.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -112.22 166.72 11.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -65.05 158.49 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 110.724 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.38 17.77 60.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.487 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -126.81 29.73 5.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER 22.77 -82.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.097 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' GLU . 16.7 tp 174.95 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 88.49 63.5 1.35 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.819 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -152.7 156.07 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 117.18 0.49 . . . . 0.0 111.795 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 31.1 t -126.35 116.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.588 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -103.24 152.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.44 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' ILE . 26.8 m -140.09 168.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -58.46 132.14 52.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.939 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.6 p -74.11 84.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.423 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.84 -9.62 84.22 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.123 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.23 -161.65 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.723 0.296 . . . . 0.0 110.439 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.73 -26.07 7.55 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.801 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.43 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 9.1 m 80.54 35.87 0.11 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.264 0.554 . . . . 0.0 111.49 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.556 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 74.2 mt -49.25 -39.36 12.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.056 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG2' ' A' ' 46' ' ' THR . 1.5 mt -145.66 87.71 6.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.091 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 6.7 Cg_endo -50.39 90.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.873 2.382 . . . . 0.0 113.308 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.9 -91.58 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.818 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -158.67 167.58 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.38 131.11 63.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -68.1 93.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.06 -1.89 53.73 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.115 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.515 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.1 t-20 -170.01 152.6 4.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 mtm -146.7 121.35 9.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 0.0 111.448 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.413 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -54.48 90.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.607 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -59.25 82.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.05 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.76 -29.92 0.27 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.953 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.57 32.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.52 -16.06 38.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.704 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.25 63.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 -33.38 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.751 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -61.37 -45.58 93.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 m -63.73 -68.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.22 -25.65 17.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.505 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -54.89 -27.07 40.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.76 134.53 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -140.43 134.73 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.711 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.515 HD13 ' CA ' ' A' ' 51' ' ' ASN . 49.4 mm -46.42 144.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.705 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.22 84.57 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.659 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 74.6 m-20 -85.59 164.0 18.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.678 0.275 . . . . 0.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.451 ' NE2' ' CZ2' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -119.45 118.29 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 111.193 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.427 ' CG2' HG22 ' A' ' 103' ' ' ILE . 4.4 mt -91.62 108.73 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -68.85 -66.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.876 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.8 p -135.65 148.53 48.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.408 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -118.22 112.5 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.77 23.85 12.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.78 -30.49 7.43 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.886 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -67.7 102.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.716 0.293 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -69.04 136.75 52.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.054 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 40.5 mt -112.24 -13.52 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -67.05 94.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.341 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.91 -22.73 3.8 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.479 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.93 157.61 33.57 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.983 0.391 . . . . 0.0 111.472 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.01 -174.15 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.818 2.346 . . . . 0.0 112.801 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.15 -48.43 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.459 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 p -52.99 -42.21 65.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.1 m -61.55 -48.33 81.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.839 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.8 m -56.13 -50.16 71.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.883 0.373 . . . . 0.0 111.07 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -50.22 -46.2 54.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.305 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.3 m -59.69 -35.7 75.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.64 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 85' ' ' THR . 18.2 mm -58.15 -50.0 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.505 HG21 ' HB ' ' B' ' 0' ' ' ILE . 58.7 mt -69.54 -45.31 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -55.57 -23.42 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.31 -33.3 32.38 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.0 pp -95.65 35.12 1.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.915 0.388 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -5.79 58.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -107.65 43.96 1.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.97 176.07 8.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 110.9 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.2 t -102.17 -16.74 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.62 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 28.3 mmt85 -131.21 150.49 52.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.4 104.3 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.524 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mmpt? -90.0 120.92 31.62 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.3 117.84 11.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 111.804 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.78 99.41 12.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.574 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.68 167.35 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.153 0.501 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 69' ' ' GLN . 4.3 p -112.06 129.09 68.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.247 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.781 0.242 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.76 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.451 ' CD2' HG23 ' A' ' 34' ' ' VAL . 36.6 m-85 -109.33 131.51 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.509 ' CD1' ' C ' ' B' ' 0' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.83 0.347 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CD2' HG22 ' A' ' 104' ' ' VAL . 4.0 m-85 -67.29 151.55 47.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 125.9 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.314 0.578 . . . . 0.0 111.616 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.56 105.88 6.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.572 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -84.38 141.2 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -132.84 104.53 6.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.217 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' CB ' ' A' ' 61' ' ' SER . 14.1 mm -106.57 99.63 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.63 109.55 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.023 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -172.86 3.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.154 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.8 169.07 8.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.423 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 157.12 30.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.532 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 9.92 65.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.507 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ILE . 4.4 mt-10 -120.13 31.87 6.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.197 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 5.77 -75.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.103 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . 2.5 tp 171.73 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.844 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.15 62.73 1.79 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.249 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -146.03 156.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 111.715 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' B' ' -1' ' ' TYR . 38.3 t -119.43 132.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -117.16 156.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.635 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 32.0 m -148.28 165.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.808 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.19 131.82 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 87.5 p -69.13 84.09 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.403 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.47 -1.19 90.24 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.541 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.8 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.579 0.228 . . . . 0.0 110.475 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.28 -25.5 8.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.833 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.41 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 83.05 64.27 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.739 0.78 . . . . 0.0 111.459 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 43.5 mt -83.0 -31.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' THR . 85.2 mt -156.51 101.39 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.809 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 9.6 Cg_endo -52.11 83.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.58 2.187 . . . . 0.0 113.363 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -133.45 -157.7 0.83 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.041 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.6 m -105.64 153.36 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.933 0.396 . . . . 0.0 111.651 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -115.78 132.79 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.8 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.433 ' CG2' HD12 ' A' ' 66' ' ' ILE . 48.8 mt -69.31 90.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.44 -11.3 52.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.192 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.476 ' CA ' HD13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -161.8 159.9 27.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 17.1 ttm -149.15 135.64 19.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.935 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.404 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 2.9 mtm -51.95 -27.19 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 38.6 t60 58.66 54.67 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.676 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.2 -37.14 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.217 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.88 -166.14 2.45 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.951 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 51.0 Cg_endo -68.91 -16.94 41.6 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.292 1.995 . . . . 0.0 112.131 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.53 -44.74 73.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.482 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -39.42 49.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.565 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -58.34 -47.12 84.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.419 ' CB ' HD11 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -61.06 -63.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.079 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.14 -23.42 27.3 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.287 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -36.59 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.08 104.39 15.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.995 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -121.54 141.23 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.531 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.476 HD13 ' CA ' ' A' ' 51' ' ' ASN . 28.5 mm -46.34 145.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 111.809 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.62 4.82 61.9 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.64 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -106.07 150.96 25.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.29 . . . . 0.0 110.54 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -113.08 126.72 55.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.49 ' HA ' HG21 ' A' ' 103' ' ' ILE . 6.3 mt -88.93 134.87 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -96.81 -57.82 2.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.241 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.0 p -147.23 145.26 29.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.969 0.414 . . . . 0.0 111.401 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 78' ' ' LEU . 2.8 mp -115.23 120.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 55.87 27.98 11.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.37 -26.01 24.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.795 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -65.51 102.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -68.77 131.48 45.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.252 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 73' ' ' ILE . 21.0 mt -109.82 -25.34 10.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 26.0 t -54.99 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.524 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.45 -38.09 1.49 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.242 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.409 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -84.66 159.73 57.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.372 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 -172.14 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.847 2.365 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 tp -78.04 -45.01 24.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.6 t -53.34 -43.0 67.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.983 0.421 . . . . 0.0 110.47 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 89' ' ' ILE . 89.7 m -63.86 -48.63 75.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.646 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 71.9 m -55.97 -57.16 13.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.549 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -48.86 -42.09 35.33 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.968 0.413 . . . . 0.0 110.043 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -60.94 -35.69 77.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.311 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 85' ' ' THR . 13.9 mm -59.0 -49.4 83.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.491 HG23 ' HB ' ' B' ' 0' ' ' ILE . 29.1 mt -71.96 -46.09 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -55.42 -24.41 30.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -47.25 47.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.209 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.33 55.72 3.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 0.0 110.814 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 -19.47 27.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.288 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -109.29 54.37 0.66 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.21 156.15 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.618 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 p -93.98 -12.23 29.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.763 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -143.58 139.49 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.522 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.87 104.43 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.516 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.38 119.45 32.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.826 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.0 154.35 49.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.024 0.44 . . . . 0.0 111.118 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.5 OUTLIER -122.29 92.25 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.49 HG21 ' HA ' ' A' ' 70' ' ' ILE . 2.2 pt -116.05 170.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 112.161 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 18' ' ' PHE . 35.9 t -119.98 113.9 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.889 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttm105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.961 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.787 0.264 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 61.35 122.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.375 . . . . 0.0 111.278 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 34' ' ' VAL . 32.9 m-85 -117.84 143.9 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.491 ' HB ' HG23 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 71' ' ' MET . 2.5 m-85 -64.2 154.28 35.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.754 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.12 127.57 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 111.834 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.47 102.05 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.524 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.77 135.3 25.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -127.28 104.84 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -104.71 99.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -90.07 109.61 20.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.121 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.07 -165.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -106.47 162.34 13.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.407 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.81 158.78 15.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.511 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.87 19.48 50.16 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -124.68 29.24 6.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 110.07 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.565 ' HA ' ' HB2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER 15.73 -80.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.482 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER 174.13 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.794 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.17 67.49 1.08 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.59 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.9 OUTLIER -152.45 156.12 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.707 0.289 . . . . 0.0 111.008 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 47.9 t -120.62 123.64 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.045 0.45 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -110.91 140.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.803 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 48' ' ' ILE . 35.6 m -133.12 168.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.121 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.47 132.32 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.823 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.481 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.3 p -72.92 84.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.469 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.05 -8.44 83.94 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.032 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.39 -161.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.478 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.4 8.61 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.816 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.424 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.424 0.63 . . . . 0.0 111.172 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.551 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 92.3 mt -55.95 -42.18 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.944 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -152.63 88.68 3.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.32 178.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.44 108.91 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.123 2.548 . . . . 0.0 114.108 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -154.85 -91.48 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.379 178.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.18 167.49 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 110.962 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -132.67 130.23 59.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 66.1 mt -69.09 94.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.5 -1.9 49.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.434 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.508 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -166.69 159.36 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.0 ttm -154.07 135.19 13.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.446 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 9.7 mtm -71.82 99.84 2.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.59 76.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.84 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -35.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -170.13 18.26 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.997 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 56.2 Cg_endo -69.11 -15.68 39.72 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.541 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.52 67.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.898 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.43 -38.99 48.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -57.47 -47.1 82.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.253 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.8 p -56.9 -63.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.53 -9.19 57.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.321 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -72.93 -31.41 64.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.88 0.371 . . . . 0.0 110.548 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.85 130.4 44.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -139.44 134.06 31.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.497 HD13 ' CA ' ' A' ' 51' ' ' ASN . 50.1 mm -46.49 144.32 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 111.798 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.09 13.25 57.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -108.56 160.0 16.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.684 0.278 . . . . 0.0 110.698 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.454 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -115.06 119.17 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 103' ' ' ILE . 1.8 mt -90.42 113.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 18' ' ' PHE . 24.3 mmt -72.98 -66.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.709 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 86.4 p -134.42 160.31 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.5 111.11 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.73 28.89 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.11 -30.14 5.54 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.222 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 m -78.26 99.98 6.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.465 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 67.3 m -84.8 137.49 33.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.638 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 24.77 5.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.6 t -75.64 93.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.005 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.09 -18.78 4.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.143 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 163.19 33.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.982 0.391 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.05 -179.28 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.803 2.335 . . . . 0.0 112.417 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 tp -78.13 -44.62 25.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.24 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -53.14 -42.55 66.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.544 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.2 m -63.73 -47.8 79.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.715 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.413 ' HA ' HG13 ' A' ' 89' ' ' ILE . 77.0 m -55.76 -57.48 11.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.358 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -49.77 -39.95 39.7 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.496 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 16.7 t -62.45 -36.61 82.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.26 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 85' ' ' THR . 2.1 mm -58.84 -49.73 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.347 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.516 HG23 ' HB ' ' B' ' 0' ' ' ILE . 54.6 mt -69.4 -50.45 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.131 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.62 -22.01 55.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.881 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.15 -30.31 59.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.38 35.32 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 111.062 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.82 -5.92 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.592 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -96.08 35.69 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.682 0.277 . . . . 0.0 111.73 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.53 170.67 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.737 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 t -99.18 -8.74 24.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.855 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.4 ttm180 -139.6 140.03 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.51 106.1 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 7.9 tttt -88.13 131.8 34.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 117.9 10.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.002 0.43 . . . . 0.0 111.448 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.31 89.66 8.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -111.67 166.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.913 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 69' ' ' GLN . 6.3 p -109.07 122.78 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.638 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 -179.601 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . 0.415 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 98.3 Cg_endo . . . . . 0 N--CA 1.464 -0.216 0 CA-C-O 120.789 0.245 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.17 142.7 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 0.5 OUTLIER -119.56 115.91 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.516 ' HB ' HG23 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.904 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 4.9 m-85 -61.75 148.68 42.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.06 126.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.171 0.51 . . . . 0.0 111.805 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.66 133.01 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.938 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.404 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 18.9 t -116.29 111.41 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.253 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.37 115.72 31.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -114.86 99.4 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.862 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -88.81 128.31 35.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.327 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.44 -166.83 2.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.58 167.43 10.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.87 157.64 17.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.0 110.736 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.92 11.1 73.79 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.542 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -123.96 32.51 5.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.258 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.479 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 10.64 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.154 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' GLU . 59.1 tp 177.35 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.709 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.62 63.51 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.702 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -152.45 156.46 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 40.9 t -122.16 117.28 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.56 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -106.18 147.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.471 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 m -140.38 169.71 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.18 129.37 40.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.455 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 59.2 p -71.12 83.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.98 -3.56 89.08 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.695 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.566 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.56 -163.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.698 0.285 . . . . 0.0 110.603 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.24 -24.69 7.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.811 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.409 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.52 35.38 0.07 Allowed 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.182 0.515 . . . . 0.0 111.562 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.566 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 69.2 mt -49.1 -39.34 12.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.765 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -148.31 111.69 3.74 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.019 178.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' GLY . 34.8 Cg_exo -59.71 98.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.096 1.864 . . . . 0.0 112.62 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -152.57 -155.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.009 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -106.25 165.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.71 130.53 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 69.0 mt -71.42 93.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.94 -5.06 53.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.114 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.556 ' CA ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -163.03 164.3 25.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -160.79 132.13 5.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.442 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 8.2 mtm -69.3 101.97 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.343 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.84 78.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.26 -30.69 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.164 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.37 -176.1 38.3 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.099 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.75 -16.55 38.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.594 2.196 . . . . 0.0 112.712 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.24 -50.26 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -32.7 49.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.349 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.26 -47.15 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.287 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -56.54 -69.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.28 22.97 7.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.126 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -107.88 -33.0 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.753 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.404 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 54.0 mt -96.03 123.21 39.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.664 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -127.49 133.32 49.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.593 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.556 HD11 ' CA ' ' A' ' 51' ' ' ASN . 46.6 mm -45.46 141.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' N ' HG23 ' A' ' 66' ' ' ILE . . . 90.97 15.07 56.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.214 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 98.1 m-20 -101.42 164.63 11.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.779 0.324 . . . . 0.0 110.695 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.522 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 5.2 mm100 -120.32 115.17 23.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 103' ' ' ILE . 2.5 mt -89.06 117.78 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.444 ' HE2' ' CB ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -81.5 -64.28 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.376 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.4 t -132.24 146.17 51.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mt -117.11 111.3 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 60.92 25.93 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.09 -28.59 11.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.618 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.4 m -63.9 96.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.076 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -74.41 117.97 16.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.722 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -125.03 27.71 6.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.6 80.22 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 139.23 -13.28 3.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.779 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.11 157.8 65.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 110.819 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.1 -174.93 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.577 2.185 . . . . 0.0 111.891 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.5 tp -78.31 -39.95 38.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.699 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.3 p -53.71 -44.69 70.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.349 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.9 m -63.95 -52.97 57.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.859 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.74 -52.15 64.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.769 0.318 . . . . 0.0 111.002 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -49.71 -42.62 46.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.021 0.439 . . . . 0.0 109.896 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.47 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.3 m -60.9 -36.86 80.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.271 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 85' ' ' THR . 14.7 mm -58.98 -49.37 83.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.398 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' B' ' 0' ' ' ILE . 34.6 mt -72.59 -49.96 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.46 -20.33 54.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.895 0.378 . . . . 0.0 110.956 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.38 -28.49 67.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.362 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -106.92 57.67 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.7 -30.58 29.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.104 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -96.57 37.47 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -100.69 144.05 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.019 0.438 . . . . 0.0 111.353 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.9 p -96.63 -5.77 38.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.576 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.75 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 10.8 ttm180 -157.0 137.79 13.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.245 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.01 123.87 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -100.8 128.48 46.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.627 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.37 116.66 11.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 111.931 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.05 93.02 9.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 70' ' ' ILE . 2.6 pt -116.34 168.87 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.984 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.423 HG22 ' CD2' ' A' ' 18' ' ' PHE . 37.3 t -115.05 119.44 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.544 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 CA-C-O 120.818 0.258 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 9.1 p -64.17 142.81 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.457 ' CE1' HG23 ' A' ' 34' ' ' VAL . 4.7 m-85 -112.31 135.69 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.99 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 7.8 m-85 -65.14 154.52 37.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.17 125.15 3.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 111.734 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.87 101.94 4.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.407 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 139.3 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.91 104.91 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.527 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 mm -103.42 99.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.21 109.98 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.319 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 -174.35 4.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -107.52 176.38 5.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.601 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 155.72 39.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.04 13.97 65.16 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.497 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 30' ' ' ILE . 5.5 mt-10 -125.45 31.19 5.6 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.157 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 9.83 -78.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.288 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.39 -43.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.757 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.56 60.53 1.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.664 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -144.92 155.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 88.4 t -123.62 129.37 74.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.744 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.94 153.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -141.93 169.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.838 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.72 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.482 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 88.5 p -68.37 84.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.507 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.21 -3.73 87.02 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.801 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.61 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.616 0.246 . . . . 0.0 110.443 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.96 -24.28 6.23 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.766 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 82.16 38.71 0.05 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.327 0.584 . . . . 0.0 111.277 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 65.4 mt -54.15 -34.99 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.792 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 46' ' ' THR . 85.2 mt -152.01 104.41 2.82 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.16 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 61.9 Cg_exo -52.14 84.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.516 2.144 . . . . 0.0 113.14 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -133.72 -154.65 0.61 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.501 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -108.12 167.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.5 125.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.459 ' CG2' HD11 ' A' ' 66' ' ' ILE . 59.3 mt -65.18 91.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -8.11 55.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.123 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.461 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -166.26 161.02 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 111.344 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -155.65 142.71 19.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.413 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 7.2 mtt -52.66 -25.01 9.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.66 47.75 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.802 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.97 -39.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.05 -169.59 1.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.278 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.19 -23.91 56.14 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.644 2.229 . . . . 0.0 112.196 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -62.65 -49.31 75.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -76.99 -39.02 51.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -50.89 -47.1 60.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.41 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -60.45 -51.95 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.831 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.08 55.62 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE3' ' CB ' ' A' ' 61' ' ' SER . 1.4 mtmt -69.06 -35.27 76.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.03 113.65 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -127.92 135.23 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.459 HD11 ' CG2' ' A' ' 49' ' ' ILE . 26.0 mm -46.27 145.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 0.0 111.752 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.45 64.66 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.876 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.38 163.43 12.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.902 0.351 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -114.68 121.47 43.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.477 ' HA ' HG22 ' A' ' 103' ' ' ILE . 7.7 mt -91.17 112.64 25.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.444 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -77.51 -63.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 t -133.16 154.09 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.429 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 4.4 mt -126.18 104.13 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.83 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 60.02 24.13 13.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.74 -33.31 4.99 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.9 m -65.2 98.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 106.8 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 25.8 mt -79.89 -31.23 40.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 7.3 p -52.75 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.78 -27.8 2.18 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.267 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.405 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.2 OUTLIER -98.72 159.73 29.66 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.887 0.375 . . . . 0.0 111.427 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 -172.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.837 2.358 . . . . 0.0 112.537 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.27 -46.22 23.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.192 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.6 m -53.16 -42.41 66.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.641 ' O ' HG12 ' A' ' 89' ' ' ILE . 85.1 m -64.52 -48.72 74.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.637 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 76.2 m -55.63 -57.22 12.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.98 -42.51 37.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -61.15 -35.15 76.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.269 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 85' ' ' THR . 8.6 mm -58.91 -49.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.513 HG21 ' HB ' ' B' ' 0' ' ' ILE . 31.2 mt -72.1 -46.45 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.44 -23.99 28.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -42.49 43.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.037 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 0.8 OUTLIER -92.47 56.35 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 -27.52 22.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.511 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -94.93 35.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.485 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.489 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 4.3 mt-30 -102.24 150.6 23.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.416 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.0 p -91.87 -13.8 30.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.616 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -148.65 137.83 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.339 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 t -122.15 104.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.896 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.53 126.28 35.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.837 179.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.886 0.374 . . . . 0.0 110.965 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -123.73 90.43 3.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 70' ' ' ILE . 1.1 pt -109.36 170.86 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.623 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 69' ' ' GLN . 3.2 p -122.81 127.98 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.292 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.411 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.782 0.242 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.73 119.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' -1' ' ' TYR . . . . . 0.431 ' CE1' HG23 ' A' ' 34' ' ' VAL . 19.6 m-85 -110.67 142.69 42.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.364 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 0' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.359 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.3 m-85 -69.45 150.96 46.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.21 127.9 3.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.793 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.6 104.64 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.407 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 13.8 t -82.78 142.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HE1' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.96 104.34 6.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.234 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -106.63 99.67 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.451 . . . . 0.0 111.263 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' CG ' ' CD ' ' A' ' 98' ' ' ARG . 1.9 mp0 -85.72 109.89 18.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.262 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -166.61 2.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 111.069 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.99 163.56 18.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -58.07 161.64 3.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.64 11.48 62.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' LEU . 48.2 mt-10 -126.45 34.39 4.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.853 0.326 . . . . 0.0 110.406 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.467 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 14.11 -78.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.083 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' GLU . 31.7 tp 176.51 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.819 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 83.34 62.62 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.575 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.98 157.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.05 0.452 . . . . 0.0 111.935 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' -1' ' ' TYR . 43.9 t -122.34 129.25 75.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.369 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.82 152.85 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.959 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 27.1 m -146.27 166.67 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.072 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.85 132.06 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.4 p -72.74 83.81 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.451 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.81 -4.73 90.24 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.961 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.51 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.67 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.668 0.27 . . . . 0.0 110.515 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.59 -25.21 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.825 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.407 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 81.79 48.03 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.486 0.66 . . . . 0.0 111.248 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.51 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 65.9 mt -63.55 -35.99 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.536 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -149.34 110.3 3.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.797 178.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.7 Cg_endo -56.47 84.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.188 1.925 . . . . 0.0 112.483 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -135.24 -154.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.386 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -109.0 163.59 6.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.682 0.277 . . . . 0.0 110.907 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -122.2 130.34 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' CG2' HD11 ' A' ' 66' ' ' ILE . 59.3 mt -70.0 90.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.02 -14.45 47.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.476 ' CA ' HD12 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -157.64 159.65 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.063 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -151.92 139.28 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.481 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.457 ' HG3' ' CD2' ' B' ' -1' ' ' TYR . 6.7 mtm -74.97 96.13 3.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.371 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -62.46 79.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.42 -29.49 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.218 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.65 -166.34 15.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.171 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.12 -16.46 40.26 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.569 2.179 . . . . 0.0 112.422 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.07 50.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.028 0.442 . . . . 0.0 110.705 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -34.89 56.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.532 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -58.99 -47.25 85.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 t -62.5 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.46 -28.18 12.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.884 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.9 mtpp -58.17 -26.28 62.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.418 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 21.3 mt -101.92 126.28 48.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.487 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.75 140.26 33.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.476 HD12 ' CA ' ' A' ' 51' ' ' ASN . 27.2 mm -48.72 146.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.54 59.57 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 2.9 m-20 -105.2 152.64 22.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.797 0.332 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.0 mm100 -107.48 115.54 30.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 2.8 mt -86.42 125.07 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.065 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.03 -63.24 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.299 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.8 p -139.47 145.77 39.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.376 . . . . 0.0 111.417 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.41 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.0 mt -115.42 116.26 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 55.25 27.65 10.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.346 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.57 -28.2 12.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.804 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -65.95 99.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -67.69 125.23 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.218 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 17.6 mt -105.19 -20.72 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -57.98 85.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.498 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.91 -41.84 1.1 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.117 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -77.45 159.86 76.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.419 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.81 -168.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.884 2.389 . . . . 0.0 112.687 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.23 -49.94 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.284 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.0 t -52.74 -39.98 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.526 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HG12 ' A' ' 89' ' ' ILE . 97.6 m -63.15 -49.48 74.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.552 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.2 m -57.84 -48.19 80.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -50.38 -44.16 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.079 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.484 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 25.5 m -60.97 -37.41 82.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.534 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 85' ' ' THR . 14.1 mm -58.51 -49.67 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.769 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.481 ' CG2' HD13 ' B' ' 0' ' ' ILE . 22.8 mt -73.94 -50.52 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.484 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.19 -23.98 38.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -40.12 90.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.208 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.4 pp -93.74 48.19 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 110.92 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' CG ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.46 -7.07 51.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.555 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -120.2 34.32 5.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.315 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -92.43 155.92 17.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.239 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 t -108.04 -9.71 15.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.126 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.9 tpp85 -154.42 114.31 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.374 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.31 104.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.558 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -92.66 97.66 10.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -107.02 154.57 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 111.155 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -124.12 86.85 2.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 70' ' ' ILE . 4.0 pt -111.74 169.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.304 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.438 HG22 ' CG ' ' A' ' 18' ' ' PHE . 27.3 t -118.05 111.08 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.909 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.647 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . 0.418 ' HD2' ' CE1' ' B' ' -1' ' ' TYR . 89.1 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 N-CA-C 112.784 0.263 . . . . 0.0 112.784 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 54.6 99.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.799 0.333 . . . . 0.0 111.426 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.458 ' CE2' HG21 ' A' ' 34' ' ' VAL . 49.0 m-85 -90.76 137.99 31.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.526 ' CD1' HG23 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.78 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.461 ' CZ ' ' HG3' ' A' ' 71' ' ' MET . 4.0 m-85 -58.25 143.87 42.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 125.63 3.35 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 111.487 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.27 104.65 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.466 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -85.76 141.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.103 0.477 . . . . 0.0 111.435 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CZ ' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -132.28 104.7 6.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.323 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.66 99.68 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.353 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.54 109.87 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.93 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 4.9 pttm -133.13 -170.4 2.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.968 0.414 . . . . 0.0 111.38 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -121.26 170.32 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.231 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.51 162.07 16.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.937 0.398 . . . . 0.0 110.74 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.52 20.09 50.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.302 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 31' ' ' LEU . 51.3 mt-10 -132.14 31.94 4.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.249 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 14.11 -81.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.307 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' GLU . 20.4 tp 177.75 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.221 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 59.45 2.1 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.575 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' B' ' 0' ' ' ILE . 0.9 OUTLIER -147.9 156.97 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.471 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 39.2 t -125.22 123.75 65.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.109 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.9 pt -114.02 145.66 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.28 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -138.11 166.76 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.87 133.76 51.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.454 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 23.2 p -76.16 83.57 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.463 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -80.34 -7.26 88.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.036 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.36 -162.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.499 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.29 8.24 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.871 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.68 49.25 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.643 0.735 . . . . 0.0 111.19 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 82.5 mt -59.56 -40.6 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.771 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD12 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.61 87.87 4.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.004 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 1.9 Cg_endo -42.66 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.163 2.575 . . . . 0.0 113.63 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -139.86 -92.87 0.17 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.953 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.14 167.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.61 129.93 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.052 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 66.7 mt -68.5 94.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.43 -2.42 54.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.33 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.539 ' CA ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -169.88 159.94 8.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.6 mtm -158.94 138.61 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.433 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.433 ' HG3' ' CD2' ' B' ' -1' ' ' TYR . 19.7 mtm -72.95 105.16 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.17 74.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.91 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.53 -33.56 0.17 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.946 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.95 -179.19 32.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.941 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 31.4 Cg_exo -58.93 -16.47 32.3 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.464 2.11 . . . . 0.0 112.601 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.01 53.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 110.813 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -36.98 55.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.497 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -57.73 -46.85 83.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -65.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.19 29.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.387 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -35.52 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.61 118.06 33.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -129.09 141.06 51.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.539 HD11 ' CA ' ' A' ' 51' ' ' ASN . 48.2 mm -47.57 143.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 111.832 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.66 11.38 58.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.592 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 64.9 m-20 -101.59 161.38 13.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB2' HG21 ' A' ' 104' ' ' VAL . 1.9 mm100 -119.99 97.99 5.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.47 ' O ' ' OG1' ' A' ' 46' ' ' THR . 3.4 mt -67.6 143.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.574 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.461 ' HG3' ' CZ ' ' A' ' 18' ' ' PHE . 12.3 mmt -111.94 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -125.61 138.35 53.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 111.445 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -112.79 108.32 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 59.69 21.17 9.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.96 -34.45 4.47 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -66.69 104.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.747 0.308 . . . . 0.0 111.116 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 p -68.13 146.59 53.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.02 -28.41 5.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.308 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.72 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.56 -21.87 2.71 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.305 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.86 162.41 20.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.983 0.391 . . . . 0.0 111.543 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 44.9 Cg_endo -66.8 -171.65 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.045 2.496 . . . . 0.0 112.584 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.413 HD22 ' NE2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -78.45 -50.47 11.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.37 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 p -52.99 -36.51 60.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.713 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.589 ' O ' HG12 ' A' ' 89' ' ' ILE . 77.5 m -66.87 -50.81 61.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.56 -49.75 73.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 110.707 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.413 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.4 mt-30 -50.33 -49.48 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.452 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 3.2 t -55.04 -37.95 67.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 85' ' ' THR . 23.5 mm -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.175 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 0' ' ' ILE . 22.5 mt -67.68 -50.23 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.452 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.03 -20.0 62.01 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.85 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.46 -19.18 70.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.485 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.2 pp -116.33 51.83 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 110.948 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.48 -30.74 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -97.75 32.6 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -95.9 155.88 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.016 0.436 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -104.26 -12.84 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 tpp85 -148.5 126.75 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.9 t -110.42 104.79 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -91.28 127.69 36.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.583 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.36 154.81 46.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.026 0.441 . . . . 0.0 111.211 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 91.4 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.431 HG23 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -114.9 172.61 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.125 0.488 . . . . 0.0 112.309 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -113.23 119.02 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.979 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.914 0.297 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.57 -10.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.46 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 34' ' ' VAL . 26.2 m-85 62.78 167.13 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.376 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.791 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CE1' ' CG2' ' A' ' 104' ' ' VAL . 1.6 m-85 -62.81 153.22 33.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.994 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.69 124.45 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.0 111.517 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.91 102.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.185 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 37.3 t -88.15 112.32 23.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.787 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -106.3 113.52 27.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -111.37 99.85 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.468 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.87 124.64 29.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.09 -172.07 3.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.255 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -111.47 176.83 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.655 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -72.99 157.03 38.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.742 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.52 11.05 67.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.615 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 31' ' ' LEU . 16.9 mt-10 -124.32 32.84 5.4 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.285 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.492 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 14.4 -80.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.994 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 29' ' ' GLU . 5.1 tp 174.43 -49.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.297 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.406 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.37 69.79 1.12 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.79 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.9 OUTLIER -154.06 155.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 117.01 0.405 . . . . 0.0 111.656 178.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' B' ' -1' ' ' TYR . 55.1 t -118.72 128.94 75.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.505 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -119.7 141.82 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.34 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 48' ' ' ILE . 32.7 m -136.51 163.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -50.96 134.81 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 110.956 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.1 p -78.17 83.66 4.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.596 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.09 -7.65 88.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.946 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.536 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.63 -161.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.429 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.75 -25.98 7.52 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.717 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.423 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.76 33.58 0.07 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.536 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 70.7 mt -47.34 -40.86 6.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.034 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 1.3 mt -146.72 97.2 4.29 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.08 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 12.2 Cg_endo -56.11 91.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.551 2.167 . . . . 0.0 113.097 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -138.61 -91.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.063 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -160.3 167.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.787 0.327 . . . . 0.0 111.362 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -128.9 130.52 68.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.789 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' A' ' 66' ' ' ILE . 49.5 mt -69.16 88.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.52 -13.0 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.785 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CA ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -159.83 160.31 33.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.751 0.31 . . . . 0.0 110.888 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 ttp -147.82 134.1 19.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.03 0.443 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -70.48 83.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.569 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.455 ' CG ' ' HG2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -56.24 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 163.32 -28.21 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.409 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.74 -165.36 39.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.08 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.11 -16.31 40.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.506 2.137 . . . . 0.0 112.477 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -49.39 73.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.727 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HG2' ' CG ' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -77.76 -37.09 49.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -63.69 -41.37 98.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.23 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.45 -71.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.254 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.05 15.72 10.45 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.802 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.37 -32.1 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.918 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.435 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 21.5 mt -85.61 126.9 34.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.65 129.92 23.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.462 HD11 ' CA ' ' A' ' 51' ' ' ASN . 24.9 mm -45.02 143.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.944 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 11.94 55.01 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -107.03 159.83 16.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 1.2 mm100 -113.85 114.55 26.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.449 ' O ' ' OG1' ' A' ' 46' ' ' THR . 1.7 mt -84.9 136.02 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.445 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 30.6 mmt -96.06 -69.12 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 24.3 p -132.39 146.68 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.69 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.41 ' CG2' HD23 ' A' ' 101' ' ' LEU . 2.7 mp -120.17 120.1 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.776 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 61.01 19.42 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.332 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 -27.47 10.85 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.792 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -71.23 111.6 6.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.943 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 22.1 p -76.17 142.48 41.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.311 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.12 -20.65 12.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.161 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 t -59.98 92.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.409 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.98 -22.15 3.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.469 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -102.04 161.05 24.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 111.481 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 57.8 Cg_endo -69.16 -167.49 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.0 112.572 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -78.1 -50.15 12.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.268 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -52.4 -38.22 58.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.584 ' O ' HG12 ' A' ' 89' ' ' ILE . 36.3 m -64.39 -49.16 72.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.519 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.29 -51.6 69.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.771 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' NE2' HD23 ' A' ' 83' ' ' LEU . 56.8 mt-30 -49.63 -39.88 37.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.484 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 2.8 m -64.96 -37.95 89.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.659 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 85' ' ' THR . 23.9 mm -58.65 -49.97 80.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' B' ' 0' ' ' ILE . 38.1 mt -72.94 -49.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.484 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -57.4 -22.82 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.452 . . . . 0.0 110.741 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.51 -39.33 61.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.171 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -94.83 46.16 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -76.73 -36.01 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.026 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -88.79 51.57 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.123 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -111.24 172.37 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.393 0.616 . . . . 0.0 111.573 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.6 p -113.99 -7.1 13.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.656 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.787 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.2 ttm180 -161.94 150.43 15.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -133.09 113.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.513 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.65 130.96 38.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -140.06 154.92 47.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.3 90.72 3.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.431 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -113.63 172.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.45 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 24.3 t -111.73 119.93 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 CA-C-O 120.724 0.218 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.4 t -59.55 136.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.5 ' CE1' HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -120.31 138.68 53.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.841 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 2.2 m-85 -58.94 151.57 21.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.815 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 129.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.95 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.8 122.73 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.744 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' HG ' ' A' ' 64' ' ' LEU . 44.3 t -106.68 111.48 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -107.84 114.91 29.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.443 ' HB ' HG11 ' A' ' 99' ' ' VAL . 19.9 mm -114.16 99.25 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 112.48 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.949 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 -170.81 2.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.336 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -117.46 158.23 24.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.522 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -58.38 145.89 36.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.947 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.51 18.45 79.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.382 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -129.19 29.1 5.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.137 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 19.17 -82.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.123 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . 15.3 tp 179.24 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.916 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.45 62.53 1.63 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.598 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.22 155.9 7.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.966 0.413 . . . . 0.0 111.433 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.482 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 30.7 t -123.67 116.35 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.791 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -104.46 146.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.259 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 30.0 m -135.66 167.3 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.08 131.19 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.458 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 51.4 p -74.25 84.49 1.89 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.539 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -82.7 -6.7 88.26 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.11 -163.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.714 0.292 . . . . 0.0 110.287 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.38 -26.38 6.92 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.798 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 p 80.0 51.7 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.801 0.81 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 82.3 mt -61.18 -41.75 90.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.774 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 0.4 OUTLIER -149.2 81.53 7.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.103 178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.35 90.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.536 2.824 . . . . 0.0 114.136 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -136.41 -96.43 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.149 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -156.14 167.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-O 120.687 0.279 . . . . 0.0 111.05 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.14 128.68 62.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 66' ' ' ILE . 52.4 mt -67.78 90.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.45 -8.88 55.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.158 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.52 ' CA ' HD11 ' A' ' 66' ' ' ILE . 1.4 t-20 -162.01 159.81 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.006 0.431 . . . . 0.0 111.405 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 13.4 ttm -152.0 148.11 27.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.429 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 8.7 mtt -56.07 -22.41 27.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 61.09 47.26 7.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.63 -34.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.134 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.63 -171.18 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.11 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.02 -24.83 34.01 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.428 2.085 . . . . 0.0 112.408 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.71 70.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.001 0.429 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -39.38 44.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.709 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -53.26 -47.23 69.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.44 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -56.32 5.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.06 -16.8 53.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.066 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 25.1 mmmt -57.3 -30.08 64.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.368 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.454 ' HG ' HG13 ' A' ' 21' ' ' VAL . 26.0 mt -103.12 134.68 46.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -144.15 128.19 17.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.52 HD11 ' CA ' ' A' ' 51' ' ' ASN . 30.5 mm -44.1 142.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.125 0.488 . . . . 0.0 111.891 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.31 18.37 46.22 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.464 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -112.31 164.8 12.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.449 ' NE2' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -118.65 116.49 26.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.176 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.6 mt -85.87 143.99 10.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.219 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.468 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 8.3 mmt -112.17 -67.52 0.99 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 132.11 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 111.692 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.3 mt -115.96 114.18 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 58.51 23.86 11.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.4 -35.5 4.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.672 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 m -68.63 117.1 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.356 . . . . 0.0 110.943 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.54 154.17 34.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' MET . 61.9 mt -121.49 -37.58 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.23 91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.303 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.32 -24.84 2.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.117 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -103.6 160.95 24.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 111.406 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.37 -169.6 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.859 2.372 . . . . 0.0 112.726 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.18 -47.74 17.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 83' ' ' LEU . 17.8 m -53.15 -42.06 65.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.451 . . . . 0.0 110.446 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.9 m -65.05 -49.28 70.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.764 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 90.2 m -55.76 -56.2 23.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.324 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.425 ' NE2' HD23 ' A' ' 83' ' ' LEU . 27.9 mt-30 -48.88 -46.11 42.13 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 110.14 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.93 -36.93 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.556 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 85' ' ' THR . 24.8 mm -57.99 -49.95 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' B' ' 0' ' ' ILE . 44.0 mt -71.25 -43.71 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -54.96 -24.86 25.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.88 -45.43 42.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.337 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -85.95 58.86 5.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.912 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -87.37 -31.34 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -113.8 65.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.337 . . . . 0.0 111.595 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.506 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.4 mm100 -118.95 -28.45 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t 75.44 5.87 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.994 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.659 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.9 ttm180 -165.07 127.48 2.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.062 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.443 HG11 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.01 126.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 0.0 111.932 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -108.71 108.87 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.414 ' HG ' HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.37 117.58 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.228 0.537 . . . . 0.0 112.356 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 90.77 8.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.977 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 70' ' ' ILE . 1.4 pt -109.02 171.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.068 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 69' ' ' GLN . 3.4 p -115.38 131.6 67.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.725 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.755 0.231 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.3 t -58.41 150.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.855 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -117.86 138.06 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.327 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.488 ' CD1' HG21 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.596 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.996 0.426 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 71' ' ' MET . 2.8 m-85 -67.73 154.28 41.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.83 126.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.512 . . . . 0.0 112.13 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 106.44 3.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.062 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -93.29 104.25 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.128 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.87 104.78 15.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.663 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -102.55 99.29 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.29 109.82 9.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -177.23 4.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.595 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -113.86 168.88 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.82 155.09 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.923 0.392 . . . . 0.0 110.698 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.6 15.14 73.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.469 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -129.45 32.8 4.6 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.942 0.401 . . . . 0.0 110.248 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.496 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.2 OUTLIER 13.74 -80.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.273 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' GLU . 13.6 tp 175.67 -45.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.789 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 85.38 63.63 1.56 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.609 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 ' CD1' ' B' ' 0' ' ' ILE . 1.0 OUTLIER -153.28 155.81 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 111.323 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.507 HG22 ' CE1' ' B' ' -1' ' ' TYR . 46.5 t -123.5 129.02 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.5 pt -114.53 144.22 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 48' ' ' ILE . 27.1 m -137.13 165.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.47 133.83 45.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.446 ' HA ' HG12 ' A' ' 48' ' ' ILE . 52.4 p -76.28 83.08 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.451 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.68 -4.45 90.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.707 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.535 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.75 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.22 -26.66 6.7 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.667 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.78 44.98 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.501 0.667 . . . . 0.0 111.56 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.535 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 70.1 mt -59.15 -35.02 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.49 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' CE ' ' A' ' 71' ' ' MET . 85.0 mt -155.65 96.32 2.4 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.029 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.3 91.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.653 2.235 . . . . 0.0 113.497 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.11 -90.15 0.33 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.69 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.66 167.58 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.879 0.371 . . . . 0.0 111.463 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.84 129.56 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.629 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' CG2' HD12 ' A' ' 66' ' ' ILE . 66.6 mt -68.57 89.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.4 -15.77 45.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.049 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.1 m-20 -154.38 158.99 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.729 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.8 ttp -149.2 137.45 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.534 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -53.42 -24.63 13.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.351 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m80 60.61 46.4 9.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.494 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.63 -38.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.051 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -174.01 2.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.942 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.78 -24.07 29.24 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.357 2.038 . . . . 0.0 112.313 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.12 69.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 110.733 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.2 -39.0 50.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.524 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -55.8 -47.15 77.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 t -65.15 -64.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.783 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.9 -24.34 19.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -58.15 -25.53 61.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 22.6 mt -103.41 131.61 50.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -144.06 133.93 23.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.419 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.487 HD13 ' CA ' ' A' ' 51' ' ' ASN . 26.7 mm -44.91 142.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.004 0.431 . . . . 0.0 111.924 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.56 13.53 47.36 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.662 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 66.4 m-20 -102.88 162.43 12.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.434 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 2.3 mm100 -119.24 98.11 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 46' ' ' THR . 3.5 mt -71.97 143.84 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.618 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mmt -108.97 -69.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.849 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.84 142.03 51.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.337 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mt -115.35 106.95 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.78 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 58.15 26.39 13.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.06 -36.43 3.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -67.78 107.74 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.9 t -72.71 148.7 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.081 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.6 mt -118.49 -12.44 9.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.99 101.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.677 0.275 . . . . 0.0 111.522 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.28 6.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.29 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.4 158.12 32.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.011 0.405 . . . . 0.0 111.421 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.69 -172.07 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.945 2.43 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' NE2' ' A' ' 87' ' ' GLN . 12.1 tp -78.12 -44.34 26.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -41.1 65.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.083 0.468 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.542 ' O ' HG12 ' A' ' 89' ' ' ILE . 56.6 m -64.26 -52.77 57.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 58.2 m -56.58 -50.03 73.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.834 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.4 ' NE2' ' HG ' ' A' ' 83' ' ' LEU . 9.9 mt-30 -50.19 -42.87 52.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 109.962 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.496 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -61.12 -37.21 81.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 85' ' ' THR . 17.6 mm -58.83 -49.84 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.61 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.673 HG21 ' HB ' ' B' ' 0' ' ' ILE . 22.3 mt -68.98 -50.32 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.4 -25.1 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.996 0.427 . . . . 0.0 110.765 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.83 -46.27 90.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.969 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -88.79 66.92 8.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 110.659 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -40.88 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.357 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -88.87 50.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.292 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.72 150.4 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 111.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 p -92.32 -8.14 45.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.459 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.28 145.49 5.86 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.778 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.48 104.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 0.0 111.915 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -85.1 121.14 27.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.886 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 154.36 48.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 111.128 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.97 89.89 3.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 70' ' ' ILE . 1.5 pt -107.9 171.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 0.0 112.282 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.443 HG21 ' CE1' ' A' ' 18' ' ' PHE . 5.1 t -122.82 113.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . 0.433 ' HG2' ' CG2' ' A' ' 34' ' ' VAL . 78.6 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 CA-C-O 120.744 0.227 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.9 t 69.12 -67.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.507 ' CE1' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER 68.14 99.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.308 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.673 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.2 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.82 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 9.7 m-85 -62.89 146.79 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.985 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 124.01 2.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.974 0.416 . . . . 0.0 111.48 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.51 131.47 42.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.278 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.423 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 29.9 t -112.89 132.81 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.37 106.26 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -110.86 99.3 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.89 109.73 14.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.19 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 6.0 pttm -131.59 -169.01 2.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.211 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.5 177.74 4.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.245 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 95' ' ' ASN . 12.6 mmtm -79.86 162.16 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.96 13.92 28.76 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.905 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -123.04 33.69 5.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 109.972 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER 14.51 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.43 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 174.12 -42.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.005 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.08 1.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.621 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -150.34 155.83 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.952 0.406 . . . . 0.0 111.299 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 22.3 t -120.58 131.36 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.157 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -116.6 156.96 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.495 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 m -148.71 169.46 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -62.14 130.62 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.871 0.367 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.466 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 59.0 p -69.94 84.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.619 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.99 -3.96 88.81 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.896 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.1 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 110.462 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.74 -26.2 7.72 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.875 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.41 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.82 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.426 0.631 . . . . 0.0 111.244 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.49 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 72.9 mt -60.87 -40.17 84.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.567 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HB2' ' CE ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -149.38 117.03 3.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.574 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.21 102.58 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.199 1.933 . . . . 0.0 113.234 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 70' ' ' ILE . 1.3 p -153.54 -154.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.123 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -109.32 158.1 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.646 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -119.22 133.34 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.111 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 54.5 mt -69.74 95.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.67 -1.88 52.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.67 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.3 m-20 -170.57 159.52 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.71 144.67 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.914 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.4 mtt -55.9 -22.6 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 61.95 50.51 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.682 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.53 -36.05 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.054 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 -171.8 1.54 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.111 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 49.3 Cg_exo -55.74 -23.64 42.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.544 2.162 . . . . 0.0 112.493 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 110.715 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.06 -38.4 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -57.36 -47.12 82.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -57.24 -74.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 15.18 8.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.444 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 61.5 mtpt -108.56 -24.75 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.404 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 mt -103.0 118.66 37.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -131.62 140.72 49.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.741 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.526 HD13 ' CA ' ' A' ' 51' ' ' ASN . 47.0 mm -47.33 145.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.554 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.01 7.17 59.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.85 157.27 16.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 0.268 . . . . 0.0 110.558 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -117.32 112.23 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.881 0.372 . . . . 0.0 110.684 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 103' ' ' ILE . 5.8 mt -78.94 138.76 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.502 ' CE ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mmm -103.57 -67.49 0.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.211 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 p -131.2 133.51 45.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.56 117.07 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 56.64 27.32 12.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.1 -30.4 9.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -61.73 100.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.05 114.92 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 25.15 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.71 87.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.587 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.09 4.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.509 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.49 157.07 73.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.618 0.246 . . . . 0.0 110.775 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -175.05 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.519 2.146 . . . . 0.0 111.972 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.11 -46.43 20.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 p -53.63 -40.87 66.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.608 ' O ' HG12 ' A' ' 89' ' ' ILE . 69.8 m -66.14 -50.9 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -55.79 -57.02 13.76 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.66 0.267 . . . . 0.0 111.283 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.09 -40.22 44.93 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -63.78 -33.82 76.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.252 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 85' ' ' THR . 5.8 mm -58.93 -49.4 83.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' B' ' 0' ' ' ILE . 35.5 mt -71.06 -47.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.125 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -23.61 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.05 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -33.91 48.84 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.193 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -104.25 46.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.402 . . . . 0.0 110.704 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.23 -23.55 35.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.245 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 6.8 p30 -91.95 42.42 1.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.4 135.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.41 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 t -78.53 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.183 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 ttm180 -145.51 127.5 15.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.02 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.6 t -112.93 104.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -87.73 126.47 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.7 117.83 13.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.273 0.559 . . . . 0.0 112.302 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 71' ' ' MET . 1.1 m120 -89.37 97.69 11.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.445 HG22 HG12 ' A' ' 70' ' ' ILE . 2.7 pt -121.33 172.64 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.131 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 t -115.97 110.76 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.412 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.029 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.79 0.246 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.64 154.06 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' A' ' 34' ' ' VAL . 3.7 m-85 -127.43 123.38 35.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.95 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.83 0.347 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.43 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 1.2 m-85 -58.85 144.27 44.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.329 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.85 128.47 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.306 0.574 . . . . 0.0 112.11 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.43 101.64 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.019 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.455 HG13 ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -82.27 115.84 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CD1' ' CE ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -116.53 104.52 11.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.27 99.53 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.39 109.89 11.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -170.91 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.36 154.09 25.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -56.67 153.95 9.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.27 12.12 79.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.597 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' LEU . 38.0 mt-10 -124.93 31.68 5.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.204 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 18.49 -81.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' GLU . 14.7 tp 175.74 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.72 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.51 65.1 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.427 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.15 156.08 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 111.893 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 77.1 t -117.69 129.7 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.637 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -118.11 150.78 20.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 33.9 m -147.49 166.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.206 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -56.3 133.48 52.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 60.5 p -74.37 83.51 1.93 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.435 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.91 -3.87 90.28 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.512 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.95 -164.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.629 0.252 . . . . 0.0 110.541 179.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.06 -24.86 7.01 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.823 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.73 54.96 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.578 0.704 . . . . 0.0 111.217 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.512 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 60.3 mt -70.71 -36.33 64.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.624 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.43 HD21 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -150.04 110.14 3.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.782 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_endo -56.09 86.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.207 1.938 . . . . 0.0 112.62 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.18 -155.32 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.17 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.9 OUTLIER -107.71 161.87 6.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.625 0.25 . . . . 0.0 110.745 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -120.33 133.13 68.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.771 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 61.0 mt -73.62 91.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.73 -13.9 44.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.844 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -156.59 159.56 38.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 111.144 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.2 ttm -153.36 130.66 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' GLY . 8.2 mtm -64.95 93.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -57.86 80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.29 -28.74 0.27 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.743 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.07 18.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.844 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.52 -14.36 36.71 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.808 2.339 . . . . 0.0 113.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 -52.32 60.25 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 -40.21 30.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -50.81 -47.22 60.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.447 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.16 -70.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.62 16.72 6.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.345 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 1.3 mmmm -101.08 -28.5 12.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.691 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' HG ' HG13 ' A' ' 21' ' ' VAL . 63.4 mt -103.89 134.71 46.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -142.51 127.34 18.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.255 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.498 HD13 ' CA ' ' A' ' 51' ' ' ASN . 22.4 mm -43.31 142.56 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 112.078 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.3 45.29 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.428 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 89.5 m-20 -104.27 178.88 4.43 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.946 0.403 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 4.0 mm100 -134.33 114.92 13.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 103' ' ' ILE . 5.4 mt -87.89 125.07 41.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.056 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -87.63 -44.77 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.668 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 p -158.51 144.64 17.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 mp -118.7 126.4 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.015 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 53.84 26.92 6.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.358 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.9 -21.78 40.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.768 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -67.89 101.36 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 m -65.69 111.27 3.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.5 mt -90.99 -20.66 21.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 22.0 t -54.61 88.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.366 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.67 -25.94 4.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.691 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.52 152.68 81.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.99 -169.51 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 111.95 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD21 ' NE2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -78.31 -52.25 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.227 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -53.07 -40.72 64.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.5 m -65.05 -50.2 67.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -58.85 -50.44 73.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.682 0.277 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.412 ' NE2' HD21 ' A' ' 83' ' ' LEU . 6.2 mt-30 -49.4 -43.66 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.176 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.441 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 35.3 m -61.27 -38.83 88.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.657 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 85' ' ' THR . 24.1 mm -58.25 -50.13 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.761 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.602 HG23 ' HB ' ' B' ' 0' ' ' ILE . 24.1 mt -67.74 -50.23 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.08 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.63 -21.11 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.93 -39.05 55.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.25 45.77 1.18 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.902 0.382 . . . . 0.0 110.989 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -5.97 58.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -114.8 49.96 1.0 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.688 0.28 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.74 161.41 30.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.675 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 t -93.5 -11.5 31.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.538 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -141.26 138.88 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.771 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.03 103.74 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.448 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -90.83 118.57 30.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.445 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.03 117.44 12.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 95.25 9.73 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 ' HA ' ' A' ' 70' ' ' ILE . 1.2 pt -117.64 171.46 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.167 0.508 . . . . 0.0 111.999 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.427 HG21 ' CG ' ' A' ' 18' ' ' PHE . 40.5 t -124.62 128.1 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.647 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . 0.481 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 49.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.937 0.307 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.02 -23.26 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.806 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.438 ' CE1' HG23 ' A' ' 34' ' ' VAL . 10.8 m-85 63.59 136.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.602 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.666 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 2.4 m-85 -66.28 153.34 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.564 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.95 125.98 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 0.0 111.31 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.71 106.39 7.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.402 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.532 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CE2' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -129.06 104.33 7.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.035 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 mm -105.9 99.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.451 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' CG ' ' HD2' ' A' ' 98' ' ' ARG . 1.6 mp0 -82.92 109.29 16.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -132.08 -171.41 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.916 0.388 . . . . 0.0 111.359 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.57 156.57 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -59.93 154.43 18.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.011 0.434 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.52 13.13 74.15 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.416 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' LEU . 15.9 mt-10 -124.79 32.26 5.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.391 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 17.73 -80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.159 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . 14.7 tp 178.06 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.075 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.13 60.51 1.83 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.756 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.7 156.78 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 111.45 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 20.2 t -123.7 121.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.114 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 pt -111.75 149.21 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.189 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.2 168.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.06 130.85 48.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.681 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 49.6 p -71.41 83.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.544 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -5.36 87.14 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.713 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CZ2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.0 -162.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 110.948 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -53.17 -18.83 6.94 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.765 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.4 m 107.48 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.598 0.759 . . . . 0.0 111.082 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.507 ' HB ' ' CZ2' ' A' ' 40' ' ' TRP . 81.4 mt 57.71 -65.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.353 0.597 . . . . 0.0 111.399 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.649 ' N ' ' O ' ' A' ' 42' ' ' SER . 1.3 mt -138.54 81.66 23.83 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.798 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.57 93.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.641 2.227 . . . . 0.0 113.072 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -139.77 -87.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.29 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.3 167.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 120.661 0.267 . . . . 0.0 111.059 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.06 126.94 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG2' HD12 ' A' ' 66' ' ' ILE . 65.0 mt -66.18 91.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 -8.73 55.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.31 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.476 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.3 m-20 -163.68 162.06 23.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.441 . . . . 0.0 111.316 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.1 ttm -153.8 134.28 13.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.408 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 4.9 mtt -50.93 -26.07 5.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.247 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 57.6 56.44 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 110.686 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -35.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.07 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.5 -160.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.911 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.4 Cg_endo -69.13 -22.65 34.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 112.212 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.57 77.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.026 0.441 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -38.61 52.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -59.21 -29.96 67.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.241 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.413 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -73.42 -68.31 0.51 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.804 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.37 -32.82 5.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.369 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.69 -27.15 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.705 0.288 . . . . 0.0 110.983 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.6 mt -97.97 126.6 43.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.02 137.08 27.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.476 HD13 ' CA ' ' A' ' 51' ' ' ASN . 24.3 mm -46.0 145.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.13 14.09 58.0 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.428 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 83.6 m-20 -103.7 163.0 12.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.671 0.272 . . . . 0.0 110.899 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.42 106.44 11.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 103' ' ' ILE . 3.2 mt -78.72 139.68 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.518 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 20.7 mmt -104.38 -68.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.2 t -124.11 140.84 52.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.985 0.421 . . . . 0.0 111.579 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mt -117.56 109.79 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.717 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 59.09 25.94 14.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.186 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.8 -34.73 5.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.681 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.9 m -67.85 109.88 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.44 147.46 41.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -115.89 -22.06 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.241 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -62.88 102.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.411 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.24 -30.53 4.28 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.337 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.98 159.49 34.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.957 0.408 . . . . 0.0 111.387 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.94 -174.33 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.943 2.428 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -77.89 -43.39 30.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -41.53 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.156 0.503 . . . . 0.0 110.527 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 89' ' ' ILE . 63.7 m -64.79 -50.49 66.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.73 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.53 -57.2 12.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.328 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.14 -39.53 43.61 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.7 t -61.65 -38.06 86.33 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.208 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 85' ' ' THR . 24.3 mm -58.96 -49.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.739 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' B' ' 0' ' ' ILE . 29.0 mt -69.34 -50.42 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.825 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.73 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.9 -42.68 68.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.988 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -91.63 52.18 2.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.569 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -88.0 -20.75 25.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -99.85 49.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.738 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 1.3 pt20 -128.41 -179.14 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.564 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.1 m -123.68 -3.85 8.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.462 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.3 134.56 24.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 110.476 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -119.38 104.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -97.4 97.86 9.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.456 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.97 154.99 23.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.57 91.86 3.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -113.62 172.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' A' ' 18' ' ' PHE . 9.8 t -121.44 124.76 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.658 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.905 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.801 0.251 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.3 -15.89 7.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.712 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.434 ' CD2' HG22 ' A' ' 34' ' ' VAL . 50.0 m-85 64.79 170.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.03 0.443 . . . . 0.0 111.321 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.511 ' CD1' HG23 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.597 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.7 m-85 -58.63 154.1 15.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.45 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.33 125.93 1.9 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.183 0.516 . . . . 0.0 112.024 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 101.15 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.354 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 101' ' ' LEU . 22.7 t -82.73 108.23 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.56 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' CE1' ' CG ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.89 104.76 15.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.83 99.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' CG ' ' CD ' ' A' ' 98' ' ' ARG . 6.6 mp0 -82.31 117.23 22.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.01 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.74 -170.93 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -117.76 -179.54 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.47 161.7 30.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.36 15.17 58.69 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' ILE . 41.6 mt-10 -129.59 33.5 4.47 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 110.269 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 8.25 -78.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.225 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' GLU . 11.2 tp 176.27 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.822 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.07 63.67 1.44 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.515 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -152.78 156.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.195 179.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.457 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 45.9 t -126.45 123.95 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -109.51 148.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.74 167.58 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -54.56 135.16 46.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.377 . . . . 0.0 110.807 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.48 ' HA ' HG12 ' A' ' 48' ' ' ILE . 53.1 p -78.54 83.11 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.807 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.28 -4.87 87.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.604 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.09 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 122.338 0.255 . . . . 0.0 110.383 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.41 -26.63 7.22 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.689 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.424 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.75 40.31 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.402 0.62 . . . . 0.0 111.605 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.551 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 69.9 mt -54.21 -35.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.611 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 89.2 mt -155.09 96.55 2.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.147 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.2 Cg_endo -55.53 92.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.569 2.18 . . . . 0.0 113.45 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -138.65 -88.8 0.22 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.785 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.46 167.64 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.74 131.06 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' A' ' 66' ' ' ILE . 60.8 mt -68.9 92.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.3 -6.5 55.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.219 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.473 ' CA ' HD12 ' A' ' 66' ' ' ILE . 1.5 t-20 -163.53 157.72 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -154.82 133.96 12.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.529 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.468 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 10.8 mtm -75.07 96.75 3.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.31 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -62.97 78.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 170.71 -33.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.057 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.33 -168.1 18.52 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.927 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.8 Cg_endo -69.1 -16.33 40.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.456 2.104 . . . . 0.0 112.471 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.15 65.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.191 0.519 . . . . 0.0 110.607 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -77.22 -36.45 54.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.87 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -58.01 -47.27 83.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.85 -7.64 59.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.288 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 1.9 mmmt -72.86 -29.56 63.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.416 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 92.4 mt -101.45 120.06 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -132.49 133.6 43.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.426 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.473 HD12 ' CA ' ' A' ' 51' ' ' ASN . 28.1 mm -45.65 143.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.063 0.459 . . . . 0.0 111.7 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.53 57.54 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.564 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -105.34 172.01 7.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -128.37 112.34 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.357 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.475 ' O ' ' OG1' ' A' ' 46' ' ' THR . 3.3 mt -82.88 142.89 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.659 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.469 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 14.1 mmt -105.7 -70.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.36 131.8 52.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.435 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.439 HG21 HD22 ' A' ' 93' ' ' LEU . 3.4 mt -103.6 111.73 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 60.43 20.11 9.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.84 -33.46 5.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.743 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -68.71 100.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 110.985 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m -65.94 149.05 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.89 -22.82 8.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.367 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.6 t -50.44 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.348 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.33 1.65 20.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.985 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.13 151.24 41.28 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.954 0.377 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.91 168.02 25.04 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.59 2.193 . . . . 0.0 111.828 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.2 tp -62.01 -45.24 94.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.969 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -43.06 68.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.462 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.7 m -65.27 -51.31 61.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.0 m -55.73 -56.24 22.84 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 111.096 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -49.44 -41.13 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.105 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 44.8 m -61.53 -38.77 88.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.424 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 85' ' ' THR . 19.8 mm -58.26 -49.98 79.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.972 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 14.5 mt -75.67 -50.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.185 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -55.77 -23.89 32.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 110.911 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.32 -44.1 76.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.222 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 1.5 pp -85.82 62.62 7.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.068 0.461 . . . . 0.0 110.942 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' CG ' ' CG2' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -84.61 -23.54 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.13 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.8 38.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.257 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -96.73 162.2 13.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.191 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.6 p -118.52 -10.7 10.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.532 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 4.1 tpp85 -156.03 116.07 3.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.186 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 t -99.09 117.86 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.901 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.25 97.8 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.144 179.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -109.73 155.3 21.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.451 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.66 91.52 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.472 HG22 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -111.51 169.83 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 4.7 t -116.28 124.81 72.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.696 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.712 0.213 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.27 124.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.468 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 12.5 m-85 -102.33 113.16 26.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.487 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CE2' HD22 ' A' ' 44' ' ' LEU . 4.9 m-85 -58.93 153.11 18.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -166.91 125.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 112.065 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.3 103.37 2.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.99 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 63' ' ' LYS . 26.2 t -87.16 108.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.491 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.778 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -96.83 112.18 24.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.453 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.27 102.62 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.28 114.99 24.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -171.54 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.215 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -109.68 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.342 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -55.4 148.57 14.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.46 14.4 82.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.126 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 31' ' ' LEU . 3.2 mt-10 -128.02 31.21 5.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.494 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.2 OUTLIER 14.48 -79.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.348 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.57 -47.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.66 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 67.58 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.651 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -150.71 155.97 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.326 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 38.4 t -116.8 128.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.2 pt -116.03 149.85 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.609 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 48' ' ' ILE . 31.0 m -141.68 167.71 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.032 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.77 129.69 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.45 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 70.0 p -70.8 84.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.344 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.47 90.05 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.96 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.544 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.01 -163.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.663 0.268 . . . . 0.0 110.59 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.94 -25.38 7.33 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.788 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.413 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 4.7 p 80.43 44.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.694 0.759 . . . . 0.0 111.61 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.544 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 78.4 mt -58.64 -37.68 66.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -148.58 104.73 3.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.884 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' GLY . 51.6 Cg_exo -52.71 94.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.091 1.861 . . . . 0.0 112.612 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -145.02 -153.74 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -109.27 164.6 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.595 0.236 . . . . 0.0 110.634 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.54 129.3 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 71.2 mt -67.61 93.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.22 -6.15 51.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.287 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.515 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.3 m-20 -165.59 162.52 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -150.86 144.08 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.259 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 mtm -57.13 -28.56 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 61.47 61.02 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.82 -33.54 0.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.196 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -165.78 6.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.055 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.13 -16.93 40.56 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.443 2.095 . . . . 0.0 112.407 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.05 70.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.19 -34.21 56.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.748 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -59.62 -47.23 86.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.041 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 m -59.68 -52.19 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.55 64.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.076 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 2.3 mmmt -72.13 -31.56 66.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.0 mt -97.23 99.89 11.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -119.59 144.9 46.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.515 HD13 ' CA ' ' A' ' 51' ' ' ASN . 51.7 mm -47.22 142.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.722 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' N ' HG21 ' A' ' 66' ' ' ILE . . . 92.34 9.28 61.96 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 25.3 m-20 -96.97 154.5 17.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.682 0.277 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 6.2 mm100 -111.08 111.44 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.971 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 3.2 mt -86.57 113.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -77.6 -64.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.256 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.39 148.43 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.91 114.35 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 60.78 29.77 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.832 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.32 -20.0 52.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -69.86 95.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -71.87 121.06 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 pp -128.91 28.18 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.7 t -75.39 86.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 140.26 -50.26 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.684 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.413 HD11 ' CG2' ' A' ' 85' ' ' THR . 0.0 OUTLIER -51.02 163.82 0.48 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 111.116 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.59 -178.68 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.768 2.312 . . . . 0.0 112.829 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 tp -78.26 -45.04 23.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 p -53.41 -40.88 65.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.093 0.473 . . . . 0.0 110.69 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.7 m -66.08 -49.25 68.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 74.4 m -55.52 -56.28 22.15 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.286 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -49.18 -46.24 45.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.465 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 34.8 t -56.42 -35.18 67.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.345 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 85' ' ' THR . 6.5 mm -59.58 -47.28 91.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.494 HG22 ' HB ' ' B' ' 0' ' ' ILE . 44.6 mt -69.88 -50.63 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.161 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.465 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -63.24 -17.53 62.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.215 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.45 73.61 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.691 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.17 42.86 2.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 111.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -7.21 57.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.442 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.61 35.01 1.4 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.666 0.27 . . . . 0.0 111.591 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -126.12 134.67 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.836 0.35 . . . . 0.0 110.31 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -8.71 51.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.757 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.778 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.4 ttm105 -145.35 150.11 36.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 0.0 110.873 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.67 118.16 21.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 111.798 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.1 mtpt -97.73 97.84 9.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 153.44 19.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.969 0.414 . . . . 0.0 111.074 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.84 94.49 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' A' ' 70' ' ' ILE . 4.4 pt -120.52 171.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.45 117.83 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.552 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 C--O 1.23 0.123 0 CA-C-O 120.784 0.244 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.41 110.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.112 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -100.29 143.05 30.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.113 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.917 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 7.7 m-85 -62.33 154.32 28.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.236 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.64 125.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.342 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 101.53 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.42 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 23.8 t -83.89 116.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.75 104.56 12.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.488 179.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.25 99.74 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.098 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.53 109.99 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.969 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -131.51 -173.95 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.4 . . . . 0.0 111.492 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.49 159.34 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.9 156.96 13.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.17 18.03 62.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.355 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -130.23 31.7 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.891 0.377 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 14.31 -80.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.311 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' GLU . 11.9 tp 177.8 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.866 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.76 61.48 1.86 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.537 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -147.43 156.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 111.66 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' B' ' -1' ' ' TYR . 37.6 t -120.82 126.79 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.01 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.8 pt -116.74 144.15 25.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.206 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 48' ' ' ILE . 36.0 m -133.97 163.26 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 124.29 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' ' CG1' ' A' ' 48' ' ' ILE . 51.8 p -65.48 84.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.386 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.6 -3.97 90.49 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.754 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CZ2' ' HB ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -56.17 -162.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -52.94 -18.94 6.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.842 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.2 m 107.27 -86.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.486 0.714 . . . . 0.0 111.004 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.499 ' HB ' ' CZ2' ' A' ' 40' ' ' TRP . 84.4 mt 57.3 -64.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.387 0.613 . . . . 0.0 111.4 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 42' ' ' SER . 1.4 mt -135.87 73.39 60.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.625 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 87.1 Cg_exo -47.1 90.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.882 2.388 . . . . 0.0 113.359 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.76 -91.57 0.29 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.372 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -154.04 167.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 111.431 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.31 129.59 50.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.775 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 79.2 mt -66.41 94.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.01 0.91 55.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.4 m-20 -174.07 161.62 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 111.141 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 mtm -154.96 159.78 40.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.415 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 8.0 mtt -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 60.96 47.11 7.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.614 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -35.31 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.23 -171.97 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.173 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.11 -21.93 45.03 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.549 2.166 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.65 -49.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.961 0.41 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -39.36 41.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -52.8 -47.39 67.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.393 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -68.9 -61.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.78 -1.97 38.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.196 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 1.9 mmmm -76.97 -28.75 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.42 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 53.6 mt -107.04 113.97 27.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.042 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -130.92 141.41 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.395 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.487 HD13 ' CA ' ' A' ' 51' ' ' ASN . 42.0 mm -44.87 141.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 111.84 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 17.72 52.37 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.428 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 65.5 m-20 -102.83 158.49 16.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.622 0.249 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -117.57 106.99 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 1.4 mt -85.4 119.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -80.44 -65.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.66 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -133.64 146.97 51.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 111.473 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.409 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.2 mt -113.89 114.37 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.759 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 59.12 22.22 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.263 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.86 8.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -68.18 108.27 3.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 t -69.98 138.16 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 57.6 mt -111.07 -23.32 10.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.7 t -58.82 98.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.03 -29.47 3.71 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.413 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 159.8 31.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 111.609 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.74 178.68 2.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.003 2.469 . . . . 0.0 112.517 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.35 -39.45 68.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.091 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.5 t -53.32 -46.08 69.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.451 . . . . 0.0 110.393 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.593 ' O ' HG12 ' A' ' 89' ' ' ILE . 28.6 m -62.07 -50.5 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.992 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.8 m -55.39 -55.77 27.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -49.28 -40.48 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 110.289 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -63.57 -37.11 86.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.407 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 85' ' ' THR . 27.4 mm -58.15 -49.56 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.987 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.491 ' CG2' HD11 ' B' ' 0' ' ' ILE . 36.6 mt -71.83 -44.27 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -25.36 29.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.828 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.01 -51.05 48.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.091 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 1.6 pp -79.04 60.96 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 110.953 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -87.2 -26.07 23.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.358 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -108.51 51.95 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.33 . . . . 0.0 111.324 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.501 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 mt-30 -109.45 163.9 12.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 0.0 111.683 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.0 p -98.47 -10.92 22.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.36 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.56 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.69 150.4 10.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.279 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -119.91 119.19 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 112.054 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -97.6 117.81 32.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.9 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.37 117.95 13.9 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.994 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.99 96.22 9.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.418 ' CD1' ' HB3' ' A' ' 68' ' ' ASP . 2.0 pt -120.44 170.46 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.183 0.516 . . . . 0.0 112.229 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 18' ' ' PHE . 21.3 t -108.25 113.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.237 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.493 -179.416 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.881 0.284 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.53 161.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.47 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 5.5 m-85 -119.74 160.33 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.492 ' CD1' HG23 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.886 0.374 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.9 m-85 -59.38 154.28 17.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.49 125.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.105 0.478 . . . . 0.0 111.542 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.8 129.93 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.164 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 15.4 t -110.39 129.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.08 104.64 9.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -107.48 99.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.01 110.88 21.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.16 -167.75 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.0 111.307 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.48 172.81 6.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.489 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.93 158.82 34.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.696 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.68 16.62 56.24 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.389 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 31' ' ' LEU . 8.6 mt-10 -126.32 30.83 5.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.503 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 16.46 -80.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.966 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 29' ' ' GLU . 2.9 tp 177.58 -45.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.06 64.71 1.23 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.977 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -151.47 156.35 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 19.6 t -121.18 122.74 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 0.0 111.359 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 pt -111.47 142.37 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.0 m -135.18 170.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -60.57 135.22 57.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.46 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.0 p -75.52 83.57 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.432 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -8.47 83.33 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.82 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.539 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.45 -161.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.637 0.256 . . . . 0.0 110.468 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.43 -26.67 7.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.883 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.98 42.04 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.404 0.621 . . . . 0.0 111.384 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.539 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 89.0 mt -51.49 -42.46 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.887 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD13 ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.58 89.72 4.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.231 178.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 80' ' ' GLY . 85.4 Cg_exo -45.58 111.34 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.974 2.449 . . . . 0.0 113.841 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -156.54 -89.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.48 167.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.236 . . . . 0.0 111.015 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -133.68 129.41 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 78.9 mt -70.3 96.2 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.84 0.57 52.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.233 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.1 m-20 -169.46 161.2 9.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.451 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 14.4 mtm -155.23 134.93 12.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.42 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.428 ' HG2' ' CZ ' ' B' ' -1' ' ' TYR . 13.9 mtm -70.39 95.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.299 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -60.64 80.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.125 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 165.45 -31.45 0.22 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.59 -167.43 31.96 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.086 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 56.5 Cg_endo -69.28 -16.12 39.37 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.652 2.234 . . . . 0.0 112.529 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 33' ' ' VAL . . . -66.89 -49.6 65.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 110.83 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.57 -38.59 48.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.43 -47.21 82.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.193 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -59.34 -68.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.55 38.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.165 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -72.33 -30.01 64.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.51 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 53.6 mt -102.7 129.97 49.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.456 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 73.8 m-80 -142.75 138.12 30.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.726 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 6.2 mt -46.67 140.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.202 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.8 16.62 44.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.58 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.409 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 2.1 m-20 -111.87 157.22 20.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 110.739 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -112.79 117.75 33.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 103' ' ' ILE . 2.3 mt -91.8 108.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.464 ' HG3' ' CE2' ' A' ' 18' ' ' PHE . 21.6 mmt -66.94 -67.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 53.5 p -131.57 156.07 46.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.348 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.44 109.8 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.493 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 64.23 29.42 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.879 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.62 50.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.924 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 m -77.75 95.84 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.741 0.305 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 56.4 p -77.02 131.63 38.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.247 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' CA ' ' HG ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.98 19.26 7.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 23.5 t -60.39 88.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.848 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 133.07 -24.66 3.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.779 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HG ' ' CA ' ' A' ' 78' ' ' LEU . 1.3 mt -70.72 155.42 93.42 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 110.766 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.99 -173.75 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 tp -78.13 -47.21 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.008 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 p -53.37 -43.35 67.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.085 0.469 . . . . 0.0 110.263 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 89' ' ' ILE . 83.1 m -65.04 -52.23 57.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.852 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 85.9 m -56.56 -50.33 72.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -49.89 -45.1 50.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 110.07 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -60.26 -35.95 76.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.519 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 85' ' ' THR . 7.5 mm -58.21 -48.99 83.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.432 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' B' ' 0' ' ' ILE . 57.1 mt -73.08 -42.17 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.158 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -55.18 -25.83 35.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.5 69.21 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.397 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.2 mt -93.31 45.28 1.16 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.68 30.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.193 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.01 35.69 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.74 159.78 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.134 0.493 . . . . 0.0 111.635 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 p -114.24 -9.26 12.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.455 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 ttm180 -150.73 134.9 16.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.368 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.403 ' CG2' ' NZ ' ' A' ' 25' ' ' LYS . 13.1 t -122.59 104.84 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 0.0 111.723 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.99 100.48 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 123.33 48.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.458 . . . . 0.0 112.089 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.3 93.81 9.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.317 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 70' ' ' ILE . 2.0 pt -114.42 170.25 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.045 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.0 126.51 72.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.81 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . 0.47 ' HG2' ' CG2' ' A' ' 34' ' ' VAL . 64.9 Cg_endo . . . . . 0 CA--C 1.528 0.215 0 CA-C-O 120.626 0.178 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 23.0 t -45.11 -56.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.584 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' A' ' 34' ' ' VAL . 1.0 OUTLIER 64.16 149.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.07 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.946 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 5.9 m-85 -58.8 154.06 15.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.809 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.73 125.44 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 111.468 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -73.3 105.89 4.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.648 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' CG1' ' HG3' ' A' ' 63' ' ' LYS . 26.6 t -82.37 132.17 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.466 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -123.99 104.71 9.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -110.3 99.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.337 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.81 109.79 20.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.268 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.77 -172.07 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -106.86 163.36 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.42 155.94 27.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.35 16.13 64.49 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.425 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -126.38 30.51 5.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.508 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 19.36 -82.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.957 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER 175.19 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.624 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 91.19 67.67 1.17 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.814 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.84 156.53 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.375 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 36.5 t -124.73 119.81 57.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 2.0 pt -110.41 145.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -136.4 165.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 131.62 51.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.025 0.441 . . . . 0.0 110.623 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.0 p -69.85 84.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.653 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.36 -4.31 89.53 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.832 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.528 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.73 -163.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.667 0.27 . . . . 0.0 110.302 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' OG ' ' A' ' 42' ' ' SER . . . -50.07 -25.68 7.99 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.77 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.434 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 8.9 p 82.21 63.04 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.001 0.905 . . . . 0.0 111.517 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.528 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 48.3 mt -78.91 -32.31 15.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.757 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' O ' ' CG2' ' A' ' 46' ' ' THR . 80.9 mt -156.13 89.74 2.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.286 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 Cg_exo -49.19 86.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.822 2.348 . . . . 0.0 113.515 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.81 -91.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.055 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 2.9 m -160.27 167.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 120.684 0.278 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -133.5 127.68 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.93 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 60.8 mt -67.74 93.39 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.25 55.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.137 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.561 ' CA ' HD12 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -165.95 156.82 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.301 . . . . 0.0 110.9 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 ttm -153.38 131.57 11.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.262 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.433 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 6.2 mtm -63.23 100.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.493 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -66.45 73.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.15 -34.13 0.15 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.126 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.3 -168.2 13.85 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.919 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.0 Cg_endo -69.32 -16.57 39.51 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.502 2.134 . . . . 0.0 112.424 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.48 71.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -40.39 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -58.12 -29.67 65.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.446 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -69.23 -66.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.11 -33.47 5.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.136 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HE3' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.4 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 15.4 mt -92.6 119.25 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.814 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -133.07 130.07 38.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.585 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 ' CA ' ' A' ' 51' ' ' ASN . 42.3 mm -45.74 142.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.87 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.418 ' N ' HG21 ' A' ' 66' ' ' ILE . . . 94.96 12.01 55.85 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.502 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -105.88 161.33 14.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.763 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' NE2' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -113.1 119.85 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' HA ' HG21 ' A' ' 103' ' ' ILE . 4.4 mt -89.7 97.82 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.434 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -57.81 -64.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.599 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.2 p -137.14 149.9 47.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.26 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.409 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.2 mt -117.59 118.24 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 56.08 29.09 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.28 11.98 56.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.796 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -100.65 95.91 7.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.09 126.7 28.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 23.5 mt -109.14 -23.62 11.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.3 t -56.03 88.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.464 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.16 -38.79 1.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.362 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.21 159.68 67.23 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.436 . . . . 0.0 111.464 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.19 -175.04 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.956 2.438 . . . . 0.0 112.659 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' CD1' ' NE2' ' A' ' 87' ' ' GLN . 1.6 tm? -78.25 -46.42 20.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.0 m -53.6 -42.61 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.996 0.427 . . . . 0.0 110.589 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.514 ' O ' HG12 ' A' ' 89' ' ' ILE . 71.0 m -62.01 -49.28 76.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.7 m -56.56 -46.5 80.69 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.811 0.339 . . . . 0.0 110.729 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' NE2' ' CD1' ' A' ' 83' ' ' LEU . 10.3 mt-30 -52.69 -43.11 65.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.049 0.452 . . . . 0.0 109.896 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.1 p -60.9 -37.23 81.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.422 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 85' ' ' THR . 21.0 mm -58.22 -49.44 81.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.963 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.612 HG21 ' HB ' ' B' ' 0' ' ' ILE . 52.7 mt -71.46 -45.04 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.224 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -58.48 -20.68 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -20.71 67.85 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.055 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.5 pp -100.53 43.88 1.04 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.001 0.401 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -5.89 58.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.291 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -122.55 54.21 1.22 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.871 0.367 . . . . 0.0 111.208 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -136.27 160.48 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -98.79 -15.84 19.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.828 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -139.68 143.87 37.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.749 0.309 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 104.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.064 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -95.92 97.6 9.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.225 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.83 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.927 0.394 . . . . 0.0 111.002 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.6 OUTLIER -118.94 97.58 5.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 70' ' ' ILE . 1.1 pt -118.77 170.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 111.681 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 69' ' ' GLN . 3.5 p -121.4 132.61 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.801 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.837 0.265 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.33 119.35 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' A' ' 34' ' ' VAL . 2.3 m-85 -100.21 132.17 45.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.612 ' HB ' HG21 ' A' ' 90' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.01 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.001 0.429 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 13.1 m-85 -60.21 151.94 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.878 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -162.35 124.51 2.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.137 0.494 . . . . 0.0 111.18 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 120.54 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 101' ' ' LEU . 16.4 t -103.16 147.2 9.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -140.34 104.79 4.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.825 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 57' ' ' PRO . 12.7 mm -107.4 99.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -83.99 109.87 17.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.405 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -132.27 -175.32 3.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -104.63 144.27 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.372 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG2' ' CB ' ' A' ' 95' ' ' ASN . 15.6 mttt -50.24 144.45 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.076 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 10.73 80.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.624 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 31' ' ' LEU . 26.9 mm-40 -124.86 31.05 5.75 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.499 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.0 OUTLIER 25.5 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.089 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 29' ' ' GLU . 56.8 tp 177.56 -41.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.791 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.79 63.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.856 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG22 ' CD1' ' B' ' 0' ' ' ILE . 0.9 OUTLIER -151.11 156.12 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 111.216 178.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 51' ' ' ASN . 38.6 t -121.61 129.83 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.76 140.84 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.434 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 28.9 m -131.52 168.15 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.91 132.57 54.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.914 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.454 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.4 p -74.1 84.08 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -79.27 -7.74 88.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.074 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.59 -162.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 110.322 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.02 -26.5 6.01 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.445 -0.884 . . . . 0.0 111.816 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.31 45.74 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.544 0.688 . . . . 0.0 111.256 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 83.6 mt -59.01 -39.28 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.942 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' HB2' ' HE1' ' A' ' 71' ' ' MET . 2.0 mt -146.22 80.99 9.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.386 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 80' ' ' GLY . 94.8 Cg_exo -42.57 91.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.913 2.408 . . . . 0.0 113.581 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.13 -89.42 0.2 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.354 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.41 ' H ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.61 167.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.653 0.264 . . . . 0.0 111.205 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.43 129.44 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HD13 ' A' ' 66' ' ' ILE . 52.2 mt -68.21 91.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -13.26 41.46 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.764 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.532 ' CA ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -158.13 159.1 35.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.975 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.13 129.14 10.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.42 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 3.3 mtm -56.3 102.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.0 70.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.777 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.88 -34.26 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.066 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.09 -167.86 4.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.093 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.5 Cg_endo -69.27 -16.11 39.37 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.813 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.41 -49.69 58.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.856 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -36.87 50.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -56.73 -47.28 80.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -73.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.39 -4.05 23.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.309 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -75.93 -37.49 58.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.539 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 mt -91.81 126.53 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -132.15 128.13 37.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.496 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.532 HD11 ' CA ' ' A' ' 51' ' ' ASN . 43.8 mm -44.18 142.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.5 . . . . 0.0 111.937 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 66' ' ' ILE . . . 93.12 13.33 56.38 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.563 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 87.4 m-20 -102.37 166.93 10.29 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.761 0.315 . . . . 0.0 110.615 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 3.4 mm100 -120.32 105.71 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.467 ' HA ' HG21 ' A' ' 103' ' ' ILE . 4.9 mt -78.82 129.48 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -95.42 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 p -126.56 142.26 51.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.598 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.08 122.85 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.515 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.76 31.23 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.85 14.52 69.71 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.522 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 m -109.14 95.63 5.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -73.56 131.01 41.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.591 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 16.32 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.04 89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.999 0.428 . . . . 0.0 110.28 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 134.63 -22.04 3.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.1 167.71 33.04 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.276 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 85' ' ' THR . 9.7 Cg_exo -68.9 -177.27 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.751 2.301 . . . . 0.0 111.439 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -52.9 7.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 -38.84 65.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.723 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 89' ' ' ILE . 37.2 m -62.4 -43.12 99.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.79 -51.48 69.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -50.99 -44.05 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.276 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.5 m -60.42 -35.19 75.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.371 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 85' ' ' THR . 2.8 mm -58.35 -49.43 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' B' ' 0' ' ' ILE . 59.1 mt -71.45 -43.44 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.769 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.38 -24.44 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.84 -42.28 38.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.627 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.4 OUTLIER -89.19 51.15 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 111.142 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -23.84 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.421 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 56.6 m-80 -116.07 63.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.434 ' O ' ' CB ' ' A' ' 97' ' ' SER . 3.3 mm100 -124.19 -29.78 3.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.602 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 3.8 t 82.28 -2.16 1.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.247 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.1 ttm180 -154.93 134.02 12.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.73 0.3 . . . . 0.0 110.229 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.7 t -119.75 104.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.711 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -90.98 100.85 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.71 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.415 ' CD1' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -115.84 120.76 40.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -90.45 90.58 8.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 70' ' ' ILE . 1.7 pt -111.94 164.63 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.05 107.96 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.333 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.6 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . 0.434 ' CG ' HG23 ' A' ' 34' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.823 0.26 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.96 -42.51 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.365 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.453 ' CE1' HG21 ' A' ' 34' ' ' VAL . 1.5 m-85 64.97 90.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.609 ' HB ' HG22 ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.042 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 44' ' ' LEU . 5.4 m-85 -58.68 151.98 19.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.965 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -164.38 125.23 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 111.508 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.09 102.14 4.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.7 136.66 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -124.95 104.77 8.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -105.88 99.78 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -86.87 109.82 19.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -138.04 -171.15 2.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.995 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.54 169.38 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.59 156.99 31.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 18.84 61.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.292 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' C ' ' A' ' 30' ' ' ILE . 2.7 mm-40 -127.7 29.5 5.46 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.522 ' HB ' ' OXT' ' B' ' 0' ' ' ILE . 0.3 OUTLIER 10.29 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.326 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 172.75 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.77 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.01 66.65 1.26 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.467 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.9 OUTLIER -149.39 156.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 21.9 t -121.23 126.51 75.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.721 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -113.94 151.92 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.77 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 35.2 m -142.61 167.3 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.32 131.1 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.462 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 25.2 p -70.4 84.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.62 -5.82 89.21 Favored Glycine 0 C--N 1.328 0.135 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.967 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.517 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.24 -163.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.566 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.08 -24.49 6.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.409 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.76 36.52 0.08 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.233 0.54 . . . . 0.0 111.404 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.517 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 65.5 mt -52.45 -36.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.657 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -147.59 101.06 3.74 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.943 178.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 75.6 Cg_exo -51.76 83.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.398 2.065 . . . . 0.0 112.876 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -133.84 -152.35 0.48 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.214 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 15.8 m -111.28 166.1 5.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.634 0.254 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.04 131.33 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 73.1 mt -68.2 93.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.28 -9.58 44.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.238 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.541 ' CA ' HD12 ' A' ' 66' ' ' ILE . 1.2 m-20 -162.12 160.22 27.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 111.053 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -152.06 147.65 26.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.9 mtt -59.64 -27.86 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 60.61 60.85 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.697 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.96 -30.15 0.16 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.278 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.7 -170.68 29.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.043 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 29.7 Cg_endo -63.09 -17.21 59.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.301 2.001 . . . . 0.0 112.343 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -49.02 66.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -38.77 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -56.38 -45.95 80.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 p -56.04 -56.15 24.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -29.21 11.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.289 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -61.02 -29.3 69.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.69 125.96 48.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.14 147.75 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.541 HD12 ' CA ' ' A' ' 51' ' ' ASN . 50.8 mm -50.41 146.5 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.647 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.93 59.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.262 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.55 174.18 6.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.689 0.281 . . . . 0.0 110.658 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.5 mm100 -130.35 107.8 9.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.147 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 103' ' ' ILE . 7.5 mt -88.71 134.2 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -97.02 -69.91 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t -129.62 144.95 51.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.267 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 3.4 mt -113.88 110.95 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 57.69 22.77 8.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.94 -34.21 4.71 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.868 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -65.55 103.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.984 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 p -68.81 135.59 51.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.309 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 29.5 mt -112.58 -20.16 11.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.089 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.9 t -56.28 88.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.649 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.51 -49.69 0.86 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.361 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 159.88 55.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.554 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.67 -177.39 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.037 2.491 . . . . 0.0 112.654 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 36' ' ' VAL . 1.9 tm? -78.17 -49.91 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.712 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 m -53.15 -41.14 64.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.991 0.424 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.633 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.8 m -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.036 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.0 m -55.7 -54.1 48.41 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -49.03 -48.01 44.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.2 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 23.2 t -56.81 -35.26 68.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.556 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 85' ' ' THR . 7.0 mm -58.8 -48.58 85.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' B' ' 0' ' ' ILE . 23.7 mt -67.49 -50.55 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.17 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.27 -19.97 62.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.87 -23.22 69.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.583 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.4 pp -113.82 44.27 1.66 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -12.27 43.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.42 39.15 1.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 1.8 pt20 -126.02 147.98 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 110.677 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 t -83.13 -9.12 59.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.71 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 1.9 ttm180 -147.15 141.78 26.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.746 0.308 . . . . 0.0 110.725 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.7 104.89 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.36 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.45 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -88.68 97.91 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.28 154.55 18.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 111.297 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.4 OUTLIER -124.13 97.65 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 70' ' ' ILE . 1.7 pt -121.51 172.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.129 0.49 . . . . 0.0 112.295 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 69' ' ' GLN . 4.3 m -125.9 130.99 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.587 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . 0.409 ' HG2' ' CG2' ' A' ' 34' ' ' VAL . 68.1 Cg_endo . . . . . 0 N--CA 1.464 -0.243 0 N-CA-C 112.623 0.201 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.1 t 54.39 87.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -81.89 145.77 30.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.522 ' OXT' ' HB ' ' A' ' 30' ' ' ILE . 2.2 pp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.775 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.865 0.364 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 6.4 m-85 -64.71 154.44 36.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.784 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.59 125.32 2.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.233 0.539 . . . . 0.0 111.559 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.55 100.15 1.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.502 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.41 HG12 ' CD1' ' A' ' 101' ' ' LEU . 24.9 t -82.43 112.01 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.131 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -110.92 104.82 13.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CG2' ' HB2' ' A' ' 57' ' ' PRO . 4.1 mm -105.96 104.16 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.2 mp0 -84.05 110.3 18.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.5 -171.3 2.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -112.22 166.72 11.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -65.05 158.49 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 110.724 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.38 17.77 60.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.487 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -126.81 29.73 5.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER 22.77 -82.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.097 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' GLU . 16.7 tp 174.95 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 88.49 63.5 1.35 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.819 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -152.7 156.07 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 117.18 0.49 . . . . 0.0 111.795 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 31.1 t -126.35 116.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.588 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -103.24 152.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.44 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' ILE . 26.8 m -140.09 168.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -58.46 132.14 52.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.939 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.6 p -74.11 84.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.423 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.84 -9.62 84.22 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.123 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.23 -161.65 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.723 0.296 . . . . 0.0 110.439 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.73 -26.07 7.55 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.801 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.43 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 9.1 m 80.54 35.87 0.11 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.264 0.554 . . . . 0.0 111.49 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.556 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 74.2 mt -49.25 -39.36 12.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.056 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG2' ' A' ' 46' ' ' THR . 1.5 mt -145.66 87.71 6.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.091 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 6.7 Cg_endo -50.39 90.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.873 2.382 . . . . 0.0 113.308 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.9 -91.58 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.818 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -158.67 167.58 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.38 131.11 63.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -68.1 93.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.06 -1.89 53.73 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.115 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.515 ' CA ' HD13 ' A' ' 66' ' ' ILE . 1.1 t-20 -170.01 152.6 4.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 mtm -146.7 121.35 9.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 0.0 111.448 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.413 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -54.48 90.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.607 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -59.25 82.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.05 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.76 -29.92 0.27 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.953 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.57 32.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.52 -16.06 38.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.704 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.25 63.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 -33.38 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.751 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -61.37 -45.58 93.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 m -63.73 -68.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.22 -25.65 17.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.505 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -54.89 -27.07 40.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.76 134.53 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -140.43 134.73 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.711 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.515 HD13 ' CA ' ' A' ' 51' ' ' ASN . 49.4 mm -46.42 144.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.705 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.22 84.57 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.659 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 74.6 m-20 -85.59 164.0 18.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.678 0.275 . . . . 0.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.451 ' NE2' ' CZ2' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -119.45 118.29 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 111.193 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.427 ' CG2' HG22 ' A' ' 103' ' ' ILE . 4.4 mt -91.62 108.73 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -68.85 -66.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.876 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.8 p -135.65 148.53 48.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.408 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -118.22 112.5 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.77 23.85 12.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.78 -30.49 7.43 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.886 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -67.7 102.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.716 0.293 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -69.04 136.75 52.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.054 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 40.5 mt -112.24 -13.52 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -67.05 94.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.341 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.91 -22.73 3.8 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.479 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.93 157.61 33.57 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.983 0.391 . . . . 0.0 111.472 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.01 -174.15 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.818 2.346 . . . . 0.0 112.801 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.15 -48.43 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.459 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 p -52.99 -42.21 65.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.1 m -61.55 -48.33 81.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.839 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.8 m -56.13 -50.16 71.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.883 0.373 . . . . 0.0 111.07 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -50.22 -46.2 54.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.305 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.3 m -59.69 -35.7 75.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.64 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 85' ' ' THR . 18.2 mm -58.15 -50.0 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.505 HG21 ' HB ' ' B' ' 0' ' ' ILE . 58.7 mt -69.54 -45.31 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -55.57 -23.42 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.31 -33.3 32.38 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 2.0 pp -95.65 35.12 1.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.915 0.388 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -5.79 58.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -107.65 43.96 1.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.97 176.07 8.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 110.9 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.2 t -102.17 -16.74 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.62 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 28.3 mmt85 -131.21 150.49 52.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.4 104.3 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.524 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mmpt? -90.0 120.92 31.62 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.3 117.84 11.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 111.804 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.78 99.41 12.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.574 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.68 167.35 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.153 0.501 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 69' ' ' GLN . 4.3 p -112.06 129.09 68.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.247 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.781 0.242 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.76 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.451 ' CD2' HG23 ' A' ' 34' ' ' VAL . 36.6 m-85 -109.33 131.51 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.509 ' CD1' ' C ' ' B' ' 0' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.83 0.347 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CD2' HG22 ' A' ' 104' ' ' VAL . 4.0 m-85 -67.29 151.55 47.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 125.9 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.314 0.578 . . . . 0.0 111.616 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.56 105.88 6.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.572 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -84.38 141.2 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -132.84 104.53 6.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.217 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' CB ' ' A' ' 61' ' ' SER . 14.1 mm -106.57 99.63 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.63 109.55 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.023 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -172.86 3.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.154 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.8 169.07 8.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.423 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 157.12 30.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.532 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 9.92 65.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.507 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ILE . 4.4 mt-10 -120.13 31.87 6.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.197 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 5.77 -75.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.103 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . 2.5 tp 171.73 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.844 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.15 62.73 1.79 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.249 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' B' ' 0' ' ' ILE . 0.8 OUTLIER -146.03 156.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 111.715 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' B' ' -1' ' ' TYR . 38.3 t -119.43 132.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -117.16 156.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.635 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 32.0 m -148.28 165.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.808 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.19 131.82 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 87.5 p -69.13 84.09 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.403 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.47 -1.19 90.24 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.541 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.8 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.579 0.228 . . . . 0.0 110.475 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.28 -25.5 8.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.833 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.41 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 83.05 64.27 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.739 0.78 . . . . 0.0 111.459 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 43.5 mt -83.0 -31.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' THR . 85.2 mt -156.51 101.39 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.809 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 9.6 Cg_endo -52.11 83.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.58 2.187 . . . . 0.0 113.363 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -133.45 -157.7 0.83 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.041 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.6 m -105.64 153.36 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.933 0.396 . . . . 0.0 111.651 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -115.78 132.79 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.8 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.433 ' CG2' HD12 ' A' ' 66' ' ' ILE . 48.8 mt -69.31 90.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.44 -11.3 52.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.192 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.476 ' CA ' HD13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -161.8 159.9 27.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 17.1 ttm -149.15 135.64 19.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.935 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.404 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 2.9 mtm -51.95 -27.19 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 38.6 t60 58.66 54.67 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.676 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.2 -37.14 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.217 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.88 -166.14 2.45 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.951 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 51.0 Cg_endo -68.91 -16.94 41.6 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.292 1.995 . . . . 0.0 112.131 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.53 -44.74 73.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.482 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -39.42 49.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.565 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -58.34 -47.12 84.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.419 ' CB ' HD11 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -61.06 -63.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.079 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.14 -23.42 27.3 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.287 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -36.59 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.08 104.39 15.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.995 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -121.54 141.23 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.531 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.476 HD13 ' CA ' ' A' ' 51' ' ' ASN . 28.5 mm -46.34 145.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 111.809 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.62 4.82 61.9 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.64 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -106.07 150.96 25.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.29 . . . . 0.0 110.54 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -113.08 126.72 55.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.49 ' HA ' HG21 ' A' ' 103' ' ' ILE . 6.3 mt -88.93 134.87 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -96.81 -57.82 2.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.241 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.0 p -147.23 145.26 29.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.969 0.414 . . . . 0.0 111.401 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 78' ' ' LEU . 2.8 mp -115.23 120.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 55.87 27.98 11.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.37 -26.01 24.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.795 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -65.51 102.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -68.77 131.48 45.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.252 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 73' ' ' ILE . 21.0 mt -109.82 -25.34 10.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 26.0 t -54.99 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.524 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.45 -38.09 1.49 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.242 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.409 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.1 OUTLIER -84.66 159.73 57.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.372 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 -172.14 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.847 2.365 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 tp -78.04 -45.01 24.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.6 t -53.34 -43.0 67.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.983 0.421 . . . . 0.0 110.47 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 89' ' ' ILE . 89.7 m -63.86 -48.63 75.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.646 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 71.9 m -55.97 -57.16 13.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.549 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -48.86 -42.09 35.33 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.968 0.413 . . . . 0.0 110.043 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -60.94 -35.69 77.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.311 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 85' ' ' THR . 13.9 mm -59.0 -49.4 83.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.491 HG23 ' HB ' ' B' ' 0' ' ' ILE . 29.1 mt -71.96 -46.09 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -55.42 -24.41 30.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -47.25 47.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.209 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.33 55.72 3.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 0.0 110.814 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 -19.47 27.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.288 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -109.29 54.37 0.66 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.21 156.15 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.618 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 p -93.98 -12.23 29.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.763 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -143.58 139.49 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.522 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.87 104.43 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.516 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.38 119.45 32.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.826 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.0 154.35 49.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.024 0.44 . . . . 0.0 111.118 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.5 OUTLIER -122.29 92.25 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.49 HG21 ' HA ' ' A' ' 70' ' ' ILE . 2.2 pt -116.05 170.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 112.161 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 18' ' ' PHE . 35.9 t -119.98 113.9 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.889 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttm105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.961 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.787 0.264 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 61.35 122.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.375 . . . . 0.0 111.278 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 34' ' ' VAL . 32.9 m-85 -117.84 143.9 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.491 ' HB ' HG23 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 71' ' ' MET . 2.5 m-85 -64.2 154.28 35.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.754 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.12 127.57 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 111.834 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.47 102.05 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.524 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.77 135.3 25.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -127.28 104.84 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -104.71 99.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -90.07 109.61 20.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.121 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.07 -165.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -106.47 162.34 13.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.407 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.81 158.78 15.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.511 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.87 19.48 50.16 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -124.68 29.24 6.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 110.07 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.565 ' HA ' ' HB2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER 15.73 -80.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.482 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER 174.13 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.794 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.17 67.49 1.08 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.59 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.9 OUTLIER -152.45 156.12 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.707 0.289 . . . . 0.0 111.008 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 47.9 t -120.62 123.64 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.045 0.45 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -110.91 140.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.803 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 48' ' ' ILE . 35.6 m -133.12 168.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.121 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.47 132.32 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.823 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.481 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.3 p -72.92 84.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.469 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.05 -8.44 83.94 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.032 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.39 -161.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.478 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.4 8.61 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.816 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.424 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.424 0.63 . . . . 0.0 111.172 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.551 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 92.3 mt -55.95 -42.18 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.944 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -152.63 88.68 3.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.32 178.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.44 108.91 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.123 2.548 . . . . 0.0 114.108 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -154.85 -91.48 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.379 178.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.18 167.49 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 110.962 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -132.67 130.23 59.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 66.1 mt -69.09 94.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.5 -1.9 49.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.434 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.508 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -166.69 159.36 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.0 ttm -154.07 135.19 13.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.446 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 9.7 mtm -71.82 99.84 2.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.59 76.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.84 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -35.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -170.13 18.26 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.997 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 56.2 Cg_endo -69.11 -15.68 39.72 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.541 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.52 67.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.898 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.43 -38.99 48.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -57.47 -47.1 82.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.253 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.8 p -56.9 -63.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.53 -9.19 57.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.321 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -72.93 -31.41 64.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.88 0.371 . . . . 0.0 110.548 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.5 mt -96.85 130.4 44.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -139.44 134.06 31.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.497 HD13 ' CA ' ' A' ' 51' ' ' ASN . 50.1 mm -46.49 144.32 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 111.798 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.09 13.25 57.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -108.56 160.0 16.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.684 0.278 . . . . 0.0 110.698 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.454 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -115.06 119.17 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 103' ' ' ILE . 1.8 mt -90.42 113.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 18' ' ' PHE . 24.3 mmt -72.98 -66.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.709 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 86.4 p -134.42 160.31 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -118.5 111.11 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.73 28.89 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.11 -30.14 5.54 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.222 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 m -78.26 99.98 6.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.465 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 67.3 m -84.8 137.49 33.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.638 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.76 24.77 5.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.6 t -75.64 93.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.005 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.09 -18.78 4.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.143 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 163.19 33.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.982 0.391 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.05 -179.28 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.803 2.335 . . . . 0.0 112.417 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 tp -78.13 -44.62 25.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.24 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -53.14 -42.55 66.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.544 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.2 m -63.73 -47.8 79.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.715 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.413 ' HA ' HG13 ' A' ' 89' ' ' ILE . 77.0 m -55.76 -57.48 11.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.358 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -49.77 -39.95 39.7 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.496 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 16.7 t -62.45 -36.61 82.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.26 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 85' ' ' THR . 2.1 mm -58.84 -49.73 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.347 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.516 HG23 ' HB ' ' B' ' 0' ' ' ILE . 54.6 mt -69.4 -50.45 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.131 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.62 -22.01 55.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.881 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.15 -30.31 59.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.38 35.32 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 111.062 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.82 -5.92 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.592 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -96.08 35.69 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.682 0.277 . . . . 0.0 111.73 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.53 170.67 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.737 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 t -99.18 -8.74 24.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.855 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.4 ttm180 -139.6 140.03 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.51 106.1 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 7.9 tttt -88.13 131.8 34.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 117.9 10.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.002 0.43 . . . . 0.0 111.448 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.31 89.66 8.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -111.67 166.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.913 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 69' ' ' GLN . 6.3 p -109.07 122.78 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.638 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 -179.601 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . 0.415 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 98.3 Cg_endo . . . . . 0 N--CA 1.464 -0.216 0 CA-C-O 120.789 0.245 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.17 142.7 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 0.5 OUTLIER -119.56 115.91 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.516 ' HB ' HG23 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.904 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 4.9 m-85 -61.75 148.68 42.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.06 126.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.171 0.51 . . . . 0.0 111.805 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.66 133.01 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.938 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.404 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 18.9 t -116.29 111.41 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.253 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.37 115.72 31.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -114.86 99.4 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.862 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -88.81 128.31 35.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.327 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.44 -166.83 2.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.58 167.43 10.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.87 157.64 17.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.0 110.736 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.92 11.1 73.79 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.542 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -123.96 32.51 5.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.258 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.479 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 10.64 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.154 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' GLU . 59.1 tp 177.35 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.709 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.62 63.51 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.702 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -152.45 156.46 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 40.9 t -122.16 117.28 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.56 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -106.18 147.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.471 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 m -140.38 169.71 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.18 129.37 40.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.455 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 59.2 p -71.12 83.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.98 -3.56 89.08 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.695 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.566 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.56 -163.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.698 0.285 . . . . 0.0 110.603 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.24 -24.69 7.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.811 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.409 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.52 35.38 0.07 Allowed 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.182 0.515 . . . . 0.0 111.562 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.566 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 69.2 mt -49.1 -39.34 12.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.765 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -148.31 111.69 3.74 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.019 178.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' GLY . 34.8 Cg_exo -59.71 98.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.096 1.864 . . . . 0.0 112.62 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -152.57 -155.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.009 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -106.25 165.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.71 130.53 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 66' ' ' ILE . 69.0 mt -71.42 93.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.94 -5.06 53.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.114 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.556 ' CA ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -163.03 164.3 25.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -160.79 132.13 5.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.442 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 8.2 mtm -69.3 101.97 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.343 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.84 78.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.26 -30.69 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.164 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.37 -176.1 38.3 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.099 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.75 -16.55 38.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.594 2.196 . . . . 0.0 112.712 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.24 -50.26 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -32.7 49.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.349 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.26 -47.15 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.287 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -56.54 -69.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.28 22.97 7.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.126 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -107.88 -33.0 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.753 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.404 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 54.0 mt -96.03 123.21 39.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.664 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -127.49 133.32 49.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.593 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.556 HD11 ' CA ' ' A' ' 51' ' ' ASN . 46.6 mm -45.46 141.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' N ' HG23 ' A' ' 66' ' ' ILE . . . 90.97 15.07 56.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.214 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HB3' ' CD1' ' A' ' 103' ' ' ILE . 98.1 m-20 -101.42 164.63 11.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.779 0.324 . . . . 0.0 110.695 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.522 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 5.2 mm100 -120.32 115.17 23.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 103' ' ' ILE . 2.5 mt -89.06 117.78 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.444 ' HE2' ' CB ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -81.5 -64.28 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.376 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.4 t -132.24 146.17 51.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mt -117.11 111.3 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 60.92 25.93 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.09 -28.59 11.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.618 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.4 m -63.9 96.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.076 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -74.41 117.97 16.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.722 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -125.03 27.71 6.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.6 80.22 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 139.23 -13.28 3.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.779 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.11 157.8 65.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 110.819 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.1 -174.93 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.577 2.185 . . . . 0.0 111.891 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.5 tp -78.31 -39.95 38.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.699 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.3 p -53.71 -44.69 70.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.349 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.9 m -63.95 -52.97 57.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.859 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.74 -52.15 64.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.769 0.318 . . . . 0.0 111.002 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -49.71 -42.62 46.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.021 0.439 . . . . 0.0 109.896 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.47 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.3 m -60.9 -36.86 80.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.271 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 85' ' ' THR . 14.7 mm -58.98 -49.37 83.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.398 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' B' ' 0' ' ' ILE . 34.6 mt -72.59 -49.96 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.46 -20.33 54.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.895 0.378 . . . . 0.0 110.956 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.38 -28.49 67.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.362 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -106.92 57.67 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.7 -30.58 29.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.104 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -96.57 37.47 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -100.69 144.05 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.019 0.438 . . . . 0.0 111.353 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.9 p -96.63 -5.77 38.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.576 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.75 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 10.8 ttm180 -157.0 137.79 13.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.245 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.01 123.87 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -100.8 128.48 46.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.627 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.37 116.66 11.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 111.931 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.05 93.02 9.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 70' ' ' ILE . 2.6 pt -116.34 168.87 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.984 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.423 HG22 ' CD2' ' A' ' 18' ' ' PHE . 37.3 t -115.05 119.44 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.544 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 CA-C-O 120.818 0.258 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 9.1 p -64.17 142.81 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.457 ' CE1' HG23 ' A' ' 34' ' ' VAL . 4.7 m-85 -112.31 135.69 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.99 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 7.8 m-85 -65.14 154.52 37.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.17 125.15 3.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 111.734 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.87 101.94 4.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.407 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 139.3 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.91 104.91 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.527 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 mm -103.42 99.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.21 109.98 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.319 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 -174.35 4.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -107.52 176.38 5.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.601 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 155.72 39.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.04 13.97 65.16 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.497 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 30' ' ' ILE . 5.5 mt-10 -125.45 31.19 5.6 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.157 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 9.83 -78.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.288 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.39 -43.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.757 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.56 60.53 1.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.664 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -144.92 155.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 88.4 t -123.62 129.37 74.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.744 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.94 153.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -141.93 169.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.838 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.72 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.482 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 88.5 p -68.37 84.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.507 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.21 -3.73 87.02 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.801 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.61 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.616 0.246 . . . . 0.0 110.443 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.96 -24.28 6.23 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.766 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 82.16 38.71 0.05 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.327 0.584 . . . . 0.0 111.277 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 65.4 mt -54.15 -34.99 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.792 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 46' ' ' THR . 85.2 mt -152.01 104.41 2.82 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.16 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 61.9 Cg_exo -52.14 84.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.516 2.144 . . . . 0.0 113.14 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -133.72 -154.65 0.61 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.501 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -108.12 167.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.5 125.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.459 ' CG2' HD11 ' A' ' 66' ' ' ILE . 59.3 mt -65.18 91.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -8.11 55.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.123 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.461 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -166.26 161.02 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 111.344 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -155.65 142.71 19.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.413 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 7.2 mtt -52.66 -25.01 9.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.66 47.75 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.802 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.97 -39.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.05 -169.59 1.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.278 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.19 -23.91 56.14 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.644 2.229 . . . . 0.0 112.196 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -62.65 -49.31 75.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -76.99 -39.02 51.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -50.89 -47.1 60.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.41 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -60.45 -51.95 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.831 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.08 55.62 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE3' ' CB ' ' A' ' 61' ' ' SER . 1.4 mtmt -69.06 -35.27 76.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.03 113.65 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -127.92 135.23 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.459 HD11 ' CG2' ' A' ' 49' ' ' ILE . 26.0 mm -46.27 145.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 0.0 111.752 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.45 64.66 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.876 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.38 163.43 12.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.902 0.351 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -114.68 121.47 43.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.477 ' HA ' HG22 ' A' ' 103' ' ' ILE . 7.7 mt -91.17 112.64 25.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.444 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -77.51 -63.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 t -133.16 154.09 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 4.4 mt -126.18 104.13 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.83 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 60.02 24.13 13.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.74 -33.31 4.99 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.9 m -65.2 98.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 106.8 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 25.8 mt -79.89 -31.23 40.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 7.3 p -52.75 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.78 -27.8 2.18 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.267 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.405 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 0.2 OUTLIER -98.72 159.73 29.66 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.887 0.375 . . . . 0.0 111.427 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 -172.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.837 2.358 . . . . 0.0 112.537 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.27 -46.22 23.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.192 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.6 m -53.16 -42.41 66.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.641 ' O ' HG12 ' A' ' 89' ' ' ILE . 85.1 m -64.52 -48.72 74.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.637 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 76.2 m -55.63 -57.22 12.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.98 -42.51 37.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -61.15 -35.15 76.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.269 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 85' ' ' THR . 8.6 mm -58.91 -49.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.513 HG21 ' HB ' ' B' ' 0' ' ' ILE . 31.2 mt -72.1 -46.45 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.44 -23.99 28.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -42.49 43.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.037 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 0.8 OUTLIER -92.47 56.35 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 -27.52 22.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.511 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -94.93 35.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.485 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.489 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 4.3 mt-30 -102.24 150.6 23.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.416 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.0 p -91.87 -13.8 30.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.616 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.431 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -148.65 137.83 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.339 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 t -122.15 104.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.896 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.53 126.28 35.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.837 179.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.886 0.374 . . . . 0.0 110.965 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -123.73 90.43 3.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 70' ' ' ILE . 1.1 pt -109.36 170.86 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.623 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 69' ' ' GLN . 3.2 p -122.81 127.98 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.292 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.411 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' -3' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.782 0.242 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.73 119.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -1' ' ' TYR . . . . . 0.431 ' CE1' HG23 ' A' ' 34' ' ' VAL . 19.6 m-85 -110.67 142.69 42.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.364 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' C ' HG13 ' A' ' 104' ' ' VAL . 1.7 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.359 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.3 m-85 -69.45 150.96 46.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.21 127.9 3.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.793 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.6 104.64 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.407 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.839 HG11 ' HG ' ' A' ' 64' ' ' LEU . 13.8 t -82.78 142.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HE1' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.96 104.34 6.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.234 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 31' ' ' LEU . 15.4 mm -106.63 99.67 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.451 . . . . 0.0 111.263 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' CB ' ' HD3' ' A' ' 98' ' ' ARG . 1.9 mp0 -85.72 109.89 18.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.262 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.49 -166.61 2.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 111.069 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.99 163.56 18.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -58.07 161.64 3.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.64 11.48 62.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' LEU . 48.2 mt-10 -126.45 34.39 4.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.853 0.326 . . . . 0.0 110.406 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -78.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.083 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' GLU . 31.7 tp 176.51 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.819 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.34 62.62 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.575 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.983 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.98 157.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.05 0.452 . . . . 0.0 111.935 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.685 HG21 ' HG2' ' B' ' -3' ' ' PRO . 43.9 t -122.34 129.25 75.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.369 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.82 152.85 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.959 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' HD11 ' A' ' 83' ' ' LEU . 27.1 m -146.27 166.67 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.072 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' O ' HD11 ' A' ' 48' ' ' ILE . 39.9 mt-10 -57.85 132.06 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.4 p -72.74 83.81 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.451 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.81 -4.73 90.24 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.961 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.67 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.668 0.27 . . . . 0.0 110.515 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.59 -25.21 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.825 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 81.79 48.03 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.486 0.66 . . . . 0.0 111.248 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.758 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.9 mt -63.55 -35.99 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.536 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.865 HD13 ' HE1' ' A' ' 71' ' ' MET . 0.5 OUTLIER -149.34 110.3 3.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.797 178.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.7 Cg_endo -56.47 84.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.188 1.925 . . . . 0.0 112.483 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.24 -154.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.386 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -109.0 163.59 6.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.682 0.277 . . . . 0.0 110.907 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -122.2 130.34 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.049 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -70.0 90.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.02 -14.45 47.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.613 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -157.64 159.65 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.063 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -151.92 139.28 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.481 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.717 ' CE ' HD11 ' A' ' 30' ' ' ILE . 6.7 mtm -74.97 96.13 3.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.371 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -62.46 79.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.42 -29.49 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.218 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.65 -166.34 15.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.171 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.3 Cg_endo -69.12 -16.46 40.26 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.569 2.179 . . . . 0.0 112.422 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.07 50.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.028 0.442 . . . . 0.0 110.705 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -34.89 56.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.532 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -58.99 -47.25 85.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 t -62.5 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.46 -28.18 12.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.884 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' CB ' HG13 ' A' ' 21' ' ' VAL . 11.9 mtpp -58.17 -26.28 62.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.839 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.3 mt -101.92 126.28 48.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.487 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 6.2 p-10 -141.75 140.26 33.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.049 HD13 HG22 ' A' ' 49' ' ' ILE . 27.2 mm -48.72 146.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.54 59.57 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.813 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.9 m-20 -105.2 152.64 22.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.797 0.332 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -107.48 115.54 30.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.7 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -86.42 125.07 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.065 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.865 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -90.03 -63.24 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.299 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.8 p -139.47 145.77 39.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.376 . . . . 0.0 111.417 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.0 mt -115.42 116.26 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.1 m-80 55.25 27.65 10.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.346 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.57 -28.2 12.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.804 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.927 HG21 HG23 ' A' ' 89' ' ' ILE . 3.1 m -65.95 99.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.791 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.7 m -67.69 125.23 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.6 mt -105.19 -20.72 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -57.98 85.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.498 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.91 -41.84 1.1 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.117 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.869 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -77.45 159.86 76.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.419 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.81 -168.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.884 2.389 . . . . 0.0 112.687 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.23 -49.94 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.284 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.0 t -52.74 -39.98 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.526 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.869 HG22 HD13 ' A' ' 81' ' ' LEU . 97.6 m -63.15 -49.48 74.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.552 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.2 m -57.84 -48.19 80.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -50.38 -44.16 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.079 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 25.5 m -60.97 -37.41 82.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.534 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 76' ' ' THR . 14.1 mm -58.51 -49.67 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.769 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.8 mt -73.94 -50.52 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.19 -23.98 38.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -40.12 90.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.208 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.4 pp -93.74 48.19 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 110.92 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.46 -7.07 51.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.555 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -120.2 34.32 5.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.315 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -92.43 155.92 17.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.239 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 t -108.04 -9.71 15.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.126 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.9 tpp85 -154.42 114.31 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.374 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.635 ' CG1' HD21 ' A' ' 101' ' ' LEU . 12.7 t -99.31 104.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.558 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -92.66 97.66 10.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -107.02 154.57 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 111.155 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -124.12 86.85 2.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.437 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.0 pt -111.74 169.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.304 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.658 HG22 ' CG ' ' A' ' 18' ' ' PHE . 27.3 t -118.05 111.08 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.909 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.647 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.685 ' HG2' HG21 ' A' ' 34' ' ' VAL . 89.1 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 N-CA-C 112.784 0.263 . . . . 0.0 112.784 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 54.6 99.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.799 0.333 . . . . 0.0 111.426 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 34' ' ' VAL . 49.0 m-85 -90.76 137.99 31.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.9 pp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.78 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.0 tp10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CD1' HG13 ' A' ' 104' ' ' VAL . 4.0 m-85 -58.25 143.87 42.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 125.63 3.35 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 111.487 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.27 104.65 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.466 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 ' HG ' ' A' ' 64' ' ' LEU . 17.6 t -85.76 141.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.103 0.477 . . . . 0.0 111.435 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -132.28 104.7 6.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.323 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 31' ' ' LEU . 8.8 mm -106.66 99.68 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.353 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -79.54 109.87 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.93 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 4.9 pttm -133.13 -170.4 2.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.968 0.414 . . . . 0.0 111.38 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -121.26 170.32 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.231 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.51 162.07 16.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.937 0.398 . . . . 0.0 110.74 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.52 20.09 50.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.302 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 31' ' ' LEU . 51.3 mt-10 -132.14 31.94 4.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.249 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -81.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.307 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 23' ' ' ILE . 20.4 tp 177.75 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.221 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.75 59.45 2.1 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.575 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -147.9 156.97 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.471 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 39.2 t -125.22 123.75 65.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.109 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.484 HD12 HG11 ' A' ' 47' ' ' VAL . 1.9 pt -114.02 145.66 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.28 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.692 ' HA ' HD11 ' A' ' 83' ' ' LEU . 34.7 m -138.11 166.76 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' HD11 ' A' ' 48' ' ' ILE . 31.6 mt-10 -55.87 133.76 51.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.452 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 23.2 p -76.16 83.57 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.463 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -80.34 -7.26 88.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.036 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.955 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.36 -162.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.499 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.29 8.24 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.871 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.42 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.68 49.25 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.643 0.735 . . . . 0.0 111.19 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.955 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.5 mt -59.56 -40.6 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.771 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.965 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -150.61 87.87 4.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.004 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.66 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.163 2.575 . . . . 0.0 113.63 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.86 -92.87 0.17 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.953 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.14 167.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.61 129.93 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.052 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.093 HG22 HD13 ' A' ' 66' ' ' ILE . 66.7 mt -68.5 94.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.43 -2.42 54.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.33 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.475 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -169.88 159.94 8.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.6 mtm -158.94 138.61 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.433 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.688 ' CE ' HD11 ' A' ' 30' ' ' ILE . 19.7 mtm -72.95 105.16 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.17 74.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.91 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.53 -33.56 0.17 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.946 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.95 -179.19 32.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.941 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.446 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 31.4 Cg_exo -58.93 -16.47 32.3 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.464 2.11 . . . . 0.0 112.601 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.01 53.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 110.813 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -36.98 55.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.497 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -57.73 -46.85 83.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.458 ' CB ' HD13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -63.14 -65.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.19 29.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.387 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.754 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -56.88 -35.52 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.854 ' HG ' HG11 ' A' ' 21' ' ' VAL . 6.9 mt -97.61 118.06 33.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -129.09 141.06 51.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG22 ' A' ' 49' ' ' ILE . 48.2 mm -47.57 143.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 111.832 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.66 11.38 58.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.592 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.877 ' HB3' HD12 ' A' ' 103' ' ' ILE . 64.9 m-20 -101.59 161.38 13.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.564 ' HB2' HG23 ' A' ' 104' ' ' VAL . 1.9 mm100 -119.99 97.99 5.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 103' ' ' ILE . 3.4 mt -67.6 143.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.574 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 44' ' ' LEU . 12.3 mmt -111.94 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -125.61 138.35 53.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 111.445 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.869 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.5 mt -112.79 108.32 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.654 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.602 ' ND2' HD22 ' A' ' 93' ' ' LEU . 90.1 m-20 59.69 21.17 9.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.164 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.96 -34.45 4.47 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.596 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -66.69 104.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.747 0.308 . . . . 0.0 111.116 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 p -68.13 146.59 53.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD11 ' CD1' ' A' ' 73' ' ' ILE . 13.9 mt -120.02 -28.41 5.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.308 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.2 p -56.72 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.56 -21.87 2.71 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.305 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -100.86 162.41 20.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.983 0.391 . . . . 0.0 111.543 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 44.9 Cg_endo -66.8 -171.65 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.045 2.496 . . . . 0.0 112.584 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.45 -50.47 11.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.37 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 p -52.99 -36.51 60.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.713 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' ILE . 77.5 m -66.87 -50.81 61.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.56 -49.75 73.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 110.707 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -50.33 -49.48 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.16 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.462 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 3.2 t -55.04 -37.95 67.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 76' ' ' THR . 23.5 mm -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.175 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.5 mt -67.68 -50.23 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.462 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.03 -20.0 62.01 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.85 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.46 -19.18 70.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.485 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 73' ' ' ILE . 2.2 pp -116.33 51.83 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 110.948 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.0 tttt -78.48 -30.74 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -97.75 32.6 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -95.9 155.88 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.016 0.436 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -104.26 -12.84 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 tpp85 -148.5 126.75 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.741 HG12 HD21 ' A' ' 101' ' ' LEU . 18.9 t -110.42 104.79 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -91.28 127.69 36.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.583 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -140.36 154.81 46.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.026 0.441 . . . . 0.0 111.211 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 91.4 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.877 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -114.9 172.61 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.125 0.488 . . . . 0.0 112.309 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -113.23 119.02 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.979 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.456 ' CG ' HG21 ' A' ' 34' ' ' VAL . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.914 0.297 . . . . 0.0 112.282 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.44 HG22 ' O ' ' B' ' -2' ' ' VAL . 10.7 p -99.57 -10.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.46 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.456 ' CD2' ' HG3' ' A' ' 53' ' ' MET . 26.2 m-85 62.78 167.13 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.376 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.791 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.76 ' CD1' HG22 ' A' ' 104' ' ' VAL . 1.6 m-85 -62.81 153.22 33.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.994 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.69 124.45 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.0 111.517 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.91 102.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.185 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.7 ' HB ' HD12 ' A' ' 101' ' ' LEU . 37.3 t -88.15 112.32 23.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -106.3 113.52 27.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.699 HD13 ' OG ' ' A' ' 61' ' ' SER . 16.0 mm -111.37 99.85 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.468 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.87 124.64 29.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -157.09 -172.07 3.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.255 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -111.47 176.83 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.655 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -72.99 157.03 38.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.742 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.52 11.05 67.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.615 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 31' ' ' LEU . 16.9 mt-10 -124.32 32.84 5.4 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.285 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.752 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 14.4 -80.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.994 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 23' ' ' ILE . 5.1 tp 174.43 -49.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.297 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.37 69.79 1.12 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.79 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.03 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -154.06 155.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 117.01 0.405 . . . . 0.0 111.656 178.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' B' ' -3' ' ' PRO . 55.1 t -118.72 128.94 75.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.505 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.568 ' O ' HD21 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -119.7 141.82 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.34 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 83' ' ' LEU . 32.7 m -136.51 163.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HD11 ' A' ' 48' ' ' ILE . 14.4 mt-10 -50.96 134.81 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.468 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.1 p -78.17 83.66 4.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.596 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.09 -7.65 88.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.946 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.839 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.63 -161.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.429 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.75 -25.98 7.52 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.717 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.76 33.58 0.07 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.839 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.7 mt -47.34 -40.86 6.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.034 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -146.72 97.2 4.29 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.08 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 12.2 Cg_endo -56.11 91.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.551 2.167 . . . . 0.0 113.097 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.796 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.61 -91.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.063 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -160.3 167.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.787 0.327 . . . . 0.0 111.362 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.9 130.52 68.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.789 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.058 HG22 HD13 ' A' ' 66' ' ' ILE . 49.5 mt -69.16 88.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.52 -13.0 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.785 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.59 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -159.83 160.31 33.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.751 0.31 . . . . 0.0 110.888 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 ttp -147.82 134.1 19.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.03 0.443 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.425 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -70.48 83.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.569 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CG ' ' HG2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -56.24 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 163.32 -28.21 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.409 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.74 -165.36 39.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.08 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.1 Cg_endo -69.11 -16.31 40.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.506 2.137 . . . . 0.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -49.39 73.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.727 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' CG ' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -77.76 -37.09 49.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -63.69 -41.37 98.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.23 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.699 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -46.45 -71.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.254 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.05 15.72 10.45 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.802 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.37 -32.1 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.918 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.683 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.5 mt -85.61 126.9 34.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -140.65 129.92 23.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.058 HD13 HG22 ' A' ' 49' ' ' ILE . 24.9 mm -45.02 143.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.944 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 11.94 55.01 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.736 ' CB ' HD12 ' A' ' 103' ' ' ILE . 3.1 m-20 -107.03 159.83 16.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 1.2 mm100 -113.85 114.55 26.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.901 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -84.9 136.02 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.613 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 30.6 mmt -96.06 -69.12 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 24.3 p -132.39 146.68 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.69 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.79 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -120.17 120.1 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.776 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 61.01 19.42 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.332 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 -27.47 10.85 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.792 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.762 HG21 HD12 ' A' ' 89' ' ' ILE . 3.0 m -71.23 111.6 6.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.943 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.519 ' O ' HD21 ' A' ' 81' ' ' LEU . 22.1 p -76.17 142.48 41.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.311 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HA ' HD21 ' A' ' 81' ' ' LEU . 65.9 mt -111.12 -20.65 12.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.161 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.402 HG22 ' SD ' ' A' ' 71' ' ' MET . 16.7 t -59.98 92.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.409 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.98 -22.15 3.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.469 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.616 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -102.04 161.05 24.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 111.481 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 57.8 Cg_endo -69.16 -167.49 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.0 112.572 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -78.1 -50.15 12.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.268 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -52.4 -38.22 58.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 HD13 ' A' ' 81' ' ' LEU . 36.3 m -64.39 -49.16 72.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.519 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.29 -51.6 69.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.771 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' HG11 ' B' ' -2' ' ' VAL . 56.8 mt-30 -49.63 -39.88 37.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 2.8 m -64.96 -37.95 89.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.659 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.762 HD12 HG21 ' A' ' 76' ' ' THR . 23.9 mm -58.65 -49.97 80.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.022 HG21 HD13 ' B' ' 0' ' ' ILE . 38.1 mt -72.94 -49.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -57.4 -22.82 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.452 . . . . 0.0 110.741 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.51 -39.33 61.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.171 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -94.83 46.16 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.752 ' CD ' HG23 ' A' ' 30' ' ' ILE . 21.1 ttpp -76.73 -36.01 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -88.79 51.57 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.123 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -111.24 172.37 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.393 0.616 . . . . 0.0 111.573 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.6 p -113.99 -7.1 13.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.656 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.791 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.2 ttm180 -161.94 150.43 15.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 31' ' ' LEU . 4.0 t -133.09 113.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.65 130.96 38.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 HG23 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -140.06 154.92 47.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -127.3 90.72 3.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.901 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -113.63 172.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.45 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.76 HG22 ' CD1' ' A' ' 18' ' ' PHE . 24.3 t -111.73 119.93 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.625 ' HB2' HG11 ' A' ' 34' ' ' VAL . 68.0 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 CA-C-O 120.724 0.218 . . . . 0.0 112.385 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.666 HG11 ' OE1' ' A' ' 87' ' ' GLN . 18.4 t -59.55 136.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.575 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -120.31 138.68 53.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.03 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.841 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.637 ' HZ ' HD22 ' A' ' 44' ' ' LEU . 2.2 m-85 -58.94 151.57 21.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.815 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 129.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.95 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.8 122.73 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.744 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.914 HG13 ' CB ' ' A' ' 63' ' ' LYS . 44.3 t -106.68 111.48 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -107.84 114.91 29.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 99' ' ' VAL . 19.9 mm -114.16 99.25 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 112.48 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.949 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.71 -170.81 2.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.336 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -117.46 158.23 24.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.522 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HG3' ' CA ' ' A' ' 95' ' ' ASN . 8.6 mptt -58.38 145.89 36.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.947 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.51 18.45 79.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.382 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -129.19 29.1 5.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.137 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 19.17 -82.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.123 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . 15.3 tp 179.24 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.916 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.447 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.45 62.53 1.63 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.598 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.067 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.22 155.9 7.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.966 0.413 . . . . 0.0 111.433 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' -3' ' ' PRO . 30.7 t -123.67 116.35 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.791 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -104.46 146.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.259 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.852 ' HA ' HD12 ' A' ' 83' ' ' LEU . 30.0 m -135.66 167.3 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 48' ' ' ILE . 2.0 mt-10 -56.08 131.19 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 51.4 p -74.25 84.49 1.89 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.539 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -82.7 -6.7 88.26 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.917 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.11 -163.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.714 0.292 . . . . 0.0 110.287 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.38 -26.38 6.92 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.798 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 p 80.0 51.7 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.801 0.81 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.3 mt -61.18 -41.75 90.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.774 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.976 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -149.2 81.53 7.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.103 178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.35 90.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.536 2.824 . . . . 0.0 114.136 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.976 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -136.41 -96.43 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.149 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -156.14 167.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-O 120.687 0.279 . . . . 0.0 111.05 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.14 128.68 62.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.035 HG22 HD13 ' A' ' 66' ' ' ILE . 52.4 mt -67.78 90.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.45 -8.88 55.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.158 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.589 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.4 t-20 -162.01 159.81 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.006 0.431 . . . . 0.0 111.405 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 13.4 ttm -152.0 148.11 27.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.7 mtt -56.07 -22.41 27.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 61.09 47.26 7.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.63 -34.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.134 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.63 -171.18 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.11 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 51.0 Cg_exo -54.02 -24.83 34.01 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.428 2.085 . . . . 0.0 112.408 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.71 70.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.001 0.429 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -39.38 44.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.709 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -53.26 -47.23 69.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.44 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -56.32 5.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.06 -16.8 53.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.066 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.914 ' CB ' HG13 ' A' ' 21' ' ' VAL . 25.1 mmmt -57.3 -30.08 64.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.368 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HG11 ' A' ' 21' ' ' VAL . 26.0 mt -103.12 134.68 46.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -144.15 128.19 17.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.035 HD13 HG22 ' A' ' 49' ' ' ILE . 30.5 mm -44.1 142.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.125 0.488 . . . . 0.0 111.891 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.31 18.37 46.22 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.464 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.827 ' HB3' HD12 ' A' ' 103' ' ' ILE . 78.9 m-20 -112.31 164.8 12.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.756 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -118.65 116.49 26.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.176 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.724 HG23 HG22 ' A' ' 103' ' ' ILE . 5.6 mt -85.87 143.99 10.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.219 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.798 ' CE ' HD13 ' A' ' 44' ' ' LEU . 8.3 mmt -112.17 -67.52 0.99 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 132.11 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 111.692 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.876 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.3 mt -115.96 114.18 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 58.51 23.86 11.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.4 -35.5 4.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.672 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.72 HG21 HG23 ' A' ' 89' ' ' ILE . 3.7 m -68.63 117.1 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.356 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.54 154.17 34.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.876 HD11 ' CD1' ' A' ' 73' ' ' ILE . 61.9 mt -121.49 -37.58 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -53.23 91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.303 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.32 -24.84 2.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.117 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -103.6 160.95 24.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 111.406 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.37 -169.6 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.859 2.372 . . . . 0.0 112.726 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.18 -47.74 17.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.816 ' N ' HD23 ' A' ' 83' ' ' LEU . 17.8 m -53.15 -42.06 65.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.451 . . . . 0.0 110.446 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.653 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.9 m -65.05 -49.28 70.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.764 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.418 ' HA ' HD22 ' A' ' 78' ' ' LEU . 90.2 m -55.76 -56.2 23.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.324 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.403 ' CG ' HD11 ' A' ' 35' ' ' ILE . 92.2 mt-30 -48.88 -46.11 42.13 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 110.14 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.93 -36.93 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.556 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 HG21 ' A' ' 76' ' ' THR . 24.8 mm -57.99 -49.95 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.973 HG21 HD13 ' B' ' 0' ' ' ILE . 44.0 mt -71.25 -43.71 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.7 ' HG3' HG22 ' B' ' 0' ' ' ILE . 8.7 mttp -54.96 -24.86 25.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.88 -45.43 42.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.337 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -85.95 58.86 5.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.912 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.559 ' CD ' HG23 ' A' ' 30' ' ' ILE . 22.1 ttpp -87.37 -31.34 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.273 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' CA ' ' HG3' ' A' ' 27' ' ' LYS . 71.1 m-80 -113.8 65.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.337 . . . . 0.0 111.595 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.4 mm100 -118.95 -28.45 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t 75.44 5.87 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.994 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.9 ttm180 -165.07 127.48 2.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.062 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.01 126.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 0.0 111.932 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -108.71 108.87 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -127.37 117.58 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.228 0.537 . . . . 0.0 112.356 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 90.77 8.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.977 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -109.02 171.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.068 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.4 p -115.38 131.6 67.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.725 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 73.8 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.755 0.231 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.3 t -58.41 150.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.855 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -117.86 138.06 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.327 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.067 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.596 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' C ' HG13 ' A' ' 104' ' ' VAL . 9.3 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.996 0.426 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.8 m-85 -67.73 154.28 41.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.648 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -166.83 126.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.512 . . . . 0.0 112.13 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 106.44 3.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.062 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -93.29 104.25 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.128 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.87 104.78 15.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.663 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -102.55 99.29 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.29 109.82 9.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -130.36 -177.23 4.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.595 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -113.86 168.88 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.82 155.09 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.923 0.392 . . . . 0.0 110.698 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.6 15.14 73.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.469 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -129.45 32.8 4.6 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.942 0.401 . . . . 0.0 110.248 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.59 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 13.74 -80.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.273 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.953 HD13 HG21 ' A' ' 99' ' ' VAL . 13.6 tp 175.67 -45.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.789 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 85.38 63.63 1.56 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.609 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 HD11 ' B' ' 0' ' ' ILE . 1.0 OUTLIER -153.28 155.81 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 111.323 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.63 HG21 ' HG2' ' B' ' -3' ' ' PRO . 46.5 t -123.5 129.02 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.5 pt -114.53 144.22 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.774 ' HA ' HD22 ' A' ' 83' ' ' LEU . 27.1 m -137.13 165.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' O ' HD11 ' A' ' 48' ' ' ILE . 7.1 mt-10 -54.47 133.83 45.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 48' ' ' ILE . 52.4 p -76.28 83.08 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.451 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.68 -4.45 90.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.707 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.898 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.75 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.22 -26.66 6.7 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.667 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.436 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.78 44.98 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.501 0.667 . . . . 0.0 111.56 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.898 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.1 mt -59.15 -35.02 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.49 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.799 ' O ' HG22 ' A' ' 46' ' ' THR . 85.0 mt -155.65 96.32 2.4 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.029 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.3 91.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.653 2.235 . . . . 0.0 113.497 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.11 -90.15 0.33 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.69 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.66 167.58 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.879 0.371 . . . . 0.0 111.463 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.84 129.56 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.629 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.051 HG22 HD13 ' A' ' 66' ' ' ILE . 66.6 mt -68.57 89.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.4 -15.77 45.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.049 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.643 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -154.38 158.99 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.729 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.8 ttp -149.2 137.45 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.534 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -53.42 -24.63 13.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.351 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m80 60.61 46.4 9.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.494 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.63 -38.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.051 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -174.01 2.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.942 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.8 Cg_exo -53.78 -24.07 29.24 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.357 2.038 . . . . 0.0 112.313 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.416 ' HB1' ' SD ' ' A' ' 52' ' ' MET . . . -65.68 -49.12 69.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 110.733 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.2 -39.0 50.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.524 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -55.8 -47.15 77.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 t -65.15 -64.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.783 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.9 -24.34 19.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.5 mtpt -58.15 -25.53 61.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.788 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -103.41 131.61 50.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -144.06 133.93 23.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.419 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.051 HD13 HG22 ' A' ' 49' ' ' ILE . 26.7 mm -44.91 142.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.004 0.431 . . . . 0.0 111.924 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.56 13.53 47.36 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.662 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.844 ' HB3' HD12 ' A' ' 103' ' ' ILE . 66.4 m-20 -102.88 162.43 12.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 2.3 mm100 -119.24 98.11 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.777 HG23 HG22 ' A' ' 103' ' ' ILE . 3.5 mt -71.97 143.84 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.618 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.712 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 15.2 mmt -108.97 -69.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.849 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.84 142.03 51.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.337 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.808 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.7 mt -115.35 106.95 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.78 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 58.15 26.39 13.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.06 -36.43 3.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.997 HG21 HD12 ' A' ' 89' ' ' ILE . 3.2 m -67.78 107.74 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.43 ' O ' HD21 ' A' ' 81' ' ' LEU . 10.9 t -72.71 148.7 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.081 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.808 HD11 ' CD1' ' A' ' 73' ' ' ILE . 62.6 mt -118.49 -12.44 9.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.516 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' SD ' ' A' ' 71' ' ' MET . 14.2 t -69.99 101.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.677 0.275 . . . . 0.0 111.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.28 6.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.29 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -104.4 158.12 32.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.011 0.405 . . . . 0.0 111.421 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.69 -172.07 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.945 2.43 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 36' ' ' VAL . 12.1 tp -78.12 -44.34 26.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -41.1 65.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.083 0.468 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 81' ' ' LEU . 56.6 m -64.26 -52.77 57.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.2 m -56.58 -50.03 73.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.402 ' NE2' ' HG ' ' A' ' 83' ' ' LEU . 9.9 mt-30 -50.19 -42.87 52.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 109.962 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -61.12 -37.21 81.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.997 HD12 HG21 ' A' ' 76' ' ' THR . 17.6 mm -58.83 -49.84 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.61 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.821 HG21 HD13 ' B' ' 0' ' ' ILE . 22.3 mt -68.98 -50.32 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.51 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.4 -25.1 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.996 0.427 . . . . 0.0 110.765 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.83 -46.27 90.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.969 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -88.79 66.92 8.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 110.659 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -40.88 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.357 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -88.87 50.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.292 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.72 150.4 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 111.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 p -92.32 -8.14 45.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.459 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.28 145.49 5.86 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.778 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.953 HG21 HD13 ' A' ' 31' ' ' LEU . 1.4 t -112.48 104.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 0.0 111.915 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HE3' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -85.1 121.14 27.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.886 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.912 HD21 HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -138.91 154.36 48.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 111.128 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.97 89.89 3.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.844 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.5 pt -107.9 171.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 0.0 112.282 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 18' ' ' PHE . 5.1 t -122.82 113.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.409 ' CD ' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.63 ' HG2' HG21 ' A' ' 34' ' ' VAL . 78.6 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 CA-C-O 120.744 0.227 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.9 t 69.12 -67.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.534 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER 68.14 99.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.308 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.004 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.82 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 104' ' ' VAL . 24.8 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.5 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 9.7 m-85 -62.89 146.79 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.985 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 124.01 2.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.974 0.416 . . . . 0.0 111.48 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.51 131.47 42.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.278 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 29.9 t -112.89 132.81 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.37 106.26 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -110.86 99.3 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.89 109.73 14.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.19 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 6.0 pttm -131.59 -169.01 2.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.211 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.5 177.74 4.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.245 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -79.86 162.16 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.761 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.96 13.92 28.76 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.905 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -123.04 33.69 5.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 109.972 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.707 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.4 OUTLIER 14.51 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.43 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER 174.12 -42.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.005 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 86.91 62.08 1.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.621 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.34 155.83 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.952 0.406 . . . . 0.0 111.299 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' CE1' ' B' ' -1' ' ' TYR . 22.3 t -120.58 131.36 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.157 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.801 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -116.6 156.96 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.495 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.71 169.46 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.975 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' HD11 ' A' ' 48' ' ' ILE . 17.5 mt-10 -62.14 130.62 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.871 0.367 . . . . 0.0 110.984 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.0 p -69.94 84.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.619 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.99 -3.96 88.81 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.896 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.845 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.1 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 110.462 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.74 -26.2 7.72 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.875 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.82 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.426 0.631 . . . . 0.0 111.244 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.845 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 72.9 mt -60.87 -40.17 84.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.567 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -149.38 117.03 3.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.574 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 20.7 Cg_endo -61.21 102.58 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.199 1.933 . . . . 0.0 113.234 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 HG13 ' A' ' 79' ' ' VAL . 1.3 p -153.54 -154.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.123 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -109.32 158.1 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.646 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -119.22 133.34 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.111 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.082 HG22 HD13 ' A' ' 66' ' ' ILE . 54.5 mt -69.74 95.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.67 -1.88 52.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.67 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.454 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -170.57 159.52 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.71 144.67 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.914 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.707 ' CE ' HD11 ' A' ' 30' ' ' ILE . 5.4 mtt -55.9 -22.6 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 61.95 50.51 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.682 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.53 -36.05 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.054 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 -171.8 1.54 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.111 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 49.3 Cg_exo -55.74 -23.64 42.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.544 2.162 . . . . 0.0 112.493 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.56 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -66.5 -50.11 64.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.06 -38.4 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -57.36 -47.12 82.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -57.24 -74.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 15.18 8.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.444 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 61.5 mtpt -108.56 -24.75 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.816 ' HG ' HG11 ' A' ' 21' ' ' VAL . 69.0 mt -103.0 118.66 37.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -131.62 140.72 49.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.741 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.082 HD13 HG22 ' A' ' 49' ' ' ILE . 47.0 mm -47.33 145.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.554 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.01 7.17 59.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.862 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.4 m-20 -99.85 157.27 16.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 0.268 . . . . 0.0 110.558 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -117.32 112.23 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.881 0.372 . . . . 0.0 110.684 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.824 HG23 HG22 ' A' ' 103' ' ' ILE . 5.8 mt -78.94 138.76 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.83 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.9 mmm -103.57 -67.49 0.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.211 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 p -131.2 133.51 45.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -105.56 117.07 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.809 ' ND2' HD13 ' A' ' 93' ' ' LEU . 66.5 m-20 56.64 27.32 12.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.1 -30.4 9.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.842 HG21 HG23 ' A' ' 89' ' ' ILE . 37.7 m -61.73 100.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 111.124 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.05 114.92 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.745 HD21 HD12 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.34 25.15 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 46' ' ' THR . 22.0 t -72.71 87.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.587 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 45' ' ' PRO . . . 134.74 -17.09 4.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.509 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.49 157.07 73.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.618 0.246 . . . . 0.0 110.775 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -175.05 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.519 2.146 . . . . 0.0 111.972 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 36' ' ' VAL . 23.6 tp -78.11 -46.43 20.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.983 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 52.8 p -53.63 -40.87 66.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 89' ' ' ILE . 69.8 m -66.14 -50.9 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -55.79 -57.02 13.76 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.66 0.267 . . . . 0.0 111.283 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.801 ' HA ' HD11 ' A' ' 35' ' ' ILE . 18.2 pt20 -50.09 -40.22 44.93 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -63.78 -33.82 76.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.252 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.842 HG23 HG21 ' A' ' 76' ' ' THR . 5.8 mm -58.93 -49.4 83.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.037 HG21 HD13 ' B' ' 0' ' ' ILE . 35.5 mt -71.06 -47.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.125 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.689 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -55.64 -23.61 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.05 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -33.91 48.84 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.193 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.809 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.3 pp -104.25 46.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.402 . . . . 0.0 110.704 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.23 -23.55 35.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.245 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -91.95 42.42 1.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.4 135.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.41 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 t -78.53 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.183 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 ttm180 -145.51 127.5 15.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.02 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 31' ' ' LEU . 11.6 t -112.93 104.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -87.73 126.47 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.766 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -137.7 117.83 13.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.273 0.559 . . . . 0.0 112.302 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 71' ' ' MET . 1.1 m120 -89.37 97.69 11.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.7 pt -121.33 172.64 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.131 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 17' ' ' GLU . 22.7 t -115.97 110.76 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.412 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.029 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.44 ' HB2' HG11 ' A' ' 34' ' ' VAL . 58.6 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.79 0.246 . . . . 0.0 112.231 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.413 HG21 ' HE3' ' A' ' 91' ' ' LYS . 11.1 p -57.64 154.06 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 34' ' ' VAL . 3.7 m-85 -127.43 123.38 35.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.037 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.95 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.83 0.347 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.2 m-85 -58.85 144.27 44.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.329 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.591 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -164.85 128.47 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.306 0.574 . . . . 0.0 112.11 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.43 101.64 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.019 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.2 t -82.27 115.84 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -116.53 104.52 11.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.27 99.53 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.0 OUTLIER -77.39 109.89 11.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.78 -170.91 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.36 154.09 25.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -56.67 153.95 9.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.27 12.12 79.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.597 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' LEU . 38.0 mt-10 -124.93 31.68 5.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.204 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.926 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 18.49 -81.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 175.74 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.72 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.51 65.1 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.427 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.043 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.15 156.08 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 111.893 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 77.1 t -117.69 129.7 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.637 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -118.11 150.78 20.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.9 m -147.49 166.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.206 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 48' ' ' ILE . 21.7 mt-10 -56.3 133.48 52.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.474 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 60.5 p -74.37 83.51 1.93 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.435 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.91 -3.87 90.28 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.73 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.95 -164.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.629 0.252 . . . . 0.0 110.541 179.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.06 -24.86 7.01 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.823 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.73 54.96 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.578 0.704 . . . . 0.0 111.217 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.73 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 60.3 mt -70.71 -36.33 64.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.624 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.807 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -150.04 110.14 3.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.782 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_endo -56.09 86.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.207 1.938 . . . . 0.0 112.62 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.18 -155.32 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.17 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.9 OUTLIER -107.71 161.87 6.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.625 0.25 . . . . 0.0 110.745 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -120.33 133.13 68.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.771 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.056 HG22 HD13 ' A' ' 66' ' ' ILE . 61.0 mt -73.62 91.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.73 -13.9 44.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.844 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.65 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -156.59 159.56 38.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 111.144 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.2 ttm -153.36 130.66 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' GLY . 8.2 mtm -64.95 93.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -57.86 80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.29 -28.74 0.27 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.743 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.07 18.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.844 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.9 Cg_endo -69.52 -14.36 36.71 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.808 2.339 . . . . 0.0 113.043 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 -52.32 60.25 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 -40.21 30.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -50.81 -47.22 60.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.447 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.16 -70.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.62 16.72 6.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.345 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.744 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.3 mmmm -101.08 -28.5 12.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.691 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD2' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -103.89 134.71 46.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -142.51 127.34 18.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.255 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.056 HD13 HG22 ' A' ' 49' ' ' ILE . 22.4 mm -43.31 142.56 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 112.078 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.3 45.29 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.428 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.855 ' HB3' HD12 ' A' ' 103' ' ' ILE . 89.5 m-20 -104.27 178.88 4.43 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.946 0.403 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.447 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -134.33 114.92 13.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.704 HG23 HG22 ' A' ' 103' ' ' ILE . 5.4 mt -87.89 125.07 41.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.056 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.795 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.63 -44.77 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.668 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 p -158.51 144.64 17.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.705 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -118.7 126.4 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.015 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.525 ' ND2' HD13 ' A' ' 93' ' ' LEU . 88.7 m-20 53.84 26.92 6.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.358 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.9 -21.78 40.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.768 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 89' ' ' ILE . 3.5 m -67.89 101.36 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 m -65.69 111.27 3.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HD12 ' A' ' 73' ' ' ILE . 48.5 mt -90.99 -20.66 21.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 22.0 t -54.61 88.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.366 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.67 -25.94 4.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.691 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.8 mt -77.52 152.68 81.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.99 -169.51 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 111.95 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.569 HD22 ' NE2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -78.31 -52.25 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.227 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -53.07 -40.72 64.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.5 m -65.05 -50.2 67.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 78' ' ' LEU . 92.2 m -58.85 -50.44 73.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.682 0.277 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.569 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.2 mt-30 -49.4 -43.66 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.176 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 35.3 m -61.27 -38.83 88.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.657 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.77 HD12 HG21 ' A' ' 76' ' ' THR . 24.1 mm -58.25 -50.13 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.761 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 0' ' ' ILE . 24.1 mt -67.74 -50.23 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.08 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.63 -21.11 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.93 -39.05 55.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.6 OUTLIER -93.25 45.77 1.18 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.902 0.382 . . . . 0.0 110.989 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.926 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.37 -5.97 58.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -114.8 49.96 1.0 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.688 0.28 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.74 161.41 30.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.675 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 t -93.5 -11.5 31.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.538 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 16.9 mmt85 -141.26 138.88 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.771 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 31' ' ' LEU . 13.5 t -113.03 103.74 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -90.83 118.57 30.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.445 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.03 117.44 12.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 95.25 9.73 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -117.64 171.46 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.167 0.508 . . . . 0.0 111.999 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.723 HG23 ' SD ' ' A' ' 71' ' ' MET . 40.5 t -124.62 128.1 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.647 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.503 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 49.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.937 0.307 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.02 -23.26 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.806 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 34' ' ' VAL . 10.8 m-85 63.59 136.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 33' ' ' VAL . 1.8 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.666 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 104' ' ' VAL . 17.6 tp10 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.4 m-85 -66.28 153.34 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.564 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.95 125.98 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 0.0 111.31 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.71 106.39 7.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.402 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.5 t -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.532 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -129.06 104.33 7.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.035 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 31' ' ' LEU . 11.6 mm -105.9 99.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.451 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 98' ' ' ARG . 1.6 mp0 -82.92 109.29 16.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -132.08 -171.41 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.916 0.388 . . . . 0.0 111.359 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.57 156.57 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -59.93 154.43 18.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.011 0.434 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.52 13.13 74.15 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.416 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' LEU . 15.9 mt-10 -124.79 32.26 5.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.391 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.704 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 17.73 -80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.159 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 178.06 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.075 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.481 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 85.13 60.51 1.83 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.756 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.066 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.7 156.78 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 111.45 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' B' ' -3' ' ' PRO . 20.2 t -123.7 121.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.114 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 47' ' ' VAL . 2.1 pt -111.75 149.21 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.189 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.0 m -137.2 168.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.06 130.85 48.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.681 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' HD11 ' A' ' 48' ' ' ILE . 49.6 p -71.41 83.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.544 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -5.36 87.14 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.713 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.0 -162.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 110.948 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -53.17 -18.83 6.94 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.765 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.4 m 107.48 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.598 0.759 . . . . 0.0 111.082 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.763 HG22 ' HG ' ' A' ' 44' ' ' LEU . 81.4 mt 57.71 -65.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.353 0.597 . . . . 0.0 111.399 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.957 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -138.54 81.66 23.83 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.798 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 76.8 Cg_exo -50.57 93.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.641 2.227 . . . . 0.0 113.072 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.957 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.77 -87.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.29 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.3 167.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 120.661 0.267 . . . . 0.0 111.059 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.06 126.94 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 66' ' ' ILE . 65.0 mt -66.18 91.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 -8.73 55.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.31 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.619 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -163.68 162.06 23.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.441 . . . . 0.0 111.316 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.1 ttm -153.8 134.28 13.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.679 ' CE ' HD11 ' A' ' 30' ' ' ILE . 4.9 mtt -50.93 -26.07 5.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.247 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 57.6 56.44 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 110.686 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -35.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.07 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.5 -160.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.911 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.4 Cg_endo -69.13 -22.65 34.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 112.212 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.57 77.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.026 0.441 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -38.61 52.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -59.21 -29.96 67.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.241 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -73.42 -68.31 0.51 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.804 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.37 -32.82 5.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.369 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -60.69 -27.15 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.705 0.288 . . . . 0.0 110.983 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -97.97 126.6 43.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.02 137.08 27.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 49' ' ' ILE . 24.3 mm -46.0 145.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.13 14.09 58.0 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.428 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.883 ' HB3' HD12 ' A' ' 103' ' ' ILE . 83.6 m-20 -103.7 163.0 12.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.671 0.272 . . . . 0.0 110.899 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.42 106.44 11.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.822 HG23 HG22 ' A' ' 103' ' ' ILE . 3.2 mt -78.72 139.68 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.634 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 mmt -104.38 -68.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.2 t -124.11 140.84 52.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.985 0.421 . . . . 0.0 111.579 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -117.56 109.79 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.456 ' OD1' HD13 ' A' ' 93' ' ' LEU . 21.7 m120 59.09 25.94 14.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.186 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.8 -34.73 5.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.681 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.73 HG21 HG23 ' A' ' 89' ' ' ILE . 3.9 m -67.85 109.88 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.429 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -74.44 147.46 41.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 73' ' ' ILE . 81.2 mt -115.89 -22.06 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.241 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 71' ' ' MET . 13.1 t -62.88 102.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.411 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.24 -30.53 4.28 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.337 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.469 HD13 ' CG2' ' A' ' 85' ' ' THR . 0.2 OUTLIER -93.98 159.49 34.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.957 0.408 . . . . 0.0 111.387 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.94 -174.33 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.943 2.428 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -77.89 -43.39 30.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -53.32 -41.53 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.156 0.503 . . . . 0.0 110.527 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.612 ' O ' HG12 ' A' ' 89' ' ' ILE . 63.7 m -64.79 -50.49 66.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.73 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.498 ' HA ' HD22 ' A' ' 78' ' ' LEU . 64.0 m -55.53 -57.2 12.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.328 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' SER . 16.9 pt20 -50.14 -39.53 43.61 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.7 t -61.65 -38.06 86.33 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.208 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 76' ' ' THR . 24.3 mm -58.96 -49.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.739 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.066 HG21 HD13 ' B' ' 0' ' ' ILE . 29.0 mt -69.34 -50.42 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.825 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.73 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.9 -42.68 68.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.988 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.5 OUTLIER -91.63 52.18 2.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.569 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.704 ' HG3' HG23 ' A' ' 30' ' ' ILE . 1.4 tmmm? -88.0 -20.75 25.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.932 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -99.85 49.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.738 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.565 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.3 pt20 -128.41 -179.14 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.564 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.1 m -123.68 -3.85 8.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.3 134.56 24.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 110.476 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 31' ' ' LEU . 3.9 t -119.38 104.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.39 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -97.4 97.86 9.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.456 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.97 154.99 23.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.57 91.86 3.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.883 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -113.62 172.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 18' ' ' PHE . 9.8 t -121.44 124.76 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.658 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.905 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.538 ' CG ' HG21 ' A' ' 34' ' ' VAL . 34.8 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.801 0.251 . . . . 0.0 112.403 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.3 -15.89 7.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.712 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 64.79 170.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.03 0.443 . . . . 0.0 111.321 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.597 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 104' ' ' VAL . 4.7 m-85 -58.63 154.1 15.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.45 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.33 125.93 1.9 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.183 0.516 . . . . 0.0 112.024 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 101.15 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.354 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.833 HG13 ' HB2' ' A' ' 63' ' ' LYS . 22.7 t -82.73 108.23 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.56 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' CE1' ' CG ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.89 104.76 15.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 31' ' ' LEU . 17.2 mm -104.83 99.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 6.6 mp0 -82.31 117.23 22.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.01 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.74 -170.93 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -117.76 -179.54 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.47 161.7 30.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.36 15.17 58.69 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' ILE . 41.6 mt-10 -129.59 33.5 4.47 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 110.269 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 8.25 -78.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.225 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 23' ' ' ILE . 11.2 tp 176.27 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.822 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 87.07 63.67 1.44 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.515 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.079 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.78 156.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.195 179.033 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' -3' ' ' PRO . 45.9 t -126.45 123.95 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -109.51 148.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.649 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.3 m -140.74 167.58 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.501 ' O ' HD11 ' A' ' 48' ' ' ILE . 11.5 mt-10 -54.56 135.16 46.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.377 . . . . 0.0 110.807 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 48' ' ' ILE . 53.1 p -78.54 83.11 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.807 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.28 -4.87 87.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.604 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.925 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.09 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 122.338 0.255 . . . . 0.0 110.383 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.41 -26.63 7.22 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.689 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.434 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.75 40.31 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.402 0.62 . . . . 0.0 111.605 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.925 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.9 mt -54.21 -35.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.611 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.806 ' O ' HG22 ' A' ' 46' ' ' THR . 89.2 mt -155.09 96.55 2.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.147 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.2 Cg_endo -55.53 92.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.569 2.18 . . . . 0.0 113.45 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.65 -88.8 0.22 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.785 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.46 167.64 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.501 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.74 131.06 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -68.9 92.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.3 -6.5 55.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.219 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.622 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.5 t-20 -163.53 157.72 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -154.82 133.96 12.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.529 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 30' ' ' ILE . 10.8 mtm -75.07 96.75 3.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.31 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -62.97 78.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 170.71 -33.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.057 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.33 -168.1 18.52 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.927 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.1 -16.33 40.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.456 2.104 . . . . 0.0 112.471 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.15 65.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.191 0.519 . . . . 0.0 110.607 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -77.22 -36.45 54.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.87 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -58.01 -47.27 83.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.85 -7.64 59.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.288 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.833 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmt -72.86 -29.56 63.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 21' ' ' VAL . 92.4 mt -101.45 120.06 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -132.49 133.6 43.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.426 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.029 HD13 HG22 ' A' ' 49' ' ' ILE . 28.1 mm -45.65 143.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.063 0.459 . . . . 0.0 111.7 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.53 57.54 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.564 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.891 ' HB3' HD12 ' A' ' 103' ' ' ILE . 0.9 OUTLIER -105.34 172.01 7.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.46 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -128.37 112.34 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.357 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 HG22 ' A' ' 103' ' ' ILE . 3.3 mt -82.88 142.89 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.659 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.673 ' SD ' HG21 ' A' ' 46' ' ' THR . 14.1 mmt -105.7 -70.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.36 131.8 52.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.435 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.892 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -103.6 111.73 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m120 60.43 20.11 9.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.84 -33.46 5.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.743 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.537 HG21 HD12 ' A' ' 89' ' ' ILE . 3.6 m -68.71 100.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 110.985 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m -65.94 149.05 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 73' ' ' ILE . 63.0 mt -116.89 -22.82 8.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.367 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG22 ' SD ' ' A' ' 71' ' ' MET . 34.6 t -50.44 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.348 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.606 ' C ' HD23 ' A' ' 81' ' ' LEU . . . 116.33 1.65 20.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.985 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 80' ' ' GLY . 2.2 mt -108.13 151.24 41.28 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.954 0.377 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.91 168.02 25.04 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.59 2.193 . . . . 0.0 111.828 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.2 tp -62.01 -45.24 94.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.969 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -43.06 68.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.462 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.7 m -65.27 -51.31 61.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 78' ' ' LEU . 33.0 m -55.73 -56.24 22.84 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.422 ' HG3' HD12 ' A' ' 83' ' ' LEU . 28.6 mt-30 -49.44 -41.13 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.105 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 44.8 m -61.53 -38.77 88.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.424 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 85' ' ' THR . 19.8 mm -58.26 -49.98 79.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.972 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.988 HG21 HD13 ' B' ' 0' ' ' ILE . 14.5 mt -75.67 -50.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.185 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.492 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -55.77 -23.89 32.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 110.911 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.32 -44.1 76.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.222 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.5 pp -85.82 62.62 7.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.068 0.461 . . . . 0.0 110.942 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.611 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -84.61 -23.54 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.13 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.8 38.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.257 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -96.73 162.2 13.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.191 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.6 p -118.52 -10.7 10.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.532 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 4.1 tpp85 -156.03 116.07 3.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.186 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 101' ' ' LEU . 10.3 t -99.09 117.86 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.901 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.25 97.8 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.144 179.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -109.73 155.3 21.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.451 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -125.66 91.52 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.909 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -111.51 169.83 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.619 HG22 ' CD1' ' A' ' 18' ' ' PHE . 4.7 t -116.28 124.81 72.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.696 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' A' ' 34' ' ' VAL . 70.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.712 0.213 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' -2' ' ' VAL . 30.9 m -57.27 124.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 34' ' ' VAL . 12.5 m-85 -102.33 113.16 26.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.079 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 104' ' ' VAL . 2.4 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.9 m-85 -58.93 153.11 18.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -166.91 125.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 112.065 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.3 103.37 2.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.99 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.929 HG11 ' HG ' ' A' ' 64' ' ' LEU . 26.2 t -87.16 108.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.491 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -96.83 112.18 24.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.453 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.27 102.62 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.28 114.99 24.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -145.06 -171.54 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.215 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -109.68 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.342 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -55.4 148.57 14.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.46 14.4 82.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.126 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 31' ' ' LEU . 3.2 mt-10 -128.02 31.21 5.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.592 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 14.48 -79.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.348 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.57 -47.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.66 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 89.72 67.58 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.651 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.08 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.71 155.97 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.326 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.4 t -116.8 128.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.715 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.2 pt -116.03 149.85 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.609 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' HD22 ' A' ' 83' ' ' LEU . 31.0 m -141.68 167.71 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.032 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.77 129.69 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.516 ' HA ' HD11 ' A' ' 48' ' ' ILE . 70.0 p -70.8 84.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.344 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.47 90.05 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.96 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.777 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.01 -163.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.663 0.268 . . . . 0.0 110.59 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.94 -25.38 7.33 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.788 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 4.7 p 80.43 44.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.694 0.759 . . . . 0.0 111.61 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.777 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 78.4 mt -58.64 -37.68 66.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -148.58 104.73 3.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.884 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' GLY . 51.6 Cg_exo -52.71 94.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.091 1.861 . . . . 0.0 112.612 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -145.02 -153.74 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -109.27 164.6 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.595 0.236 . . . . 0.0 110.634 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.54 129.3 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.041 HG22 HD13 ' A' ' 66' ' ' ILE . 71.2 mt -67.61 93.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.22 -6.15 51.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.287 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -165.59 162.52 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -150.86 144.08 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.259 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.592 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.0 mtm -57.13 -28.56 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 61.47 61.02 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.82 -33.54 0.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.196 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -165.78 6.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.055 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.9 Cg_endo -69.13 -16.93 40.56 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.443 2.095 . . . . 0.0 112.407 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.05 70.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.19 -34.21 56.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.748 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -59.62 -47.23 86.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.041 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 m -59.68 -52.19 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.55 64.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.076 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB2' HG13 ' A' ' 21' ' ' VAL . 2.3 mmmt -72.13 -31.56 66.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.929 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.0 mt -97.23 99.89 11.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -119.59 144.9 46.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 49' ' ' ILE . 51.7 mm -47.22 142.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.722 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 9.28 61.96 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.927 ' HB3' HD12 ' A' ' 103' ' ' ILE . 25.3 m-20 -96.97 154.5 17.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.682 0.277 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 6.2 mm100 -111.08 111.44 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.971 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 103' ' ' ILE . 3.2 mt -86.57 113.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.748 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -77.6 -64.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.256 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.39 148.43 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.836 HD12 HD21 ' A' ' 78' ' ' LEU . 2.7 mp -118.91 114.35 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.626 ' OD1' HD13 ' A' ' 93' ' ' LEU . 8.4 m120 60.78 29.77 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.32 -20.0 52.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.804 HG21 HG23 ' A' ' 89' ' ' ILE . 2.9 m -69.86 95.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.774 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -71.87 121.06 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 73' ' ' ILE . 1.3 pp -128.91 28.18 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 46' ' ' THR . 22.7 t -75.39 86.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 140.26 -50.26 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.684 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -51.02 163.82 0.48 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 111.116 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.59 -178.68 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.768 2.312 . . . . 0.0 112.829 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.8 tp -78.26 -45.04 23.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.104 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 9.7 p -53.41 -40.88 65.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.093 0.473 . . . . 0.0 110.69 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.7 m -66.08 -49.25 68.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 74.4 m -55.52 -56.28 22.15 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.286 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.715 ' HA ' HD11 ' A' ' 35' ' ' ILE . 17.3 pt20 -49.18 -46.24 45.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 34.8 t -56.42 -35.18 67.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.345 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 76' ' ' THR . 6.5 mm -59.58 -47.28 91.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.017 HG21 HD13 ' B' ' 0' ' ' ILE . 44.6 mt -69.88 -50.63 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.161 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -63.24 -17.53 62.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.215 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.45 73.61 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.691 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.626 HD13 ' OD1' ' A' ' 74' ' ' ASN . 1.3 pp -117.17 42.86 2.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.02 -7.21 57.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.442 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.61 35.01 1.4 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.666 0.27 . . . . 0.0 111.591 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 2.2 pt20 -126.12 134.67 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.836 0.35 . . . . 0.0 110.31 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -8.71 51.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.757 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.779 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.4 ttm105 -145.35 150.11 36.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 0.0 110.873 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.451 ' CG1' HD21 ' A' ' 101' ' ' LEU . 2.8 t -135.67 118.16 21.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.554 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.1 mtpt -97.73 97.84 9.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.708 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -102.13 153.44 19.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.969 0.414 . . . . 0.0 111.074 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.84 94.49 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.4 pt -120.52 171.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.748 HG23 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -116.45 117.83 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.552 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.602 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.4 Cg_endo . . . . . 0 C--O 1.23 0.123 0 CA-C-O 120.784 0.244 . . . . 0.0 112.291 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.597 HG21 ' OE1' ' A' ' 87' ' ' GLN . 28.5 m -58.41 110.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -100.29 143.05 30.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.113 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.08 HD11 HG22 ' A' ' 33' ' ' VAL . 2.4 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.917 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' C ' HG13 ' A' ' 104' ' ' VAL . 10.1 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CD1' HG22 ' A' ' 104' ' ' VAL . 7.7 m-85 -62.33 154.32 28.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.236 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -167.64 125.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.342 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 101.53 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.862 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.8 t -83.89 116.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.75 104.56 12.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.488 179.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.25 99.74 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.098 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 50.1 mt-10 -75.53 109.99 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -131.51 -173.95 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.4 . . . . 0.0 111.492 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.49 159.34 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.9 156.96 13.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.17 18.03 62.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.355 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -130.23 31.7 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.891 0.377 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.661 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 14.31 -80.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.311 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 99' ' ' VAL . 11.9 tp 177.8 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.866 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.76 61.48 1.86 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.537 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.06 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -147.43 156.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 111.66 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' B' ' -1' ' ' TYR . 37.6 t -120.82 126.79 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.01 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.576 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.8 pt -116.74 144.15 25.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.206 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 83' ' ' LEU . 36.0 m -133.97 163.26 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 124.29 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 48' ' ' ILE . 51.8 p -65.48 84.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.386 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.6 -3.97 90.49 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.754 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -56.17 -162.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -52.94 -18.94 6.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.842 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.2 m 107.27 -86.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.486 0.714 . . . . 0.0 111.004 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.701 HG22 ' HG ' ' A' ' 44' ' ' LEU . 84.4 mt 57.3 -64.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.387 0.613 . . . . 0.0 111.4 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.971 ' O ' HG22 ' A' ' 46' ' ' THR . 1.4 mt -135.87 73.39 60.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.625 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 87.1 Cg_exo -47.1 90.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.882 2.388 . . . . 0.0 113.359 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.971 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.76 -91.57 0.29 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.372 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -154.04 167.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 111.431 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.31 129.59 50.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.775 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.118 HG22 HD13 ' A' ' 66' ' ' ILE . 79.2 mt -66.41 94.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.01 0.91 55.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 m-20 -174.07 161.62 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 111.141 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 mtm -154.96 159.78 40.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.502 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.0 mtt -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 60.96 47.11 7.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.614 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -35.31 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.23 -171.97 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.173 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.11 -21.93 45.03 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.549 2.166 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.65 -49.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.961 0.41 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -39.36 41.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -52.8 -47.39 67.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.393 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -68.9 -61.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.78 -1.97 38.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.196 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.795 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmm -76.97 -28.75 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.862 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -107.04 113.97 27.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.042 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.92 141.41 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.395 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.118 HD13 HG22 ' A' ' 49' ' ' ILE . 42.0 mm -44.87 141.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 111.84 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 17.72 52.37 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.428 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.902 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.5 m-20 -102.83 158.49 16.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.622 0.249 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -117.57 106.99 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.963 HG23 HG22 ' A' ' 103' ' ' ILE . 1.4 mt -85.4 119.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.632 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -80.44 -65.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.66 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -133.64 146.97 51.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 111.473 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.2 mt -113.89 114.37 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.759 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.477 ' OD1' HD22 ' A' ' 93' ' ' LEU . 9.8 m120 59.12 22.22 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.86 8.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.846 HG21 HD12 ' A' ' 89' ' ' ILE . 3.4 m -68.18 108.27 3.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.528 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.3 t -69.98 138.16 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.967 HD11 ' CD1' ' A' ' 73' ' ' ILE . 57.6 mt -111.07 -23.32 10.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.7 t -58.82 98.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.03 -29.47 3.71 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.413 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -96.15 159.8 31.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 111.609 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.74 178.68 2.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.003 2.469 . . . . 0.0 112.517 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.3 tp -72.35 -39.45 68.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.091 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.5 t -53.32 -46.08 69.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.451 . . . . 0.0 110.393 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 89' ' ' ILE . 28.6 m -62.07 -50.5 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.992 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 28.8 m -55.39 -55.77 27.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HA ' HD11 ' A' ' 35' ' ' ILE . 27.9 mt-30 -49.28 -40.48 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 110.289 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -63.57 -37.11 86.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.407 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 HG21 ' A' ' 76' ' ' THR . 27.4 mm -58.15 -49.56 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.987 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.01 HG21 HD13 ' B' ' 0' ' ' ILE . 36.6 mt -71.83 -44.27 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.1 OUTLIER -54.97 -25.36 29.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.828 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.01 -51.05 48.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.091 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.6 pp -79.04 60.96 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 110.953 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.2 ttpm? -87.2 -26.07 23.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.358 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -108.51 51.95 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.33 . . . . 0.0 111.324 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 mt-30 -109.45 163.9 12.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 0.0 111.683 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.0 p -98.47 -10.92 22.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.36 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.69 150.4 10.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.279 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 31' ' ' LEU . 13.1 t -119.91 119.19 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 112.054 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -97.6 117.81 32.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.9 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.37 117.95 13.9 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.994 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.99 96.22 9.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.963 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -120.44 170.46 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.183 0.516 . . . . 0.0 112.229 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.3 t -108.25 113.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.237 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 3.4 ttt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.493 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.443 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.881 0.284 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' VAL . 31.1 m -84.53 161.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.47 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 5.5 m-85 -119.74 160.33 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.06 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' C ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.886 0.374 . . . . 0.0 111.062 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.9 m-85 -59.38 154.28 17.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.49 125.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.105 0.478 . . . . 0.0 111.542 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.8 129.93 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.164 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.4 t -110.39 129.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.08 104.64 9.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 ' CD1' ' A' ' 31' ' ' LEU . 18.1 mm -107.48 99.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.01 110.88 21.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.16 -167.75 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.0 111.307 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.48 172.81 6.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.489 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.93 158.82 34.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.696 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.68 16.62 56.24 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.389 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 31' ' ' LEU . 8.6 mt-10 -126.32 30.83 5.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.755 HG23 ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 16.46 -80.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.966 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.719 HD23 ' CG1' ' A' ' 33' ' ' VAL . 2.9 tp 177.58 -45.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 90.06 64.71 1.23 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.977 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.47 156.35 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.635 HG21 ' HG2' ' B' ' -3' ' ' PRO . 19.6 t -121.18 122.74 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 0.0 111.359 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 HG11 ' A' ' 47' ' ' VAL . 2.4 pt -111.47 142.37 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.0 m -135.18 170.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.645 ' O ' HD11 ' A' ' 48' ' ' ILE . 32.0 mt-10 -60.57 135.22 57.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.461 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.0 p -75.52 83.57 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.432 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -8.47 83.33 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.82 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.994 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.45 -161.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.637 0.256 . . . . 0.0 110.468 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.43 -26.67 7.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.883 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.423 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.98 42.04 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.404 0.621 . . . . 0.0 111.384 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.994 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 89.0 mt -51.49 -42.46 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.887 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.918 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -151.58 89.72 4.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.231 178.418 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 80' ' ' GLY . 85.4 Cg_exo -45.58 111.34 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.974 2.449 . . . . 0.0 113.841 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -156.54 -89.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.48 167.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.236 . . . . 0.0 111.015 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.645 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -133.68 129.41 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.634 ' CG1' HD11 ' A' ' 70' ' ' ILE . 78.9 mt -70.3 96.2 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.84 0.57 52.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.233 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.912 ' HA ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -169.46 161.2 9.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.451 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 14.4 mtm -155.23 134.93 12.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.42 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.489 ' HE1' HD11 ' A' ' 30' ' ' ILE . 13.9 mtm -70.39 95.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.299 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -60.64 80.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.125 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 165.45 -31.45 0.22 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.59 -167.43 31.96 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.086 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 56.5 Cg_endo -69.28 -16.12 39.37 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.652 2.234 . . . . 0.0 112.529 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -66.89 -49.6 65.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 110.83 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.57 -38.59 48.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.43 -47.21 82.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.193 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -59.34 -68.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.55 38.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.165 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.776 ' HB2' HG13 ' A' ' 21' ' ' VAL . 19.5 mmmt -72.33 -30.01 64.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.51 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.689 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -102.7 129.97 49.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.576 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 73.8 m-80 -142.75 138.12 30.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.726 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.912 HD11 ' HA ' ' A' ' 51' ' ' ASN . 6.2 mt -46.67 140.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.202 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.8 16.62 44.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.58 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.866 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.1 m-20 -111.87 157.22 20.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 110.739 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -112.79 117.75 33.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.873 HG23 HG22 ' A' ' 103' ' ' ILE . 2.3 mt -91.8 108.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.787 ' CE ' HD13 ' A' ' 44' ' ' LEU . 21.6 mmt -66.94 -67.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.425 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 53.5 p -131.57 156.07 46.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.348 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HD11 ' A' ' 93' ' ' LEU . 3.3 mt -124.44 109.8 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.493 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.7 m120 64.23 29.42 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.879 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.62 50.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.924 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 89' ' ' ILE . 15.0 m -77.75 95.84 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.741 0.305 . . . . 0.0 111.315 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.425 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 56.4 p -77.02 131.63 38.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.247 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.98 19.26 7.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 23.5 t -60.39 88.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.848 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 133.07 -24.66 3.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.779 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.3 mt -70.72 155.42 93.42 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 110.766 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.99 -173.75 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 tp -78.13 -47.21 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.008 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 p -53.37 -43.35 67.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.085 0.469 . . . . 0.0 110.263 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 89' ' ' ILE . 83.1 m -65.04 -52.23 57.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.852 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.461 ' SG ' HD13 ' A' ' 78' ' ' LEU . 85.9 m -56.56 -50.33 72.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.474 ' OE1' HG11 ' B' ' -2' ' ' VAL . 11.5 mt-30 -49.89 -45.1 50.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 110.07 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -60.26 -35.95 76.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.519 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' THR . 7.5 mm -58.21 -48.99 83.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.432 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.915 HG21 HD13 ' B' ' 0' ' ' ILE . 57.1 mt -73.08 -42.17 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.158 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -55.18 -25.83 35.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.5 69.21 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.397 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 73' ' ' ILE . 2.2 mt -93.31 45.28 1.16 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.755 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.22 -26.68 30.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.193 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.01 35.69 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -105.74 159.78 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.134 0.493 . . . . 0.0 111.635 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 p -114.24 -9.26 12.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.455 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -150.73 134.9 16.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.368 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.646 ' CG1' HD21 ' A' ' 101' ' ' LEU . 13.1 t -122.59 104.84 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 0.0 111.723 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.99 100.48 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -115.57 123.33 48.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.458 . . . . 0.0 112.089 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.3 93.81 9.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.317 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.873 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -114.42 170.25 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.045 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.7 t -115.0 126.51 72.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.822 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.81 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.635 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.9 Cg_endo . . . . . 0 CA--C 1.528 0.215 0 CA-C-O 120.626 0.178 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.474 HG11 ' OE1' ' A' ' 87' ' ' GLN . 23.0 t -45.11 -56.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.584 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 53' ' ' MET . 1.0 OUTLIER 64.16 149.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.07 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.053 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.946 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.519 ' N ' HG23 ' A' ' 104' ' ' VAL . 5.9 m-85 -58.8 154.06 15.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.809 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.73 125.44 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 111.468 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -73.3 105.89 4.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.648 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 101' ' ' LEU . 26.6 t -82.37 132.17 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -123.99 104.71 9.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.645 HD13 ' OG ' ' A' ' 61' ' ' SER . 10.3 mm -110.3 99.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.337 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.81 109.79 20.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.268 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.77 -172.07 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -106.86 163.36 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.42 155.94 27.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.35 16.13 64.49 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.425 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -126.38 30.51 5.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.916 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 19.36 -82.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.957 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.787 ' CD1' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 175.19 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.624 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.45 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 91.19 67.67 1.17 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.814 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.019 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.84 156.53 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.375 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' B' ' -3' ' ' PRO . 36.5 t -124.73 119.81 57.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 47' ' ' VAL . 2.0 pt -110.41 145.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -136.4 165.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 131.62 51.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.025 0.441 . . . . 0.0 110.623 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.471 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.0 p -69.85 84.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.653 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.36 -4.31 89.53 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.832 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.73 -163.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.667 0.27 . . . . 0.0 110.302 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.07 -25.68 7.99 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.77 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 8.9 p 82.21 63.04 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.001 0.905 . . . . 0.0 111.517 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' HD23 ' A' ' 44' ' ' LEU . 48.3 mt -78.91 -32.31 15.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.757 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 80.9 mt -156.13 89.74 2.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.286 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 Cg_exo -49.19 86.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.822 2.348 . . . . 0.0 113.515 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.81 -91.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.055 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 83' ' ' LEU . 2.9 m -160.27 167.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 120.684 0.278 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -133.5 127.68 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.93 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.071 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -67.74 93.39 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.25 55.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.137 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.474 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -165.95 156.82 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.301 . . . . 0.0 110.9 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 ttm -153.38 131.57 11.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.262 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.45 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 6.2 mtm -63.23 100.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.493 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -66.45 73.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.15 -34.13 0.15 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.126 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.3 -168.2 13.85 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.919 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.0 Cg_endo -69.32 -16.57 39.51 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.502 2.134 . . . . 0.0 112.424 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.48 71.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -40.39 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -58.12 -29.67 65.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.645 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -69.23 -66.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.11 -33.47 5.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.136 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 21' ' ' VAL . 15.4 mt -92.6 119.25 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.814 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -133.07 130.07 38.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.585 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.071 HD13 HG22 ' A' ' 49' ' ' ILE . 42.3 mm -45.74 142.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.87 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.96 12.01 55.85 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.502 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 103' ' ' ILE . 69.6 m-20 -105.88 161.33 14.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.785 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.1 119.85 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.767 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -89.7 97.82 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.708 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.81 -64.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.599 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.2 p -137.14 149.9 47.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.26 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 78' ' ' LEU . 3.2 mt -117.59 118.24 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.08 29.09 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.28 11.98 56.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.796 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.88 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -100.65 95.91 7.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.762 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.722 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -58.09 126.7 28.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 73' ' ' ILE . 23.5 mt -109.14 -23.62 11.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.3 t -56.03 88.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.464 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.16 -38.79 1.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.362 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -81.21 159.68 67.23 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.436 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.19 -175.04 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.956 2.438 . . . . 0.0 112.659 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -78.25 -46.42 20.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.0 m -53.6 -42.61 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.996 0.427 . . . . 0.0 110.589 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG12 ' A' ' 89' ' ' ILE . 71.0 m -62.01 -49.28 76.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.7 m -56.56 -46.5 80.69 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.811 0.339 . . . . 0.0 110.729 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' NE2' ' CD1' ' A' ' 83' ' ' LEU . 10.3 mt-30 -52.69 -43.11 65.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.049 0.452 . . . . 0.0 109.896 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.1 p -60.9 -37.23 81.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.422 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.88 HD12 HG21 ' A' ' 76' ' ' THR . 21.0 mm -58.22 -49.44 81.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.963 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.965 HG21 HD13 ' B' ' 0' ' ' ILE . 52.7 mt -71.46 -45.04 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.224 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -58.48 -20.68 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -20.71 67.85 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.055 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.618 HD21 HG21 ' A' ' 73' ' ' ILE . 2.5 pp -100.53 43.88 1.04 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.001 0.401 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.06 -5.89 58.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.291 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -122.55 54.21 1.22 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.871 0.367 . . . . 0.0 111.208 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.78 ' OE1' HG22 ' A' ' 99' ' ' VAL . 3.3 pt20 -136.27 160.48 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -98.79 -15.84 19.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.828 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -139.68 143.87 37.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.749 0.309 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 31' ' ' LEU . 2.4 t -124.65 104.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -95.92 97.6 9.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.225 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -109.51 154.83 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.927 0.394 . . . . 0.0 111.002 -179.459 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.6 OUTLIER -118.94 97.58 5.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.789 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.77 170.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 111.681 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.785 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.5 p -121.4 132.61 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.801 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.642 ' HB2' HG11 ' A' ' 34' ' ' VAL . 71.7 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.837 0.265 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.33 119.35 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 34' ' ' VAL . 2.3 m-85 -100.21 132.17 45.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.01 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.001 0.429 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 13.1 m-85 -60.21 151.94 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.878 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.64 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.35 124.51 2.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.137 0.494 . . . . 0.0 111.18 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 120.54 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.4 t -103.16 147.2 9.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -140.34 104.79 4.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.825 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mm -107.4 99.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -83.99 109.87 17.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.405 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -132.27 -175.32 3.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -104.63 144.27 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.372 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HG2' ' CB ' ' A' ' 95' ' ' ASN . 15.6 mttt -50.24 144.45 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.076 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 10.73 80.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.624 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 31' ' ' LEU . 26.9 mm-40 -124.86 31.05 5.75 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.851 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 25.5 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.089 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 23' ' ' ILE . 56.8 tp 177.56 -41.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.791 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.79 63.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.856 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.025 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -151.11 156.12 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 111.216 178.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' B' ' -3' ' ' PRO . 38.6 t -121.61 129.83 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -119.76 140.84 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.434 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.9 m -131.52 168.15 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -58.91 132.57 54.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.914 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.4 p -74.1 84.08 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -79.27 -7.74 88.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.074 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.59 -162.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 110.322 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.02 -26.5 6.01 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.445 -0.884 . . . . 0.0 111.816 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.31 45.74 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.544 0.688 . . . . 0.0 111.256 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.893 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 83.6 mt -59.01 -39.28 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.942 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.97 ' O ' HG22 ' A' ' 46' ' ' THR . 2.0 mt -146.22 80.99 9.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.386 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 80' ' ' GLY . 94.8 Cg_exo -42.57 91.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.913 2.408 . . . . 0.0 113.581 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.13 -89.42 0.2 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.354 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.667 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.61 167.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.653 0.264 . . . . 0.0 111.205 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.43 129.44 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.075 HG22 HD13 ' A' ' 66' ' ' ILE . 52.2 mt -68.21 91.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -13.26 41.46 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.764 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -158.13 159.1 35.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.975 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.13 129.14 10.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.439 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 3.3 mtm -56.3 102.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.0 70.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.777 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.88 -34.26 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.066 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.09 -167.86 4.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.093 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.5 Cg_endo -69.27 -16.11 39.37 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.813 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.41 -49.69 58.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.856 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -36.87 50.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -56.73 -47.28 80.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -73.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.39 -4.05 23.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.309 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.693 ' HB2' HG13 ' A' ' 21' ' ' VAL . 20.1 mmmt -75.93 -37.49 58.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.539 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.847 HD21 HD13 ' A' ' 101' ' ' LEU . 53.3 mt -91.81 126.53 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -132.15 128.13 37.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.496 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.075 HD13 HG22 ' A' ' 49' ' ' ILE . 43.8 mm -44.18 142.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.5 . . . . 0.0 111.937 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.12 13.33 56.38 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.563 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.908 ' HB3' HD12 ' A' ' 103' ' ' ILE . 87.4 m-20 -102.37 166.93 10.29 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.761 0.315 . . . . 0.0 110.615 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 3.4 mm100 -120.32 105.71 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.762 HG23 HG22 ' A' ' 103' ' ' ILE . 4.9 mt -78.82 129.48 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.706 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -95.42 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 p -126.56 142.26 51.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.598 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 HD21 ' A' ' 78' ' ' LEU . 2.8 mp -120.08 122.85 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.515 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.76 31.23 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.85 14.52 69.71 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.522 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 m -109.14 95.63 5.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -73.56 131.01 41.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.591 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.682 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.24 16.32 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.136 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -63.04 89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.999 0.428 . . . . 0.0 110.28 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 134.63 -22.04 3.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.5 mt -74.1 167.71 33.04 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.276 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 85' ' ' THR . 9.7 Cg_exo -68.9 -177.27 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.751 2.301 . . . . 0.0 111.439 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -78.64 -52.9 7.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 179.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 -38.84 65.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.723 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 89' ' ' ILE . 37.2 m -62.4 -43.12 99.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HG13 ' A' ' 89' ' ' ILE . 77.3 m -58.79 -51.48 69.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HA ' HD11 ' A' ' 35' ' ' ILE . 8.8 mt-30 -50.99 -44.05 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.276 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.5 m -60.42 -35.19 75.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.371 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 85' ' ' THR . 2.8 mm -58.35 -49.43 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.104 HG21 HD13 ' B' ' 0' ' ' ILE . 59.1 mt -71.45 -43.44 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.769 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.38 -24.44 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.84 -42.28 38.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.627 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -89.19 51.15 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 111.142 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.851 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -87.32 -23.84 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.442 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 56.6 m-80 -116.07 63.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.3 mm100 -124.19 -29.78 3.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.602 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 3.8 t 82.28 -2.16 1.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.247 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.1 ttm180 -154.93 134.02 12.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.73 0.3 . . . . 0.0 110.229 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.631 ' CG1' HD21 ' A' ' 101' ' ' LEU . 17.7 t -119.75 104.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.711 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -90.98 100.85 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.71 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.847 HD13 HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -115.84 120.76 40.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 5.3 t30 -90.45 90.58 8.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.908 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.7 pt -111.94 164.63 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.706 HG23 ' SD ' ' A' ' 71' ' ' MET . 61.6 t -103.05 107.96 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.333 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.6 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.715 ' CG ' HG21 ' A' ' 34' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.823 0.26 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.402 HG23 ' N ' ' B' ' -1' ' ' TYR . 18.2 m -55.96 -42.51 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.365 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 34' ' ' VAL . 1.5 m-85 64.97 90.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.104 HD13 HG21 ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.042 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CA ' HG12 ' A' ' 104' ' ' VAL . 5.4 m-85 -58.68 151.98 19.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.965 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -164.38 125.23 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 111.508 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.09 102.14 4.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.4 t -82.7 136.66 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.153 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -124.95 104.77 8.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 61' ' ' SER . 15.3 mm -105.88 99.78 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -86.87 109.82 19.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -138.04 -171.15 2.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.995 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.54 169.38 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.59 156.99 31.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 18.84 61.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.292 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' C ' ' A' ' 30' ' ' ILE . 2.7 mm-40 -127.7 29.5 5.46 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.582 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 10.29 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.326 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 172.75 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.77 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 89.01 66.65 1.26 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.467 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.045 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -149.39 156.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' B' ' -3' ' ' PRO . 21.9 t -121.23 126.51 75.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.721 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.552 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -113.94 151.92 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.77 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 35.2 m -142.61 167.3 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.32 131.1 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 48' ' ' ILE . 25.2 p -70.4 84.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.62 -5.82 89.21 Favored Glycine 0 C--N 1.328 0.135 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.967 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.751 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.24 -163.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.566 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.08 -24.49 6.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.76 36.52 0.08 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.233 0.54 . . . . 0.0 111.404 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.751 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.5 mt -52.45 -36.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.657 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -147.59 101.06 3.74 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.943 178.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 75.6 Cg_exo -51.76 83.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.398 2.065 . . . . 0.0 112.876 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -133.84 -152.35 0.48 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.214 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 83' ' ' LEU . 15.8 m -111.28 166.1 5.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.634 0.254 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.04 131.33 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.019 HG22 HD13 ' A' ' 66' ' ' ILE . 73.1 mt -68.2 93.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.28 -9.58 44.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.238 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.466 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.2 m-20 -162.12 160.22 27.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 111.053 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -152.06 147.65 26.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.582 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.9 mtt -59.64 -27.86 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 60.61 60.85 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.697 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.96 -30.15 0.16 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.278 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.7 -170.68 29.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.043 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.411 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 29.7 Cg_endo -63.09 -17.21 59.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.301 2.001 . . . . 0.0 112.343 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -49.02 66.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -38.77 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -56.38 -45.95 80.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.415 ' CB ' HD13 ' A' ' 23' ' ' ILE . 1.6 p -56.04 -56.15 24.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.93 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -29.21 11.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.289 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.528 ' CB ' HG13 ' A' ' 21' ' ' VAL . 5.4 mtmt -61.02 -29.3 69.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' A' ' 21' ' ' VAL . 86.8 mt -101.69 125.96 48.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.14 147.75 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.019 HD13 HG22 ' A' ' 49' ' ' ILE . 50.8 mm -50.41 146.5 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.647 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.93 59.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.262 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.62 ' HB3' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -102.55 174.18 6.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.689 0.281 . . . . 0.0 110.658 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.68 ' HB2' HG23 ' A' ' 104' ' ' VAL . 3.5 mm100 -130.35 107.8 9.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.147 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.72 HG23 HG22 ' A' ' 103' ' ' ILE . 7.5 mt -88.71 134.2 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.808 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -97.02 -69.91 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t -129.62 144.95 51.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.267 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.966 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -113.88 110.95 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.591 ' ND2' ' H ' ' A' ' 100' ' ' LYS . 30.2 m120 57.69 22.77 8.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.94 -34.21 4.71 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.868 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.85 HG21 HD12 ' A' ' 89' ' ' ILE . 3.8 m -65.55 103.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.795 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 p -68.81 135.59 51.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.309 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.966 HD11 ' CD1' ' A' ' 73' ' ' ILE . 29.5 mt -112.58 -20.16 11.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.089 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 46' ' ' THR . 35.9 t -56.28 88.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.649 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.51 -49.69 0.86 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.361 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.795 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -64.46 159.88 55.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.554 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.67 -177.39 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.037 2.491 . . . . 0.0 112.654 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.587 HD23 HG12 ' A' ' 47' ' ' VAL . 1.9 tm? -78.17 -49.91 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.712 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 m -53.15 -41.14 64.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.991 0.424 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.8 m -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.036 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.0 m -55.7 -54.1 48.41 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' B' ' -2' ' ' VAL . 85.6 mt-30 -49.03 -48.01 44.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.2 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 23.2 t -56.81 -35.26 68.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.556 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.85 HD12 HG21 ' A' ' 76' ' ' THR . 7.0 mm -58.8 -48.58 85.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.999 HG21 HD13 ' B' ' 0' ' ' ILE . 23.7 mt -67.49 -50.55 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.17 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.27 -19.97 62.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.87 -23.22 69.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.583 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.4 pp -113.82 44.27 1.66 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.33 -12.27 43.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.42 39.15 1.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.775 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.02 147.98 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 110.677 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.1 t -83.13 -9.12 59.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 1.9 ttm180 -147.15 141.78 26.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.746 0.308 . . . . 0.0 110.725 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.775 HG22 ' OE1' ' A' ' 96' ' ' GLN . 10.4 t -127.7 104.89 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.36 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.591 ' H ' ' ND2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -88.68 97.91 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.739 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -102.28 154.55 18.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 111.297 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 71' ' ' MET . 2.6 m-20 -124.13 97.65 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.72 HG22 HG23 ' A' ' 70' ' ' ILE . 1.7 pt -121.51 172.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.129 0.49 . . . . 0.0 112.295 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 69' ' ' GLN . 4.3 m -125.9 130.99 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.587 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.527 ' CG ' HG11 ' A' ' 34' ' ' VAL . 68.1 Cg_endo . . . . . 0 N--CA 1.464 -0.243 0 N-CA-C 112.623 0.201 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.529 ' HB ' ' NE2' ' A' ' 87' ' ' GLN . 33.1 t 54.39 87.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.006 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.42 ' CZ ' HG23 ' A' ' 34' ' ' VAL . 1.2 m-85 -81.89 145.77 30.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.045 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.775 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.865 0.364 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 44' ' ' LEU . 6.4 m-85 -64.71 154.44 36.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.784 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.59 125.32 2.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.233 0.539 . . . . 0.0 111.559 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.55 100.15 1.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.502 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 101' ' ' LEU . 24.9 t -82.43 112.01 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.131 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -110.92 104.82 13.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' CB ' ' A' ' 61' ' ' SER . 4.1 mm -105.96 104.16 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.2 mp0 -84.05 110.3 18.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.5 -171.3 2.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -112.22 166.72 11.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -65.05 158.49 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 110.724 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.38 17.77 60.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.487 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -126.81 29.73 5.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 22.77 -82.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.097 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 99' ' ' VAL . 16.7 tp 174.95 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' HA2' ' HE1' ' A' ' 53' ' ' MET . . . 88.49 63.5 1.35 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.819 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.046 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -152.7 156.07 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 117.18 0.49 . . . . 0.0 111.795 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 31.1 t -126.35 116.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.588 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -103.24 152.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.44 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 48' ' ' ILE . 26.8 m -140.09 168.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 48' ' ' ILE . 28.7 mt-10 -58.46 132.14 52.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.939 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.5 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.6 p -74.11 84.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.423 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.84 -9.62 84.22 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.123 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.903 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.23 -161.65 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.723 0.296 . . . . 0.0 110.439 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.73 -26.07 7.55 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.801 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.439 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 9.1 m 80.54 35.87 0.11 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.264 0.554 . . . . 0.0 111.49 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.903 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 74.2 mt -49.25 -39.36 12.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.056 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.906 ' O ' HG22 ' A' ' 46' ' ' THR . 1.5 mt -145.66 87.71 6.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.091 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 6.7 Cg_endo -50.39 90.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.873 2.382 . . . . 0.0 113.308 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.9 -91.58 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.818 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.497 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -158.67 167.58 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.38 131.11 63.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.091 HG22 HD13 ' A' ' 66' ' ' ILE . 56.0 mt -68.1 93.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.06 -1.89 53.73 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.115 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.543 HD21 ' HA ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -170.01 152.6 4.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 110.577 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 mtm -146.7 121.35 9.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 0.0 111.448 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.482 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -54.48 90.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.607 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -59.25 82.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.05 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.76 -29.92 0.27 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.953 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.57 32.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.52 -16.06 38.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.704 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.25 63.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 -33.38 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.751 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -61.37 -45.58 93.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.417 ' CB ' HD13 ' A' ' 23' ' ' ILE . 6.8 m -63.73 -68.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.22 -25.65 17.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.505 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.567 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.89 -27.07 40.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.643 ' HG ' HG11 ' A' ' 21' ' ' VAL . 71.5 mt -98.76 134.53 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -140.43 134.73 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.711 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.091 HD13 HG22 ' A' ' 49' ' ' ILE . 49.4 mm -46.42 144.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.705 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.22 84.57 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.659 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.922 ' HB3' HD12 ' A' ' 103' ' ' ILE . 74.6 m-20 -85.59 164.0 18.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.678 0.275 . . . . 0.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.737 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -119.45 118.29 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 111.193 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.783 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -91.62 108.73 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.53 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.85 -66.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.876 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.8 p -135.65 148.53 48.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.408 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 3.2 mt -118.22 112.5 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.77 23.85 12.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.78 -30.49 7.43 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.886 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.877 HG21 HG23 ' A' ' 89' ' ' ILE . 3.0 m -67.7 102.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.716 0.293 . . . . 0.0 111.039 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.593 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.9 m -69.04 136.75 52.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.054 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HA ' HD21 ' A' ' 81' ' ' LEU . 40.5 mt -112.24 -13.52 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -67.05 94.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.341 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.91 -22.73 3.8 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.479 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.93 157.61 33.57 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.983 0.391 . . . . 0.0 111.472 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.01 -174.15 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.818 2.346 . . . . 0.0 112.801 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -78.15 -48.43 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.459 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 p -52.99 -42.21 65.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.705 HG22 HD13 ' A' ' 81' ' ' LEU . 99.1 m -61.55 -48.33 81.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.839 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' HD12 ' A' ' 81' ' ' LEU . 78.8 m -56.13 -50.16 71.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.883 0.373 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -50.22 -46.2 54.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.305 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.3 m -59.69 -35.7 75.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.64 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.877 HG23 HG21 ' A' ' 76' ' ' THR . 18.2 mm -58.15 -50.0 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.063 HG21 HD13 ' B' ' 0' ' ' ILE . 58.7 mt -69.54 -45.31 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -55.57 -23.42 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.31 -33.3 32.38 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.0 pp -95.65 35.12 1.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.915 0.388 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.76 -5.79 58.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -107.65 43.96 1.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.404 ' CD ' ' HB2' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -131.97 176.07 8.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 110.9 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.2 t -102.17 -16.74 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 28.3 mmt85 -131.21 150.49 52.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 101' ' ' LEU . 7.7 t -129.4 104.3 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mmpt? -90.0 120.92 31.62 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.3 117.84 11.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 111.804 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.78 99.41 12.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.574 178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.922 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.68 167.35 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.153 0.501 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' HB2' ' A' ' 69' ' ' GLN . 4.3 p -112.06 129.09 68.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.247 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 72.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.781 0.242 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.76 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.542 ' CE2' HG23 ' A' ' 34' ' ' VAL . 36.6 m-85 -109.33 131.51 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 90' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.593 ' C ' HG13 ' A' ' 104' ' ' VAL . 2.3 tt0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.83 0.347 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.512 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.0 m-85 -67.29 151.55 47.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.692 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.73 125.9 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.314 0.578 . . . . 0.0 111.616 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.56 105.88 6.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.572 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 63' ' ' LYS . 22.8 t -84.38 141.2 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -132.84 104.53 6.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.217 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 31' ' ' LEU . 14.1 mm -106.57 99.63 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 98' ' ' ARG . 37.2 mt-10 -85.63 109.55 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.023 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -140.54 -172.86 3.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.154 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.8 169.07 8.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.423 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 157.12 30.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.532 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 9.92 65.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.507 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ILE . 4.4 mt-10 -120.13 31.87 6.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.197 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 5.77 -75.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.103 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 99' ' ' VAL . 2.5 tp 171.73 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.844 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 83.15 62.73 1.79 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.249 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.036 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -146.03 156.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 111.715 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.553 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.3 t -119.43 132.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER -117.16 156.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.635 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.749 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.28 165.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.808 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.19 131.82 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.609 ' HA ' HD11 ' A' ' 48' ' ' ILE . 87.5 p -69.13 84.09 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.403 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.47 -1.19 90.24 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.63 ' CE2' ' NE2' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -55.8 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.579 0.228 . . . . 0.0 110.475 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.28 -25.5 8.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.833 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 83.05 64.27 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.739 0.78 . . . . 0.0 111.459 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.586 ' O ' HD23 ' A' ' 44' ' ' LEU . 43.5 mt -83.0 -31.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.841 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -156.51 101.39 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.809 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 9.6 Cg_endo -52.11 83.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.58 2.187 . . . . 0.0 113.363 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -133.45 -157.7 0.83 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.041 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.6 m -105.64 153.36 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.933 0.396 . . . . 0.0 111.651 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -115.78 132.79 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.8 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.063 HG22 HD13 ' A' ' 66' ' ' ILE . 48.8 mt -69.31 90.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.44 -11.3 52.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.192 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.626 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -161.8 159.9 27.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 17.1 ttm -149.15 135.64 19.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.935 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 30' ' ' ILE . 2.9 mtm -51.95 -27.19 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 58.66 54.67 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.676 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.2 -37.14 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.217 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.88 -166.14 2.45 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.951 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 51.0 Cg_endo -68.91 -16.94 41.6 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.292 1.995 . . . . 0.0 112.131 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.53 -44.74 73.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.482 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -39.42 49.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.565 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -58.34 -47.12 84.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -63.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.14 -23.42 27.3 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.287 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.876 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -56.84 -36.59 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 21' ' ' VAL . 23.1 mt -101.08 104.39 15.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.995 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 8.7 p-10 -121.54 141.23 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.531 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.063 HD13 HG22 ' A' ' 49' ' ' ILE . 28.5 mm -46.34 145.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 111.809 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.62 4.82 61.9 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.64 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.6 m-20 -106.07 150.96 25.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.29 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 40' ' ' TRP . 1.3 tt0 -113.08 126.72 55.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.729 HG23 HG22 ' A' ' 103' ' ' ILE . 6.3 mt -88.93 134.87 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.726 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -96.81 -57.82 2.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.241 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.0 p -147.23 145.26 29.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.969 0.414 . . . . 0.0 111.401 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.75 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -115.23 120.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 73' ' ' ILE . 71.9 m-80 55.87 27.98 11.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.37 -26.01 24.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.795 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.655 HG21 HG23 ' A' ' 89' ' ' ILE . 3.4 m -65.51 102.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD21 ' A' ' 81' ' ' LEU . 4.9 t -68.77 131.48 45.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 73' ' ' ILE . 21.0 mt -109.82 -25.34 10.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.715 HG22 HG22 ' A' ' 46' ' ' THR . 26.0 t -54.99 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.524 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.45 -38.09 1.49 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.242 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.66 159.73 57.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.372 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 -172.14 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.847 2.365 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.8 tp -78.04 -45.01 24.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.018 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 7.6 t -53.34 -43.0 67.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.983 0.421 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.683 HG22 HD13 ' A' ' 81' ' ' LEU . 89.7 m -63.86 -48.63 75.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.646 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 71.9 m -55.97 -57.16 13.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.549 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.681 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.4 pt20 -48.86 -42.09 35.33 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.968 0.413 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -60.94 -35.69 77.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.311 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 85' ' ' THR . 13.9 mm -59.0 -49.4 83.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.013 HG21 HD13 ' B' ' 0' ' ' ILE . 29.1 mt -71.96 -46.09 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.721 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.2 mtpt -55.42 -24.41 30.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -47.25 47.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.209 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.33 55.72 3.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 0.0 110.814 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -87.93 -19.47 27.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.288 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -109.29 54.37 0.66 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.785 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.21 156.15 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.618 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 p -93.98 -12.23 29.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.763 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -143.58 139.49 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.522 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 ' OE1' ' A' ' 96' ' ' GLN . 2.7 t -120.87 104.43 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.516 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.38 119.45 32.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.826 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -132.0 154.35 49.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.024 0.44 . . . . 0.0 111.118 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.5 OUTLIER -122.29 92.25 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.2 pt -116.05 170.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 112.161 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.726 HG23 ' SD ' ' A' ' 71' ' ' MET . 35.9 t -119.98 113.9 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.889 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttm105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.961 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.553 ' HG2' HG21 ' A' ' 34' ' ' VAL . 88.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.787 0.264 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 61.35 122.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.375 . . . . 0.0 111.278 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 34' ' ' VAL . 32.9 m-85 -117.84 143.9 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.036 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HE1' HD21 ' A' ' 44' ' ' LEU . 2.5 m-85 -64.2 154.28 35.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.754 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.12 127.57 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 111.834 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.47 102.05 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.524 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 63' ' ' LYS . 24.8 t -82.77 135.3 25.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.022 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -127.28 104.84 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 31' ' ' LEU . 15.0 mm -104.71 99.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -90.07 109.61 20.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.121 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -135.07 -165.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -106.47 162.34 13.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.407 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.81 158.78 15.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.511 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.87 19.48 50.16 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -124.68 29.24 6.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 110.07 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 15.73 -80.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.482 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.566 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER 174.13 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.794 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.17 67.49 1.08 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.59 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.044 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -152.45 156.12 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.707 0.289 . . . . 0.0 111.008 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 47.9 t -120.62 123.64 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.045 0.45 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.565 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -110.91 140.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.803 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.635 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.6 m -133.12 168.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.121 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.6 mt-10 -58.47 132.32 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.3 p -72.92 84.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.469 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.05 -8.44 83.94 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.032 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.974 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.39 -161.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.478 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.4 8.61 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.816 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.424 0.63 . . . . 0.0 111.172 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 92.3 mt -55.95 -42.18 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.944 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -152.63 88.68 3.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.32 178.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.44 108.91 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.123 2.548 . . . . 0.0 114.108 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -154.85 -91.48 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.379 178.315 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.18 167.49 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 110.962 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.513 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.67 130.23 59.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.039 HG22 HD13 ' A' ' 66' ' ' ILE . 66.1 mt -69.09 94.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.5 -1.9 49.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.434 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -166.69 159.36 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.0 ttm -154.07 135.19 13.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.654 ' CE ' HD11 ' A' ' 30' ' ' ILE . 9.7 mtm -71.82 99.84 2.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.59 76.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.84 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -35.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -170.13 18.26 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.997 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 56.2 Cg_endo -69.11 -15.68 39.72 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.541 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.52 67.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.898 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.43 -38.99 48.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -57.47 -47.1 82.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.253 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.8 p -56.9 -63.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.53 -9.19 57.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.321 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.794 ' HB2' HG13 ' A' ' 21' ' ' VAL . 8.8 mmmt -72.93 -31.41 64.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.88 0.371 . . . . 0.0 110.548 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 21' ' ' VAL . 87.5 mt -96.85 130.4 44.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -139.44 134.06 31.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.039 HD13 HG22 ' A' ' 49' ' ' ILE . 50.1 mm -46.49 144.32 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 111.798 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.09 13.25 57.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.8 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.7 m-20 -108.56 160.0 16.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.684 0.278 . . . . 0.0 110.698 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -115.06 119.17 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -90.42 113.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.812 ' CE ' HD13 ' A' ' 44' ' ' LEU . 24.3 mmt -72.98 -66.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.709 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 86.4 p -134.42 160.31 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.719 HD12 HD21 ' A' ' 78' ' ' LEU . 3.3 mt -118.5 111.11 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.73 28.89 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.11 -30.14 5.54 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.222 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 89' ' ' ILE . 11.1 m -78.26 99.98 6.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.465 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 67.3 m -84.8 137.49 33.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.638 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.743 ' HA ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -128.76 24.77 5.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.879 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.6 t -75.64 93.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.005 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.09 -18.78 4.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.143 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.68 163.19 33.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.982 0.391 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.05 -179.28 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.803 2.335 . . . . 0.0 112.417 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 tp -78.13 -44.62 25.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.24 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -53.14 -42.55 66.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.2 m -63.73 -47.8 79.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.715 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.514 ' SG ' HD13 ' A' ' 78' ' ' LEU . 77.0 m -55.76 -57.48 11.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.358 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.447 ' N ' HD11 ' A' ' 35' ' ' ILE . 15.7 pt20 -49.77 -39.95 39.7 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.508 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 16.7 t -62.45 -36.61 82.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.26 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 76' ' ' THR . 2.1 mm -58.84 -49.73 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.347 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.041 HG21 HD13 ' B' ' 0' ' ' ILE . 54.6 mt -69.4 -50.45 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.131 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.62 -22.01 55.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.881 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.15 -30.31 59.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 89' ' ' ILE . 1.1 pp -104.38 35.32 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 111.062 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.82 -5.92 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.592 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.08 35.69 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.682 0.277 . . . . 0.0 111.73 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.53 170.67 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.737 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 t -99.18 -8.74 24.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.855 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.4 ttm180 -139.6 140.03 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 93' ' ' LEU . 13.9 t -130.51 106.1 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.643 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.483 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 7.9 tttt -88.13 131.8 34.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.68 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -142.07 117.9 10.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.002 0.43 . . . . 0.0 111.448 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -89.31 89.66 8.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -111.67 166.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.913 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 69' ' ' GLN . 6.3 p -109.07 122.78 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.638 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 -179.601 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.484 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.3 Cg_endo . . . . . 0 N--CA 1.464 -0.216 0 CA-C-O 120.789 0.245 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.17 142.7 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 0.5 OUTLIER -119.56 115.91 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.044 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.904 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.582 ' C ' HG13 ' A' ' 104' ' ' VAL . 3.2 tp10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.428 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 4.9 m-85 -61.75 148.68 42.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.06 126.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.171 0.51 . . . . 0.0 111.805 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.66 133.01 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.938 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 63' ' ' LYS . 18.9 t -116.29 111.41 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.253 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.749 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.37 115.72 31.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.5 mm -114.86 99.4 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.862 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -88.81 128.31 35.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.327 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.556 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -157.44 -166.83 2.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -115.58 167.43 10.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.87 157.64 17.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.0 110.736 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.92 11.1 73.79 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.542 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -123.96 32.51 5.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.258 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.775 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 10.64 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.154 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.67 ' CD1' HG21 ' A' ' 23' ' ' ILE . 59.1 tp 177.35 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.709 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.62 63.51 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.702 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.45 156.46 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 40.9 t -122.16 117.28 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.56 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -106.18 147.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.471 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.8 m -140.38 169.71 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' O ' HD11 ' A' ' 48' ' ' ILE . 6.5 mt-10 -63.18 129.37 40.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.927 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.51 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.2 p -71.12 83.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.98 -3.56 89.08 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.695 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.876 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.56 -163.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.698 0.285 . . . . 0.0 110.603 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.24 -24.69 7.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.811 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.52 35.38 0.07 Allowed 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.182 0.515 . . . . 0.0 111.562 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.876 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.2 mt -49.1 -39.34 12.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.765 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -148.31 111.69 3.74 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.019 178.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' GLY . 34.8 Cg_exo -59.71 98.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.096 1.864 . . . . 0.0 112.62 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -152.57 -155.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.009 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -106.25 165.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.71 130.53 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.068 HG22 HD13 ' A' ' 66' ' ' ILE . 69.0 mt -71.42 93.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.94 -5.06 53.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.114 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -163.03 164.3 25.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -160.79 132.13 5.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 8.2 mtm -69.3 101.97 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.343 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.84 78.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.26 -30.69 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.164 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.37 -176.1 38.3 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.099 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 34.4 Cg_exo -59.75 -16.55 38.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.594 2.196 . . . . 0.0 112.712 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.24 -50.26 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -32.7 49.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.349 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.26 -47.15 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.287 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -56.54 -69.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.28 22.97 7.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.126 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.771 ' CB ' HG13 ' A' ' 21' ' ' VAL . 8.7 mtpp -107.88 -33.0 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.753 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.763 ' HG ' HG11 ' A' ' 21' ' ' VAL . 54.0 mt -96.03 123.21 39.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.664 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -127.49 133.32 49.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.593 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.068 HD13 HG22 ' A' ' 49' ' ' ILE . 46.6 mm -45.46 141.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.97 15.07 56.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.214 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.938 ' HB3' HD12 ' A' ' 103' ' ' ILE . 98.1 m-20 -101.42 164.63 11.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.779 0.324 . . . . 0.0 110.695 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.523 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 5.2 mm100 -120.32 115.17 23.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -89.06 117.78 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.56 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.5 -64.28 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.376 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.4 t -132.24 146.17 51.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.821 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -117.11 111.3 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.559 HD22 HD22 ' A' ' 93' ' ' LEU . 89.1 m-20 60.92 25.93 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.09 -28.59 11.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.618 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 1.054 HG21 HD12 ' A' ' 89' ' ' ILE . 86.4 m -63.9 96.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.076 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -74.41 117.97 16.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.722 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.795 HD21 HD12 ' A' ' 73' ' ' ILE . 1.2 pp -125.03 27.71 6.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' THR . 24.8 t -74.6 80.22 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 139.23 -13.28 3.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.779 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -83.11 157.8 65.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 110.819 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.1 -174.93 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.577 2.185 . . . . 0.0 111.891 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.5 tp -78.31 -39.95 38.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.699 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.3 p -53.71 -44.69 70.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.349 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.9 m -63.95 -52.97 57.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.859 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 78' ' ' LEU . 73.5 m -55.74 -52.15 64.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.769 0.318 . . . . 0.0 111.002 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.449 ' OE1' HG11 ' B' ' -2' ' ' VAL . 19.2 mt-30 -49.71 -42.62 46.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.021 0.439 . . . . 0.0 109.896 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.3 m -60.9 -36.86 80.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.271 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.054 HD12 HG21 ' A' ' 76' ' ' THR . 14.7 mm -58.98 -49.37 83.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.398 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.133 HG21 HD13 ' B' ' 0' ' ' ILE . 34.6 mt -72.59 -49.96 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.46 -20.33 54.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.895 0.378 . . . . 0.0 110.956 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.38 -28.49 67.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.362 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.4 pp -106.92 57.67 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.7 -30.58 29.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.104 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -96.57 37.47 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -100.69 144.05 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.019 0.438 . . . . 0.0 111.353 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.9 p -96.63 -5.77 38.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.576 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.749 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 10.8 ttm180 -157.0 137.79 13.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.245 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.556 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 2.5 t -132.01 123.87 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -100.8 128.48 46.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.627 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.821 HD23 HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -139.37 116.66 11.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 111.931 -179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -89.05 93.02 9.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.938 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.6 pt -116.34 168.87 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.984 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.582 HG13 ' C ' ' A' ' 17' ' ' GLU . 37.3 t -115.05 119.44 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.544 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 91.1 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 CA-C-O 120.818 0.258 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.449 HG11 ' OE1' ' A' ' 87' ' ' GLN . 9.1 p -64.17 142.81 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 34' ' ' VAL . 4.7 m-85 -112.31 135.69 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.133 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.99 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' C ' HG23 ' A' ' 104' ' ' VAL . 4.3 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.458 ' N ' HG23 ' A' ' 104' ' ' VAL . 7.8 m-85 -65.14 154.52 37.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.17 125.15 3.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 111.734 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.87 101.94 4.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.407 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.843 HG11 ' HG ' ' A' ' 64' ' ' LEU . 15.8 t -83.54 139.3 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.91 104.91 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.527 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.627 HG13 HD21 ' A' ' 31' ' ' LEU . 11.1 mm -103.42 99.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.21 109.98 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.319 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 -174.35 4.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -107.52 176.38 5.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.601 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 155.72 39.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.04 13.97 65.16 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.497 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 30' ' ' ILE . 5.5 mt-10 -125.45 31.19 5.6 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.157 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.61 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 9.83 -78.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.288 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER 173.39 -43.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.757 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.56 60.53 1.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.664 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.02 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -144.92 155.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' O ' ' B' ' -2' ' ' VAL . 88.4 t -123.62 129.37 74.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.744 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.94 153.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.632 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.6 m -141.93 169.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.838 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.2 mt-10 -61.72 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.491 ' HA ' HD11 ' A' ' 48' ' ' ILE . 88.5 p -68.37 84.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.507 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.21 -3.73 87.02 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.801 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.61 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.616 0.246 . . . . 0.0 110.443 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.96 -24.28 6.23 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.766 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 82.16 38.71 0.05 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.327 0.584 . . . . 0.0 111.277 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.769 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.4 mt -54.15 -34.99 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.792 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -152.01 104.41 2.82 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.16 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 61.9 Cg_exo -52.14 84.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.516 2.144 . . . . 0.0 113.14 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -133.72 -154.65 0.61 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -108.12 167.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.5 125.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.993 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -65.18 91.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -8.11 55.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.123 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.533 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -166.26 161.02 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 111.344 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -155.65 142.71 19.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.597 ' CE ' HD11 ' A' ' 30' ' ' ILE . 7.2 mtt -52.66 -25.01 9.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.66 47.75 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.802 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.97 -39.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.05 -169.59 1.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.278 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.19 -23.91 56.14 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.644 2.229 . . . . 0.0 112.196 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -62.65 -49.31 75.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -76.99 -39.02 51.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -50.89 -47.1 60.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.43 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -60.45 -51.95 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.831 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.08 55.62 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mtmt -69.06 -35.27 76.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.843 ' HG ' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -88.03 113.65 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -127.92 135.23 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 49' ' ' ILE . 26.0 mm -46.27 145.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 0.0 111.752 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.45 64.66 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.876 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.856 ' HB3' HD12 ' A' ' 103' ' ' ILE . 3.0 m-20 -106.38 163.43 12.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.902 0.351 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -114.68 121.47 43.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.708 HG23 HG22 ' A' ' 103' ' ' ILE . 7.7 mt -91.17 112.64 25.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.444 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.626 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -77.51 -63.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 t -133.16 154.09 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.935 ' CD1' HD11 ' A' ' 78' ' ' LEU . 4.4 mt -126.18 104.13 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.83 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.526 HD22 HG22 ' A' ' 73' ' ' ILE . 50.9 m-80 60.02 24.13 13.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.74 -33.31 4.99 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.926 HG21 HD12 ' A' ' 89' ' ' ILE . 3.9 m -65.2 98.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.586 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -70.21 106.8 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.935 HD11 ' CD1' ' A' ' 73' ' ' ILE . 25.8 mt -79.89 -31.23 40.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.3 p -52.75 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.78 -27.8 2.18 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.267 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.744 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -98.72 159.73 29.66 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.887 0.375 . . . . 0.0 111.427 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 -172.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.837 2.358 . . . . 0.0 112.537 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.5 tp -77.27 -46.22 23.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.192 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 39.6 m -53.16 -42.41 66.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 110.506 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.707 HG22 HD13 ' A' ' 81' ' ' LEU . 85.1 m -64.52 -48.72 74.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.637 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 76.2 m -55.63 -57.22 12.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.7 pt20 -48.98 -42.51 37.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -61.15 -35.15 76.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.269 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 76' ' ' THR . 8.6 mm -58.91 -49.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.026 HG21 HD13 ' B' ' 0' ' ' ILE . 31.2 mt -72.1 -46.45 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.4 mttm -55.44 -23.99 28.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -42.49 43.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.037 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.8 OUTLIER -92.47 56.35 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.21 -27.52 22.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.511 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -94.93 35.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.485 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -102.24 150.6 23.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.416 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.0 p -91.87 -13.8 30.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.616 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -148.65 137.83 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.339 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 31' ' ' LEU . 14.4 t -122.15 104.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.896 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.53 126.28 35.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.837 179.023 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.886 0.374 . . . . 0.0 110.965 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 71' ' ' MET . 6.8 t30 -123.73 90.43 3.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -109.36 170.86 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.623 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.2 p -122.81 127.98 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.292 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.411 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' -3' ' ' PRO . . . . . 0.731 ' HG2' HG21 ' A' ' 34' ' ' VAL . 67.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.782 0.242 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' -2' ' ' VAL . . . . . 0.782 ' O ' HG22 ' A' ' 34' ' ' VAL . 30.4 m -57.73 119.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' -1' ' ' TYR . . . . . 0.592 ' CE1' HG23 ' A' ' 34' ' ' VAL . 19.6 m-85 -110.67 142.69 42.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.364 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 0' ' ' ILE . . . . . 1.026 HD13 HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' C ' HG13 ' A' ' 104' ' ' VAL . 1.7 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.359 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.3 m-85 -69.45 150.96 46.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.21 127.9 3.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.793 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.6 104.64 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.407 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.839 HG11 ' HG ' ' A' ' 64' ' ' LEU . 13.8 t -82.78 142.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HE1' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.96 104.34 6.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.234 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 31' ' ' LEU . 15.4 mm -106.63 99.67 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.451 . . . . 0.0 111.263 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' CB ' ' HD3' ' A' ' 98' ' ' ARG . 1.9 mp0 -85.72 109.89 18.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.262 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.49 -166.61 2.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 111.069 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.99 163.56 18.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -58.07 161.64 3.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.64 11.48 62.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' LEU . 48.2 mt-10 -126.45 34.39 4.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.853 0.326 . . . . 0.0 110.406 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -78.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.083 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' GLU . 31.7 tp 176.51 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.819 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.34 62.62 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.575 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.983 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.98 157.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.05 0.452 . . . . 0.0 111.935 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.685 HG21 ' HG2' ' B' ' -3' ' ' PRO . 43.9 t -122.34 129.25 75.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.369 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.82 152.85 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.959 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' HD11 ' A' ' 83' ' ' LEU . 27.1 m -146.27 166.67 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.072 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' O ' HD11 ' A' ' 48' ' ' ILE . 39.9 mt-10 -57.85 132.06 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.4 p -72.74 83.81 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.451 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.81 -4.73 90.24 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.961 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.67 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.668 0.27 . . . . 0.0 110.515 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.59 -25.21 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.825 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 81.79 48.03 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.486 0.66 . . . . 0.0 111.248 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.758 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.9 mt -63.55 -35.99 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.536 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.865 HD13 ' HE1' ' A' ' 71' ' ' MET . 0.5 OUTLIER -149.34 110.3 3.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.797 178.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.7 Cg_endo -56.47 84.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.188 1.925 . . . . 0.0 112.483 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.24 -154.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.386 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -109.0 163.59 6.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.682 0.277 . . . . 0.0 110.907 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -122.2 130.34 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.049 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -70.0 90.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.02 -14.45 47.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.613 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -157.64 159.65 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.063 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -151.92 139.28 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.481 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.717 ' CE ' HD11 ' A' ' 30' ' ' ILE . 6.7 mtm -74.97 96.13 3.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.371 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -62.46 79.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.42 -29.49 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.218 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.65 -166.34 15.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.171 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.3 Cg_endo -69.12 -16.46 40.26 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.569 2.179 . . . . 0.0 112.422 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.07 50.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.028 0.442 . . . . 0.0 110.705 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -34.89 56.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.532 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -58.99 -47.25 85.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 t -62.5 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.46 -28.18 12.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.884 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' CB ' HG13 ' A' ' 21' ' ' VAL . 11.9 mtpp -58.17 -26.28 62.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.839 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.3 mt -101.92 126.28 48.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.487 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 6.2 p-10 -141.75 140.26 33.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.049 HD13 HG22 ' A' ' 49' ' ' ILE . 27.2 mm -48.72 146.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.54 59.57 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.813 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.9 m-20 -105.2 152.64 22.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.797 0.332 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -107.48 115.54 30.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.7 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -86.42 125.07 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.065 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.865 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -90.03 -63.24 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.299 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.8 p -139.47 145.77 39.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.376 . . . . 0.0 111.417 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.0 mt -115.42 116.26 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.1 m-80 55.25 27.65 10.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.346 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.57 -28.2 12.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.804 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.927 HG21 HG23 ' A' ' 89' ' ' ILE . 3.1 m -65.95 99.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.791 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.7 m -67.69 125.23 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.6 mt -105.19 -20.72 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -57.98 85.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.498 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.91 -41.84 1.1 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.117 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.869 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -77.45 159.86 76.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.419 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.81 -168.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.884 2.389 . . . . 0.0 112.687 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.23 -49.94 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.284 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.0 t -52.74 -39.98 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.526 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.869 HG22 HD13 ' A' ' 81' ' ' LEU . 97.6 m -63.15 -49.48 74.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.552 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.2 m -57.84 -48.19 80.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -50.38 -44.16 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.079 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 25.5 m -60.97 -37.41 82.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.534 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 76' ' ' THR . 14.1 mm -58.51 -49.67 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.769 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.8 mt -73.94 -50.52 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.19 -23.98 38.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -40.12 90.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.208 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.4 pp -93.74 48.19 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 110.92 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.46 -7.07 51.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.555 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -120.2 34.32 5.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.315 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -92.43 155.92 17.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.239 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 t -108.04 -9.71 15.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.126 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.9 tpp85 -154.42 114.31 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.374 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.635 ' CG1' HD21 ' A' ' 101' ' ' LEU . 12.7 t -99.31 104.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.558 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -92.66 97.66 10.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -107.02 154.57 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 111.155 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -124.12 86.85 2.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.0 pt -111.74 169.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.304 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.658 HG22 ' CG ' ' A' ' 18' ' ' PHE . 27.3 t -118.05 111.08 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.909 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.647 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.685 ' HG2' HG21 ' A' ' 34' ' ' VAL . 89.1 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 N-CA-C 112.784 0.263 . . . . 0.0 112.784 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 54.6 99.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.799 0.333 . . . . 0.0 111.426 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 34' ' ' VAL . 49.0 m-85 -90.76 137.99 31.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.9 pp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.78 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.0 tp10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CD1' HG13 ' A' ' 104' ' ' VAL . 4.0 m-85 -58.25 143.87 42.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 125.63 3.35 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 111.487 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.27 104.65 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.466 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 ' HG ' ' A' ' 64' ' ' LEU . 17.6 t -85.76 141.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.103 0.477 . . . . 0.0 111.435 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -132.28 104.7 6.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.323 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 31' ' ' LEU . 8.8 mm -106.66 99.68 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.353 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -79.54 109.87 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.93 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 4.9 pttm -133.13 -170.4 2.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.968 0.414 . . . . 0.0 111.38 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -121.26 170.32 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.231 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.51 162.07 16.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.937 0.398 . . . . 0.0 110.74 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.52 20.09 50.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.302 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 31' ' ' LEU . 51.3 mt-10 -132.14 31.94 4.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.249 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -81.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.307 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 23' ' ' ILE . 20.4 tp 177.75 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.221 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.75 59.45 2.1 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.575 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -147.9 156.97 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.471 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 39.2 t -125.22 123.75 65.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.109 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.484 HD12 HG11 ' A' ' 47' ' ' VAL . 1.9 pt -114.02 145.66 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.28 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.692 ' HA ' HD11 ' A' ' 83' ' ' LEU . 34.7 m -138.11 166.76 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' HD11 ' A' ' 48' ' ' ILE . 31.6 mt-10 -55.87 133.76 51.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 23.2 p -76.16 83.57 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.463 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -80.34 -7.26 88.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.036 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.955 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.36 -162.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.499 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.29 8.24 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.871 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.42 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.68 49.25 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.643 0.735 . . . . 0.0 111.19 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.955 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.5 mt -59.56 -40.6 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.771 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.965 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -150.61 87.87 4.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.004 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.66 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.163 2.575 . . . . 0.0 113.63 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.86 -92.87 0.17 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.953 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.14 167.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.61 129.93 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.052 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.093 HG22 HD13 ' A' ' 66' ' ' ILE . 66.7 mt -68.5 94.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.43 -2.42 54.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.33 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.475 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -169.88 159.94 8.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.6 mtm -158.94 138.61 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.433 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.688 ' CE ' HD11 ' A' ' 30' ' ' ILE . 19.7 mtm -72.95 105.16 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.17 74.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.91 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.53 -33.56 0.17 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.946 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.95 -179.19 32.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.941 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 31.4 Cg_exo -58.93 -16.47 32.3 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.464 2.11 . . . . 0.0 112.601 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.01 53.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 110.813 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -36.98 55.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.497 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -57.73 -46.85 83.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.458 ' CB ' HD13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -63.14 -65.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.19 29.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.387 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.754 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -56.88 -35.52 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.854 ' HG ' HG11 ' A' ' 21' ' ' VAL . 6.9 mt -97.61 118.06 33.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -129.09 141.06 51.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG22 ' A' ' 49' ' ' ILE . 48.2 mm -47.57 143.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 111.832 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.66 11.38 58.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.592 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.877 ' HB3' HD12 ' A' ' 103' ' ' ILE . 64.9 m-20 -101.59 161.38 13.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.564 ' HB2' HG23 ' A' ' 104' ' ' VAL . 1.9 mm100 -119.99 97.99 5.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 103' ' ' ILE . 3.4 mt -67.6 143.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.574 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 44' ' ' LEU . 12.3 mmt -111.94 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -125.61 138.35 53.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 111.445 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.869 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.5 mt -112.79 108.32 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.654 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.602 ' ND2' HD22 ' A' ' 93' ' ' LEU . 90.1 m-20 59.69 21.17 9.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.164 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.96 -34.45 4.47 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.596 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -66.69 104.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.747 0.308 . . . . 0.0 111.116 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 p -68.13 146.59 53.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD11 ' CD1' ' A' ' 73' ' ' ILE . 13.9 mt -120.02 -28.41 5.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.308 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.2 p -56.72 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.56 -21.87 2.71 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.305 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -100.86 162.41 20.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.983 0.391 . . . . 0.0 111.543 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 44.9 Cg_endo -66.8 -171.65 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.045 2.496 . . . . 0.0 112.584 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.45 -50.47 11.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.37 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 p -52.99 -36.51 60.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.713 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' ILE . 77.5 m -66.87 -50.81 61.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.56 -49.75 73.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 110.707 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -50.33 -49.48 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.16 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.462 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 3.2 t -55.04 -37.95 67.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 76' ' ' THR . 23.5 mm -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.175 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.5 mt -67.68 -50.23 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.462 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.03 -20.0 62.01 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.85 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.46 -19.18 70.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.485 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 73' ' ' ILE . 2.2 pp -116.33 51.83 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 110.948 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.0 tttt -78.48 -30.74 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -97.75 32.6 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -95.9 155.88 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.016 0.436 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -104.26 -12.84 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 tpp85 -148.5 126.75 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.741 HG12 HD21 ' A' ' 101' ' ' LEU . 18.9 t -110.42 104.79 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -91.28 127.69 36.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.583 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -140.36 154.81 46.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.026 0.441 . . . . 0.0 111.211 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 91.4 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.877 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -114.9 172.61 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.125 0.488 . . . . 0.0 112.309 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -113.23 119.02 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.979 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.456 ' CG ' HG21 ' A' ' 34' ' ' VAL . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.914 0.297 . . . . 0.0 112.282 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.44 HG22 ' O ' ' B' ' -2' ' ' VAL . 10.7 p -99.57 -10.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.46 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.456 ' CD2' ' HG3' ' A' ' 53' ' ' MET . 26.2 m-85 62.78 167.13 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.376 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.791 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.76 ' CD1' HG22 ' A' ' 104' ' ' VAL . 1.6 m-85 -62.81 153.22 33.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.994 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.69 124.45 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.0 111.517 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.91 102.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.185 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.7 ' HB ' HD12 ' A' ' 101' ' ' LEU . 37.3 t -88.15 112.32 23.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -106.3 113.52 27.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.699 HD13 ' OG ' ' A' ' 61' ' ' SER . 16.0 mm -111.37 99.85 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.468 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.87 124.64 29.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -157.09 -172.07 3.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.255 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -111.47 176.83 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.655 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -72.99 157.03 38.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.742 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.52 11.05 67.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.615 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 31' ' ' LEU . 16.9 mt-10 -124.32 32.84 5.4 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.285 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.752 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 14.4 -80.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.994 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 23' ' ' ILE . 5.1 tp 174.43 -49.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.297 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.37 69.79 1.12 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.79 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.03 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -154.06 155.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 117.01 0.405 . . . . 0.0 111.656 178.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' B' ' -3' ' ' PRO . 55.1 t -118.72 128.94 75.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.505 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.568 ' O ' HD21 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -119.7 141.82 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.34 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 83' ' ' LEU . 32.7 m -136.51 163.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HD11 ' A' ' 48' ' ' ILE . 14.4 mt-10 -50.96 134.81 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.468 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.1 p -78.17 83.66 4.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.596 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.09 -7.65 88.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.946 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.839 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.63 -161.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.429 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.75 -25.98 7.52 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.717 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.76 33.58 0.07 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.839 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.7 mt -47.34 -40.86 6.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.034 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -146.72 97.2 4.29 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.08 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 12.2 Cg_endo -56.11 91.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.551 2.167 . . . . 0.0 113.097 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.796 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.61 -91.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.063 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -160.3 167.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.787 0.327 . . . . 0.0 111.362 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.9 130.52 68.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.789 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.058 HG22 HD13 ' A' ' 66' ' ' ILE . 49.5 mt -69.16 88.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.52 -13.0 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.785 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.59 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -159.83 160.31 33.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.751 0.31 . . . . 0.0 110.888 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 ttp -147.82 134.1 19.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.03 0.443 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.425 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -70.48 83.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.569 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CG ' ' HG2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -56.24 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 163.32 -28.21 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.409 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.74 -165.36 39.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.08 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.1 Cg_endo -69.11 -16.31 40.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.506 2.137 . . . . 0.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -49.39 73.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.727 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' CG ' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -77.76 -37.09 49.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -63.69 -41.37 98.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.23 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.699 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -46.45 -71.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.254 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.05 15.72 10.45 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.802 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.37 -32.1 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.918 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.683 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.5 mt -85.61 126.9 34.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -140.65 129.92 23.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.058 HD13 HG22 ' A' ' 49' ' ' ILE . 24.9 mm -45.02 143.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.944 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 11.94 55.01 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.736 ' CB ' HD12 ' A' ' 103' ' ' ILE . 3.1 m-20 -107.03 159.83 16.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 1.2 mm100 -113.85 114.55 26.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.901 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -84.9 136.02 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.613 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 30.6 mmt -96.06 -69.12 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 24.3 p -132.39 146.68 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.69 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.79 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -120.17 120.1 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.776 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 61.01 19.42 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.332 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 -27.47 10.85 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.792 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.762 HG21 HD12 ' A' ' 89' ' ' ILE . 3.0 m -71.23 111.6 6.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.943 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.519 ' O ' HD21 ' A' ' 81' ' ' LEU . 22.1 p -76.17 142.48 41.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.311 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HA ' HD21 ' A' ' 81' ' ' LEU . 65.9 mt -111.12 -20.65 12.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.161 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.402 HG22 ' SD ' ' A' ' 71' ' ' MET . 16.7 t -59.98 92.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.409 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.98 -22.15 3.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.469 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.616 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -102.04 161.05 24.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 111.481 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 57.8 Cg_endo -69.16 -167.49 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.0 112.572 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -78.1 -50.15 12.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.268 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -52.4 -38.22 58.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 HD13 ' A' ' 81' ' ' LEU . 36.3 m -64.39 -49.16 72.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.519 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.29 -51.6 69.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.771 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' HG11 ' B' ' -2' ' ' VAL . 56.8 mt-30 -49.63 -39.88 37.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 2.8 m -64.96 -37.95 89.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.659 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.762 HD12 HG21 ' A' ' 76' ' ' THR . 23.9 mm -58.65 -49.97 80.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.022 HG21 HD13 ' B' ' 0' ' ' ILE . 38.1 mt -72.94 -49.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -57.4 -22.82 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.452 . . . . 0.0 110.741 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.51 -39.33 61.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.171 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -94.83 46.16 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.752 ' CD ' HG23 ' A' ' 30' ' ' ILE . 21.1 ttpp -76.73 -36.01 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -88.79 51.57 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.123 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -111.24 172.37 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.393 0.616 . . . . 0.0 111.573 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.6 p -113.99 -7.1 13.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.656 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.791 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.2 ttm180 -161.94 150.43 15.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 31' ' ' LEU . 4.0 t -133.09 113.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.65 130.96 38.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 HG23 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -140.06 154.92 47.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -127.3 90.72 3.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.901 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -113.63 172.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.45 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.76 HG22 ' CD1' ' A' ' 18' ' ' PHE . 24.3 t -111.73 119.93 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.625 ' HB2' HG11 ' A' ' 34' ' ' VAL . 68.0 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 CA-C-O 120.724 0.218 . . . . 0.0 112.385 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.666 HG11 ' OE1' ' A' ' 87' ' ' GLN . 18.4 t -59.55 136.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.575 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -120.31 138.68 53.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.03 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.841 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.637 ' HZ ' HD22 ' A' ' 44' ' ' LEU . 2.2 m-85 -58.94 151.57 21.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.815 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 129.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.95 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.8 122.73 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.744 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.914 HG13 ' CB ' ' A' ' 63' ' ' LYS . 44.3 t -106.68 111.48 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -107.84 114.91 29.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 99' ' ' VAL . 19.9 mm -114.16 99.25 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 112.48 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.949 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.71 -170.81 2.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.336 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -117.46 158.23 24.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.522 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HG3' ' CA ' ' A' ' 95' ' ' ASN . 8.6 mptt -58.38 145.89 36.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.947 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.51 18.45 79.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.382 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -129.19 29.1 5.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.137 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 19.17 -82.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.123 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . 15.3 tp 179.24 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.916 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.447 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.45 62.53 1.63 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.598 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.067 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.22 155.9 7.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.966 0.413 . . . . 0.0 111.433 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' -3' ' ' PRO . 30.7 t -123.67 116.35 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.791 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -104.46 146.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.259 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.852 ' HA ' HD12 ' A' ' 83' ' ' LEU . 30.0 m -135.66 167.3 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 48' ' ' ILE . 2.0 mt-10 -56.08 131.19 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 51.4 p -74.25 84.49 1.89 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.539 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -82.7 -6.7 88.26 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.917 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.11 -163.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.714 0.292 . . . . 0.0 110.287 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.38 -26.38 6.92 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.798 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 p 80.0 51.7 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.801 0.81 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.3 mt -61.18 -41.75 90.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.774 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.976 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -149.2 81.53 7.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.103 178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.35 90.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.536 2.824 . . . . 0.0 114.136 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.976 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -136.41 -96.43 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.149 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -156.14 167.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-O 120.687 0.279 . . . . 0.0 111.05 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.14 128.68 62.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.035 HG22 HD13 ' A' ' 66' ' ' ILE . 52.4 mt -67.78 90.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.45 -8.88 55.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.158 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.589 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.4 t-20 -162.01 159.81 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.006 0.431 . . . . 0.0 111.405 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 13.4 ttm -152.0 148.11 27.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.7 mtt -56.07 -22.41 27.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 61.09 47.26 7.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.63 -34.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.134 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.63 -171.18 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.11 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 51.0 Cg_exo -54.02 -24.83 34.01 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.428 2.085 . . . . 0.0 112.408 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.71 70.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.001 0.429 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -39.38 44.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.709 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -53.26 -47.23 69.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.44 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -56.32 5.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.06 -16.8 53.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.066 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.914 ' CB ' HG13 ' A' ' 21' ' ' VAL . 25.1 mmmt -57.3 -30.08 64.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.368 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HG11 ' A' ' 21' ' ' VAL . 26.0 mt -103.12 134.68 46.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -144.15 128.19 17.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.035 HD13 HG22 ' A' ' 49' ' ' ILE . 30.5 mm -44.1 142.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.125 0.488 . . . . 0.0 111.891 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.31 18.37 46.22 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.464 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.827 ' HB3' HD12 ' A' ' 103' ' ' ILE . 78.9 m-20 -112.31 164.8 12.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.756 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -118.65 116.49 26.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.176 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.724 HG23 HG22 ' A' ' 103' ' ' ILE . 5.6 mt -85.87 143.99 10.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.219 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.798 ' CE ' HD13 ' A' ' 44' ' ' LEU . 8.3 mmt -112.17 -67.52 0.99 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 132.11 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 111.692 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.876 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.3 mt -115.96 114.18 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 58.51 23.86 11.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.4 -35.5 4.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.672 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.72 HG21 HG23 ' A' ' 89' ' ' ILE . 3.7 m -68.63 117.1 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.356 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.54 154.17 34.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.876 HD11 ' CD1' ' A' ' 73' ' ' ILE . 61.9 mt -121.49 -37.58 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -53.23 91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.303 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.32 -24.84 2.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.117 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -103.6 160.95 24.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 111.406 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.37 -169.6 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.859 2.372 . . . . 0.0 112.726 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.18 -47.74 17.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.816 ' N ' HD23 ' A' ' 83' ' ' LEU . 17.8 m -53.15 -42.06 65.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.451 . . . . 0.0 110.446 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.653 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.9 m -65.05 -49.28 70.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.764 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.418 ' HA ' HD22 ' A' ' 78' ' ' LEU . 90.2 m -55.76 -56.2 23.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.324 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.403 ' CG ' HD11 ' A' ' 35' ' ' ILE . 92.2 mt-30 -48.88 -46.11 42.13 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 110.14 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.93 -36.93 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.556 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 HG21 ' A' ' 76' ' ' THR . 24.8 mm -57.99 -49.95 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.973 HG21 HD13 ' B' ' 0' ' ' ILE . 44.0 mt -71.25 -43.71 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.7 ' HG3' HG22 ' B' ' 0' ' ' ILE . 8.7 mttp -54.96 -24.86 25.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.88 -45.43 42.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.337 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -85.95 58.86 5.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.912 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.559 ' CD ' HG23 ' A' ' 30' ' ' ILE . 22.1 ttpp -87.37 -31.34 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.273 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.406 ' CA ' ' HG3' ' A' ' 27' ' ' LYS . 71.1 m-80 -113.8 65.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.337 . . . . 0.0 111.595 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.4 mm100 -118.95 -28.45 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t 75.44 5.87 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.994 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.9 ttm180 -165.07 127.48 2.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.062 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.01 126.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 0.0 111.932 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -108.71 108.87 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -127.37 117.58 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.228 0.537 . . . . 0.0 112.356 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 90.77 8.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.977 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -109.02 171.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.068 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.4 p -115.38 131.6 67.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.725 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 73.8 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.755 0.231 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.3 t -58.41 150.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.855 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -117.86 138.06 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.327 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.067 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.596 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' C ' HG13 ' A' ' 104' ' ' VAL . 9.3 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.996 0.426 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.8 m-85 -67.73 154.28 41.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.648 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -166.83 126.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.512 . . . . 0.0 112.13 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 106.44 3.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.062 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -93.29 104.25 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.128 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.87 104.78 15.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.663 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -102.55 99.29 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.29 109.82 9.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -130.36 -177.23 4.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.595 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -113.86 168.88 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.82 155.09 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.923 0.392 . . . . 0.0 110.698 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.6 15.14 73.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.469 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -129.45 32.8 4.6 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.942 0.401 . . . . 0.0 110.248 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.59 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 13.74 -80.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.273 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.953 HD13 HG21 ' A' ' 99' ' ' VAL . 13.6 tp 175.67 -45.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.789 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 85.38 63.63 1.56 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.609 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 HD11 ' B' ' 0' ' ' ILE . 1.0 OUTLIER -153.28 155.81 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 111.323 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.63 HG21 ' HG2' ' B' ' -3' ' ' PRO . 46.5 t -123.5 129.02 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.5 pt -114.53 144.22 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.774 ' HA ' HD22 ' A' ' 83' ' ' LEU . 27.1 m -137.13 165.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' O ' HD11 ' A' ' 48' ' ' ILE . 7.1 mt-10 -54.47 133.83 45.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 48' ' ' ILE . 52.4 p -76.28 83.08 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.451 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.68 -4.45 90.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.707 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.898 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.75 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.22 -26.66 6.7 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.667 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.436 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.78 44.98 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.501 0.667 . . . . 0.0 111.56 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.898 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.1 mt -59.15 -35.02 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.49 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.799 ' O ' HG22 ' A' ' 46' ' ' THR . 85.0 mt -155.65 96.32 2.4 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.029 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.3 91.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.653 2.235 . . . . 0.0 113.497 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.11 -90.15 0.33 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.69 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.66 167.58 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.879 0.371 . . . . 0.0 111.463 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.84 129.56 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.629 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.051 HG22 HD13 ' A' ' 66' ' ' ILE . 66.6 mt -68.57 89.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.4 -15.77 45.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.049 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.643 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -154.38 158.99 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.729 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.8 ttp -149.2 137.45 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.534 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -53.42 -24.63 13.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.351 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m80 60.61 46.4 9.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.494 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.63 -38.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.051 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -174.01 2.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.942 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.8 Cg_exo -53.78 -24.07 29.24 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.357 2.038 . . . . 0.0 112.313 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.416 ' HB1' ' SD ' ' A' ' 52' ' ' MET . . . -65.68 -49.12 69.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 110.733 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.2 -39.0 50.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.524 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -55.8 -47.15 77.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 t -65.15 -64.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.783 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.9 -24.34 19.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.5 mtpt -58.15 -25.53 61.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.788 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -103.41 131.61 50.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -144.06 133.93 23.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.419 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.051 HD13 HG22 ' A' ' 49' ' ' ILE . 26.7 mm -44.91 142.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.004 0.431 . . . . 0.0 111.924 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.56 13.53 47.36 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.662 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.844 ' HB3' HD12 ' A' ' 103' ' ' ILE . 66.4 m-20 -102.88 162.43 12.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 2.3 mm100 -119.24 98.11 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.777 HG23 HG22 ' A' ' 103' ' ' ILE . 3.5 mt -71.97 143.84 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.618 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.712 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 15.2 mmt -108.97 -69.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.849 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.84 142.03 51.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.337 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.808 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.7 mt -115.35 106.95 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.78 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 58.15 26.39 13.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.06 -36.43 3.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.997 HG21 HD12 ' A' ' 89' ' ' ILE . 3.2 m -67.78 107.74 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.43 ' O ' HD21 ' A' ' 81' ' ' LEU . 10.9 t -72.71 148.7 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.081 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.808 HD11 ' CD1' ' A' ' 73' ' ' ILE . 62.6 mt -118.49 -12.44 9.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.516 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' SD ' ' A' ' 71' ' ' MET . 14.2 t -69.99 101.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.677 0.275 . . . . 0.0 111.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.28 6.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.29 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -104.4 158.12 32.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.011 0.405 . . . . 0.0 111.421 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.69 -172.07 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.945 2.43 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 36' ' ' VAL . 12.1 tp -78.12 -44.34 26.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -41.1 65.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.083 0.468 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 81' ' ' LEU . 56.6 m -64.26 -52.77 57.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.2 m -56.58 -50.03 73.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.402 ' NE2' ' HG ' ' A' ' 83' ' ' LEU . 9.9 mt-30 -50.19 -42.87 52.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 109.962 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -61.12 -37.21 81.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.997 HD12 HG21 ' A' ' 76' ' ' THR . 17.6 mm -58.83 -49.84 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.61 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.821 HG21 HD13 ' B' ' 0' ' ' ILE . 22.3 mt -68.98 -50.32 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.51 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.4 -25.1 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.996 0.427 . . . . 0.0 110.765 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.83 -46.27 90.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.969 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -88.79 66.92 8.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 110.659 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -40.88 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.357 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -88.87 50.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.292 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.72 150.4 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 111.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 p -92.32 -8.14 45.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.459 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.28 145.49 5.86 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.778 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.953 HG21 HD13 ' A' ' 31' ' ' LEU . 1.4 t -112.48 104.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 0.0 111.915 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HE3' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -85.1 121.14 27.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.886 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.912 HD21 HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -138.91 154.36 48.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 111.128 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.97 89.89 3.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.844 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.5 pt -107.9 171.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 0.0 112.282 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 18' ' ' PHE . 5.1 t -122.82 113.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.409 ' CD ' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.63 ' HG2' HG21 ' A' ' 34' ' ' VAL . 78.6 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 CA-C-O 120.744 0.227 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.9 t 69.12 -67.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.534 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER 68.14 99.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.308 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.004 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.82 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 104' ' ' VAL . 24.8 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.5 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 9.7 m-85 -62.89 146.79 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.985 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 124.01 2.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.974 0.416 . . . . 0.0 111.48 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.51 131.47 42.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.278 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 29.9 t -112.89 132.81 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.37 106.26 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -110.86 99.3 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.89 109.73 14.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.19 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 6.0 pttm -131.59 -169.01 2.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.211 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.5 177.74 4.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.245 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -79.86 162.16 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.761 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.96 13.92 28.76 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.905 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -123.04 33.69 5.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 109.972 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.707 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.4 OUTLIER 14.51 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.43 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER 174.12 -42.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.005 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 86.91 62.08 1.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.621 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.34 155.83 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.952 0.406 . . . . 0.0 111.299 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' CE1' ' B' ' -1' ' ' TYR . 22.3 t -120.58 131.36 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.157 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.801 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -116.6 156.96 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.495 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.71 169.46 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.975 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' HD11 ' A' ' 48' ' ' ILE . 17.5 mt-10 -62.14 130.62 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.871 0.367 . . . . 0.0 110.984 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.0 p -69.94 84.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.619 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.99 -3.96 88.81 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.896 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.845 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.1 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 110.462 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.74 -26.2 7.72 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.875 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.82 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.426 0.631 . . . . 0.0 111.244 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.845 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 72.9 mt -60.87 -40.17 84.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.567 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -149.38 117.03 3.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.574 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 20.7 Cg_endo -61.21 102.58 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.199 1.933 . . . . 0.0 113.234 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 HG13 ' A' ' 79' ' ' VAL . 1.3 p -153.54 -154.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.123 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -109.32 158.1 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.646 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -119.22 133.34 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.111 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.082 HG22 HD13 ' A' ' 66' ' ' ILE . 54.5 mt -69.74 95.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.67 -1.88 52.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.67 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.454 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -170.57 159.52 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.71 144.67 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.914 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.707 ' CE ' HD11 ' A' ' 30' ' ' ILE . 5.4 mtt -55.9 -22.6 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 61.95 50.51 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.682 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.53 -36.05 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.054 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 -171.8 1.54 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.111 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 49.3 Cg_exo -55.74 -23.64 42.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.544 2.162 . . . . 0.0 112.493 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.56 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -66.5 -50.11 64.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.06 -38.4 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -57.36 -47.12 82.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -57.24 -74.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 15.18 8.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.444 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 61.5 mtpt -108.56 -24.75 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.816 ' HG ' HG11 ' A' ' 21' ' ' VAL . 69.0 mt -103.0 118.66 37.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -131.62 140.72 49.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.741 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.082 HD13 HG22 ' A' ' 49' ' ' ILE . 47.0 mm -47.33 145.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.554 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.01 7.17 59.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.862 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.4 m-20 -99.85 157.27 16.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 0.268 . . . . 0.0 110.558 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -117.32 112.23 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.881 0.372 . . . . 0.0 110.684 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.824 HG23 HG22 ' A' ' 103' ' ' ILE . 5.8 mt -78.94 138.76 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.83 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.9 mmm -103.57 -67.49 0.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.211 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 p -131.2 133.51 45.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -105.56 117.07 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.809 ' ND2' HD13 ' A' ' 93' ' ' LEU . 66.5 m-20 56.64 27.32 12.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.1 -30.4 9.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.842 HG21 HG23 ' A' ' 89' ' ' ILE . 37.7 m -61.73 100.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 111.124 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.05 114.92 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.745 HD21 HD12 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.34 25.15 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 46' ' ' THR . 22.0 t -72.71 87.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.587 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 45' ' ' PRO . . . 134.74 -17.09 4.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.509 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.49 157.07 73.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.618 0.246 . . . . 0.0 110.775 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -175.05 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.519 2.146 . . . . 0.0 111.972 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 36' ' ' VAL . 23.6 tp -78.11 -46.43 20.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.983 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 52.8 p -53.63 -40.87 66.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 89' ' ' ILE . 69.8 m -66.14 -50.9 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -55.79 -57.02 13.76 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.66 0.267 . . . . 0.0 111.283 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.801 ' HA ' HD11 ' A' ' 35' ' ' ILE . 18.2 pt20 -50.09 -40.22 44.93 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -63.78 -33.82 76.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.252 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.842 HG23 HG21 ' A' ' 76' ' ' THR . 5.8 mm -58.93 -49.4 83.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.037 HG21 HD13 ' B' ' 0' ' ' ILE . 35.5 mt -71.06 -47.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.125 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.689 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -55.64 -23.61 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.05 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -33.91 48.84 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.193 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.809 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.3 pp -104.25 46.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.402 . . . . 0.0 110.704 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.23 -23.55 35.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.245 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -91.95 42.42 1.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.4 135.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.41 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 t -78.53 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.183 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 ttm180 -145.51 127.5 15.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.02 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 31' ' ' LEU . 11.6 t -112.93 104.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -87.73 126.47 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.766 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -137.7 117.83 13.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.273 0.559 . . . . 0.0 112.302 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 71' ' ' MET . 1.1 m120 -89.37 97.69 11.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.7 pt -121.33 172.64 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.131 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 17' ' ' GLU . 22.7 t -115.97 110.76 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.412 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.029 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.44 ' HB2' HG11 ' A' ' 34' ' ' VAL . 58.6 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.79 0.246 . . . . 0.0 112.231 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.413 HG21 ' HE3' ' A' ' 91' ' ' LYS . 11.1 p -57.64 154.06 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 34' ' ' VAL . 3.7 m-85 -127.43 123.38 35.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.037 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.95 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.83 0.347 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.2 m-85 -58.85 144.27 44.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.329 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.591 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -164.85 128.47 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.306 0.574 . . . . 0.0 112.11 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.43 101.64 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.019 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.2 t -82.27 115.84 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -116.53 104.52 11.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.27 99.53 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.0 OUTLIER -77.39 109.89 11.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.78 -170.91 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.36 154.09 25.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -56.67 153.95 9.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.27 12.12 79.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.597 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' LEU . 38.0 mt-10 -124.93 31.68 5.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.204 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.926 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 18.49 -81.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 175.74 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.72 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.51 65.1 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.427 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.043 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.15 156.08 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 111.893 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 77.1 t -117.69 129.7 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.637 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -118.11 150.78 20.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.9 m -147.49 166.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.206 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 48' ' ' ILE . 21.7 mt-10 -56.3 133.48 52.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.474 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 60.5 p -74.37 83.51 1.93 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.435 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.91 -3.87 90.28 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.73 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.95 -164.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.629 0.252 . . . . 0.0 110.541 179.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.06 -24.86 7.01 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.823 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.73 54.96 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.578 0.704 . . . . 0.0 111.217 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.73 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 60.3 mt -70.71 -36.33 64.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.624 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.807 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -150.04 110.14 3.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.782 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_endo -56.09 86.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.207 1.938 . . . . 0.0 112.62 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.18 -155.32 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.17 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.9 OUTLIER -107.71 161.87 6.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.625 0.25 . . . . 0.0 110.745 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -120.33 133.13 68.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.771 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.056 HG22 HD13 ' A' ' 66' ' ' ILE . 61.0 mt -73.62 91.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.73 -13.9 44.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.844 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.65 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -156.59 159.56 38.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 111.144 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.2 ttm -153.36 130.66 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' GLY . 8.2 mtm -64.95 93.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -57.86 80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.29 -28.74 0.27 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.743 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.07 18.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.844 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.9 Cg_endo -69.52 -14.36 36.71 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.808 2.339 . . . . 0.0 113.043 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 -52.32 60.25 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 -40.21 30.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -50.81 -47.22 60.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.447 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.16 -70.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.62 16.72 6.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.345 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.744 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.3 mmmm -101.08 -28.5 12.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.691 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD2' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -103.89 134.71 46.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -142.51 127.34 18.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.255 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.056 HD13 HG22 ' A' ' 49' ' ' ILE . 22.4 mm -43.31 142.56 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 112.078 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.3 45.29 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.428 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.855 ' HB3' HD12 ' A' ' 103' ' ' ILE . 89.5 m-20 -104.27 178.88 4.43 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.946 0.403 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.447 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -134.33 114.92 13.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.704 HG23 HG22 ' A' ' 103' ' ' ILE . 5.4 mt -87.89 125.07 41.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.056 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.795 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.63 -44.77 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.668 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 p -158.51 144.64 17.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.705 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -118.7 126.4 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.015 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.525 ' ND2' HD13 ' A' ' 93' ' ' LEU . 88.7 m-20 53.84 26.92 6.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.358 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.9 -21.78 40.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.768 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 89' ' ' ILE . 3.5 m -67.89 101.36 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 m -65.69 111.27 3.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HD12 ' A' ' 73' ' ' ILE . 48.5 mt -90.99 -20.66 21.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 22.0 t -54.61 88.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.366 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.67 -25.94 4.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.691 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.8 mt -77.52 152.68 81.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.99 -169.51 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 111.95 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.569 HD22 ' NE2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -78.31 -52.25 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.227 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -53.07 -40.72 64.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.5 m -65.05 -50.2 67.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 78' ' ' LEU . 92.2 m -58.85 -50.44 73.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.682 0.277 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.569 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.2 mt-30 -49.4 -43.66 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.176 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 35.3 m -61.27 -38.83 88.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.657 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.77 HD12 HG21 ' A' ' 76' ' ' THR . 24.1 mm -58.25 -50.13 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.761 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 0' ' ' ILE . 24.1 mt -67.74 -50.23 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.08 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.63 -21.11 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.93 -39.05 55.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.6 OUTLIER -93.25 45.77 1.18 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.902 0.382 . . . . 0.0 110.989 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.926 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.37 -5.97 58.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -114.8 49.96 1.0 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.688 0.28 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.74 161.41 30.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.675 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 t -93.5 -11.5 31.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.538 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 16.9 mmt85 -141.26 138.88 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.771 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 31' ' ' LEU . 13.5 t -113.03 103.74 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -90.83 118.57 30.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.445 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.03 117.44 12.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 95.25 9.73 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -117.64 171.46 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.167 0.508 . . . . 0.0 111.999 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.723 HG23 ' SD ' ' A' ' 71' ' ' MET . 40.5 t -124.62 128.1 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.647 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.503 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 49.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.937 0.307 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.02 -23.26 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.806 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 34' ' ' VAL . 10.8 m-85 63.59 136.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 33' ' ' VAL . 1.8 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.666 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 104' ' ' VAL . 17.6 tp10 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.4 m-85 -66.28 153.34 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.564 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.95 125.98 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 0.0 111.31 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.71 106.39 7.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.402 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.5 t -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.532 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -129.06 104.33 7.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.035 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 31' ' ' LEU . 11.6 mm -105.9 99.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.451 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 98' ' ' ARG . 1.6 mp0 -82.92 109.29 16.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -132.08 -171.41 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.916 0.388 . . . . 0.0 111.359 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.57 156.57 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -59.93 154.43 18.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.011 0.434 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.52 13.13 74.15 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.416 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' LEU . 15.9 mt-10 -124.79 32.26 5.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.391 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.704 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 17.73 -80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.159 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 178.06 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.075 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 85.13 60.51 1.83 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.756 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.066 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.7 156.78 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 111.45 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' B' ' -3' ' ' PRO . 20.2 t -123.7 121.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.114 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 47' ' ' VAL . 2.1 pt -111.75 149.21 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.189 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.0 m -137.2 168.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.06 130.85 48.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.681 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' HD11 ' A' ' 48' ' ' ILE . 49.6 p -71.41 83.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.544 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -5.36 87.14 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.713 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.0 -162.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 110.948 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -53.17 -18.83 6.94 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.765 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.4 m 107.48 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.598 0.759 . . . . 0.0 111.082 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.763 HG22 ' HG ' ' A' ' 44' ' ' LEU . 81.4 mt 57.71 -65.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.353 0.597 . . . . 0.0 111.399 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.957 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -138.54 81.66 23.83 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.798 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 76.8 Cg_exo -50.57 93.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.641 2.227 . . . . 0.0 113.072 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.957 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.77 -87.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.29 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.3 167.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 120.661 0.267 . . . . 0.0 111.059 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.06 126.94 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 66' ' ' ILE . 65.0 mt -66.18 91.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 -8.73 55.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.31 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.619 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -163.68 162.06 23.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.441 . . . . 0.0 111.316 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.1 ttm -153.8 134.28 13.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.679 ' CE ' HD11 ' A' ' 30' ' ' ILE . 4.9 mtt -50.93 -26.07 5.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.247 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 57.6 56.44 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 110.686 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -35.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.07 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.5 -160.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.911 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.4 Cg_endo -69.13 -22.65 34.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 112.212 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.57 77.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.026 0.441 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -38.61 52.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -59.21 -29.96 67.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.241 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -73.42 -68.31 0.51 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.804 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.37 -32.82 5.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.369 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -60.69 -27.15 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.705 0.288 . . . . 0.0 110.983 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -97.97 126.6 43.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.02 137.08 27.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 49' ' ' ILE . 24.3 mm -46.0 145.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.13 14.09 58.0 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.428 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.883 ' HB3' HD12 ' A' ' 103' ' ' ILE . 83.6 m-20 -103.7 163.0 12.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.671 0.272 . . . . 0.0 110.899 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.42 106.44 11.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.822 HG23 HG22 ' A' ' 103' ' ' ILE . 3.2 mt -78.72 139.68 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.634 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 mmt -104.38 -68.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.2 t -124.11 140.84 52.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.985 0.421 . . . . 0.0 111.579 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -117.56 109.79 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.456 ' OD1' HD13 ' A' ' 93' ' ' LEU . 21.7 m120 59.09 25.94 14.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.186 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.8 -34.73 5.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.681 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.73 HG21 HG23 ' A' ' 89' ' ' ILE . 3.9 m -67.85 109.88 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.429 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -74.44 147.46 41.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 73' ' ' ILE . 81.2 mt -115.89 -22.06 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.241 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 71' ' ' MET . 13.1 t -62.88 102.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.411 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.24 -30.53 4.28 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.337 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.469 HD13 ' CG2' ' A' ' 85' ' ' THR . 0.2 OUTLIER -93.98 159.49 34.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.957 0.408 . . . . 0.0 111.387 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.94 -174.33 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.943 2.428 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -77.89 -43.39 30.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -53.32 -41.53 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.156 0.503 . . . . 0.0 110.527 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.612 ' O ' HG12 ' A' ' 89' ' ' ILE . 63.7 m -64.79 -50.49 66.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.73 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.498 ' HA ' HD22 ' A' ' 78' ' ' LEU . 64.0 m -55.53 -57.2 12.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.328 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' SER . 16.9 pt20 -50.14 -39.53 43.61 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.7 t -61.65 -38.06 86.33 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.208 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 76' ' ' THR . 24.3 mm -58.96 -49.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.739 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.066 HG21 HD13 ' B' ' 0' ' ' ILE . 29.0 mt -69.34 -50.42 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.825 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.73 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.9 -42.68 68.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.988 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.5 OUTLIER -91.63 52.18 2.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.569 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.704 ' HG3' HG23 ' A' ' 30' ' ' ILE . 1.4 tmmm? -88.0 -20.75 25.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.932 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -99.85 49.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.738 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.565 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.3 pt20 -128.41 -179.14 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.564 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.1 m -123.68 -3.85 8.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.3 134.56 24.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 110.476 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 31' ' ' LEU . 3.9 t -119.38 104.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.39 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -97.4 97.86 9.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.456 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.97 154.99 23.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.57 91.86 3.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.883 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -113.62 172.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 18' ' ' PHE . 9.8 t -121.44 124.76 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.658 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.905 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.538 ' CG ' HG21 ' A' ' 34' ' ' VAL . 34.8 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.801 0.251 . . . . 0.0 112.403 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.3 -15.89 7.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.712 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 64.79 170.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.03 0.443 . . . . 0.0 111.321 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.597 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 104' ' ' VAL . 4.7 m-85 -58.63 154.1 15.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.45 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.33 125.93 1.9 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.183 0.516 . . . . 0.0 112.024 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 101.15 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.354 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.833 HG13 ' HB2' ' A' ' 63' ' ' LYS . 22.7 t -82.73 108.23 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.56 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' CE1' ' CG ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.89 104.76 15.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 31' ' ' LEU . 17.2 mm -104.83 99.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 6.6 mp0 -82.31 117.23 22.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.01 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.74 -170.93 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -117.76 -179.54 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.47 161.7 30.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.36 15.17 58.69 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' ILE . 41.6 mt-10 -129.59 33.5 4.47 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 110.269 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 8.25 -78.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.225 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 23' ' ' ILE . 11.2 tp 176.27 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.822 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 87.07 63.67 1.44 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.515 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.079 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.78 156.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.195 179.033 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' -3' ' ' PRO . 45.9 t -126.45 123.95 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -109.51 148.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.649 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.3 m -140.74 167.58 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.501 ' O ' HD11 ' A' ' 48' ' ' ILE . 11.5 mt-10 -54.56 135.16 46.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.377 . . . . 0.0 110.807 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 48' ' ' ILE . 53.1 p -78.54 83.11 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.807 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.28 -4.87 87.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.604 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.925 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.09 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 122.338 0.255 . . . . 0.0 110.383 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.41 -26.63 7.22 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.689 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.434 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.75 40.31 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.402 0.62 . . . . 0.0 111.605 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.925 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.9 mt -54.21 -35.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.611 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.806 ' O ' HG22 ' A' ' 46' ' ' THR . 89.2 mt -155.09 96.55 2.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.147 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.2 Cg_endo -55.53 92.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.569 2.18 . . . . 0.0 113.45 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.65 -88.8 0.22 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.785 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.46 167.64 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.501 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.74 131.06 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -68.9 92.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.3 -6.5 55.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.219 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.622 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.5 t-20 -163.53 157.72 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -154.82 133.96 12.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.529 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 30' ' ' ILE . 10.8 mtm -75.07 96.75 3.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.31 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -62.97 78.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 170.71 -33.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.057 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.33 -168.1 18.52 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.927 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.1 -16.33 40.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.456 2.104 . . . . 0.0 112.471 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.15 65.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.191 0.519 . . . . 0.0 110.607 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -77.22 -36.45 54.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.87 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -58.01 -47.27 83.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.85 -7.64 59.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.288 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.833 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmt -72.86 -29.56 63.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 21' ' ' VAL . 92.4 mt -101.45 120.06 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -132.49 133.6 43.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.426 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.029 HD13 HG22 ' A' ' 49' ' ' ILE . 28.1 mm -45.65 143.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.063 0.459 . . . . 0.0 111.7 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.53 57.54 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.564 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.891 ' HB3' HD12 ' A' ' 103' ' ' ILE . 0.9 OUTLIER -105.34 172.01 7.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.46 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -128.37 112.34 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.357 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 HG22 ' A' ' 103' ' ' ILE . 3.3 mt -82.88 142.89 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.659 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.673 ' SD ' HG21 ' A' ' 46' ' ' THR . 14.1 mmt -105.7 -70.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.36 131.8 52.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.435 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.892 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -103.6 111.73 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m120 60.43 20.11 9.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.84 -33.46 5.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.743 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.537 HG21 HD12 ' A' ' 89' ' ' ILE . 3.6 m -68.71 100.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 110.985 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m -65.94 149.05 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 73' ' ' ILE . 63.0 mt -116.89 -22.82 8.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.367 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG22 ' SD ' ' A' ' 71' ' ' MET . 34.6 t -50.44 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.348 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.606 ' C ' HD23 ' A' ' 81' ' ' LEU . . . 116.33 1.65 20.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.985 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 80' ' ' GLY . 2.2 mt -108.13 151.24 41.28 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.954 0.377 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.91 168.02 25.04 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.59 2.193 . . . . 0.0 111.828 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.2 tp -62.01 -45.24 94.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.969 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -43.06 68.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.462 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.7 m -65.27 -51.31 61.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 78' ' ' LEU . 33.0 m -55.73 -56.24 22.84 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.422 ' HG3' HD12 ' A' ' 83' ' ' LEU . 28.6 mt-30 -49.44 -41.13 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.105 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 44.8 m -61.53 -38.77 88.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.424 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 85' ' ' THR . 19.8 mm -58.26 -49.98 79.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.972 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.988 HG21 HD13 ' B' ' 0' ' ' ILE . 14.5 mt -75.67 -50.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.185 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.492 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -55.77 -23.89 32.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 110.911 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.32 -44.1 76.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.222 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.5 pp -85.82 62.62 7.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.068 0.461 . . . . 0.0 110.942 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.611 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -84.61 -23.54 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.13 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.8 38.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.257 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -96.73 162.2 13.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.191 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.6 p -118.52 -10.7 10.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.532 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 4.1 tpp85 -156.03 116.07 3.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.186 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 101' ' ' LEU . 10.3 t -99.09 117.86 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.901 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.25 97.8 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.144 179.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -109.73 155.3 21.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.451 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -125.66 91.52 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.909 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -111.51 169.83 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.619 HG22 ' CD1' ' A' ' 18' ' ' PHE . 4.7 t -116.28 124.81 72.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.696 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' A' ' 34' ' ' VAL . 70.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.712 0.213 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' -2' ' ' VAL . 30.9 m -57.27 124.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 34' ' ' VAL . 12.5 m-85 -102.33 113.16 26.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.079 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 104' ' ' VAL . 2.4 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.9 m-85 -58.93 153.11 18.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -166.91 125.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 112.065 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.3 103.37 2.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.99 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.929 HG11 ' HG ' ' A' ' 64' ' ' LEU . 26.2 t -87.16 108.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.491 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -96.83 112.18 24.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.453 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.27 102.62 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.28 114.99 24.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -145.06 -171.54 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.215 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -109.68 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.342 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -55.4 148.57 14.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.46 14.4 82.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.126 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 31' ' ' LEU . 3.2 mt-10 -128.02 31.21 5.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.592 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 14.48 -79.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.348 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.57 -47.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.66 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 89.72 67.58 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.651 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.08 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.71 155.97 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.326 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.4 t -116.8 128.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.715 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.2 pt -116.03 149.85 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.609 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' HD22 ' A' ' 83' ' ' LEU . 31.0 m -141.68 167.71 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.032 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.77 129.69 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.516 ' HA ' HD11 ' A' ' 48' ' ' ILE . 70.0 p -70.8 84.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.344 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.47 90.05 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.96 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.777 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.01 -163.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.663 0.268 . . . . 0.0 110.59 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.94 -25.38 7.33 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.788 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 4.7 p 80.43 44.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.694 0.759 . . . . 0.0 111.61 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.777 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 78.4 mt -58.64 -37.68 66.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -148.58 104.73 3.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.884 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' GLY . 51.6 Cg_exo -52.71 94.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.091 1.861 . . . . 0.0 112.612 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -145.02 -153.74 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -109.27 164.6 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.595 0.236 . . . . 0.0 110.634 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.54 129.3 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.041 HG22 HD13 ' A' ' 66' ' ' ILE . 71.2 mt -67.61 93.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.22 -6.15 51.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.287 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -165.59 162.52 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -150.86 144.08 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.259 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.592 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.0 mtm -57.13 -28.56 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 61.47 61.02 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.82 -33.54 0.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.196 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -165.78 6.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.055 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.9 Cg_endo -69.13 -16.93 40.56 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.443 2.095 . . . . 0.0 112.407 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.05 70.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.19 -34.21 56.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.748 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -59.62 -47.23 86.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.041 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 m -59.68 -52.19 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.55 64.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.076 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB2' HG13 ' A' ' 21' ' ' VAL . 2.3 mmmt -72.13 -31.56 66.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.929 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.0 mt -97.23 99.89 11.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -119.59 144.9 46.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 49' ' ' ILE . 51.7 mm -47.22 142.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.722 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 9.28 61.96 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.927 ' HB3' HD12 ' A' ' 103' ' ' ILE . 25.3 m-20 -96.97 154.5 17.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.682 0.277 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 6.2 mm100 -111.08 111.44 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.971 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 103' ' ' ILE . 3.2 mt -86.57 113.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.748 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -77.6 -64.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.256 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.39 148.43 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.836 HD12 HD21 ' A' ' 78' ' ' LEU . 2.7 mp -118.91 114.35 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.626 ' OD1' HD13 ' A' ' 93' ' ' LEU . 8.4 m120 60.78 29.77 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.32 -20.0 52.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.804 HG21 HG23 ' A' ' 89' ' ' ILE . 2.9 m -69.86 95.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.774 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -71.87 121.06 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 73' ' ' ILE . 1.3 pp -128.91 28.18 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 46' ' ' THR . 22.7 t -75.39 86.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 140.26 -50.26 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.684 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -51.02 163.82 0.48 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 111.116 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.59 -178.68 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.768 2.312 . . . . 0.0 112.829 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.8 tp -78.26 -45.04 23.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.104 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 9.7 p -53.41 -40.88 65.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.093 0.473 . . . . 0.0 110.69 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.7 m -66.08 -49.25 68.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 74.4 m -55.52 -56.28 22.15 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.286 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.715 ' HA ' HD11 ' A' ' 35' ' ' ILE . 17.3 pt20 -49.18 -46.24 45.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 34.8 t -56.42 -35.18 67.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.345 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 76' ' ' THR . 6.5 mm -59.58 -47.28 91.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.017 HG21 HD13 ' B' ' 0' ' ' ILE . 44.6 mt -69.88 -50.63 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.161 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -63.24 -17.53 62.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.215 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.45 73.61 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.691 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.626 HD13 ' OD1' ' A' ' 74' ' ' ASN . 1.3 pp -117.17 42.86 2.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.02 -7.21 57.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.442 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.61 35.01 1.4 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.666 0.27 . . . . 0.0 111.591 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 2.2 pt20 -126.12 134.67 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.836 0.35 . . . . 0.0 110.31 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -8.71 51.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.757 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.779 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.4 ttm105 -145.35 150.11 36.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 0.0 110.873 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.451 ' CG1' HD21 ' A' ' 101' ' ' LEU . 2.8 t -135.67 118.16 21.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.554 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.1 mtpt -97.73 97.84 9.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.708 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -102.13 153.44 19.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.969 0.414 . . . . 0.0 111.074 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.84 94.49 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.4 pt -120.52 171.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.748 HG23 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -116.45 117.83 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.552 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.602 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.4 Cg_endo . . . . . 0 C--O 1.23 0.123 0 CA-C-O 120.784 0.244 . . . . 0.0 112.291 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.597 HG21 ' OE1' ' A' ' 87' ' ' GLN . 28.5 m -58.41 110.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -100.29 143.05 30.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.113 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.08 HD11 HG22 ' A' ' 33' ' ' VAL . 2.4 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.917 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' C ' HG13 ' A' ' 104' ' ' VAL . 10.1 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CD1' HG22 ' A' ' 104' ' ' VAL . 7.7 m-85 -62.33 154.32 28.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.236 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -167.64 125.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.342 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 101.53 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.862 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.8 t -83.89 116.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.75 104.56 12.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.488 179.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.25 99.74 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.098 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 50.1 mt-10 -75.53 109.99 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -131.51 -173.95 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.4 . . . . 0.0 111.492 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.49 159.34 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.9 156.96 13.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.17 18.03 62.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.355 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -130.23 31.7 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.891 0.377 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.661 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 14.31 -80.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.311 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 99' ' ' VAL . 11.9 tp 177.8 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.866 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.76 61.48 1.86 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.537 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.06 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -147.43 156.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 111.66 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' B' ' -1' ' ' TYR . 37.6 t -120.82 126.79 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.01 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.576 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.8 pt -116.74 144.15 25.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.206 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 83' ' ' LEU . 36.0 m -133.97 163.26 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 124.29 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 48' ' ' ILE . 51.8 p -65.48 84.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.386 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.6 -3.97 90.49 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.754 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -56.17 -162.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -52.94 -18.94 6.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.842 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.2 m 107.27 -86.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.486 0.714 . . . . 0.0 111.004 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.701 HG22 ' HG ' ' A' ' 44' ' ' LEU . 84.4 mt 57.3 -64.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.387 0.613 . . . . 0.0 111.4 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.971 ' O ' HG22 ' A' ' 46' ' ' THR . 1.4 mt -135.87 73.39 60.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.625 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 87.1 Cg_exo -47.1 90.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.882 2.388 . . . . 0.0 113.359 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.971 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.76 -91.57 0.29 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.372 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -154.04 167.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 111.431 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.31 129.59 50.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.775 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.118 HG22 HD13 ' A' ' 66' ' ' ILE . 79.2 mt -66.41 94.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.01 0.91 55.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 m-20 -174.07 161.62 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 111.141 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 mtm -154.96 159.78 40.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.502 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.0 mtt -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 60.96 47.11 7.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.614 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -35.31 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.23 -171.97 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.173 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.11 -21.93 45.03 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.549 2.166 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.65 -49.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.961 0.41 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -39.36 41.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -52.8 -47.39 67.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.393 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -68.9 -61.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.78 -1.97 38.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.196 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.795 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmm -76.97 -28.75 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.862 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -107.04 113.97 27.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.042 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.92 141.41 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.395 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.118 HD13 HG22 ' A' ' 49' ' ' ILE . 42.0 mm -44.87 141.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 111.84 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 17.72 52.37 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.428 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.902 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.5 m-20 -102.83 158.49 16.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.622 0.249 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -117.57 106.99 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.963 HG23 HG22 ' A' ' 103' ' ' ILE . 1.4 mt -85.4 119.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.632 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -80.44 -65.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.66 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -133.64 146.97 51.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 111.473 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.2 mt -113.89 114.37 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.759 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.477 ' OD1' HD22 ' A' ' 93' ' ' LEU . 9.8 m120 59.12 22.22 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.86 8.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.846 HG21 HD12 ' A' ' 89' ' ' ILE . 3.4 m -68.18 108.27 3.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.528 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.3 t -69.98 138.16 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.967 HD11 ' CD1' ' A' ' 73' ' ' ILE . 57.6 mt -111.07 -23.32 10.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.7 t -58.82 98.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.03 -29.47 3.71 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.413 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -96.15 159.8 31.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 111.609 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.74 178.68 2.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.003 2.469 . . . . 0.0 112.517 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.3 tp -72.35 -39.45 68.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.091 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.5 t -53.32 -46.08 69.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.451 . . . . 0.0 110.393 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 89' ' ' ILE . 28.6 m -62.07 -50.5 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.992 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 28.8 m -55.39 -55.77 27.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HA ' HD11 ' A' ' 35' ' ' ILE . 27.9 mt-30 -49.28 -40.48 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 110.289 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -63.57 -37.11 86.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.407 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 HG21 ' A' ' 76' ' ' THR . 27.4 mm -58.15 -49.56 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.987 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.01 HG21 HD13 ' B' ' 0' ' ' ILE . 36.6 mt -71.83 -44.27 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.1 OUTLIER -54.97 -25.36 29.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.828 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.01 -51.05 48.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.091 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.6 pp -79.04 60.96 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 110.953 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.2 ttpm? -87.2 -26.07 23.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.358 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -108.51 51.95 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.33 . . . . 0.0 111.324 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 mt-30 -109.45 163.9 12.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 0.0 111.683 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.0 p -98.47 -10.92 22.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.36 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.69 150.4 10.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.279 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 31' ' ' LEU . 13.1 t -119.91 119.19 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 112.054 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -97.6 117.81 32.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.9 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.37 117.95 13.9 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.994 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.99 96.22 9.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.963 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -120.44 170.46 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.183 0.516 . . . . 0.0 112.229 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.3 t -108.25 113.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.237 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 3.4 ttt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.493 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.443 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.881 0.284 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' VAL . 31.1 m -84.53 161.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.47 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 5.5 m-85 -119.74 160.33 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.06 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' C ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.886 0.374 . . . . 0.0 111.062 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.9 m-85 -59.38 154.28 17.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.49 125.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.105 0.478 . . . . 0.0 111.542 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.8 129.93 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.164 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.4 t -110.39 129.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.08 104.64 9.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 ' CD1' ' A' ' 31' ' ' LEU . 18.1 mm -107.48 99.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.01 110.88 21.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.16 -167.75 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.0 111.307 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.48 172.81 6.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.489 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.93 158.82 34.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.696 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.68 16.62 56.24 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.389 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 31' ' ' LEU . 8.6 mt-10 -126.32 30.83 5.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.755 HG23 ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 16.46 -80.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.966 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.719 HD23 ' CG1' ' A' ' 33' ' ' VAL . 2.9 tp 177.58 -45.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 90.06 64.71 1.23 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.977 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.47 156.35 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.635 HG21 ' HG2' ' B' ' -3' ' ' PRO . 19.6 t -121.18 122.74 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 0.0 111.359 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 HG11 ' A' ' 47' ' ' VAL . 2.4 pt -111.47 142.37 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.0 m -135.18 170.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.645 ' O ' HD11 ' A' ' 48' ' ' ILE . 32.0 mt-10 -60.57 135.22 57.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.461 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.0 p -75.52 83.57 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.432 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -8.47 83.33 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.82 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.994 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.45 -161.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.637 0.256 . . . . 0.0 110.468 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.43 -26.67 7.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.883 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.423 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.98 42.04 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.404 0.621 . . . . 0.0 111.384 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.994 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 89.0 mt -51.49 -42.46 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.887 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.918 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -151.58 89.72 4.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.231 178.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 80' ' ' GLY . 85.4 Cg_exo -45.58 111.34 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.974 2.449 . . . . 0.0 113.841 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -156.54 -89.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.48 167.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.236 . . . . 0.0 111.015 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.645 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -133.68 129.41 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.634 ' CG1' HD11 ' A' ' 70' ' ' ILE . 78.9 mt -70.3 96.2 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.84 0.57 52.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.233 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.912 ' HA ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -169.46 161.2 9.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.451 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 14.4 mtm -155.23 134.93 12.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.42 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.489 ' HE1' HD11 ' A' ' 30' ' ' ILE . 13.9 mtm -70.39 95.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.299 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -60.64 80.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.125 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 165.45 -31.45 0.22 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.59 -167.43 31.96 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.086 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 56.5 Cg_endo -69.28 -16.12 39.37 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.652 2.234 . . . . 0.0 112.529 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -66.89 -49.6 65.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 110.83 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.57 -38.59 48.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.43 -47.21 82.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.193 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -59.34 -68.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.55 38.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.165 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.776 ' HB2' HG13 ' A' ' 21' ' ' VAL . 19.5 mmmt -72.33 -30.01 64.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.51 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.689 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -102.7 129.97 49.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.576 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 73.8 m-80 -142.75 138.12 30.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.726 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.912 HD11 ' HA ' ' A' ' 51' ' ' ASN . 6.2 mt -46.67 140.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.202 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.8 16.62 44.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.58 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.866 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.1 m-20 -111.87 157.22 20.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 110.739 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -112.79 117.75 33.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.873 HG23 HG22 ' A' ' 103' ' ' ILE . 2.3 mt -91.8 108.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.787 ' CE ' HD13 ' A' ' 44' ' ' LEU . 21.6 mmt -66.94 -67.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.425 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 53.5 p -131.57 156.07 46.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.348 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HD11 ' A' ' 93' ' ' LEU . 3.3 mt -124.44 109.8 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.493 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.7 m120 64.23 29.42 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.879 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.62 50.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.924 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 89' ' ' ILE . 15.0 m -77.75 95.84 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.741 0.305 . . . . 0.0 111.315 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.425 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 56.4 p -77.02 131.63 38.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.247 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.98 19.26 7.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 23.5 t -60.39 88.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.848 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 133.07 -24.66 3.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.779 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.3 mt -70.72 155.42 93.42 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 110.766 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.99 -173.75 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 tp -78.13 -47.21 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.008 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 p -53.37 -43.35 67.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.085 0.469 . . . . 0.0 110.263 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 89' ' ' ILE . 83.1 m -65.04 -52.23 57.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.852 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.461 ' SG ' HD13 ' A' ' 78' ' ' LEU . 85.9 m -56.56 -50.33 72.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.474 ' OE1' HG11 ' B' ' -2' ' ' VAL . 11.5 mt-30 -49.89 -45.1 50.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 110.07 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -60.26 -35.95 76.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.519 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' THR . 7.5 mm -58.21 -48.99 83.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.432 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.915 HG21 HD13 ' B' ' 0' ' ' ILE . 57.1 mt -73.08 -42.17 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.158 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -55.18 -25.83 35.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.5 69.21 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.397 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 73' ' ' ILE . 2.2 mt -93.31 45.28 1.16 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.755 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.22 -26.68 30.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.193 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.01 35.69 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -105.74 159.78 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.134 0.493 . . . . 0.0 111.635 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 p -114.24 -9.26 12.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.455 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -150.73 134.9 16.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.368 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.646 ' CG1' HD21 ' A' ' 101' ' ' LEU . 13.1 t -122.59 104.84 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 0.0 111.723 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.99 100.48 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -115.57 123.33 48.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.458 . . . . 0.0 112.089 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.3 93.81 9.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.317 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.873 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -114.42 170.25 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.045 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.7 t -115.0 126.51 72.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.822 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.81 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.635 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.9 Cg_endo . . . . . 0 CA--C 1.528 0.215 0 CA-C-O 120.626 0.178 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.474 HG11 ' OE1' ' A' ' 87' ' ' GLN . 23.0 t -45.11 -56.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.584 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 53' ' ' MET . 1.0 OUTLIER 64.16 149.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.07 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.053 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.946 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.519 ' N ' HG23 ' A' ' 104' ' ' VAL . 5.9 m-85 -58.8 154.06 15.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.809 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.73 125.44 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 111.468 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -73.3 105.89 4.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.648 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 101' ' ' LEU . 26.6 t -82.37 132.17 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -123.99 104.71 9.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.645 HD13 ' OG ' ' A' ' 61' ' ' SER . 10.3 mm -110.3 99.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.337 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.81 109.79 20.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.268 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.77 -172.07 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -106.86 163.36 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.42 155.94 27.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.35 16.13 64.49 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.425 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -126.38 30.51 5.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.916 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 19.36 -82.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.957 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.787 ' CD1' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 175.19 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.624 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.45 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 91.19 67.67 1.17 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.814 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.019 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.84 156.53 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.375 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' B' ' -3' ' ' PRO . 36.5 t -124.73 119.81 57.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 47' ' ' VAL . 2.0 pt -110.41 145.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -136.4 165.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 131.62 51.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.025 0.441 . . . . 0.0 110.623 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.471 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.0 p -69.85 84.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.653 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.36 -4.31 89.53 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.832 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.73 -163.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.667 0.27 . . . . 0.0 110.302 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.07 -25.68 7.99 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.77 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 8.9 p 82.21 63.04 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.001 0.905 . . . . 0.0 111.517 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' HD23 ' A' ' 44' ' ' LEU . 48.3 mt -78.91 -32.31 15.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.757 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 80.9 mt -156.13 89.74 2.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.286 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 Cg_exo -49.19 86.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.822 2.348 . . . . 0.0 113.515 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.81 -91.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.055 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 83' ' ' LEU . 2.9 m -160.27 167.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 120.684 0.278 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -133.5 127.68 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.93 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.071 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -67.74 93.39 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.25 55.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.137 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.474 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -165.95 156.82 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.301 . . . . 0.0 110.9 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 ttm -153.38 131.57 11.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.262 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.45 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 6.2 mtm -63.23 100.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.493 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -66.45 73.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.15 -34.13 0.15 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.126 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.3 -168.2 13.85 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.919 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.0 Cg_endo -69.32 -16.57 39.51 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.502 2.134 . . . . 0.0 112.424 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.48 71.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -40.39 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -58.12 -29.67 65.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.645 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -69.23 -66.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.11 -33.47 5.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.136 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 21' ' ' VAL . 15.4 mt -92.6 119.25 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.814 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -133.07 130.07 38.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.585 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.071 HD13 HG22 ' A' ' 49' ' ' ILE . 42.3 mm -45.74 142.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.87 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.96 12.01 55.85 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.502 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 103' ' ' ILE . 69.6 m-20 -105.88 161.33 14.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.785 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.1 119.85 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.767 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -89.7 97.82 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.708 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.81 -64.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.599 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.2 p -137.14 149.9 47.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.26 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 78' ' ' LEU . 3.2 mt -117.59 118.24 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.08 29.09 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.28 11.98 56.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.796 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.88 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -100.65 95.91 7.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.762 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.722 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -58.09 126.7 28.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 73' ' ' ILE . 23.5 mt -109.14 -23.62 11.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.3 t -56.03 88.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.464 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.16 -38.79 1.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.362 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -81.21 159.68 67.23 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.436 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.19 -175.04 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.956 2.438 . . . . 0.0 112.659 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -78.25 -46.42 20.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.0 m -53.6 -42.61 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.996 0.427 . . . . 0.0 110.589 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG12 ' A' ' 89' ' ' ILE . 71.0 m -62.01 -49.28 76.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.7 m -56.56 -46.5 80.69 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.811 0.339 . . . . 0.0 110.729 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' NE2' ' CD1' ' A' ' 83' ' ' LEU . 10.3 mt-30 -52.69 -43.11 65.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.049 0.452 . . . . 0.0 109.896 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.1 p -60.9 -37.23 81.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.422 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.88 HD12 HG21 ' A' ' 76' ' ' THR . 21.0 mm -58.22 -49.44 81.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.963 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.965 HG21 HD13 ' B' ' 0' ' ' ILE . 52.7 mt -71.46 -45.04 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.224 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -58.48 -20.68 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -20.71 67.85 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.055 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.618 HD21 HG21 ' A' ' 73' ' ' ILE . 2.5 pp -100.53 43.88 1.04 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.001 0.401 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.06 -5.89 58.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.291 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -122.55 54.21 1.22 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.871 0.367 . . . . 0.0 111.208 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.78 ' OE1' HG22 ' A' ' 99' ' ' VAL . 3.3 pt20 -136.27 160.48 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -98.79 -15.84 19.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.828 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -139.68 143.87 37.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.749 0.309 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 31' ' ' LEU . 2.4 t -124.65 104.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -95.92 97.6 9.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.225 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -109.51 154.83 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.927 0.394 . . . . 0.0 111.002 -179.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.6 OUTLIER -118.94 97.58 5.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.789 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.77 170.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 111.681 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.785 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.5 p -121.4 132.61 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.801 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.642 ' HB2' HG11 ' A' ' 34' ' ' VAL . 71.7 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.837 0.265 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.33 119.35 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 34' ' ' VAL . 2.3 m-85 -100.21 132.17 45.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.01 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.001 0.429 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 13.1 m-85 -60.21 151.94 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.878 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.64 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.35 124.51 2.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.137 0.494 . . . . 0.0 111.18 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 120.54 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.4 t -103.16 147.2 9.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -140.34 104.79 4.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.825 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mm -107.4 99.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -83.99 109.87 17.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.405 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -132.27 -175.32 3.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -104.63 144.27 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.372 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HG2' ' CB ' ' A' ' 95' ' ' ASN . 15.6 mttt -50.24 144.45 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.076 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 10.73 80.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.624 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 31' ' ' LEU . 26.9 mm-40 -124.86 31.05 5.75 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.851 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 25.5 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.089 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 23' ' ' ILE . 56.8 tp 177.56 -41.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.791 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.79 63.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.856 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.025 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -151.11 156.12 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 111.216 178.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' B' ' -3' ' ' PRO . 38.6 t -121.61 129.83 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -119.76 140.84 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.434 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.9 m -131.52 168.15 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -58.91 132.57 54.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.914 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.4 p -74.1 84.08 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -79.27 -7.74 88.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.074 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.59 -162.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 110.322 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.02 -26.5 6.01 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.445 -0.884 . . . . 0.0 111.816 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.31 45.74 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.544 0.688 . . . . 0.0 111.256 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.893 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 83.6 mt -59.01 -39.28 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.942 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.97 ' O ' HG22 ' A' ' 46' ' ' THR . 2.0 mt -146.22 80.99 9.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.386 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 80' ' ' GLY . 94.8 Cg_exo -42.57 91.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.913 2.408 . . . . 0.0 113.581 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.13 -89.42 0.2 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.354 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.667 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.61 167.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.653 0.264 . . . . 0.0 111.205 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.43 129.44 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.075 HG22 HD13 ' A' ' 66' ' ' ILE . 52.2 mt -68.21 91.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -13.26 41.46 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.764 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -158.13 159.1 35.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.975 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.13 129.14 10.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.439 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 3.3 mtm -56.3 102.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.0 70.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.777 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.88 -34.26 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.066 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.09 -167.86 4.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.093 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.5 Cg_endo -69.27 -16.11 39.37 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.813 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.41 -49.69 58.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.856 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -36.87 50.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -56.73 -47.28 80.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -73.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.39 -4.05 23.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.309 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.693 ' HB2' HG13 ' A' ' 21' ' ' VAL . 20.1 mmmt -75.93 -37.49 58.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.539 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.847 HD21 HD13 ' A' ' 101' ' ' LEU . 53.3 mt -91.81 126.53 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -132.15 128.13 37.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.496 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.075 HD13 HG22 ' A' ' 49' ' ' ILE . 43.8 mm -44.18 142.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.5 . . . . 0.0 111.937 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.12 13.33 56.38 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.563 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.908 ' HB3' HD12 ' A' ' 103' ' ' ILE . 87.4 m-20 -102.37 166.93 10.29 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.761 0.315 . . . . 0.0 110.615 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 3.4 mm100 -120.32 105.71 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.762 HG23 HG22 ' A' ' 103' ' ' ILE . 4.9 mt -78.82 129.48 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.706 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -95.42 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 p -126.56 142.26 51.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.598 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 HD21 ' A' ' 78' ' ' LEU . 2.8 mp -120.08 122.85 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.515 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.76 31.23 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.85 14.52 69.71 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.522 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 m -109.14 95.63 5.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -73.56 131.01 41.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.591 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.682 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.24 16.32 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.136 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -63.04 89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.999 0.428 . . . . 0.0 110.28 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 134.63 -22.04 3.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.5 mt -74.1 167.71 33.04 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.276 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 85' ' ' THR . 9.7 Cg_exo -68.9 -177.27 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.751 2.301 . . . . 0.0 111.439 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -78.64 -52.9 7.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 179.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 -38.84 65.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.723 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 89' ' ' ILE . 37.2 m -62.4 -43.12 99.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HG13 ' A' ' 89' ' ' ILE . 77.3 m -58.79 -51.48 69.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HA ' HD11 ' A' ' 35' ' ' ILE . 8.8 mt-30 -50.99 -44.05 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.276 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.5 m -60.42 -35.19 75.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.371 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 85' ' ' THR . 2.8 mm -58.35 -49.43 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.104 HG21 HD13 ' B' ' 0' ' ' ILE . 59.1 mt -71.45 -43.44 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.769 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.38 -24.44 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.84 -42.28 38.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.627 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -89.19 51.15 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 111.142 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.851 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -87.32 -23.84 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 56.6 m-80 -116.07 63.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.3 mm100 -124.19 -29.78 3.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.602 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 3.8 t 82.28 -2.16 1.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.247 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.43 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.1 ttm180 -154.93 134.02 12.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.73 0.3 . . . . 0.0 110.229 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.631 ' CG1' HD21 ' A' ' 101' ' ' LEU . 17.7 t -119.75 104.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.711 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -90.98 100.85 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.71 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.847 HD13 HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -115.84 120.76 40.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 5.3 t30 -90.45 90.58 8.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.908 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.7 pt -111.94 164.63 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.706 HG23 ' SD ' ' A' ' 71' ' ' MET . 61.6 t -103.05 107.96 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.333 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.6 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.715 ' CG ' HG21 ' A' ' 34' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.823 0.26 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.402 HG23 ' N ' ' B' ' -1' ' ' TYR . 18.2 m -55.96 -42.51 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.365 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 34' ' ' VAL . 1.5 m-85 64.97 90.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.104 HD13 HG21 ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.042 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CA ' HG12 ' A' ' 104' ' ' VAL . 5.4 m-85 -58.68 151.98 19.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.965 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -164.38 125.23 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 111.508 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.09 102.14 4.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.4 t -82.7 136.66 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.153 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -124.95 104.77 8.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 61' ' ' SER . 15.3 mm -105.88 99.78 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -86.87 109.82 19.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -138.04 -171.15 2.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.995 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.54 169.38 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.59 156.99 31.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 18.84 61.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.292 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' C ' ' A' ' 30' ' ' ILE . 2.7 mm-40 -127.7 29.5 5.46 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.582 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 10.29 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.326 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 172.75 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.77 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 89.01 66.65 1.26 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.467 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.045 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -149.39 156.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' B' ' -3' ' ' PRO . 21.9 t -121.23 126.51 75.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.721 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.552 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -113.94 151.92 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.77 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 35.2 m -142.61 167.3 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.32 131.1 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 48' ' ' ILE . 25.2 p -70.4 84.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.62 -5.82 89.21 Favored Glycine 0 C--N 1.328 0.135 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.967 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.751 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.24 -163.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.566 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.08 -24.49 6.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.76 36.52 0.08 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.233 0.54 . . . . 0.0 111.404 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.751 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.5 mt -52.45 -36.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.657 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -147.59 101.06 3.74 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.943 178.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 75.6 Cg_exo -51.76 83.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.398 2.065 . . . . 0.0 112.876 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -133.84 -152.35 0.48 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.214 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 83' ' ' LEU . 15.8 m -111.28 166.1 5.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.634 0.254 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.04 131.33 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.019 HG22 HD13 ' A' ' 66' ' ' ILE . 73.1 mt -68.2 93.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.28 -9.58 44.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.238 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.466 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.2 m-20 -162.12 160.22 27.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 111.053 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -152.06 147.65 26.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.582 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.9 mtt -59.64 -27.86 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 60.61 60.85 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.697 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.96 -30.15 0.16 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.278 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.7 -170.68 29.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.043 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.411 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 29.7 Cg_endo -63.09 -17.21 59.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.301 2.001 . . . . 0.0 112.343 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -49.02 66.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -38.77 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -56.38 -45.95 80.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.415 ' CB ' HD13 ' A' ' 23' ' ' ILE . 1.6 p -56.04 -56.15 24.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.93 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -29.21 11.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.289 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' CB ' HG13 ' A' ' 21' ' ' VAL . 5.4 mtmt -61.02 -29.3 69.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' A' ' 21' ' ' VAL . 86.8 mt -101.69 125.96 48.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.14 147.75 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.019 HD13 HG22 ' A' ' 49' ' ' ILE . 50.8 mm -50.41 146.5 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.647 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.93 59.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.262 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.62 ' HB3' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -102.55 174.18 6.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.689 0.281 . . . . 0.0 110.658 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.68 ' HB2' HG23 ' A' ' 104' ' ' VAL . 3.5 mm100 -130.35 107.8 9.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.147 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.72 HG23 HG22 ' A' ' 103' ' ' ILE . 7.5 mt -88.71 134.2 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.808 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -97.02 -69.91 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t -129.62 144.95 51.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.267 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.966 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -113.88 110.95 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.591 ' ND2' ' H ' ' A' ' 100' ' ' LYS . 30.2 m120 57.69 22.77 8.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.94 -34.21 4.71 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.868 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.85 HG21 HD12 ' A' ' 89' ' ' ILE . 3.8 m -65.55 103.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.795 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 p -68.81 135.59 51.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.309 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.966 HD11 ' CD1' ' A' ' 73' ' ' ILE . 29.5 mt -112.58 -20.16 11.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.089 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 46' ' ' THR . 35.9 t -56.28 88.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.649 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.51 -49.69 0.86 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.361 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.795 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -64.46 159.88 55.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.554 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.67 -177.39 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.037 2.491 . . . . 0.0 112.654 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.587 HD23 HG12 ' A' ' 47' ' ' VAL . 1.9 tm? -78.17 -49.91 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.712 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 m -53.15 -41.14 64.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.991 0.424 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.8 m -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.036 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.0 m -55.7 -54.1 48.41 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' B' ' -2' ' ' VAL . 85.6 mt-30 -49.03 -48.01 44.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.2 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 23.2 t -56.81 -35.26 68.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.556 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.85 HD12 HG21 ' A' ' 76' ' ' THR . 7.0 mm -58.8 -48.58 85.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.999 HG21 HD13 ' B' ' 0' ' ' ILE . 23.7 mt -67.49 -50.55 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.17 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.27 -19.97 62.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.87 -23.22 69.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.583 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.4 pp -113.82 44.27 1.66 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.33 -12.27 43.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.42 39.15 1.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.775 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.02 147.98 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 110.677 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.1 t -83.13 -9.12 59.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 1.9 ttm180 -147.15 141.78 26.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.746 0.308 . . . . 0.0 110.725 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.775 HG22 ' OE1' ' A' ' 96' ' ' GLN . 10.4 t -127.7 104.89 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.36 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.591 ' H ' ' ND2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -88.68 97.91 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.739 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -102.28 154.55 18.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 111.297 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 71' ' ' MET . 2.6 m-20 -124.13 97.65 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.72 HG22 HG23 ' A' ' 70' ' ' ILE . 1.7 pt -121.51 172.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.129 0.49 . . . . 0.0 112.295 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 69' ' ' GLN . 4.3 m -125.9 130.99 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.587 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.527 ' CG ' HG11 ' A' ' 34' ' ' VAL . 68.1 Cg_endo . . . . . 0 N--CA 1.464 -0.243 0 N-CA-C 112.623 0.201 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.529 ' HB ' ' NE2' ' A' ' 87' ' ' GLN . 33.1 t 54.39 87.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.006 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.42 ' CZ ' HG23 ' A' ' 34' ' ' VAL . 1.2 m-85 -81.89 145.77 30.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.045 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.775 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.865 0.364 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 44' ' ' LEU . 6.4 m-85 -64.71 154.44 36.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.784 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.59 125.32 2.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.233 0.539 . . . . 0.0 111.559 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.55 100.15 1.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.502 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 101' ' ' LEU . 24.9 t -82.43 112.01 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.131 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -110.92 104.82 13.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' CB ' ' A' ' 61' ' ' SER . 4.1 mm -105.96 104.16 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.2 mp0 -84.05 110.3 18.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.5 -171.3 2.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -112.22 166.72 11.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -65.05 158.49 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 110.724 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.38 17.77 60.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.487 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -126.81 29.73 5.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 22.77 -82.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.097 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 99' ' ' VAL . 16.7 tp 174.95 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' HA2' ' HE1' ' A' ' 53' ' ' MET . . . 88.49 63.5 1.35 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.819 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.046 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -152.7 156.07 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 117.18 0.49 . . . . 0.0 111.795 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 31.1 t -126.35 116.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.588 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -103.24 152.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.44 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 48' ' ' ILE . 26.8 m -140.09 168.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 48' ' ' ILE . 28.7 mt-10 -58.46 132.14 52.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.939 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.5 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.6 p -74.11 84.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.423 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.84 -9.62 84.22 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.123 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.903 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.23 -161.65 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.723 0.296 . . . . 0.0 110.439 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.73 -26.07 7.55 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.801 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.439 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 9.1 m 80.54 35.87 0.11 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.264 0.554 . . . . 0.0 111.49 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.903 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 74.2 mt -49.25 -39.36 12.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.056 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.906 ' O ' HG22 ' A' ' 46' ' ' THR . 1.5 mt -145.66 87.71 6.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.091 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 6.7 Cg_endo -50.39 90.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.873 2.382 . . . . 0.0 113.308 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.9 -91.58 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.818 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.497 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -158.67 167.58 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.38 131.11 63.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.091 HG22 HD13 ' A' ' 66' ' ' ILE . 56.0 mt -68.1 93.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.06 -1.89 53.73 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.115 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.543 HD21 ' HA ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -170.01 152.6 4.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 110.577 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 mtm -146.7 121.35 9.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 0.0 111.448 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.482 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -54.48 90.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.607 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -59.25 82.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.05 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.76 -29.92 0.27 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.953 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.57 32.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.52 -16.06 38.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.704 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.25 63.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 -33.38 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.751 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -61.37 -45.58 93.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.417 ' CB ' HD13 ' A' ' 23' ' ' ILE . 6.8 m -63.73 -68.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.22 -25.65 17.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.505 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.567 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.89 -27.07 40.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.643 ' HG ' HG11 ' A' ' 21' ' ' VAL . 71.5 mt -98.76 134.53 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -140.43 134.73 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.711 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.091 HD13 HG22 ' A' ' 49' ' ' ILE . 49.4 mm -46.42 144.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.705 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.22 84.57 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.659 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.922 ' HB3' HD12 ' A' ' 103' ' ' ILE . 74.6 m-20 -85.59 164.0 18.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.678 0.275 . . . . 0.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.737 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -119.45 118.29 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 111.193 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.783 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -91.62 108.73 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.53 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.85 -66.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.876 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.8 p -135.65 148.53 48.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.408 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 3.2 mt -118.22 112.5 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.77 23.85 12.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.78 -30.49 7.43 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.886 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.877 HG21 HG23 ' A' ' 89' ' ' ILE . 3.0 m -67.7 102.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.716 0.293 . . . . 0.0 111.039 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.593 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.9 m -69.04 136.75 52.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.054 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HA ' HD21 ' A' ' 81' ' ' LEU . 40.5 mt -112.24 -13.52 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -67.05 94.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.341 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.91 -22.73 3.8 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.479 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.93 157.61 33.57 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.983 0.391 . . . . 0.0 111.472 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.01 -174.15 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.818 2.346 . . . . 0.0 112.801 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -78.15 -48.43 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.459 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 p -52.99 -42.21 65.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.705 HG22 HD13 ' A' ' 81' ' ' LEU . 99.1 m -61.55 -48.33 81.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.839 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' HD12 ' A' ' 81' ' ' LEU . 78.8 m -56.13 -50.16 71.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.883 0.373 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -50.22 -46.2 54.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.305 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.3 m -59.69 -35.7 75.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.64 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.877 HG23 HG21 ' A' ' 76' ' ' THR . 18.2 mm -58.15 -50.0 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.063 HG21 HD13 ' B' ' 0' ' ' ILE . 58.7 mt -69.54 -45.31 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -55.57 -23.42 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.31 -33.3 32.38 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.0 pp -95.65 35.12 1.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.915 0.388 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.76 -5.79 58.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -107.65 43.96 1.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.404 ' CD ' ' HB2' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -131.97 176.07 8.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 110.9 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.2 t -102.17 -16.74 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 28.3 mmt85 -131.21 150.49 52.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 101' ' ' LEU . 7.7 t -129.4 104.3 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mmpt? -90.0 120.92 31.62 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.3 117.84 11.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 111.804 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.78 99.41 12.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.574 178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.922 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.68 167.35 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.153 0.501 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' HB2' ' A' ' 69' ' ' GLN . 4.3 p -112.06 129.09 68.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.247 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 72.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.781 0.242 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.76 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.542 ' CE2' HG23 ' A' ' 34' ' ' VAL . 36.6 m-85 -109.33 131.51 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 90' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.593 ' C ' HG13 ' A' ' 104' ' ' VAL . 2.3 tt0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.83 0.347 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.512 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.0 m-85 -67.29 151.55 47.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.692 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.73 125.9 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.314 0.578 . . . . 0.0 111.616 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.56 105.88 6.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.572 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 63' ' ' LYS . 22.8 t -84.38 141.2 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -132.84 104.53 6.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.217 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 31' ' ' LEU . 14.1 mm -106.57 99.63 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 98' ' ' ARG . 37.2 mt-10 -85.63 109.55 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.023 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -140.54 -172.86 3.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.154 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.8 169.07 8.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.423 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 157.12 30.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.532 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 9.92 65.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.507 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ILE . 4.4 mt-10 -120.13 31.87 6.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.197 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 5.77 -75.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.103 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 99' ' ' VAL . 2.5 tp 171.73 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.844 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 83.15 62.73 1.79 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.249 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.036 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -146.03 156.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 111.715 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.553 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.3 t -119.43 132.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER -117.16 156.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.635 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.749 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.28 165.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.808 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.19 131.82 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.609 ' HA ' HD11 ' A' ' 48' ' ' ILE . 87.5 p -69.13 84.09 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.403 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.47 -1.19 90.24 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.63 ' CE2' ' NE2' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -55.8 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.579 0.228 . . . . 0.0 110.475 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.28 -25.5 8.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.833 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 83.05 64.27 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.739 0.78 . . . . 0.0 111.459 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.586 ' O ' HD23 ' A' ' 44' ' ' LEU . 43.5 mt -83.0 -31.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.841 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -156.51 101.39 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.809 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 9.6 Cg_endo -52.11 83.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.58 2.187 . . . . 0.0 113.363 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -133.45 -157.7 0.83 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.041 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.6 m -105.64 153.36 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.933 0.396 . . . . 0.0 111.651 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -115.78 132.79 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.8 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.063 HG22 HD13 ' A' ' 66' ' ' ILE . 48.8 mt -69.31 90.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.44 -11.3 52.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.192 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.626 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -161.8 159.9 27.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 17.1 ttm -149.15 135.64 19.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.935 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 30' ' ' ILE . 2.9 mtm -51.95 -27.19 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 58.66 54.67 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.676 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.2 -37.14 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.217 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.88 -166.14 2.45 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.951 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 51.0 Cg_endo -68.91 -16.94 41.6 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.292 1.995 . . . . 0.0 112.131 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.53 -44.74 73.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.482 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -39.42 49.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.565 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -58.34 -47.12 84.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -63.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.14 -23.42 27.3 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.287 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.876 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -56.84 -36.59 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 21' ' ' VAL . 23.1 mt -101.08 104.39 15.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.995 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 8.7 p-10 -121.54 141.23 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.531 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.063 HD13 HG22 ' A' ' 49' ' ' ILE . 28.5 mm -46.34 145.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 111.809 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.62 4.82 61.9 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.64 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.6 m-20 -106.07 150.96 25.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.29 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 40' ' ' TRP . 1.3 tt0 -113.08 126.72 55.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.729 HG23 HG22 ' A' ' 103' ' ' ILE . 6.3 mt -88.93 134.87 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.726 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -96.81 -57.82 2.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.241 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.0 p -147.23 145.26 29.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.969 0.414 . . . . 0.0 111.401 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.75 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -115.23 120.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 73' ' ' ILE . 71.9 m-80 55.87 27.98 11.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.37 -26.01 24.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.795 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.655 HG21 HG23 ' A' ' 89' ' ' ILE . 3.4 m -65.51 102.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD21 ' A' ' 81' ' ' LEU . 4.9 t -68.77 131.48 45.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 73' ' ' ILE . 21.0 mt -109.82 -25.34 10.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.715 HG22 HG22 ' A' ' 46' ' ' THR . 26.0 t -54.99 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.524 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.45 -38.09 1.49 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.242 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.66 159.73 57.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.372 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 -172.14 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.847 2.365 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.8 tp -78.04 -45.01 24.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.018 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 7.6 t -53.34 -43.0 67.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.983 0.421 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.683 HG22 HD13 ' A' ' 81' ' ' LEU . 89.7 m -63.86 -48.63 75.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.646 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 71.9 m -55.97 -57.16 13.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.549 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.681 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.4 pt20 -48.86 -42.09 35.33 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.968 0.413 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -60.94 -35.69 77.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.311 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 85' ' ' THR . 13.9 mm -59.0 -49.4 83.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.013 HG21 HD13 ' B' ' 0' ' ' ILE . 29.1 mt -71.96 -46.09 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.721 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.2 mtpt -55.42 -24.41 30.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -47.25 47.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.209 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.33 55.72 3.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 0.0 110.814 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -87.93 -19.47 27.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.288 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -109.29 54.37 0.66 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.785 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.21 156.15 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.618 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 p -93.98 -12.23 29.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.763 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -143.58 139.49 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.522 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 ' OE1' ' A' ' 96' ' ' GLN . 2.7 t -120.87 104.43 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.516 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.38 119.45 32.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.826 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -132.0 154.35 49.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.024 0.44 . . . . 0.0 111.118 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.5 OUTLIER -122.29 92.25 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.2 pt -116.05 170.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 112.161 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.726 HG23 ' SD ' ' A' ' 71' ' ' MET . 35.9 t -119.98 113.9 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.889 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttm105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.961 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.553 ' HG2' HG21 ' A' ' 34' ' ' VAL . 88.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.787 0.264 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 61.35 122.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.375 . . . . 0.0 111.278 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 34' ' ' VAL . 32.9 m-85 -117.84 143.9 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.036 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HE1' HD21 ' A' ' 44' ' ' LEU . 2.5 m-85 -64.2 154.28 35.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.754 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.12 127.57 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 111.834 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.47 102.05 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.524 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 63' ' ' LYS . 24.8 t -82.77 135.3 25.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.022 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -127.28 104.84 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 31' ' ' LEU . 15.0 mm -104.71 99.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -90.07 109.61 20.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.121 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -135.07 -165.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -106.47 162.34 13.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.407 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.81 158.78 15.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.511 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.87 19.48 50.16 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -124.68 29.24 6.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 110.07 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 15.73 -80.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.482 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.566 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER 174.13 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.794 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.17 67.49 1.08 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.59 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.044 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -152.45 156.12 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.707 0.289 . . . . 0.0 111.008 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 47.9 t -120.62 123.64 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.045 0.45 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.565 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -110.91 140.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.803 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.635 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.6 m -133.12 168.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.121 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.6 mt-10 -58.47 132.32 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.3 p -72.92 84.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.469 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.05 -8.44 83.94 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.032 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.974 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.39 -161.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.478 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.4 8.61 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.816 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.424 0.63 . . . . 0.0 111.172 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 92.3 mt -55.95 -42.18 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.944 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -152.63 88.68 3.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.32 178.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.44 108.91 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.123 2.548 . . . . 0.0 114.108 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -154.85 -91.48 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.379 178.315 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.18 167.49 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 110.962 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.513 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.67 130.23 59.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.039 HG22 HD13 ' A' ' 66' ' ' ILE . 66.1 mt -69.09 94.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.5 -1.9 49.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.434 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -166.69 159.36 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.0 ttm -154.07 135.19 13.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.654 ' CE ' HD11 ' A' ' 30' ' ' ILE . 9.7 mtm -71.82 99.84 2.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.59 76.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.84 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -35.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -170.13 18.26 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.997 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 56.2 Cg_endo -69.11 -15.68 39.72 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.541 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.52 67.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.898 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.43 -38.99 48.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -57.47 -47.1 82.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.253 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.8 p -56.9 -63.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.53 -9.19 57.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.321 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.794 ' HB2' HG13 ' A' ' 21' ' ' VAL . 8.8 mmmt -72.93 -31.41 64.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.88 0.371 . . . . 0.0 110.548 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 21' ' ' VAL . 87.5 mt -96.85 130.4 44.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -139.44 134.06 31.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.039 HD13 HG22 ' A' ' 49' ' ' ILE . 50.1 mm -46.49 144.32 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 111.798 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.09 13.25 57.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.8 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.7 m-20 -108.56 160.0 16.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.684 0.278 . . . . 0.0 110.698 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -115.06 119.17 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -90.42 113.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.812 ' CE ' HD13 ' A' ' 44' ' ' LEU . 24.3 mmt -72.98 -66.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.709 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 86.4 p -134.42 160.31 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.719 HD12 HD21 ' A' ' 78' ' ' LEU . 3.3 mt -118.5 111.11 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.73 28.89 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.11 -30.14 5.54 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.222 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 89' ' ' ILE . 11.1 m -78.26 99.98 6.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.465 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 67.3 m -84.8 137.49 33.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.638 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.743 ' HA ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -128.76 24.77 5.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.879 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.6 t -75.64 93.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.005 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.09 -18.78 4.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.143 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.68 163.19 33.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.982 0.391 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.05 -179.28 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.803 2.335 . . . . 0.0 112.417 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 tp -78.13 -44.62 25.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.24 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -53.14 -42.55 66.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.2 m -63.73 -47.8 79.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.715 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.514 ' SG ' HD13 ' A' ' 78' ' ' LEU . 77.0 m -55.76 -57.48 11.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.358 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.447 ' N ' HD11 ' A' ' 35' ' ' ILE . 15.7 pt20 -49.77 -39.95 39.7 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.508 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 16.7 t -62.45 -36.61 82.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.26 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 76' ' ' THR . 2.1 mm -58.84 -49.73 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.347 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.041 HG21 HD13 ' B' ' 0' ' ' ILE . 54.6 mt -69.4 -50.45 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.131 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.62 -22.01 55.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.881 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.15 -30.31 59.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 89' ' ' ILE . 1.1 pp -104.38 35.32 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 111.062 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.82 -5.92 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.592 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.08 35.69 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.682 0.277 . . . . 0.0 111.73 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.53 170.67 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.737 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 t -99.18 -8.74 24.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.855 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.4 ttm180 -139.6 140.03 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 93' ' ' LEU . 13.9 t -130.51 106.1 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.643 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.483 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 7.9 tttt -88.13 131.8 34.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.68 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -142.07 117.9 10.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.002 0.43 . . . . 0.0 111.448 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -89.31 89.66 8.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -111.67 166.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.913 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 69' ' ' GLN . 6.3 p -109.07 122.78 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.638 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 -179.601 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.484 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.3 Cg_endo . . . . . 0 N--CA 1.464 -0.216 0 CA-C-O 120.789 0.245 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.17 142.7 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 0.5 OUTLIER -119.56 115.91 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.044 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.904 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.582 ' C ' HG13 ' A' ' 104' ' ' VAL . 3.2 tp10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.428 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 4.9 m-85 -61.75 148.68 42.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.06 126.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.171 0.51 . . . . 0.0 111.805 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.66 133.01 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.938 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 63' ' ' LYS . 18.9 t -116.29 111.41 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.253 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.749 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.37 115.72 31.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.5 mm -114.86 99.4 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.862 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -88.81 128.31 35.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.327 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.556 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -157.44 -166.83 2.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -115.58 167.43 10.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.87 157.64 17.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.0 110.736 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.92 11.1 73.79 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.542 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -123.96 32.51 5.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.258 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.775 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 10.64 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.154 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.67 ' CD1' HG21 ' A' ' 23' ' ' ILE . 59.1 tp 177.35 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.709 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.62 63.51 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.702 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.45 156.46 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 40.9 t -122.16 117.28 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.56 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -106.18 147.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.471 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.8 m -140.38 169.71 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' O ' HD11 ' A' ' 48' ' ' ILE . 6.5 mt-10 -63.18 129.37 40.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.927 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.51 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.2 p -71.12 83.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.98 -3.56 89.08 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.695 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.876 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.56 -163.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.698 0.285 . . . . 0.0 110.603 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.24 -24.69 7.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.811 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.52 35.38 0.07 Allowed 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.182 0.515 . . . . 0.0 111.562 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.876 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.2 mt -49.1 -39.34 12.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.765 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -148.31 111.69 3.74 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.019 178.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' GLY . 34.8 Cg_exo -59.71 98.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.096 1.864 . . . . 0.0 112.62 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -152.57 -155.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.009 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -106.25 165.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.71 130.53 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.068 HG22 HD13 ' A' ' 66' ' ' ILE . 69.0 mt -71.42 93.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.94 -5.06 53.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.114 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -163.03 164.3 25.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -160.79 132.13 5.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 8.2 mtm -69.3 101.97 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.343 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.84 78.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.26 -30.69 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.164 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.37 -176.1 38.3 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.099 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 34.4 Cg_exo -59.75 -16.55 38.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.594 2.196 . . . . 0.0 112.712 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.24 -50.26 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -32.7 49.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.349 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.26 -47.15 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.287 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -56.54 -69.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.28 22.97 7.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.126 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.771 ' CB ' HG13 ' A' ' 21' ' ' VAL . 8.7 mtpp -107.88 -33.0 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.753 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.763 ' HG ' HG11 ' A' ' 21' ' ' VAL . 54.0 mt -96.03 123.21 39.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.664 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -127.49 133.32 49.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.593 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.068 HD13 HG22 ' A' ' 49' ' ' ILE . 46.6 mm -45.46 141.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.97 15.07 56.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.214 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.938 ' HB3' HD12 ' A' ' 103' ' ' ILE . 98.1 m-20 -101.42 164.63 11.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.779 0.324 . . . . 0.0 110.695 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.523 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 5.2 mm100 -120.32 115.17 23.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -89.06 117.78 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.56 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.5 -64.28 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.376 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.4 t -132.24 146.17 51.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.821 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -117.11 111.3 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.559 HD22 HD22 ' A' ' 93' ' ' LEU . 89.1 m-20 60.92 25.93 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.09 -28.59 11.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.618 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 1.054 HG21 HD12 ' A' ' 89' ' ' ILE . 86.4 m -63.9 96.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.076 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -74.41 117.97 16.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.722 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.795 HD21 HD12 ' A' ' 73' ' ' ILE . 1.2 pp -125.03 27.71 6.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' THR . 24.8 t -74.6 80.22 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 139.23 -13.28 3.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.779 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -83.11 157.8 65.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 110.819 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.1 -174.93 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.577 2.185 . . . . 0.0 111.891 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.5 tp -78.31 -39.95 38.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.699 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.3 p -53.71 -44.69 70.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.349 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.9 m -63.95 -52.97 57.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.859 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 78' ' ' LEU . 73.5 m -55.74 -52.15 64.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.769 0.318 . . . . 0.0 111.002 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.449 ' OE1' HG11 ' B' ' -2' ' ' VAL . 19.2 mt-30 -49.71 -42.62 46.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.021 0.439 . . . . 0.0 109.896 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.3 m -60.9 -36.86 80.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.271 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.054 HD12 HG21 ' A' ' 76' ' ' THR . 14.7 mm -58.98 -49.37 83.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.398 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.133 HG21 HD13 ' B' ' 0' ' ' ILE . 34.6 mt -72.59 -49.96 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.46 -20.33 54.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.895 0.378 . . . . 0.0 110.956 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.38 -28.49 67.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.362 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.4 pp -106.92 57.67 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.7 -30.58 29.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.104 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -96.57 37.47 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -100.69 144.05 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.019 0.438 . . . . 0.0 111.353 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.9 p -96.63 -5.77 38.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.576 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.749 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 10.8 ttm180 -157.0 137.79 13.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.245 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.556 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 2.5 t -132.01 123.87 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -100.8 128.48 46.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.627 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.821 HD23 HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -139.37 116.66 11.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 111.931 -179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -89.05 93.02 9.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.938 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.6 pt -116.34 168.87 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.984 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.582 HG13 ' C ' ' A' ' 17' ' ' GLU . 37.3 t -115.05 119.44 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.544 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 91.1 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 CA-C-O 120.818 0.258 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.449 HG11 ' OE1' ' A' ' 87' ' ' GLN . 9.1 p -64.17 142.81 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 34' ' ' VAL . 4.7 m-85 -112.31 135.69 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.133 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.99 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' C ' HG23 ' A' ' 104' ' ' VAL . 4.3 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.458 ' N ' HG23 ' A' ' 104' ' ' VAL . 7.8 m-85 -65.14 154.52 37.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.17 125.15 3.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 111.734 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.87 101.94 4.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.407 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.843 HG11 ' HG ' ' A' ' 64' ' ' LEU . 15.8 t -83.54 139.3 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.91 104.91 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.527 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.627 HG13 HD21 ' A' ' 31' ' ' LEU . 11.1 mm -103.42 99.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.21 109.98 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.319 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 -174.35 4.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -107.52 176.38 5.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.601 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 155.72 39.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.04 13.97 65.16 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.497 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 30' ' ' ILE . 5.5 mt-10 -125.45 31.19 5.6 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.157 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.61 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 9.83 -78.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.288 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER 173.39 -43.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.757 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.56 60.53 1.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.664 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.02 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -144.92 155.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' O ' ' B' ' -2' ' ' VAL . 88.4 t -123.62 129.37 74.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.744 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.94 153.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.632 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.6 m -141.93 169.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.838 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.2 mt-10 -61.72 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.491 ' HA ' HD11 ' A' ' 48' ' ' ILE . 88.5 p -68.37 84.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.507 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.21 -3.73 87.02 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.801 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.61 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.616 0.246 . . . . 0.0 110.443 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.96 -24.28 6.23 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.766 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 82.16 38.71 0.05 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.327 0.584 . . . . 0.0 111.277 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.769 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.4 mt -54.15 -34.99 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.792 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -152.01 104.41 2.82 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.16 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 61.9 Cg_exo -52.14 84.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.516 2.144 . . . . 0.0 113.14 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -133.72 -154.65 0.61 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -108.12 167.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.5 125.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.993 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -65.18 91.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -8.11 55.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.123 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.533 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -166.26 161.02 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 111.344 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -155.65 142.71 19.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.597 ' CE ' HD11 ' A' ' 30' ' ' ILE . 7.2 mtt -52.66 -25.01 9.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.66 47.75 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.802 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.97 -39.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.05 -169.59 1.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.278 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.19 -23.91 56.14 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.644 2.229 . . . . 0.0 112.196 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -62.65 -49.31 75.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -76.99 -39.02 51.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -50.89 -47.1 60.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.43 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -60.45 -51.95 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.831 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.08 55.62 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mtmt -69.06 -35.27 76.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.843 ' HG ' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -88.03 113.65 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -127.92 135.23 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 49' ' ' ILE . 26.0 mm -46.27 145.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 0.0 111.752 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.45 64.66 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.876 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.856 ' HB3' HD12 ' A' ' 103' ' ' ILE . 3.0 m-20 -106.38 163.43 12.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.902 0.351 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -114.68 121.47 43.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.708 HG23 HG22 ' A' ' 103' ' ' ILE . 7.7 mt -91.17 112.64 25.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.444 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.626 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -77.51 -63.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 t -133.16 154.09 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.935 ' CD1' HD11 ' A' ' 78' ' ' LEU . 4.4 mt -126.18 104.13 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.83 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.526 HD22 HG22 ' A' ' 73' ' ' ILE . 50.9 m-80 60.02 24.13 13.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.74 -33.31 4.99 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.926 HG21 HD12 ' A' ' 89' ' ' ILE . 3.9 m -65.2 98.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.586 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -70.21 106.8 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.935 HD11 ' CD1' ' A' ' 73' ' ' ILE . 25.8 mt -79.89 -31.23 40.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.3 p -52.75 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.78 -27.8 2.18 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.267 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.744 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -98.72 159.73 29.66 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.887 0.375 . . . . 0.0 111.427 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 -172.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.837 2.358 . . . . 0.0 112.537 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.5 tp -77.27 -46.22 23.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.192 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 39.6 m -53.16 -42.41 66.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 110.506 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.707 HG22 HD13 ' A' ' 81' ' ' LEU . 85.1 m -64.52 -48.72 74.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.637 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 76.2 m -55.63 -57.22 12.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.7 pt20 -48.98 -42.51 37.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -61.15 -35.15 76.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.269 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 76' ' ' THR . 8.6 mm -58.91 -49.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.026 HG21 HD13 ' B' ' 0' ' ' ILE . 31.2 mt -72.1 -46.45 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.4 mttm -55.44 -23.99 28.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -42.49 43.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.037 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.8 OUTLIER -92.47 56.35 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.21 -27.52 22.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.511 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -94.93 35.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.485 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -102.24 150.6 23.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.416 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.0 p -91.87 -13.8 30.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.616 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -148.65 137.83 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.339 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 31' ' ' LEU . 14.4 t -122.15 104.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.896 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.53 126.28 35.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.837 179.023 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.886 0.374 . . . . 0.0 110.965 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 71' ' ' MET . 6.8 t30 -123.73 90.43 3.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -109.36 170.86 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.623 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.2 p -122.81 127.98 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.292 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.411 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' -3' ' ' PRO . . . . . 0.731 ' HG2' HG21 ' A' ' 34' ' ' VAL . 67.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.782 0.242 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -2' ' ' VAL . . . . . 0.782 ' O ' HG22 ' A' ' 34' ' ' VAL . 30.4 m -57.73 119.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' -1' ' ' TYR . . . . . 0.592 ' CE1' HG23 ' A' ' 34' ' ' VAL . 19.6 m-85 -110.67 142.69 42.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.364 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 1.026 HD13 HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' C ' HG13 ' A' ' 104' ' ' VAL . 1.7 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.359 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.3 m-85 -69.45 150.96 46.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.21 127.9 3.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.793 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.6 104.64 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.407 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.839 HG11 ' HG ' ' A' ' 64' ' ' LEU . 13.8 t -82.78 142.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HE1' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.96 104.34 6.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.234 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 31' ' ' LEU . 15.4 mm -106.63 99.67 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.451 . . . . 0.0 111.263 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' CB ' ' HD3' ' A' ' 98' ' ' ARG . 1.9 mp0 -85.72 109.89 18.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.262 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.49 -166.61 2.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 111.069 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.99 163.56 18.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -58.07 161.64 3.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.64 11.48 62.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' LEU . 48.2 mt-10 -126.45 34.39 4.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.853 0.326 . . . . 0.0 110.406 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -78.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.083 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' GLU . 31.7 tp 176.51 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.819 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.34 62.62 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.575 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.983 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.98 157.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.05 0.452 . . . . 0.0 111.935 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.685 HG21 ' HG2' ' B' ' -3' ' ' PRO . 43.9 t -122.34 129.25 75.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.369 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.82 152.85 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.959 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' HD11 ' A' ' 83' ' ' LEU . 27.1 m -146.27 166.67 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.072 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' O ' HD11 ' A' ' 48' ' ' ILE . 39.9 mt-10 -57.85 132.06 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.4 p -72.74 83.81 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.451 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.81 -4.73 90.24 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.961 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.67 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.668 0.27 . . . . 0.0 110.515 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.59 -25.21 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.825 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 81.79 48.03 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.486 0.66 . . . . 0.0 111.248 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.758 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.9 mt -63.55 -35.99 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.536 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.865 HD13 ' HE1' ' A' ' 71' ' ' MET . 0.5 OUTLIER -149.34 110.3 3.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.797 178.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.7 Cg_endo -56.47 84.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.188 1.925 . . . . 0.0 112.483 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.24 -154.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.386 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -109.0 163.59 6.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.682 0.277 . . . . 0.0 110.907 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -122.2 130.34 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.049 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -70.0 90.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.02 -14.45 47.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.613 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -157.64 159.65 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.063 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -151.92 139.28 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.481 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.717 ' CE ' HD11 ' A' ' 30' ' ' ILE . 6.7 mtm -74.97 96.13 3.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.371 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -62.46 79.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.42 -29.49 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.218 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.65 -166.34 15.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.171 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.3 Cg_endo -69.12 -16.46 40.26 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.569 2.179 . . . . 0.0 112.422 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.07 50.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.028 0.442 . . . . 0.0 110.705 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -34.89 56.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.532 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -58.99 -47.25 85.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 t -62.5 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.46 -28.18 12.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.884 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' CB ' HG13 ' A' ' 21' ' ' VAL . 11.9 mtpp -58.17 -26.28 62.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.839 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.3 mt -101.92 126.28 48.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.487 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.8 OUTLIER -141.75 140.26 33.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.049 HD13 HG22 ' A' ' 49' ' ' ILE . 27.2 mm -48.72 146.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.54 59.57 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.813 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.9 m-20 -105.2 152.64 22.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.797 0.332 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -107.48 115.54 30.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.7 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -86.42 125.07 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.065 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.865 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -90.03 -63.24 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.299 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.8 p -139.47 145.77 39.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.376 . . . . 0.0 111.417 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.0 mt -115.42 116.26 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.1 m-80 55.25 27.65 10.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.346 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.57 -28.2 12.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.804 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.927 HG21 HG23 ' A' ' 89' ' ' ILE . 3.1 m -65.95 99.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.791 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.7 m -67.69 125.23 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.6 mt -105.19 -20.72 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -57.98 85.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.498 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.91 -41.84 1.1 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.117 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.869 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -77.45 159.86 76.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.419 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.81 -168.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.884 2.389 . . . . 0.0 112.687 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.23 -49.94 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.284 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.0 t -52.74 -39.98 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.526 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.869 HG22 HD13 ' A' ' 81' ' ' LEU . 97.6 m -63.15 -49.48 74.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.552 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.2 m -57.84 -48.19 80.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.422 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.1 mt-30 -50.38 -44.16 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.079 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 25.5 m -60.97 -37.41 82.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.534 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 76' ' ' THR . 14.1 mm -58.51 -49.67 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.769 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.8 mt -73.94 -50.52 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.19 -23.98 38.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -40.12 90.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.208 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.4 pp -93.74 48.19 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 110.92 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.46 -7.07 51.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.555 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -120.2 34.32 5.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.315 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -92.43 155.92 17.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.239 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 t -108.04 -9.71 15.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.126 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.9 tpp85 -154.42 114.31 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.374 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.635 ' CG1' HD21 ' A' ' 101' ' ' LEU . 12.7 t -99.31 104.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.558 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -92.66 97.66 10.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -107.02 154.57 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 111.155 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -124.12 86.85 2.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.0 pt -111.74 169.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.304 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.658 HG22 ' CG ' ' A' ' 18' ' ' PHE . 27.3 t -118.05 111.08 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.909 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.647 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.685 ' HG2' HG21 ' A' ' 34' ' ' VAL . 89.1 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 N-CA-C 112.784 0.263 . . . . 0.0 112.784 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 54.6 99.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.799 0.333 . . . . 0.0 111.426 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 34' ' ' VAL . 49.0 m-85 -90.76 137.99 31.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.9 pp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.78 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.0 tp10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CD1' HG13 ' A' ' 104' ' ' VAL . 4.0 m-85 -58.25 143.87 42.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 125.63 3.35 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 111.487 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.27 104.65 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.466 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 ' HG ' ' A' ' 64' ' ' LEU . 17.6 t -85.76 141.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.103 0.477 . . . . 0.0 111.435 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -132.28 104.7 6.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.323 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 31' ' ' LEU . 8.8 mm -106.66 99.68 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.353 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -79.54 109.87 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.93 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 4.9 pttm -133.13 -170.4 2.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.968 0.414 . . . . 0.0 111.38 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -121.26 170.32 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.231 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.51 162.07 16.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.937 0.398 . . . . 0.0 110.74 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.52 20.09 50.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.302 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 31' ' ' LEU . 51.3 mt-10 -132.14 31.94 4.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.249 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -81.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.307 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 23' ' ' ILE . 20.4 tp 177.75 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.221 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.75 59.45 2.1 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.575 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -147.9 156.97 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.471 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 39.2 t -125.22 123.75 65.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.109 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.484 HD12 HG11 ' A' ' 47' ' ' VAL . 1.9 pt -114.02 145.66 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.28 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.692 ' HA ' HD11 ' A' ' 83' ' ' LEU . 34.7 m -138.11 166.76 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' HD11 ' A' ' 48' ' ' ILE . 31.6 mt-10 -55.87 133.76 51.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.452 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 23.2 p -76.16 83.57 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.463 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -80.34 -7.26 88.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.036 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.955 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.36 -162.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.499 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.29 8.24 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.871 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.42 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.68 49.25 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.643 0.735 . . . . 0.0 111.19 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.955 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.5 mt -59.56 -40.6 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.771 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.965 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -150.61 87.87 4.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.004 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.66 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.163 2.575 . . . . 0.0 113.63 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.86 -92.87 0.17 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.953 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.14 167.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.61 129.93 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.052 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.093 HG22 HD13 ' A' ' 66' ' ' ILE . 66.7 mt -68.5 94.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.43 -2.42 54.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.33 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.475 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -169.88 159.94 8.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.6 mtm -158.94 138.61 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.433 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.688 ' CE ' HD11 ' A' ' 30' ' ' ILE . 19.7 mtm -72.95 105.16 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.17 74.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.91 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.53 -33.56 0.17 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.946 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.95 -179.19 32.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.941 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.446 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 31.4 Cg_exo -58.93 -16.47 32.3 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.464 2.11 . . . . 0.0 112.601 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.01 53.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 110.813 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -36.98 55.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.497 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -57.73 -46.85 83.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.458 ' CB ' HD13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -63.14 -65.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.19 29.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.387 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.754 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -56.88 -35.52 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.854 ' HG ' HG11 ' A' ' 21' ' ' VAL . 6.9 mt -97.61 118.06 33.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -129.09 141.06 51.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG22 ' A' ' 49' ' ' ILE . 48.2 mm -47.57 143.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 111.832 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.66 11.38 58.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.592 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.877 ' HB3' HD12 ' A' ' 103' ' ' ILE . 64.9 m-20 -101.59 161.38 13.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.564 ' HB2' HG23 ' A' ' 104' ' ' VAL . 1.9 mm100 -119.99 97.99 5.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 103' ' ' ILE . 3.4 mt -67.6 143.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.574 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 44' ' ' LEU . 12.3 mmt -111.94 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -125.61 138.35 53.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 111.445 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.869 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.5 mt -112.79 108.32 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.654 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.602 ' ND2' HD22 ' A' ' 93' ' ' LEU . 90.1 m-20 59.69 21.17 9.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.164 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.96 -34.45 4.47 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.596 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -66.69 104.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.747 0.308 . . . . 0.0 111.116 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 p -68.13 146.59 53.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD11 ' CD1' ' A' ' 73' ' ' ILE . 13.9 mt -120.02 -28.41 5.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.308 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.2 p -56.72 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.56 -21.87 2.71 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.305 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -100.86 162.41 20.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.983 0.391 . . . . 0.0 111.543 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 44.9 Cg_endo -66.8 -171.65 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.045 2.496 . . . . 0.0 112.584 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.45 -50.47 11.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.37 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 p -52.99 -36.51 60.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.713 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' ILE . 77.5 m -66.87 -50.81 61.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.56 -49.75 73.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 110.707 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.514 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.4 mt-30 -50.33 -49.48 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.462 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 3.2 t -55.04 -37.95 67.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 76' ' ' THR . 23.5 mm -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.175 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.5 mt -67.68 -50.23 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.462 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.03 -20.0 62.01 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.85 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.46 -19.18 70.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.485 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 73' ' ' ILE . 2.2 pp -116.33 51.83 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 110.948 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.0 tttt -78.48 -30.74 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -97.75 32.6 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -95.9 155.88 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.016 0.436 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -104.26 -12.84 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 tpp85 -148.5 126.75 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.741 HG12 HD21 ' A' ' 101' ' ' LEU . 18.9 t -110.42 104.79 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -91.28 127.69 36.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.583 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -140.36 154.81 46.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.026 0.441 . . . . 0.0 111.211 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 91.4 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.877 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -114.9 172.61 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.125 0.488 . . . . 0.0 112.309 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -113.23 119.02 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.979 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.456 ' CG ' HG21 ' A' ' 34' ' ' VAL . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.914 0.297 . . . . 0.0 112.282 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.44 HG22 ' O ' ' B' ' -2' ' ' VAL . 10.7 p -99.57 -10.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.46 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.456 ' CD2' ' HG3' ' A' ' 53' ' ' MET . 26.2 m-85 62.78 167.13 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.376 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.791 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.76 ' CD1' HG22 ' A' ' 104' ' ' VAL . 1.6 m-85 -62.81 153.22 33.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.994 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.69 124.45 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.0 111.517 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.91 102.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.185 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.7 ' HB ' HD12 ' A' ' 101' ' ' LEU . 37.3 t -88.15 112.32 23.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -106.3 113.52 27.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.699 HD13 ' OG ' ' A' ' 61' ' ' SER . 16.0 mm -111.37 99.85 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.468 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.87 124.64 29.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -157.09 -172.07 3.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.255 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -111.47 176.83 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.655 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -72.99 157.03 38.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.742 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.52 11.05 67.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.615 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 31' ' ' LEU . 16.9 mt-10 -124.32 32.84 5.4 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.285 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.752 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 14.4 -80.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.994 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 23' ' ' ILE . 5.1 tp 174.43 -49.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.297 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.37 69.79 1.12 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.79 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.03 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -154.06 155.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 117.01 0.405 . . . . 0.0 111.656 178.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' B' ' -3' ' ' PRO . 55.1 t -118.72 128.94 75.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.505 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.568 ' O ' HD21 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -119.7 141.82 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.34 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 83' ' ' LEU . 32.7 m -136.51 163.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HD11 ' A' ' 48' ' ' ILE . 14.4 mt-10 -50.96 134.81 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.468 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.1 p -78.17 83.66 4.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.596 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.09 -7.65 88.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.946 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.839 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.63 -161.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.429 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.75 -25.98 7.52 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.717 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.76 33.58 0.07 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.839 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.7 mt -47.34 -40.86 6.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.034 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -146.72 97.2 4.29 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.08 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 12.2 Cg_endo -56.11 91.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.551 2.167 . . . . 0.0 113.097 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.796 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.61 -91.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.063 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -160.3 167.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.787 0.327 . . . . 0.0 111.362 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.9 130.52 68.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.789 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.058 HG22 HD13 ' A' ' 66' ' ' ILE . 49.5 mt -69.16 88.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.52 -13.0 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.785 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.59 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -159.83 160.31 33.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.751 0.31 . . . . 0.0 110.888 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 ttp -147.82 134.1 19.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.03 0.443 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.425 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -70.48 83.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.569 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CG ' ' HG2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -56.24 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 163.32 -28.21 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.409 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.74 -165.36 39.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.08 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.1 Cg_endo -69.11 -16.31 40.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.506 2.137 . . . . 0.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -49.39 73.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.727 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' CG ' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -77.76 -37.09 49.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -63.69 -41.37 98.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.23 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.699 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -46.45 -71.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.254 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.05 15.72 10.45 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.802 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.37 -32.1 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.918 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.683 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.5 mt -85.61 126.9 34.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.65 129.92 23.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.058 HD13 HG22 ' A' ' 49' ' ' ILE . 24.9 mm -45.02 143.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.944 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 11.94 55.01 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.736 ' CB ' HD12 ' A' ' 103' ' ' ILE . 3.1 m-20 -107.03 159.83 16.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 1.2 mm100 -113.85 114.55 26.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.901 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -84.9 136.02 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.613 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 30.6 mmt -96.06 -69.12 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 24.3 p -132.39 146.68 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.69 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.79 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -120.17 120.1 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.776 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 61.01 19.42 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.332 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 -27.47 10.85 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.792 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.762 HG21 HD12 ' A' ' 89' ' ' ILE . 3.0 m -71.23 111.6 6.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.943 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.519 ' O ' HD21 ' A' ' 81' ' ' LEU . 22.1 p -76.17 142.48 41.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.311 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HA ' HD21 ' A' ' 81' ' ' LEU . 65.9 mt -111.12 -20.65 12.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.161 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.402 HG22 ' SD ' ' A' ' 71' ' ' MET . 16.7 t -59.98 92.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.409 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.98 -22.15 3.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.469 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.616 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -102.04 161.05 24.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 111.481 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 57.8 Cg_endo -69.16 -167.49 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.0 112.572 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -78.1 -50.15 12.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.268 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -52.4 -38.22 58.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 HD13 ' A' ' 81' ' ' LEU . 36.3 m -64.39 -49.16 72.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.519 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.29 -51.6 69.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.771 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' HG11 ' B' ' -2' ' ' VAL . 56.8 mt-30 -49.63 -39.88 37.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 2.8 m -64.96 -37.95 89.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.659 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.762 HD12 HG21 ' A' ' 76' ' ' THR . 23.9 mm -58.65 -49.97 80.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.022 HG21 HD13 ' B' ' 0' ' ' ILE . 38.1 mt -72.94 -49.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -57.4 -22.82 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.452 . . . . 0.0 110.741 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.51 -39.33 61.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.171 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -94.83 46.16 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.752 ' CD ' HG23 ' A' ' 30' ' ' ILE . 21.1 ttpp -76.73 -36.01 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -88.79 51.57 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.123 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -111.24 172.37 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.393 0.616 . . . . 0.0 111.573 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.6 p -113.99 -7.1 13.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.656 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.791 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.2 ttm180 -161.94 150.43 15.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 31' ' ' LEU . 4.0 t -133.09 113.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.65 130.96 38.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 HG23 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -140.06 154.92 47.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.3 90.72 3.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.901 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -113.63 172.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.45 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.76 HG22 ' CD1' ' A' ' 18' ' ' PHE . 24.3 t -111.73 119.93 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.625 ' HB2' HG11 ' A' ' 34' ' ' VAL . 68.0 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 CA-C-O 120.724 0.218 . . . . 0.0 112.385 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.666 HG11 ' OE1' ' A' ' 87' ' ' GLN . 18.4 t -59.55 136.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.575 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -120.31 138.68 53.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.03 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.841 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.637 ' HZ ' HD22 ' A' ' 44' ' ' LEU . 2.2 m-85 -58.94 151.57 21.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.815 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 129.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.95 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.8 122.73 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.744 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.914 HG13 ' CB ' ' A' ' 63' ' ' LYS . 44.3 t -106.68 111.48 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -107.84 114.91 29.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 99' ' ' VAL . 19.9 mm -114.16 99.25 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 112.48 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.949 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.71 -170.81 2.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.336 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -117.46 158.23 24.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.522 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HG3' ' CA ' ' A' ' 95' ' ' ASN . 8.6 mptt -58.38 145.89 36.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.947 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.51 18.45 79.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.382 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -129.19 29.1 5.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.137 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 19.17 -82.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.123 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . 15.3 tp 179.24 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.916 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.447 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.45 62.53 1.63 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.598 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.067 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.22 155.9 7.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.966 0.413 . . . . 0.0 111.433 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' -3' ' ' PRO . 30.7 t -123.67 116.35 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.791 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -104.46 146.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.259 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.852 ' HA ' HD12 ' A' ' 83' ' ' LEU . 30.0 m -135.66 167.3 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 48' ' ' ILE . 2.0 mt-10 -56.08 131.19 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 51.4 p -74.25 84.49 1.89 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.539 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -82.7 -6.7 88.26 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.917 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.11 -163.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.714 0.292 . . . . 0.0 110.287 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.38 -26.38 6.92 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.798 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 p 80.0 51.7 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.801 0.81 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.3 mt -61.18 -41.75 90.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.774 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.976 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -149.2 81.53 7.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.103 178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.35 90.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.536 2.824 . . . . 0.0 114.136 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.976 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -136.41 -96.43 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.149 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -156.14 167.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-O 120.687 0.279 . . . . 0.0 111.05 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.14 128.68 62.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.035 HG22 HD13 ' A' ' 66' ' ' ILE . 52.4 mt -67.78 90.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.45 -8.88 55.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.158 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.589 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.4 t-20 -162.01 159.81 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.006 0.431 . . . . 0.0 111.405 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 13.4 ttm -152.0 148.11 27.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.7 mtt -56.07 -22.41 27.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 61.09 47.26 7.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.63 -34.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.134 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.63 -171.18 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.11 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 51.0 Cg_exo -54.02 -24.83 34.01 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.428 2.085 . . . . 0.0 112.408 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.71 70.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.001 0.429 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -39.38 44.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.709 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -53.26 -47.23 69.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.44 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -56.32 5.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.06 -16.8 53.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.066 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.914 ' CB ' HG13 ' A' ' 21' ' ' VAL . 25.1 mmmt -57.3 -30.08 64.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.368 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HG11 ' A' ' 21' ' ' VAL . 26.0 mt -103.12 134.68 46.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -144.15 128.19 17.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.035 HD13 HG22 ' A' ' 49' ' ' ILE . 30.5 mm -44.1 142.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.125 0.488 . . . . 0.0 111.891 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.31 18.37 46.22 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.464 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.827 ' HB3' HD12 ' A' ' 103' ' ' ILE . 78.9 m-20 -112.31 164.8 12.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.756 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -118.65 116.49 26.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.176 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.724 HG23 HG22 ' A' ' 103' ' ' ILE . 5.6 mt -85.87 143.99 10.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.219 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.798 ' CE ' HD13 ' A' ' 44' ' ' LEU . 8.3 mmt -112.17 -67.52 0.99 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 132.11 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 111.692 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.876 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.3 mt -115.96 114.18 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 58.51 23.86 11.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.4 -35.5 4.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.672 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.72 HG21 HG23 ' A' ' 89' ' ' ILE . 3.7 m -68.63 117.1 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.356 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.54 154.17 34.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.876 HD11 ' CD1' ' A' ' 73' ' ' ILE . 61.9 mt -121.49 -37.58 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -53.23 91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.303 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.32 -24.84 2.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.117 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -103.6 160.95 24.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 111.406 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.37 -169.6 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.859 2.372 . . . . 0.0 112.726 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.18 -47.74 17.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.816 ' N ' HD23 ' A' ' 83' ' ' LEU . 17.8 m -53.15 -42.06 65.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.451 . . . . 0.0 110.446 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.653 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.9 m -65.05 -49.28 70.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.764 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.418 ' HA ' HD22 ' A' ' 78' ' ' LEU . 90.2 m -55.76 -56.2 23.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.324 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' NE2' HD21 ' A' ' 83' ' ' LEU . 27.9 mt-30 -48.88 -46.11 42.13 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 110.14 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.93 -36.93 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.556 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 HG21 ' A' ' 76' ' ' THR . 24.8 mm -57.99 -49.95 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.973 HG21 HD13 ' B' ' 0' ' ' ILE . 44.0 mt -71.25 -43.71 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.7 ' HG3' HG22 ' B' ' 0' ' ' ILE . 8.7 mttp -54.96 -24.86 25.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.88 -45.43 42.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.337 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -85.95 58.86 5.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.912 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.559 ' CD ' HG23 ' A' ' 30' ' ' ILE . 22.1 ttpp -87.37 -31.34 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.273 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' CA ' ' HG3' ' A' ' 27' ' ' LYS . 71.1 m-80 -113.8 65.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.337 . . . . 0.0 111.595 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.4 mm100 -118.95 -28.45 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t 75.44 5.87 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.994 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.9 ttm180 -165.07 127.48 2.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.062 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.01 126.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 0.0 111.932 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -108.71 108.87 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -127.37 117.58 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.228 0.537 . . . . 0.0 112.356 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 90.77 8.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.977 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -109.02 171.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.068 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.4 p -115.38 131.6 67.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.725 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 73.8 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.755 0.231 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.3 t -58.41 150.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.855 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -117.86 138.06 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.327 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.067 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.596 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' C ' HG13 ' A' ' 104' ' ' VAL . 9.3 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.996 0.426 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.8 m-85 -67.73 154.28 41.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.648 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -166.83 126.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.512 . . . . 0.0 112.13 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 106.44 3.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.062 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -93.29 104.25 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.128 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.87 104.78 15.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.663 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -102.55 99.29 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.29 109.82 9.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -130.36 -177.23 4.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.595 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -113.86 168.88 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.82 155.09 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.923 0.392 . . . . 0.0 110.698 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.6 15.14 73.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.469 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -129.45 32.8 4.6 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.942 0.401 . . . . 0.0 110.248 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.59 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 13.74 -80.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.273 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.953 HD13 HG21 ' A' ' 99' ' ' VAL . 13.6 tp 175.67 -45.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.789 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 85.38 63.63 1.56 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.609 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 HD11 ' B' ' 0' ' ' ILE . 1.0 OUTLIER -153.28 155.81 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 111.323 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.63 HG21 ' HG2' ' B' ' -3' ' ' PRO . 46.5 t -123.5 129.02 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.5 pt -114.53 144.22 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.774 ' HA ' HD22 ' A' ' 83' ' ' LEU . 27.1 m -137.13 165.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' O ' HD11 ' A' ' 48' ' ' ILE . 7.1 mt-10 -54.47 133.83 45.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 48' ' ' ILE . 52.4 p -76.28 83.08 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.451 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.68 -4.45 90.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.707 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.898 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.75 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.22 -26.66 6.7 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.667 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.436 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.78 44.98 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.501 0.667 . . . . 0.0 111.56 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.898 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.1 mt -59.15 -35.02 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.49 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.799 ' O ' HG22 ' A' ' 46' ' ' THR . 85.0 mt -155.65 96.32 2.4 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.029 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.3 91.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.653 2.235 . . . . 0.0 113.497 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.11 -90.15 0.33 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.69 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.66 167.58 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.879 0.371 . . . . 0.0 111.463 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.84 129.56 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.629 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.051 HG22 HD13 ' A' ' 66' ' ' ILE . 66.6 mt -68.57 89.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.4 -15.77 45.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.049 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.643 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -154.38 158.99 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.729 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.8 ttp -149.2 137.45 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.534 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -53.42 -24.63 13.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.351 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m80 60.61 46.4 9.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.494 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.63 -38.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.051 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -174.01 2.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.942 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.8 Cg_exo -53.78 -24.07 29.24 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.357 2.038 . . . . 0.0 112.313 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.416 ' HB1' ' SD ' ' A' ' 52' ' ' MET . . . -65.68 -49.12 69.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 110.733 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.2 -39.0 50.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.524 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -55.8 -47.15 77.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 t -65.15 -64.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.783 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.9 -24.34 19.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.5 mtpt -58.15 -25.53 61.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.788 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -103.41 131.61 50.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -144.06 133.93 23.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.419 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.051 HD13 HG22 ' A' ' 49' ' ' ILE . 26.7 mm -44.91 142.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.004 0.431 . . . . 0.0 111.924 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.56 13.53 47.36 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.662 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.844 ' HB3' HD12 ' A' ' 103' ' ' ILE . 66.4 m-20 -102.88 162.43 12.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 2.3 mm100 -119.24 98.11 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.777 HG23 HG22 ' A' ' 103' ' ' ILE . 3.5 mt -71.97 143.84 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.618 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.712 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 15.2 mmt -108.97 -69.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.849 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.84 142.03 51.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.337 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.808 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.7 mt -115.35 106.95 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.78 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 58.15 26.39 13.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.06 -36.43 3.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.997 HG21 HD12 ' A' ' 89' ' ' ILE . 3.2 m -67.78 107.74 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.43 ' O ' HD21 ' A' ' 81' ' ' LEU . 10.9 t -72.71 148.7 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.081 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.808 HD11 ' CD1' ' A' ' 73' ' ' ILE . 62.6 mt -118.49 -12.44 9.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.516 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' SD ' ' A' ' 71' ' ' MET . 14.2 t -69.99 101.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.677 0.275 . . . . 0.0 111.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.28 6.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.29 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -104.4 158.12 32.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.011 0.405 . . . . 0.0 111.421 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.69 -172.07 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.945 2.43 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 36' ' ' VAL . 12.1 tp -78.12 -44.34 26.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -41.1 65.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.083 0.468 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 81' ' ' LEU . 56.6 m -64.26 -52.77 57.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.2 m -56.58 -50.03 73.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.402 ' NE2' ' HG ' ' A' ' 83' ' ' LEU . 9.9 mt-30 -50.19 -42.87 52.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 109.962 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -61.12 -37.21 81.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.997 HD12 HG21 ' A' ' 76' ' ' THR . 17.6 mm -58.83 -49.84 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.61 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.821 HG21 HD13 ' B' ' 0' ' ' ILE . 22.3 mt -68.98 -50.32 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.51 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.4 -25.1 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.996 0.427 . . . . 0.0 110.765 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.83 -46.27 90.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.969 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -88.79 66.92 8.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 110.659 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -40.88 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.357 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -88.87 50.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.292 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.72 150.4 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 111.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 p -92.32 -8.14 45.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.459 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.28 145.49 5.86 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.778 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.953 HG21 HD13 ' A' ' 31' ' ' LEU . 1.4 t -112.48 104.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 0.0 111.915 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HE3' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -85.1 121.14 27.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.886 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.912 HD21 HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -138.91 154.36 48.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 111.128 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.97 89.89 3.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.844 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.5 pt -107.9 171.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 0.0 112.282 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 18' ' ' PHE . 5.1 t -122.82 113.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.409 ' CD ' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.63 ' HG2' HG21 ' A' ' 34' ' ' VAL . 78.6 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 CA-C-O 120.744 0.227 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.9 t 69.12 -67.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.534 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER 68.14 99.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.308 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.004 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.82 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 104' ' ' VAL . 24.8 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.5 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 9.7 m-85 -62.89 146.79 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.985 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 124.01 2.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.974 0.416 . . . . 0.0 111.48 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.51 131.47 42.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.278 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 29.9 t -112.89 132.81 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.37 106.26 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -110.86 99.3 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.89 109.73 14.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.19 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 6.0 pttm -131.59 -169.01 2.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.211 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.5 177.74 4.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.245 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -79.86 162.16 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.761 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.96 13.92 28.76 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.905 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -123.04 33.69 5.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 109.972 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.707 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.4 OUTLIER 14.51 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.43 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER 174.12 -42.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.005 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 86.91 62.08 1.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.621 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.34 155.83 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.952 0.406 . . . . 0.0 111.299 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' CE1' ' B' ' -1' ' ' TYR . 22.3 t -120.58 131.36 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.157 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.801 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -116.6 156.96 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.495 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.71 169.46 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.975 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' HD11 ' A' ' 48' ' ' ILE . 17.5 mt-10 -62.14 130.62 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.871 0.367 . . . . 0.0 110.984 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.0 p -69.94 84.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.619 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.99 -3.96 88.81 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.896 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.845 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.1 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 110.462 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.74 -26.2 7.72 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.875 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.82 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.426 0.631 . . . . 0.0 111.244 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.845 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 72.9 mt -60.87 -40.17 84.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.567 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -149.38 117.03 3.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.574 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 20.7 Cg_endo -61.21 102.58 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.199 1.933 . . . . 0.0 113.234 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 HG13 ' A' ' 79' ' ' VAL . 1.3 p -153.54 -154.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.123 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -109.32 158.1 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.646 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -119.22 133.34 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.111 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.082 HG22 HD13 ' A' ' 66' ' ' ILE . 54.5 mt -69.74 95.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.67 -1.88 52.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.67 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.454 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -170.57 159.52 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.71 144.67 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.914 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.707 ' CE ' HD11 ' A' ' 30' ' ' ILE . 5.4 mtt -55.9 -22.6 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 61.95 50.51 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.682 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.53 -36.05 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.054 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 -171.8 1.54 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.111 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 49.3 Cg_exo -55.74 -23.64 42.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.544 2.162 . . . . 0.0 112.493 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.56 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -66.5 -50.11 64.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.06 -38.4 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -57.36 -47.12 82.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -57.24 -74.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 15.18 8.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.444 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 61.5 mtpt -108.56 -24.75 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.816 ' HG ' HG11 ' A' ' 21' ' ' VAL . 69.0 mt -103.0 118.66 37.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -131.62 140.72 49.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.741 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.082 HD13 HG22 ' A' ' 49' ' ' ILE . 47.0 mm -47.33 145.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.554 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.01 7.17 59.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.862 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.4 m-20 -99.85 157.27 16.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 0.268 . . . . 0.0 110.558 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -117.32 112.23 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.881 0.372 . . . . 0.0 110.684 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.824 HG23 HG22 ' A' ' 103' ' ' ILE . 5.8 mt -78.94 138.76 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.83 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.9 mmm -103.57 -67.49 0.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.211 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 p -131.2 133.51 45.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -105.56 117.07 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.809 ' ND2' HD13 ' A' ' 93' ' ' LEU . 66.5 m-20 56.64 27.32 12.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.1 -30.4 9.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.842 HG21 HG23 ' A' ' 89' ' ' ILE . 37.7 m -61.73 100.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 111.124 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.05 114.92 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.745 HD21 HD12 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.34 25.15 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 46' ' ' THR . 22.0 t -72.71 87.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.587 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 45' ' ' PRO . . . 134.74 -17.09 4.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.509 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.49 157.07 73.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.618 0.246 . . . . 0.0 110.775 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -175.05 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.519 2.146 . . . . 0.0 111.972 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 36' ' ' VAL . 23.6 tp -78.11 -46.43 20.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.983 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 52.8 p -53.63 -40.87 66.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 89' ' ' ILE . 69.8 m -66.14 -50.9 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -55.79 -57.02 13.76 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.66 0.267 . . . . 0.0 111.283 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.801 ' HA ' HD11 ' A' ' 35' ' ' ILE . 4.2 pt20 -50.09 -40.22 44.93 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -63.78 -33.82 76.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.252 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.842 HG23 HG21 ' A' ' 76' ' ' THR . 5.8 mm -58.93 -49.4 83.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.037 HG21 HD13 ' B' ' 0' ' ' ILE . 35.5 mt -71.06 -47.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.125 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.689 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -55.64 -23.61 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.05 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -33.91 48.84 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.193 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.809 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.3 pp -104.25 46.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.402 . . . . 0.0 110.704 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.23 -23.55 35.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.245 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -91.95 42.42 1.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.4 135.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.41 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 t -78.53 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.183 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 ttm180 -145.51 127.5 15.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.02 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 31' ' ' LEU . 11.6 t -112.93 104.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -87.73 126.47 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.766 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -137.7 117.83 13.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.273 0.559 . . . . 0.0 112.302 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 71' ' ' MET . 1.1 m120 -89.37 97.69 11.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.7 pt -121.33 172.64 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.131 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 17' ' ' GLU . 22.7 t -115.97 110.76 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.412 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.029 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.44 ' HB2' HG11 ' A' ' 34' ' ' VAL . 58.6 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.79 0.246 . . . . 0.0 112.231 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.413 HG21 ' HE3' ' A' ' 91' ' ' LYS . 11.1 p -57.64 154.06 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 34' ' ' VAL . 3.7 m-85 -127.43 123.38 35.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.037 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.95 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.83 0.347 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.2 m-85 -58.85 144.27 44.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.329 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.591 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -164.85 128.47 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.306 0.574 . . . . 0.0 112.11 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.43 101.64 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.019 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.2 t -82.27 115.84 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -116.53 104.52 11.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.27 99.53 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.0 OUTLIER -77.39 109.89 11.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.78 -170.91 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.36 154.09 25.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -56.67 153.95 9.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.27 12.12 79.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.597 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' LEU . 38.0 mt-10 -124.93 31.68 5.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.204 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.926 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 18.49 -81.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 175.74 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.72 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.51 65.1 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.427 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.043 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.15 156.08 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 111.893 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 77.1 t -117.69 129.7 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.637 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -118.11 150.78 20.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.9 m -147.49 166.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.206 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 48' ' ' ILE . 21.7 mt-10 -56.3 133.48 52.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.474 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 60.5 p -74.37 83.51 1.93 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.435 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.91 -3.87 90.28 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.73 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.95 -164.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.629 0.252 . . . . 0.0 110.541 179.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.06 -24.86 7.01 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.823 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.73 54.96 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.578 0.704 . . . . 0.0 111.217 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.73 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 60.3 mt -70.71 -36.33 64.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.624 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.807 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -150.04 110.14 3.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.782 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_endo -56.09 86.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.207 1.938 . . . . 0.0 112.62 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.18 -155.32 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.17 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.9 OUTLIER -107.71 161.87 6.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.625 0.25 . . . . 0.0 110.745 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -120.33 133.13 68.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.771 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.056 HG22 HD13 ' A' ' 66' ' ' ILE . 61.0 mt -73.62 91.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.73 -13.9 44.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.844 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.65 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -156.59 159.56 38.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 111.144 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.2 ttm -153.36 130.66 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' GLY . 8.2 mtm -64.95 93.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -57.86 80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.29 -28.74 0.27 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.743 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.07 18.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.844 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.9 Cg_endo -69.52 -14.36 36.71 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.808 2.339 . . . . 0.0 113.043 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 -52.32 60.25 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 -40.21 30.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -50.81 -47.22 60.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.447 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.16 -70.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.62 16.72 6.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.345 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.744 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.3 mmmm -101.08 -28.5 12.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.691 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD2' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -103.89 134.71 46.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -142.51 127.34 18.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.255 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.056 HD13 HG22 ' A' ' 49' ' ' ILE . 22.4 mm -43.31 142.56 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 112.078 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.3 45.29 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.428 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.855 ' HB3' HD12 ' A' ' 103' ' ' ILE . 89.5 m-20 -104.27 178.88 4.43 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.946 0.403 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.447 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -134.33 114.92 13.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.704 HG23 HG22 ' A' ' 103' ' ' ILE . 5.4 mt -87.89 125.07 41.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.056 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.795 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.63 -44.77 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.668 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 p -158.51 144.64 17.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.705 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -118.7 126.4 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.015 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.525 ' ND2' HD13 ' A' ' 93' ' ' LEU . 88.7 m-20 53.84 26.92 6.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.358 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.9 -21.78 40.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.768 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 89' ' ' ILE . 3.5 m -67.89 101.36 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 m -65.69 111.27 3.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HD12 ' A' ' 73' ' ' ILE . 48.5 mt -90.99 -20.66 21.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 22.0 t -54.61 88.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.366 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.67 -25.94 4.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.691 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.8 mt -77.52 152.68 81.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.99 -169.51 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 111.95 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.569 HD22 ' NE2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -78.31 -52.25 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.227 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -53.07 -40.72 64.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.5 m -65.05 -50.2 67.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 78' ' ' LEU . 92.2 m -58.85 -50.44 73.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.682 0.277 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.569 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.2 mt-30 -49.4 -43.66 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.176 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 35.3 m -61.27 -38.83 88.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.657 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.77 HD12 HG21 ' A' ' 76' ' ' THR . 24.1 mm -58.25 -50.13 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.761 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 0' ' ' ILE . 24.1 mt -67.74 -50.23 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.08 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.63 -21.11 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.93 -39.05 55.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.6 OUTLIER -93.25 45.77 1.18 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.902 0.382 . . . . 0.0 110.989 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.926 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.37 -5.97 58.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -114.8 49.96 1.0 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.688 0.28 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.74 161.41 30.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.675 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 t -93.5 -11.5 31.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.538 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 16.9 mmt85 -141.26 138.88 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.771 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 31' ' ' LEU . 13.5 t -113.03 103.74 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -90.83 118.57 30.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.445 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.03 117.44 12.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 95.25 9.73 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -117.64 171.46 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.167 0.508 . . . . 0.0 111.999 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.723 HG23 ' SD ' ' A' ' 71' ' ' MET . 40.5 t -124.62 128.1 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.647 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.503 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 49.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.937 0.307 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.02 -23.26 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.806 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 34' ' ' VAL . 10.8 m-85 63.59 136.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 33' ' ' VAL . 1.8 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.666 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 104' ' ' VAL . 17.6 tp10 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.4 m-85 -66.28 153.34 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.564 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.95 125.98 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 0.0 111.31 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.71 106.39 7.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.402 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.5 t -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.532 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -129.06 104.33 7.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.035 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 31' ' ' LEU . 11.6 mm -105.9 99.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.451 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 98' ' ' ARG . 1.6 mp0 -82.92 109.29 16.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -132.08 -171.41 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.916 0.388 . . . . 0.0 111.359 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.57 156.57 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -59.93 154.43 18.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.011 0.434 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.52 13.13 74.15 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.416 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' LEU . 15.9 mt-10 -124.79 32.26 5.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.391 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.704 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 17.73 -80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.159 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 178.06 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.075 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.481 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 85.13 60.51 1.83 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.756 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.066 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.7 156.78 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 111.45 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' B' ' -3' ' ' PRO . 20.2 t -123.7 121.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.114 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 47' ' ' VAL . 2.1 pt -111.75 149.21 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.189 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.0 m -137.2 168.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.06 130.85 48.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.681 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' HD11 ' A' ' 48' ' ' ILE . 49.6 p -71.41 83.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.544 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -5.36 87.14 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.713 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.0 -162.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 110.948 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -53.17 -18.83 6.94 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.765 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.4 m 107.48 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.598 0.759 . . . . 0.0 111.082 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.763 HG22 ' HG ' ' A' ' 44' ' ' LEU . 81.4 mt 57.71 -65.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.353 0.597 . . . . 0.0 111.399 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.957 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -138.54 81.66 23.83 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.798 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 76.8 Cg_exo -50.57 93.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.641 2.227 . . . . 0.0 113.072 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.957 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.77 -87.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.29 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.3 167.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 120.661 0.267 . . . . 0.0 111.059 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.06 126.94 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 66' ' ' ILE . 65.0 mt -66.18 91.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 -8.73 55.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.31 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.619 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -163.68 162.06 23.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.441 . . . . 0.0 111.316 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.1 ttm -153.8 134.28 13.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.679 ' CE ' HD11 ' A' ' 30' ' ' ILE . 4.9 mtt -50.93 -26.07 5.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.247 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 57.6 56.44 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 110.686 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -35.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.07 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.5 -160.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.911 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.4 Cg_endo -69.13 -22.65 34.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 112.212 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.57 77.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.026 0.441 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -38.61 52.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -59.21 -29.96 67.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.241 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -73.42 -68.31 0.51 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.804 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.37 -32.82 5.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.369 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -60.69 -27.15 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.705 0.288 . . . . 0.0 110.983 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -97.97 126.6 43.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.02 137.08 27.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 49' ' ' ILE . 24.3 mm -46.0 145.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.13 14.09 58.0 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.428 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.883 ' HB3' HD12 ' A' ' 103' ' ' ILE . 83.6 m-20 -103.7 163.0 12.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.671 0.272 . . . . 0.0 110.899 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.42 106.44 11.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.822 HG23 HG22 ' A' ' 103' ' ' ILE . 3.2 mt -78.72 139.68 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.634 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 mmt -104.38 -68.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.2 t -124.11 140.84 52.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.985 0.421 . . . . 0.0 111.579 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -117.56 109.79 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.603 ' ND2' HD13 ' A' ' 93' ' ' LEU . 62.0 m-80 59.09 25.94 14.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.186 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.8 -34.73 5.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.681 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.73 HG21 HG23 ' A' ' 89' ' ' ILE . 3.9 m -67.85 109.88 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.429 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -74.44 147.46 41.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 73' ' ' ILE . 81.2 mt -115.89 -22.06 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.241 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 71' ' ' MET . 13.1 t -62.88 102.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.411 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.24 -30.53 4.28 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.337 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.469 HD13 ' CG2' ' A' ' 85' ' ' THR . 0.2 OUTLIER -93.98 159.49 34.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.957 0.408 . . . . 0.0 111.387 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.94 -174.33 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.943 2.428 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -77.89 -43.39 30.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -53.32 -41.53 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.156 0.503 . . . . 0.0 110.527 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.612 ' O ' HG12 ' A' ' 89' ' ' ILE . 63.7 m -64.79 -50.49 66.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.73 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.498 ' HA ' HD22 ' A' ' 78' ' ' LEU . 64.0 m -55.53 -57.2 12.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.328 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' SER . 4.0 pt20 -50.14 -39.53 43.61 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.7 t -61.65 -38.06 86.33 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.208 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 76' ' ' THR . 24.3 mm -58.96 -49.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.739 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.066 HG21 HD13 ' B' ' 0' ' ' ILE . 29.0 mt -69.34 -50.42 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.825 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.73 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.9 -42.68 68.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.988 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.603 HD13 ' ND2' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -91.63 52.18 2.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.569 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.704 ' HG3' HG23 ' A' ' 30' ' ' ILE . 1.4 tmmm? -88.0 -20.75 25.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.932 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -99.85 49.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.738 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.565 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.3 pt20 -128.41 -179.14 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.564 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.1 m -123.68 -3.85 8.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.3 134.56 24.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 110.476 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 31' ' ' LEU . 3.9 t -119.38 104.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.39 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -97.4 97.86 9.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.456 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.97 154.99 23.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.57 91.86 3.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.883 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -113.62 172.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 18' ' ' PHE . 9.8 t -121.44 124.76 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.658 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.905 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.538 ' CG ' HG21 ' A' ' 34' ' ' VAL . 34.8 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.801 0.251 . . . . 0.0 112.403 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.3 -15.89 7.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.712 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 64.79 170.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.03 0.443 . . . . 0.0 111.321 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.597 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 104' ' ' VAL . 4.7 m-85 -58.63 154.1 15.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.45 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.33 125.93 1.9 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.183 0.516 . . . . 0.0 112.024 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 101.15 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.354 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.833 HG13 ' HB2' ' A' ' 63' ' ' LYS . 22.7 t -82.73 108.23 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.56 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' CE1' ' CG ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.89 104.76 15.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 31' ' ' LEU . 17.2 mm -104.83 99.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 6.6 mp0 -82.31 117.23 22.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.01 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.74 -170.93 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -117.76 -179.54 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.47 161.7 30.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.36 15.17 58.69 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' ILE . 41.6 mt-10 -129.59 33.5 4.47 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 110.269 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 8.25 -78.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.225 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 23' ' ' ILE . 11.2 tp 176.27 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.822 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 87.07 63.67 1.44 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.515 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.079 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.78 156.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.195 179.033 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' -3' ' ' PRO . 45.9 t -126.45 123.95 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -109.51 148.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.649 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.3 m -140.74 167.58 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.501 ' O ' HD11 ' A' ' 48' ' ' ILE . 11.5 mt-10 -54.56 135.16 46.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.377 . . . . 0.0 110.807 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 48' ' ' ILE . 53.1 p -78.54 83.11 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.807 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.28 -4.87 87.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.604 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.925 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.09 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 122.338 0.255 . . . . 0.0 110.383 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.41 -26.63 7.22 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.689 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.434 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.75 40.31 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.402 0.62 . . . . 0.0 111.605 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.925 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.9 mt -54.21 -35.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.611 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.806 ' O ' HG22 ' A' ' 46' ' ' THR . 89.2 mt -155.09 96.55 2.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.147 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.2 Cg_endo -55.53 92.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.569 2.18 . . . . 0.0 113.45 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.65 -88.8 0.22 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.785 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.46 167.64 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.501 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.74 131.06 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -68.9 92.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.3 -6.5 55.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.219 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.622 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.5 t-20 -163.53 157.72 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -154.82 133.96 12.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.529 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 30' ' ' ILE . 10.8 mtm -75.07 96.75 3.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.31 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -62.97 78.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 170.71 -33.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.057 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.33 -168.1 18.52 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.927 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.1 -16.33 40.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.456 2.104 . . . . 0.0 112.471 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.15 65.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.191 0.519 . . . . 0.0 110.607 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -77.22 -36.45 54.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.87 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -58.01 -47.27 83.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.85 -7.64 59.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.288 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.833 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmt -72.86 -29.56 63.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 21' ' ' VAL . 92.4 mt -101.45 120.06 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -132.49 133.6 43.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.426 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.029 HD13 HG22 ' A' ' 49' ' ' ILE . 28.1 mm -45.65 143.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.063 0.459 . . . . 0.0 111.7 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.53 57.54 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.564 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.891 ' HB3' HD12 ' A' ' 103' ' ' ILE . 0.9 OUTLIER -105.34 172.01 7.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.46 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -128.37 112.34 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.357 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 HG22 ' A' ' 103' ' ' ILE . 3.3 mt -82.88 142.89 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.659 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.673 ' SD ' HG21 ' A' ' 46' ' ' THR . 14.1 mmt -105.7 -70.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.36 131.8 52.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.435 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.892 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -103.6 111.73 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.605 HD22 HG22 ' A' ' 73' ' ' ILE . 65.6 m-80 60.43 20.11 9.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.84 -33.46 5.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.743 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.537 HG21 HD12 ' A' ' 89' ' ' ILE . 3.6 m -68.71 100.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 110.985 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m -65.94 149.05 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 73' ' ' ILE . 63.0 mt -116.89 -22.82 8.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.367 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG22 ' SD ' ' A' ' 71' ' ' MET . 34.6 t -50.44 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.348 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.606 ' C ' HD23 ' A' ' 81' ' ' LEU . . . 116.33 1.65 20.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.985 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 80' ' ' GLY . 2.2 mt -108.13 151.24 41.28 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.954 0.377 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.91 168.02 25.04 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.59 2.193 . . . . 0.0 111.828 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.2 tp -62.01 -45.24 94.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.969 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -43.06 68.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.462 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.7 m -65.27 -51.31 61.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 78' ' ' LEU . 33.0 m -55.73 -56.24 22.84 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.422 ' HG3' HD12 ' A' ' 83' ' ' LEU . 28.6 mt-30 -49.44 -41.13 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.105 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 44.8 m -61.53 -38.77 88.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.424 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 85' ' ' THR . 19.8 mm -58.26 -49.98 79.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.972 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.988 HG21 HD13 ' B' ' 0' ' ' ILE . 14.5 mt -75.67 -50.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.185 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.492 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -55.77 -23.89 32.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 110.911 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.32 -44.1 76.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.222 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.5 pp -85.82 62.62 7.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.068 0.461 . . . . 0.0 110.942 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.611 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -84.61 -23.54 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.13 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.8 38.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.257 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -96.73 162.2 13.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.191 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.6 p -118.52 -10.7 10.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.532 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 4.1 tpp85 -156.03 116.07 3.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.186 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 101' ' ' LEU . 10.3 t -99.09 117.86 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.901 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.25 97.8 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.144 179.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -109.73 155.3 21.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.451 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.66 91.52 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.909 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -111.51 169.83 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.619 HG22 ' CD1' ' A' ' 18' ' ' PHE . 4.7 t -116.28 124.81 72.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.696 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' A' ' 34' ' ' VAL . 70.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.712 0.213 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' -2' ' ' VAL . 30.9 m -57.27 124.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 34' ' ' VAL . 12.5 m-85 -102.33 113.16 26.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.079 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 104' ' ' VAL . 2.4 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.9 m-85 -58.93 153.11 18.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -166.91 125.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 112.065 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.3 103.37 2.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.99 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.929 HG11 ' HG ' ' A' ' 64' ' ' LEU . 26.2 t -87.16 108.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.491 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -96.83 112.18 24.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.453 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.27 102.62 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.28 114.99 24.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -145.06 -171.54 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.215 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -109.68 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.342 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -55.4 148.57 14.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.46 14.4 82.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.126 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 31' ' ' LEU . 3.2 mt-10 -128.02 31.21 5.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.592 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 14.48 -79.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.348 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.57 -47.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.66 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 89.72 67.58 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.651 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.08 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.71 155.97 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.326 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.4 t -116.8 128.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.715 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.2 pt -116.03 149.85 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.609 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' HD22 ' A' ' 83' ' ' LEU . 31.0 m -141.68 167.71 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.032 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.77 129.69 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.516 ' HA ' HD11 ' A' ' 48' ' ' ILE . 70.0 p -70.8 84.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.344 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.47 90.05 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.96 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.777 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.01 -163.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.663 0.268 . . . . 0.0 110.59 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.94 -25.38 7.33 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.788 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 4.7 p 80.43 44.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.694 0.759 . . . . 0.0 111.61 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.777 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 78.4 mt -58.64 -37.68 66.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -148.58 104.73 3.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.884 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' GLY . 51.6 Cg_exo -52.71 94.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.091 1.861 . . . . 0.0 112.612 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -145.02 -153.74 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -109.27 164.6 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.595 0.236 . . . . 0.0 110.634 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.54 129.3 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.041 HG22 HD13 ' A' ' 66' ' ' ILE . 71.2 mt -67.61 93.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.22 -6.15 51.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.287 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -165.59 162.52 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -150.86 144.08 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.259 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.592 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.0 mtm -57.13 -28.56 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 61.47 61.02 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.82 -33.54 0.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.196 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -165.78 6.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.055 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.9 Cg_endo -69.13 -16.93 40.56 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.443 2.095 . . . . 0.0 112.407 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.05 70.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.19 -34.21 56.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.748 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -59.62 -47.23 86.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.041 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 m -59.68 -52.19 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.55 64.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.076 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB2' HG13 ' A' ' 21' ' ' VAL . 2.3 mmmt -72.13 -31.56 66.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.929 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.0 mt -97.23 99.89 11.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -119.59 144.9 46.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 49' ' ' ILE . 51.7 mm -47.22 142.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.722 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 9.28 61.96 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.927 ' HB3' HD12 ' A' ' 103' ' ' ILE . 25.3 m-20 -96.97 154.5 17.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.682 0.277 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 6.2 mm100 -111.08 111.44 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.971 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 103' ' ' ILE . 3.2 mt -86.57 113.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.748 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -77.6 -64.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.256 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.39 148.43 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.836 HD12 HD21 ' A' ' 78' ' ' LEU . 2.7 mp -118.91 114.35 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.776 ' ND2' HD13 ' A' ' 93' ' ' LEU . 29.0 m-80 60.78 29.77 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.32 -20.0 52.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.804 HG21 HG23 ' A' ' 89' ' ' ILE . 2.9 m -69.86 95.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.774 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -71.87 121.06 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 73' ' ' ILE . 1.3 pp -128.91 28.18 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 46' ' ' THR . 22.7 t -75.39 86.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 140.26 -50.26 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.684 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -51.02 163.82 0.48 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 111.116 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.59 -178.68 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.768 2.312 . . . . 0.0 112.829 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.8 tp -78.26 -45.04 23.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.104 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 9.7 p -53.41 -40.88 65.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.093 0.473 . . . . 0.0 110.69 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.7 m -66.08 -49.25 68.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 74.4 m -55.52 -56.28 22.15 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.286 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.747 ' NE2' HG21 ' B' ' -2' ' ' VAL . 5.8 pt20 -49.18 -46.24 45.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 34.8 t -56.42 -35.18 67.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.345 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 76' ' ' THR . 6.5 mm -59.58 -47.28 91.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.017 HG21 HD13 ' B' ' 0' ' ' ILE . 44.6 mt -69.88 -50.63 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.161 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -63.24 -17.53 62.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.215 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.45 73.61 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.691 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.776 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.3 pp -117.17 42.86 2.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.02 -7.21 57.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.442 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.61 35.01 1.4 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.666 0.27 . . . . 0.0 111.591 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 2.2 pt20 -126.12 134.67 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.836 0.35 . . . . 0.0 110.31 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -8.71 51.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.757 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.779 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.4 ttm105 -145.35 150.11 36.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 0.0 110.873 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.641 HG13 HD21 ' A' ' 74' ' ' ASN . 2.8 t -135.67 118.16 21.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.554 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.1 mtpt -97.73 97.84 9.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.708 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -102.13 153.44 19.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.969 0.414 . . . . 0.0 111.074 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.84 94.49 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.4 pt -120.52 171.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.748 HG23 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -116.45 117.83 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.552 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.602 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.4 Cg_endo . . . . . 0 C--O 1.23 0.123 0 CA-C-O 120.784 0.244 . . . . 0.0 112.291 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.747 HG21 ' NE2' ' A' ' 87' ' ' GLN . 28.5 m -58.41 110.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -100.29 143.05 30.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.113 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.08 HD11 HG22 ' A' ' 33' ' ' VAL . 2.4 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.917 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' C ' HG13 ' A' ' 104' ' ' VAL . 10.1 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CD1' HG22 ' A' ' 104' ' ' VAL . 7.7 m-85 -62.33 154.32 28.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.236 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -167.64 125.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.342 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 101.53 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.862 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.8 t -83.89 116.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.75 104.56 12.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.488 179.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.25 99.74 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.098 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 50.1 mt-10 -75.53 109.99 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -131.51 -173.95 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.4 . . . . 0.0 111.492 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.49 159.34 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.9 156.96 13.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.17 18.03 62.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.355 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -130.23 31.7 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.891 0.377 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.661 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 14.31 -80.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.311 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 99' ' ' VAL . 11.9 tp 177.8 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.866 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.76 61.48 1.86 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.537 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.06 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -147.43 156.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 111.66 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' B' ' -1' ' ' TYR . 37.6 t -120.82 126.79 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.01 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.576 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.8 pt -116.74 144.15 25.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.206 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 83' ' ' LEU . 36.0 m -133.97 163.26 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 124.29 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 48' ' ' ILE . 51.8 p -65.48 84.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.386 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.6 -3.97 90.49 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.754 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -56.17 -162.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -52.94 -18.94 6.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.842 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.2 m 107.27 -86.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.486 0.714 . . . . 0.0 111.004 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.701 HG22 ' HG ' ' A' ' 44' ' ' LEU . 84.4 mt 57.3 -64.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.387 0.613 . . . . 0.0 111.4 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.971 ' O ' HG22 ' A' ' 46' ' ' THR . 1.4 mt -135.87 73.39 60.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.625 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 87.1 Cg_exo -47.1 90.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.882 2.388 . . . . 0.0 113.359 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.971 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.76 -91.57 0.29 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.372 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -154.04 167.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 111.431 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.31 129.59 50.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.775 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.118 HG22 HD13 ' A' ' 66' ' ' ILE . 79.2 mt -66.41 94.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.01 0.91 55.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 m-20 -174.07 161.62 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 111.141 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 mtm -154.96 159.78 40.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.502 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.0 mtt -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 60.96 47.11 7.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.614 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -35.31 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.23 -171.97 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.173 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.11 -21.93 45.03 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.549 2.166 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.65 -49.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.961 0.41 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -39.36 41.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -52.8 -47.39 67.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.393 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -68.9 -61.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.78 -1.97 38.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.196 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.795 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmm -76.97 -28.75 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.862 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -107.04 113.97 27.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.042 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -130.92 141.41 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.395 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.118 HD13 HG22 ' A' ' 49' ' ' ILE . 42.0 mm -44.87 141.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 111.84 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 17.72 52.37 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.428 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.902 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.5 m-20 -102.83 158.49 16.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.622 0.249 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -117.57 106.99 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.963 HG23 HG22 ' A' ' 103' ' ' ILE . 1.4 mt -85.4 119.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.632 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -80.44 -65.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.66 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -133.64 146.97 51.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 111.473 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.2 mt -113.89 114.37 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.759 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.626 ' ND2' HD22 ' A' ' 93' ' ' LEU . 25.2 m-80 59.12 22.22 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.86 8.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.846 HG21 HD12 ' A' ' 89' ' ' ILE . 3.4 m -68.18 108.27 3.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.528 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.3 t -69.98 138.16 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.967 HD11 ' CD1' ' A' ' 73' ' ' ILE . 57.6 mt -111.07 -23.32 10.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.7 t -58.82 98.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.03 -29.47 3.71 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.413 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -96.15 159.8 31.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 111.609 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.74 178.68 2.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.003 2.469 . . . . 0.0 112.517 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.3 tp -72.35 -39.45 68.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.091 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.5 t -53.32 -46.08 69.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.451 . . . . 0.0 110.393 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 89' ' ' ILE . 28.6 m -62.07 -50.5 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.992 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 28.8 m -55.39 -55.77 27.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HA ' HD11 ' A' ' 35' ' ' ILE . 27.9 mt-30 -49.28 -40.48 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 110.289 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -63.57 -37.11 86.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.407 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 HG21 ' A' ' 76' ' ' THR . 27.4 mm -58.15 -49.56 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.987 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.01 HG21 HD13 ' B' ' 0' ' ' ILE . 36.6 mt -71.83 -44.27 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.1 OUTLIER -54.97 -25.36 29.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.828 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.01 -51.05 48.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.091 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.6 pp -79.04 60.96 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 110.953 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.2 ttpm? -87.2 -26.07 23.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.358 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -108.51 51.95 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.33 . . . . 0.0 111.324 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 mt-30 -109.45 163.9 12.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 0.0 111.683 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.0 p -98.47 -10.92 22.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.36 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.69 150.4 10.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.279 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 31' ' ' LEU . 13.1 t -119.91 119.19 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 112.054 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -97.6 117.81 32.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.9 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.37 117.95 13.9 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.994 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.99 96.22 9.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.963 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -120.44 170.46 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.183 0.516 . . . . 0.0 112.229 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.3 t -108.25 113.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.237 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 3.4 ttt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.493 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.443 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.881 0.284 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' VAL . 31.1 m -84.53 161.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.47 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 5.5 m-85 -119.74 160.33 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.06 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' C ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.886 0.374 . . . . 0.0 111.062 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.9 m-85 -59.38 154.28 17.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.49 125.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.105 0.478 . . . . 0.0 111.542 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.8 129.93 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.164 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.4 t -110.39 129.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.08 104.64 9.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 ' CD1' ' A' ' 31' ' ' LEU . 18.1 mm -107.48 99.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.01 110.88 21.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.16 -167.75 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.0 111.307 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.48 172.81 6.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.489 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.93 158.82 34.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.696 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.68 16.62 56.24 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.389 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 31' ' ' LEU . 8.6 mt-10 -126.32 30.83 5.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.755 HG23 ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 16.46 -80.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.966 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.719 HD23 ' CG1' ' A' ' 33' ' ' VAL . 2.9 tp 177.58 -45.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 90.06 64.71 1.23 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.977 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.47 156.35 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.635 HG21 ' HG2' ' B' ' -3' ' ' PRO . 19.6 t -121.18 122.74 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 0.0 111.359 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 HG11 ' A' ' 47' ' ' VAL . 2.4 pt -111.47 142.37 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.0 m -135.18 170.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.645 ' O ' HD11 ' A' ' 48' ' ' ILE . 32.0 mt-10 -60.57 135.22 57.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.461 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.0 p -75.52 83.57 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.432 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -8.47 83.33 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.82 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.994 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.45 -161.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.637 0.256 . . . . 0.0 110.468 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.43 -26.67 7.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.883 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.423 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.98 42.04 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.404 0.621 . . . . 0.0 111.384 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.994 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 89.0 mt -51.49 -42.46 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.887 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.918 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -151.58 89.72 4.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.231 178.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 80' ' ' GLY . 85.4 Cg_exo -45.58 111.34 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.974 2.449 . . . . 0.0 113.841 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -156.54 -89.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.48 167.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.236 . . . . 0.0 111.015 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.645 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -133.68 129.41 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.634 ' CG1' HD11 ' A' ' 70' ' ' ILE . 78.9 mt -70.3 96.2 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.84 0.57 52.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.233 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.912 ' HA ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -169.46 161.2 9.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.451 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 14.4 mtm -155.23 134.93 12.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.42 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.489 ' HE1' HD11 ' A' ' 30' ' ' ILE . 13.9 mtm -70.39 95.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.299 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -60.64 80.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.125 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 165.45 -31.45 0.22 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.59 -167.43 31.96 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.086 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 56.5 Cg_endo -69.28 -16.12 39.37 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.652 2.234 . . . . 0.0 112.529 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -66.89 -49.6 65.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 110.83 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.57 -38.59 48.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.43 -47.21 82.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.193 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -59.34 -68.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.55 38.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.165 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.776 ' HB2' HG13 ' A' ' 21' ' ' VAL . 19.5 mmmt -72.33 -30.01 64.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.51 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.689 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -102.7 129.97 49.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.576 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 73.8 m-80 -142.75 138.12 30.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.726 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.912 HD11 ' HA ' ' A' ' 51' ' ' ASN . 6.2 mt -46.67 140.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.202 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.8 16.62 44.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.58 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.866 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.1 m-20 -111.87 157.22 20.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 110.739 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -112.79 117.75 33.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.873 HG23 HG22 ' A' ' 103' ' ' ILE . 2.3 mt -91.8 108.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.787 ' CE ' HD13 ' A' ' 44' ' ' LEU . 21.6 mmt -66.94 -67.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.425 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 53.5 p -131.57 156.07 46.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.348 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HD11 ' A' ' 93' ' ' LEU . 3.3 mt -124.44 109.8 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.493 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.559 HD22 HG22 ' A' ' 73' ' ' ILE . 71.6 m-80 64.23 29.42 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.879 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.62 50.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.924 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 89' ' ' ILE . 15.0 m -77.75 95.84 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.741 0.305 . . . . 0.0 111.315 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.425 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 56.4 p -77.02 131.63 38.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.247 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.98 19.26 7.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 23.5 t -60.39 88.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.848 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 133.07 -24.66 3.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.779 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.3 mt -70.72 155.42 93.42 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 110.766 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.99 -173.75 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 tp -78.13 -47.21 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.008 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 p -53.37 -43.35 67.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.085 0.469 . . . . 0.0 110.263 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 89' ' ' ILE . 83.1 m -65.04 -52.23 57.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.852 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.461 ' SG ' HD13 ' A' ' 78' ' ' LEU . 85.9 m -56.56 -50.33 72.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.474 ' OE1' HG11 ' B' ' -2' ' ' VAL . 11.5 mt-30 -49.89 -45.1 50.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 110.07 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -60.26 -35.95 76.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.519 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' THR . 7.5 mm -58.21 -48.99 83.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.432 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.915 HG21 HD13 ' B' ' 0' ' ' ILE . 57.1 mt -73.08 -42.17 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.158 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -55.18 -25.83 35.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.5 69.21 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.397 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 73' ' ' ILE . 2.2 mt -93.31 45.28 1.16 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.755 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.22 -26.68 30.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.193 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.01 35.69 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.74 159.78 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.134 0.493 . . . . 0.0 111.635 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 p -114.24 -9.26 12.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.455 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -150.73 134.9 16.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.368 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.646 ' CG1' HD21 ' A' ' 101' ' ' LEU . 13.1 t -122.59 104.84 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 0.0 111.723 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.99 100.48 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -115.57 123.33 48.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.458 . . . . 0.0 112.089 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.3 93.81 9.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.317 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.873 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -114.42 170.25 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.045 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.7 t -115.0 126.51 72.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.822 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.81 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.635 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.9 Cg_endo . . . . . 0 CA--C 1.528 0.215 0 CA-C-O 120.626 0.178 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.474 HG11 ' OE1' ' A' ' 87' ' ' GLN . 23.0 t -45.11 -56.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.584 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 53' ' ' MET . 1.0 OUTLIER 64.16 149.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.07 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.053 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.946 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.519 ' N ' HG23 ' A' ' 104' ' ' VAL . 5.9 m-85 -58.8 154.06 15.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.809 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.73 125.44 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 111.468 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -73.3 105.89 4.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.648 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 101' ' ' LEU . 26.6 t -82.37 132.17 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -123.99 104.71 9.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.645 HD13 ' OG ' ' A' ' 61' ' ' SER . 10.3 mm -110.3 99.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.337 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.81 109.79 20.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.268 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.77 -172.07 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -106.86 163.36 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.42 155.94 27.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.35 16.13 64.49 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.425 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -126.38 30.51 5.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.916 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 19.36 -82.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.957 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.787 ' CD1' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 175.19 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.624 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.45 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 91.19 67.67 1.17 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.814 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.019 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.84 156.53 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.375 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' B' ' -3' ' ' PRO . 36.5 t -124.73 119.81 57.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 47' ' ' VAL . 2.0 pt -110.41 145.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -136.4 165.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 131.62 51.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.025 0.441 . . . . 0.0 110.623 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.471 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.0 p -69.85 84.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.653 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.36 -4.31 89.53 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.832 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.73 -163.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.667 0.27 . . . . 0.0 110.302 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.07 -25.68 7.99 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.77 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 8.9 p 82.21 63.04 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.001 0.905 . . . . 0.0 111.517 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' HD23 ' A' ' 44' ' ' LEU . 48.3 mt -78.91 -32.31 15.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.757 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 80.9 mt -156.13 89.74 2.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.286 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 Cg_exo -49.19 86.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.822 2.348 . . . . 0.0 113.515 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.81 -91.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.055 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 83' ' ' LEU . 2.9 m -160.27 167.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 120.684 0.278 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -133.5 127.68 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.93 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.071 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -67.74 93.39 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.25 55.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.137 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.474 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -165.95 156.82 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.301 . . . . 0.0 110.9 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 ttm -153.38 131.57 11.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.262 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.45 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 6.2 mtm -63.23 100.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.493 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -66.45 73.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.15 -34.13 0.15 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.126 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.3 -168.2 13.85 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.919 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.0 Cg_endo -69.32 -16.57 39.51 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.502 2.134 . . . . 0.0 112.424 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.48 71.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -40.39 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -58.12 -29.67 65.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.645 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -69.23 -66.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.11 -33.47 5.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.136 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 21' ' ' VAL . 15.4 mt -92.6 119.25 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.814 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -133.07 130.07 38.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.585 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.071 HD13 HG22 ' A' ' 49' ' ' ILE . 42.3 mm -45.74 142.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.87 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.96 12.01 55.85 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.502 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 103' ' ' ILE . 69.6 m-20 -105.88 161.33 14.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.785 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.1 119.85 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.767 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -89.7 97.82 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.708 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.81 -64.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.599 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.2 p -137.14 149.9 47.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.26 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 78' ' ' LEU . 3.2 mt -117.59 118.24 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 56.08 29.09 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.28 11.98 56.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.796 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.88 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -100.65 95.91 7.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.762 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.722 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -58.09 126.7 28.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 73' ' ' ILE . 23.5 mt -109.14 -23.62 11.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.3 t -56.03 88.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.464 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.16 -38.79 1.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.362 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -81.21 159.68 67.23 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.436 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.19 -175.04 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.956 2.438 . . . . 0.0 112.659 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -78.25 -46.42 20.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.0 m -53.6 -42.61 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.996 0.427 . . . . 0.0 110.589 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG12 ' A' ' 89' ' ' ILE . 71.0 m -62.01 -49.28 76.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.7 m -56.56 -46.5 80.69 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.811 0.339 . . . . 0.0 110.729 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' NE2' ' CD1' ' A' ' 83' ' ' LEU . 10.3 mt-30 -52.69 -43.11 65.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.049 0.452 . . . . 0.0 109.896 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.1 p -60.9 -37.23 81.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.422 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.88 HD12 HG21 ' A' ' 76' ' ' THR . 21.0 mm -58.22 -49.44 81.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.963 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.965 HG21 HD13 ' B' ' 0' ' ' ILE . 52.7 mt -71.46 -45.04 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.224 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -58.48 -20.68 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -20.71 67.85 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.055 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.618 HD21 HG21 ' A' ' 73' ' ' ILE . 2.5 pp -100.53 43.88 1.04 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.001 0.401 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.06 -5.89 58.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.291 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -122.55 54.21 1.22 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.871 0.367 . . . . 0.0 111.208 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.78 ' OE1' HG22 ' A' ' 99' ' ' VAL . 3.3 pt20 -136.27 160.48 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -98.79 -15.84 19.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.828 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -139.68 143.87 37.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.749 0.309 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 31' ' ' LEU . 2.4 t -124.65 104.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -95.92 97.6 9.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.225 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -109.51 154.83 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.927 0.394 . . . . 0.0 111.002 -179.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.6 OUTLIER -118.94 97.58 5.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.789 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.77 170.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 111.681 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.785 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.5 p -121.4 132.61 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.801 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.642 ' HB2' HG11 ' A' ' 34' ' ' VAL . 71.7 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.837 0.265 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.33 119.35 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 34' ' ' VAL . 2.3 m-85 -100.21 132.17 45.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.01 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.001 0.429 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 13.1 m-85 -60.21 151.94 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.878 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.64 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.35 124.51 2.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.137 0.494 . . . . 0.0 111.18 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 120.54 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.4 t -103.16 147.2 9.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -140.34 104.79 4.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.825 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mm -107.4 99.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -83.99 109.87 17.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.405 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -132.27 -175.32 3.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -104.63 144.27 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.372 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HG2' ' CB ' ' A' ' 95' ' ' ASN . 15.6 mttt -50.24 144.45 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.076 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 10.73 80.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.624 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 31' ' ' LEU . 26.9 mm-40 -124.86 31.05 5.75 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.851 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 25.5 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.089 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 23' ' ' ILE . 56.8 tp 177.56 -41.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.791 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.79 63.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.856 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.025 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -151.11 156.12 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 111.216 178.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' B' ' -3' ' ' PRO . 38.6 t -121.61 129.83 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -119.76 140.84 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.434 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.9 m -131.52 168.15 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -58.91 132.57 54.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.914 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.4 p -74.1 84.08 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -79.27 -7.74 88.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.074 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.59 -162.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 110.322 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.02 -26.5 6.01 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.445 -0.884 . . . . 0.0 111.816 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.31 45.74 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.544 0.688 . . . . 0.0 111.256 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.893 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 83.6 mt -59.01 -39.28 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.942 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.97 ' O ' HG22 ' A' ' 46' ' ' THR . 2.0 mt -146.22 80.99 9.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.386 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 80' ' ' GLY . 94.8 Cg_exo -42.57 91.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.913 2.408 . . . . 0.0 113.581 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.13 -89.42 0.2 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.354 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.667 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.61 167.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.653 0.264 . . . . 0.0 111.205 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.43 129.44 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.075 HG22 HD13 ' A' ' 66' ' ' ILE . 52.2 mt -68.21 91.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -13.26 41.46 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.764 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -158.13 159.1 35.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.975 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.13 129.14 10.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.439 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 3.3 mtm -56.3 102.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.0 70.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.777 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.88 -34.26 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.066 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.09 -167.86 4.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.093 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.5 Cg_endo -69.27 -16.11 39.37 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.813 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.41 -49.69 58.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.856 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -36.87 50.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -56.73 -47.28 80.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -73.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.39 -4.05 23.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.309 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.693 ' HB2' HG13 ' A' ' 21' ' ' VAL . 20.1 mmmt -75.93 -37.49 58.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.539 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.847 HD21 HD13 ' A' ' 101' ' ' LEU . 53.3 mt -91.81 126.53 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -132.15 128.13 37.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.496 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.075 HD13 HG22 ' A' ' 49' ' ' ILE . 43.8 mm -44.18 142.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.5 . . . . 0.0 111.937 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.12 13.33 56.38 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.563 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.908 ' HB3' HD12 ' A' ' 103' ' ' ILE . 87.4 m-20 -102.37 166.93 10.29 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.761 0.315 . . . . 0.0 110.615 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 3.4 mm100 -120.32 105.71 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.762 HG23 HG22 ' A' ' 103' ' ' ILE . 4.9 mt -78.82 129.48 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.706 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -95.42 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 p -126.56 142.26 51.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.598 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 HD21 ' A' ' 78' ' ' LEU . 2.8 mp -120.08 122.85 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.515 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.524 HD22 HD13 ' A' ' 93' ' ' LEU . 1.2 m-20 59.76 31.23 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.85 14.52 69.71 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.522 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 m -109.14 95.63 5.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -73.56 131.01 41.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.591 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.682 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.24 16.32 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.136 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -63.04 89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.999 0.428 . . . . 0.0 110.28 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 134.63 -22.04 3.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.5 mt -74.1 167.71 33.04 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.276 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 85' ' ' THR . 9.7 Cg_exo -68.9 -177.27 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.751 2.301 . . . . 0.0 111.439 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.668 HD11 HE22 ' A' ' 87' ' ' GLN . 0.8 OUTLIER -78.64 -52.9 7.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 179.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 -38.84 65.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.723 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 89' ' ' ILE . 37.2 m -62.4 -43.12 99.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HG13 ' A' ' 89' ' ' ILE . 77.3 m -58.79 -51.48 69.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.668 HE22 HD11 ' A' ' 83' ' ' LEU . 21.7 mt-30 -50.99 -44.05 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.276 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.5 m -60.42 -35.19 75.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.371 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 85' ' ' THR . 2.8 mm -58.35 -49.43 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.104 HG21 HD13 ' B' ' 0' ' ' ILE . 59.1 mt -71.45 -43.44 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.769 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.38 -24.44 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.84 -42.28 38.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.627 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.524 HD13 HD22 ' A' ' 74' ' ' ASN . 0.4 OUTLIER -89.19 51.15 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 111.142 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.851 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -87.32 -23.84 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.442 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 56.6 m-80 -116.07 63.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.3 mm100 -124.19 -29.78 3.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.602 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 3.8 t 82.28 -2.16 1.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.247 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.1 ttm180 -154.93 134.02 12.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.73 0.3 . . . . 0.0 110.229 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.631 ' CG1' HD21 ' A' ' 101' ' ' LEU . 17.7 t -119.75 104.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.711 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -90.98 100.85 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.71 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.847 HD13 HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -115.84 120.76 40.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -90.45 90.58 8.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.908 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.7 pt -111.94 164.63 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.706 HG23 ' SD ' ' A' ' 71' ' ' MET . 61.6 t -103.05 107.96 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.333 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.6 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.715 ' CG ' HG21 ' A' ' 34' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.823 0.26 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.402 HG23 ' N ' ' B' ' -1' ' ' TYR . 18.2 m -55.96 -42.51 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.365 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 34' ' ' VAL . 1.5 m-85 64.97 90.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.104 HD13 HG21 ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.042 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CA ' HG12 ' A' ' 104' ' ' VAL . 5.4 m-85 -58.68 151.98 19.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.965 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -164.38 125.23 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 111.508 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.09 102.14 4.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.4 t -82.7 136.66 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.153 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -124.95 104.77 8.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 61' ' ' SER . 15.3 mm -105.88 99.78 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -86.87 109.82 19.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -138.04 -171.15 2.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.995 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.54 169.38 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.59 156.99 31.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 18.84 61.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.292 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' C ' ' A' ' 30' ' ' ILE . 2.7 mm-40 -127.7 29.5 5.46 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.582 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 10.29 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.326 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 172.75 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.77 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 89.01 66.65 1.26 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.467 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.045 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -149.39 156.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' B' ' -3' ' ' PRO . 21.9 t -121.23 126.51 75.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.721 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.552 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -113.94 151.92 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.77 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 35.2 m -142.61 167.3 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.32 131.1 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 48' ' ' ILE . 25.2 p -70.4 84.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.62 -5.82 89.21 Favored Glycine 0 C--N 1.328 0.135 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.967 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.751 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.24 -163.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.566 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.08 -24.49 6.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.76 36.52 0.08 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.233 0.54 . . . . 0.0 111.404 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.751 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.5 mt -52.45 -36.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.657 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -147.59 101.06 3.74 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.943 178.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 75.6 Cg_exo -51.76 83.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.398 2.065 . . . . 0.0 112.876 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -133.84 -152.35 0.48 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.214 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 83' ' ' LEU . 15.8 m -111.28 166.1 5.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.634 0.254 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.04 131.33 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.019 HG22 HD13 ' A' ' 66' ' ' ILE . 73.1 mt -68.2 93.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.28 -9.58 44.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.238 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.466 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.2 m-20 -162.12 160.22 27.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 111.053 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -152.06 147.65 26.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.582 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.9 mtt -59.64 -27.86 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 60.61 60.85 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.697 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.96 -30.15 0.16 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.278 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.7 -170.68 29.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.043 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.411 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 29.7 Cg_endo -63.09 -17.21 59.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.301 2.001 . . . . 0.0 112.343 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -49.02 66.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -38.77 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -56.38 -45.95 80.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.415 ' CB ' HD13 ' A' ' 23' ' ' ILE . 1.6 p -56.04 -56.15 24.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.93 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -29.21 11.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.289 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.528 ' CB ' HG13 ' A' ' 21' ' ' VAL . 5.4 mtmt -61.02 -29.3 69.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' A' ' 21' ' ' VAL . 86.8 mt -101.69 125.96 48.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.14 147.75 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.019 HD13 HG22 ' A' ' 49' ' ' ILE . 50.8 mm -50.41 146.5 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.647 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.93 59.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.262 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.62 ' HB3' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -102.55 174.18 6.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.689 0.281 . . . . 0.0 110.658 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.68 ' HB2' HG23 ' A' ' 104' ' ' VAL . 3.5 mm100 -130.35 107.8 9.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.147 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.72 HG23 HG22 ' A' ' 103' ' ' ILE . 7.5 mt -88.71 134.2 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.808 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -97.02 -69.91 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t -129.62 144.95 51.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.267 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.966 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -113.88 110.95 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.666 ' ND2' HD13 ' A' ' 93' ' ' LEU . 70.8 m-80 57.69 22.77 8.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.94 -34.21 4.71 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.868 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.85 HG21 HD12 ' A' ' 89' ' ' ILE . 3.8 m -65.55 103.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.795 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 p -68.81 135.59 51.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.309 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.966 HD11 ' CD1' ' A' ' 73' ' ' ILE . 29.5 mt -112.58 -20.16 11.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.089 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 46' ' ' THR . 35.9 t -56.28 88.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.649 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.51 -49.69 0.86 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.361 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.795 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -64.46 159.88 55.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.554 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.67 -177.39 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.037 2.491 . . . . 0.0 112.654 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.587 HD23 HG12 ' A' ' 47' ' ' VAL . 1.9 tm? -78.17 -49.91 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.712 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 m -53.15 -41.14 64.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.991 0.424 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.8 m -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.036 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.0 m -55.7 -54.1 48.41 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.459 ' NE2' HD13 ' A' ' 83' ' ' LEU . 25.3 mt-30 -49.03 -48.01 44.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.2 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 23.2 t -56.81 -35.26 68.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.556 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.85 HD12 HG21 ' A' ' 76' ' ' THR . 7.0 mm -58.8 -48.58 85.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.999 HG21 HD13 ' B' ' 0' ' ' ILE . 23.7 mt -67.49 -50.55 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.17 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.27 -19.97 62.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.87 -23.22 69.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.583 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.666 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.4 pp -113.82 44.27 1.66 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.33 -12.27 43.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.42 39.15 1.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.775 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.02 147.98 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 110.677 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.1 t -83.13 -9.12 59.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 1.9 ttm180 -147.15 141.78 26.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.746 0.308 . . . . 0.0 110.725 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.775 HG22 ' OE1' ' A' ' 96' ' ' GLN . 10.4 t -127.7 104.89 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.36 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -88.68 97.91 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.739 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -102.28 154.55 18.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 111.297 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.4 OUTLIER -124.13 97.65 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.72 HG22 HG23 ' A' ' 70' ' ' ILE . 1.7 pt -121.51 172.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.129 0.49 . . . . 0.0 112.295 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 69' ' ' GLN . 4.3 m -125.9 130.99 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.587 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.527 ' CG ' HG11 ' A' ' 34' ' ' VAL . 68.1 Cg_endo . . . . . 0 N--CA 1.464 -0.243 0 N-CA-C 112.623 0.201 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.1 t 54.39 87.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.42 ' CZ ' HG23 ' A' ' 34' ' ' VAL . 1.2 m-85 -81.89 145.77 30.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.045 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.775 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.865 0.364 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 44' ' ' LEU . 6.4 m-85 -64.71 154.44 36.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.784 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.59 125.32 2.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.233 0.539 . . . . 0.0 111.559 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.55 100.15 1.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.502 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 101' ' ' LEU . 24.9 t -82.43 112.01 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.131 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -110.92 104.82 13.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' CB ' ' A' ' 61' ' ' SER . 4.1 mm -105.96 104.16 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.2 mp0 -84.05 110.3 18.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.5 -171.3 2.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -112.22 166.72 11.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -65.05 158.49 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 110.724 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.38 17.77 60.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.487 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -126.81 29.73 5.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 22.77 -82.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.097 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 99' ' ' VAL . 16.7 tp 174.95 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' HA2' ' HE1' ' A' ' 53' ' ' MET . . . 88.49 63.5 1.35 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.819 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.046 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -152.7 156.07 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 117.18 0.49 . . . . 0.0 111.795 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 31.1 t -126.35 116.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.588 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -103.24 152.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.44 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 48' ' ' ILE . 26.8 m -140.09 168.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 48' ' ' ILE . 28.7 mt-10 -58.46 132.14 52.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.939 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.5 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.6 p -74.11 84.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.423 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.84 -9.62 84.22 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.123 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.903 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.23 -161.65 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.723 0.296 . . . . 0.0 110.439 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.73 -26.07 7.55 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.801 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.439 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 9.1 m 80.54 35.87 0.11 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.264 0.554 . . . . 0.0 111.49 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.903 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 74.2 mt -49.25 -39.36 12.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.056 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.906 ' O ' HG22 ' A' ' 46' ' ' THR . 1.5 mt -145.66 87.71 6.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.091 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 6.7 Cg_endo -50.39 90.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.873 2.382 . . . . 0.0 113.308 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.9 -91.58 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.818 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.497 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -158.67 167.58 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.38 131.11 63.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.091 HG22 HD13 ' A' ' 66' ' ' ILE . 56.0 mt -68.1 93.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.06 -1.89 53.73 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.115 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.492 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.1 t-20 -170.01 152.6 4.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 mtm -146.7 121.35 9.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 0.0 111.448 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.482 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -54.48 90.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.607 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -59.25 82.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.05 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.76 -29.92 0.27 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.953 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.57 32.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.52 -16.06 38.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.704 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.25 63.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 -33.38 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.751 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -61.37 -45.58 93.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.417 ' CB ' HD13 ' A' ' 23' ' ' ILE . 6.8 m -63.73 -68.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.22 -25.65 17.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.505 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.567 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.89 -27.07 40.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.643 ' HG ' HG11 ' A' ' 21' ' ' VAL . 71.5 mt -98.76 134.53 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -140.43 134.73 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.711 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.091 HD13 HG22 ' A' ' 49' ' ' ILE . 49.4 mm -46.42 144.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.705 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.22 84.57 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.659 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.922 ' HB3' HD12 ' A' ' 103' ' ' ILE . 74.6 m-20 -85.59 164.0 18.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.678 0.275 . . . . 0.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.737 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -119.45 118.29 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 111.193 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.783 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -91.62 108.73 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.53 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.85 -66.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.876 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.8 p -135.65 148.53 48.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.408 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 3.2 mt -118.22 112.5 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.77 23.85 12.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.78 -30.49 7.43 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.886 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.877 HG21 HG23 ' A' ' 89' ' ' ILE . 3.0 m -67.7 102.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.716 0.293 . . . . 0.0 111.039 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.593 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.9 m -69.04 136.75 52.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.054 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HA ' HD21 ' A' ' 81' ' ' LEU . 40.5 mt -112.24 -13.52 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -67.05 94.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.341 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.91 -22.73 3.8 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.479 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.93 157.61 33.57 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.983 0.391 . . . . 0.0 111.472 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.01 -174.15 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.818 2.346 . . . . 0.0 112.801 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -78.15 -48.43 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.459 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 p -52.99 -42.21 65.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.705 HG22 HD13 ' A' ' 81' ' ' LEU . 99.1 m -61.55 -48.33 81.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.839 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' HD12 ' A' ' 81' ' ' LEU . 78.8 m -56.13 -50.16 71.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.883 0.373 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -50.22 -46.2 54.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.305 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.3 m -59.69 -35.7 75.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.64 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.877 HG23 HG21 ' A' ' 76' ' ' THR . 18.2 mm -58.15 -50.0 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.063 HG21 HD13 ' B' ' 0' ' ' ILE . 58.7 mt -69.54 -45.31 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -55.57 -23.42 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.31 -33.3 32.38 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.0 pp -95.65 35.12 1.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.915 0.388 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.76 -5.79 58.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -107.65 43.96 1.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.404 ' CD ' ' HB2' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -131.97 176.07 8.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 110.9 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.2 t -102.17 -16.74 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 28.3 mmt85 -131.21 150.49 52.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 101' ' ' LEU . 7.7 t -129.4 104.3 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mmpt? -90.0 120.92 31.62 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.3 117.84 11.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 111.804 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.78 99.41 12.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.574 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.922 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.68 167.35 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.153 0.501 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' HB2' ' A' ' 69' ' ' GLN . 4.3 p -112.06 129.09 68.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.247 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 72.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.781 0.242 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.76 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.542 ' CE2' HG23 ' A' ' 34' ' ' VAL . 36.6 m-85 -109.33 131.51 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 90' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.593 ' C ' HG13 ' A' ' 104' ' ' VAL . 2.3 tt0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.83 0.347 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.512 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.0 m-85 -67.29 151.55 47.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.692 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.73 125.9 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.314 0.578 . . . . 0.0 111.616 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.56 105.88 6.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.572 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 63' ' ' LYS . 22.8 t -84.38 141.2 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -132.84 104.53 6.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.217 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 31' ' ' LEU . 14.1 mm -106.57 99.63 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 98' ' ' ARG . 37.2 mt-10 -85.63 109.55 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.023 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -140.54 -172.86 3.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.154 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.8 169.07 8.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.423 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 157.12 30.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.532 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 9.92 65.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.507 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ILE . 4.4 mt-10 -120.13 31.87 6.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.197 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 5.77 -75.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.103 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 99' ' ' VAL . 2.5 tp 171.73 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.844 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 83.15 62.73 1.79 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.249 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.036 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -146.03 156.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 111.715 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.553 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.3 t -119.43 132.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER -117.16 156.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.635 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.749 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.28 165.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.808 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.19 131.82 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.609 ' HA ' HD11 ' A' ' 48' ' ' ILE . 87.5 p -69.13 84.09 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.403 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.47 -1.19 90.24 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.562 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.8 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.579 0.228 . . . . 0.0 110.475 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.28 -25.5 8.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.833 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 83.05 64.27 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.739 0.78 . . . . 0.0 111.459 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.586 ' O ' HD23 ' A' ' 44' ' ' LEU . 43.5 mt -83.0 -31.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.841 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -156.51 101.39 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.809 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 9.6 Cg_endo -52.11 83.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.58 2.187 . . . . 0.0 113.363 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -133.45 -157.7 0.83 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.041 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.6 m -105.64 153.36 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.933 0.396 . . . . 0.0 111.651 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -115.78 132.79 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.8 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.063 HG22 HD13 ' A' ' 66' ' ' ILE . 48.8 mt -69.31 90.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.44 -11.3 52.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.192 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.626 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -161.8 159.9 27.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 17.1 ttm -149.15 135.64 19.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.935 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 30' ' ' ILE . 2.9 mtm -51.95 -27.19 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 38.6 t60 58.66 54.67 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.676 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.2 -37.14 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.217 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.88 -166.14 2.45 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.951 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 51.0 Cg_endo -68.91 -16.94 41.6 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.292 1.995 . . . . 0.0 112.131 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.53 -44.74 73.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.482 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -39.42 49.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.565 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -58.34 -47.12 84.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -63.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.14 -23.42 27.3 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.287 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.876 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -56.84 -36.59 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 21' ' ' VAL . 23.1 mt -101.08 104.39 15.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.995 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 1.5 p30 -121.54 141.23 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.531 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.063 HD13 HG22 ' A' ' 49' ' ' ILE . 28.5 mm -46.34 145.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 111.809 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.62 4.82 61.9 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.64 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.6 m-20 -106.07 150.96 25.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.29 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -113.08 126.72 55.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.729 HG23 HG22 ' A' ' 103' ' ' ILE . 6.3 mt -88.93 134.87 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.726 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -96.81 -57.82 2.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.241 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.0 p -147.23 145.26 29.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.969 0.414 . . . . 0.0 111.401 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.75 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -115.23 120.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 73' ' ' ILE . 71.9 m-80 55.87 27.98 11.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.37 -26.01 24.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.795 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.655 HG21 HG23 ' A' ' 89' ' ' ILE . 3.4 m -65.51 102.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD21 ' A' ' 81' ' ' LEU . 4.9 t -68.77 131.48 45.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 73' ' ' ILE . 21.0 mt -109.82 -25.34 10.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.715 HG22 HG22 ' A' ' 46' ' ' THR . 26.0 t -54.99 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.524 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.45 -38.09 1.49 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.242 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.66 159.73 57.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.372 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 -172.14 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.847 2.365 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.8 tp -78.04 -45.01 24.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.018 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 7.6 t -53.34 -43.0 67.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.983 0.421 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.683 HG22 HD13 ' A' ' 81' ' ' LEU . 89.7 m -63.86 -48.63 75.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.646 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 71.9 m -55.97 -57.16 13.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.549 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.681 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.4 pt20 -48.86 -42.09 35.33 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.968 0.413 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -60.94 -35.69 77.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.311 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 85' ' ' THR . 13.9 mm -59.0 -49.4 83.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.013 HG21 HD13 ' B' ' 0' ' ' ILE . 29.1 mt -71.96 -46.09 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.721 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.2 mtpt -55.42 -24.41 30.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -47.25 47.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.209 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.33 55.72 3.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 0.0 110.814 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -87.93 -19.47 27.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.288 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -109.29 54.37 0.66 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.785 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.21 156.15 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.618 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 p -93.98 -12.23 29.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.763 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -143.58 139.49 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.522 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 ' OE1' ' A' ' 96' ' ' GLN . 2.7 t -120.87 104.43 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.516 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.38 119.45 32.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.826 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -132.0 154.35 49.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.024 0.44 . . . . 0.0 111.118 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.5 OUTLIER -122.29 92.25 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.2 pt -116.05 170.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 112.161 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.726 HG23 ' SD ' ' A' ' 71' ' ' MET . 35.9 t -119.98 113.9 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.889 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttm105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.961 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.553 ' HG2' HG21 ' A' ' 34' ' ' VAL . 88.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.787 0.264 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 61.35 122.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.375 . . . . 0.0 111.278 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 34' ' ' VAL . 32.9 m-85 -117.84 143.9 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.036 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HE1' HD21 ' A' ' 44' ' ' LEU . 2.5 m-85 -64.2 154.28 35.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.754 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.12 127.57 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 111.834 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.47 102.05 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.524 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 63' ' ' LYS . 24.8 t -82.77 135.3 25.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.022 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -127.28 104.84 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 31' ' ' LEU . 15.0 mm -104.71 99.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -90.07 109.61 20.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.121 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -135.07 -165.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -106.47 162.34 13.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.407 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.81 158.78 15.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.511 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.87 19.48 50.16 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -124.68 29.24 6.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 110.07 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 15.73 -80.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.482 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.566 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER 174.13 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.794 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.17 67.49 1.08 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.59 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.044 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -152.45 156.12 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.707 0.289 . . . . 0.0 111.008 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 47.9 t -120.62 123.64 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.045 0.45 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.565 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -110.91 140.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.803 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.635 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.6 m -133.12 168.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.121 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.6 mt-10 -58.47 132.32 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.3 p -72.92 84.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.469 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.05 -8.44 83.94 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.032 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.974 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.39 -161.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.478 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.4 8.61 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.816 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.424 0.63 . . . . 0.0 111.172 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 92.3 mt -55.95 -42.18 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.944 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -152.63 88.68 3.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.32 178.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.44 108.91 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.123 2.548 . . . . 0.0 114.108 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -154.85 -91.48 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.379 178.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.18 167.49 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 110.962 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.513 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.67 130.23 59.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.039 HG22 HD13 ' A' ' 66' ' ' ILE . 66.1 mt -69.09 94.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.5 -1.9 49.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.434 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -166.69 159.36 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.0 ttm -154.07 135.19 13.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.654 ' CE ' HD11 ' A' ' 30' ' ' ILE . 9.7 mtm -71.82 99.84 2.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.59 76.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.84 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -35.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -170.13 18.26 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.997 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 56.2 Cg_endo -69.11 -15.68 39.72 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.541 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.52 67.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.898 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.43 -38.99 48.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -57.47 -47.1 82.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.253 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.8 p -56.9 -63.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.53 -9.19 57.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.321 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.794 ' HB2' HG13 ' A' ' 21' ' ' VAL . 8.8 mmmt -72.93 -31.41 64.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.88 0.371 . . . . 0.0 110.548 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 21' ' ' VAL . 87.5 mt -96.85 130.4 44.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -139.44 134.06 31.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.039 HD13 HG22 ' A' ' 49' ' ' ILE . 50.1 mm -46.49 144.32 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 111.798 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.09 13.25 57.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.8 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.7 m-20 -108.56 160.0 16.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.684 0.278 . . . . 0.0 110.698 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -115.06 119.17 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -90.42 113.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.812 ' CE ' HD13 ' A' ' 44' ' ' LEU . 24.3 mmt -72.98 -66.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.709 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 86.4 p -134.42 160.31 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.719 HD12 HD21 ' A' ' 78' ' ' LEU . 3.3 mt -118.5 111.11 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.73 28.89 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.11 -30.14 5.54 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.222 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 89' ' ' ILE . 11.1 m -78.26 99.98 6.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.465 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 67.3 m -84.8 137.49 33.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.638 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.743 ' HA ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -128.76 24.77 5.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.879 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.6 t -75.64 93.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.005 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.09 -18.78 4.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.143 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.68 163.19 33.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.982 0.391 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.05 -179.28 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.803 2.335 . . . . 0.0 112.417 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 tp -78.13 -44.62 25.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.24 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -53.14 -42.55 66.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.2 m -63.73 -47.8 79.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.715 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.514 ' SG ' HD13 ' A' ' 78' ' ' LEU . 77.0 m -55.76 -57.48 11.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.358 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.548 ' NE2' HG21 ' B' ' -2' ' ' VAL . 5.8 pt20 -49.77 -39.95 39.7 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.508 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 16.7 t -62.45 -36.61 82.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.26 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 76' ' ' THR . 2.1 mm -58.84 -49.73 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.347 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.041 HG21 HD13 ' B' ' 0' ' ' ILE . 54.6 mt -69.4 -50.45 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.131 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.62 -22.01 55.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.881 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.15 -30.31 59.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 89' ' ' ILE . 1.1 pp -104.38 35.32 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 111.062 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.82 -5.92 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.592 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -96.08 35.69 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.682 0.277 . . . . 0.0 111.73 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.53 170.67 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.737 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 t -99.18 -8.74 24.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.855 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.4 ttm180 -139.6 140.03 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 93' ' ' LEU . 13.9 t -130.51 106.1 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.643 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.483 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 7.9 tttt -88.13 131.8 34.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.68 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -142.07 117.9 10.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.002 0.43 . . . . 0.0 111.448 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.31 89.66 8.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -111.67 166.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.913 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 69' ' ' GLN . 6.3 p -109.07 122.78 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.638 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 -179.601 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.484 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.3 Cg_endo . . . . . 0 N--CA 1.464 -0.216 0 CA-C-O 120.789 0.245 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 87' ' ' GLN . 5.0 m -58.17 142.7 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 0.5 OUTLIER -119.56 115.91 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.044 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.904 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.582 ' C ' HG13 ' A' ' 104' ' ' VAL . 3.2 tp10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.428 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 4.9 m-85 -61.75 148.68 42.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.06 126.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.171 0.51 . . . . 0.0 111.805 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.66 133.01 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.938 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 63' ' ' LYS . 18.9 t -116.29 111.41 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.253 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.749 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.37 115.72 31.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.5 mm -114.86 99.4 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.862 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -88.81 128.31 35.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.327 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.556 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -157.44 -166.83 2.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.58 167.43 10.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.87 157.64 17.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.0 110.736 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.92 11.1 73.79 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.542 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -123.96 32.51 5.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.258 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.775 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 10.64 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.154 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.67 ' CD1' HG21 ' A' ' 23' ' ' ILE . 59.1 tp 177.35 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.709 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.62 63.51 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.702 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.45 156.46 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 40.9 t -122.16 117.28 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.56 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -106.18 147.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.471 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.8 m -140.38 169.71 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' O ' HD11 ' A' ' 48' ' ' ILE . 6.5 mt-10 -63.18 129.37 40.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.927 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.51 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.2 p -71.12 83.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.98 -3.56 89.08 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.695 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.876 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.56 -163.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.698 0.285 . . . . 0.0 110.603 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.24 -24.69 7.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.811 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.52 35.38 0.07 Allowed 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.182 0.515 . . . . 0.0 111.562 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.876 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.2 mt -49.1 -39.34 12.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.765 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -148.31 111.69 3.74 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.019 178.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' GLY . 34.8 Cg_exo -59.71 98.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.096 1.864 . . . . 0.0 112.62 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -152.57 -155.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.009 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -106.25 165.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.71 130.53 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.068 HG22 HD13 ' A' ' 66' ' ' ILE . 69.0 mt -71.42 93.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.94 -5.06 53.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.114 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -163.03 164.3 25.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -160.79 132.13 5.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 8.2 mtm -69.3 101.97 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.343 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.84 78.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.26 -30.69 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.164 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.37 -176.1 38.3 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.099 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 34.4 Cg_exo -59.75 -16.55 38.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.594 2.196 . . . . 0.0 112.712 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.24 -50.26 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -32.7 49.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.349 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.26 -47.15 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.287 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -56.54 -69.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.28 22.97 7.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.126 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.771 ' CB ' HG13 ' A' ' 21' ' ' VAL . 8.7 mtpp -107.88 -33.0 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.753 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.763 ' HG ' HG11 ' A' ' 21' ' ' VAL . 54.0 mt -96.03 123.21 39.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.664 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -127.49 133.32 49.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.593 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.068 HD13 HG22 ' A' ' 49' ' ' ILE . 46.6 mm -45.46 141.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.97 15.07 56.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.214 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.938 ' HB3' HD12 ' A' ' 103' ' ' ILE . 98.1 m-20 -101.42 164.63 11.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.779 0.324 . . . . 0.0 110.695 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.523 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 5.2 mm100 -120.32 115.17 23.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -89.06 117.78 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.56 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.5 -64.28 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.376 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.4 t -132.24 146.17 51.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.821 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -117.11 111.3 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.559 HD22 HD22 ' A' ' 93' ' ' LEU . 89.1 m-20 60.92 25.93 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.09 -28.59 11.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.618 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 1.054 HG21 HD12 ' A' ' 89' ' ' ILE . 86.4 m -63.9 96.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.076 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -74.41 117.97 16.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.722 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.795 HD21 HD12 ' A' ' 73' ' ' ILE . 1.2 pp -125.03 27.71 6.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' THR . 24.8 t -74.6 80.22 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 139.23 -13.28 3.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.779 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -83.11 157.8 65.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 110.819 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.1 -174.93 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.577 2.185 . . . . 0.0 111.891 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.5 tp -78.31 -39.95 38.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.699 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.3 p -53.71 -44.69 70.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.349 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.9 m -63.95 -52.97 57.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.859 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 78' ' ' LEU . 73.5 m -55.74 -52.15 64.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.769 0.318 . . . . 0.0 111.002 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.449 ' OE1' HG11 ' B' ' -2' ' ' VAL . 19.2 mt-30 -49.71 -42.62 46.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.021 0.439 . . . . 0.0 109.896 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.3 m -60.9 -36.86 80.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.271 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.054 HD12 HG21 ' A' ' 76' ' ' THR . 14.7 mm -58.98 -49.37 83.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.398 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.133 HG21 HD13 ' B' ' 0' ' ' ILE . 34.6 mt -72.59 -49.96 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.46 -20.33 54.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.895 0.378 . . . . 0.0 110.956 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.38 -28.49 67.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.362 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.4 pp -106.92 57.67 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.7 -30.58 29.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.104 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -96.57 37.47 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -100.69 144.05 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.019 0.438 . . . . 0.0 111.353 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.9 p -96.63 -5.77 38.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.576 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.749 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 10.8 ttm180 -157.0 137.79 13.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.245 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.556 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 2.5 t -132.01 123.87 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -100.8 128.48 46.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.627 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.821 HD23 HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -139.37 116.66 11.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 111.931 -179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.05 93.02 9.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.938 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.6 pt -116.34 168.87 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.984 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.582 HG13 ' C ' ' A' ' 17' ' ' GLU . 37.3 t -115.05 119.44 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.544 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 91.1 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 CA-C-O 120.818 0.258 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.449 HG11 ' OE1' ' A' ' 87' ' ' GLN . 9.1 p -64.17 142.81 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 34' ' ' VAL . 4.7 m-85 -112.31 135.69 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.133 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.99 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' C ' HG23 ' A' ' 104' ' ' VAL . 4.3 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.458 ' N ' HG23 ' A' ' 104' ' ' VAL . 7.8 m-85 -65.14 154.52 37.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.17 125.15 3.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 111.734 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.87 101.94 4.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.407 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.843 HG11 ' HG ' ' A' ' 64' ' ' LEU . 15.8 t -83.54 139.3 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.91 104.91 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.527 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.627 HG13 HD21 ' A' ' 31' ' ' LEU . 11.1 mm -103.42 99.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.21 109.98 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.319 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 -174.35 4.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -107.52 176.38 5.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.601 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 155.72 39.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.04 13.97 65.16 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.497 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 30' ' ' ILE . 5.5 mt-10 -125.45 31.19 5.6 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.157 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.61 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 9.83 -78.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.288 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER 173.39 -43.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.757 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.56 60.53 1.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.664 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.02 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -144.92 155.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' O ' ' B' ' -2' ' ' VAL . 88.4 t -123.62 129.37 74.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.744 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.94 153.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.632 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.6 m -141.93 169.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.838 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.2 mt-10 -61.72 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.491 ' HA ' HD11 ' A' ' 48' ' ' ILE . 88.5 p -68.37 84.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.507 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.21 -3.73 87.02 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.801 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.61 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.616 0.246 . . . . 0.0 110.443 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.96 -24.28 6.23 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.766 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 82.16 38.71 0.05 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.327 0.584 . . . . 0.0 111.277 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.769 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.4 mt -54.15 -34.99 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.792 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -152.01 104.41 2.82 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.16 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 61.9 Cg_exo -52.14 84.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.516 2.144 . . . . 0.0 113.14 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -133.72 -154.65 0.61 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -108.12 167.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.5 125.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.993 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -65.18 91.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -8.11 55.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.123 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.533 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -166.26 161.02 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 111.344 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -155.65 142.71 19.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.597 ' CE ' HD11 ' A' ' 30' ' ' ILE . 7.2 mtt -52.66 -25.01 9.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.66 47.75 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.802 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.97 -39.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.05 -169.59 1.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.278 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.19 -23.91 56.14 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.644 2.229 . . . . 0.0 112.196 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -62.65 -49.31 75.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -76.99 -39.02 51.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -50.89 -47.1 60.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.43 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -60.45 -51.95 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.831 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.08 55.62 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mtmt -69.06 -35.27 76.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.843 ' HG ' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -88.03 113.65 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -127.92 135.23 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 49' ' ' ILE . 26.0 mm -46.27 145.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 0.0 111.752 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.45 64.66 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.876 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.856 ' HB3' HD12 ' A' ' 103' ' ' ILE . 3.0 m-20 -106.38 163.43 12.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.902 0.351 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -114.68 121.47 43.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.708 HG23 HG22 ' A' ' 103' ' ' ILE . 7.7 mt -91.17 112.64 25.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.444 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.626 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -77.51 -63.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 t -133.16 154.09 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.935 ' CD1' HD11 ' A' ' 78' ' ' LEU . 4.4 mt -126.18 104.13 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.83 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.526 HD22 HG22 ' A' ' 73' ' ' ILE . 50.9 m-80 60.02 24.13 13.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.74 -33.31 4.99 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.926 HG21 HD12 ' A' ' 89' ' ' ILE . 3.9 m -65.2 98.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.586 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -70.21 106.8 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.935 HD11 ' CD1' ' A' ' 73' ' ' ILE . 25.8 mt -79.89 -31.23 40.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.3 p -52.75 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.78 -27.8 2.18 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.267 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.744 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -98.72 159.73 29.66 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.887 0.375 . . . . 0.0 111.427 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 -172.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.837 2.358 . . . . 0.0 112.537 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.5 tp -77.27 -46.22 23.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.192 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 39.6 m -53.16 -42.41 66.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 110.506 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.707 HG22 HD13 ' A' ' 81' ' ' LEU . 85.1 m -64.52 -48.72 74.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.637 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 76.2 m -55.63 -57.22 12.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.7 pt20 -48.98 -42.51 37.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -61.15 -35.15 76.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.269 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 76' ' ' THR . 8.6 mm -58.91 -49.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.026 HG21 HD13 ' B' ' 0' ' ' ILE . 31.2 mt -72.1 -46.45 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.4 mttm -55.44 -23.99 28.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -42.49 43.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.037 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 0.8 OUTLIER -92.47 56.35 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.21 -27.52 22.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.511 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -94.93 35.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.485 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 4.3 mt-30 -102.24 150.6 23.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.416 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.0 p -91.87 -13.8 30.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.616 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -148.65 137.83 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.339 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 31' ' ' LEU . 14.4 t -122.15 104.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.896 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.53 126.28 35.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.837 179.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.886 0.374 . . . . 0.0 110.965 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -123.73 90.43 3.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -109.36 170.86 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.623 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.2 p -122.81 127.98 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.292 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.411 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' -3' ' ' PRO . . . . . 0.731 ' HG2' HG21 ' A' ' 34' ' ' VAL . 67.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.782 0.242 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' -2' ' ' VAL . . . . . 0.782 ' O ' HG22 ' A' ' 34' ' ' VAL . 30.4 m -57.73 119.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' -1' ' ' TYR . . . . . 0.592 ' CE1' HG23 ' A' ' 34' ' ' VAL . 19.6 m-85 -110.67 142.69 42.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.364 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 0' ' ' ILE . . . . . 1.026 HD13 HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' C ' HG13 ' A' ' 104' ' ' VAL . 1.7 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.359 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.3 m-85 -69.45 150.96 46.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.21 127.9 3.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.793 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.6 104.64 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.407 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.839 HG11 ' HG ' ' A' ' 64' ' ' LEU . 13.8 t -82.78 142.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HE1' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.96 104.34 6.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.234 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 31' ' ' LEU . 15.4 mm -106.63 99.67 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.451 . . . . 0.0 111.263 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' CB ' ' HD3' ' A' ' 98' ' ' ARG . 1.9 mp0 -85.72 109.89 18.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.262 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.49 -166.61 2.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 111.069 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.99 163.56 18.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -58.07 161.64 3.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.64 11.48 62.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' LEU . 48.2 mt-10 -126.45 34.39 4.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.853 0.326 . . . . 0.0 110.406 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -78.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.083 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' GLU . 31.7 tp 176.51 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.819 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.34 62.62 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.575 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.983 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.98 157.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.05 0.452 . . . . 0.0 111.935 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.685 HG21 ' HG2' ' B' ' -3' ' ' PRO . 43.9 t -122.34 129.25 75.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.369 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.82 152.85 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.959 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' HD11 ' A' ' 83' ' ' LEU . 27.1 m -146.27 166.67 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.072 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' O ' HD11 ' A' ' 48' ' ' ILE . 39.9 mt-10 -57.85 132.06 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.4 p -72.74 83.81 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.451 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.81 -4.73 90.24 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.961 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.67 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.668 0.27 . . . . 0.0 110.515 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.59 -25.21 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.825 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 81.79 48.03 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.486 0.66 . . . . 0.0 111.248 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.758 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.9 mt -63.55 -35.99 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.536 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.865 HD13 ' HE1' ' A' ' 71' ' ' MET . 0.5 OUTLIER -149.34 110.3 3.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.797 178.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.7 Cg_endo -56.47 84.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.188 1.925 . . . . 0.0 112.483 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.24 -154.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.386 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -109.0 163.59 6.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.682 0.277 . . . . 0.0 110.907 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -122.2 130.34 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.049 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -70.0 90.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.02 -14.45 47.33 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.613 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -157.64 159.65 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.063 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -151.92 139.28 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.481 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.717 ' CE ' HD11 ' A' ' 30' ' ' ILE . 6.7 mtm -74.97 96.13 3.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.371 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -62.46 79.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.42 -29.49 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.218 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.65 -166.34 15.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.171 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.3 Cg_endo -69.12 -16.46 40.26 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.569 2.179 . . . . 0.0 112.422 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.07 50.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.028 0.442 . . . . 0.0 110.705 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -34.89 56.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.532 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -58.99 -47.25 85.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 t -62.5 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.46 -28.18 12.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.884 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' CB ' HG13 ' A' ' 21' ' ' VAL . 11.9 mtpp -58.17 -26.28 62.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.839 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.3 mt -101.92 126.28 48.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.487 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.8 OUTLIER -141.75 140.26 33.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.049 HD13 HG22 ' A' ' 49' ' ' ILE . 27.2 mm -48.72 146.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.54 59.57 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.813 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.9 m-20 -105.2 152.64 22.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.797 0.332 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -107.48 115.54 30.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.7 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -86.42 125.07 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.065 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.865 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -90.03 -63.24 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.299 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.8 p -139.47 145.77 39.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.376 . . . . 0.0 111.417 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.0 mt -115.42 116.26 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.1 m-80 55.25 27.65 10.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.346 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.57 -28.2 12.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.804 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.927 HG21 HG23 ' A' ' 89' ' ' ILE . 3.1 m -65.95 99.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.791 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.7 m -67.69 125.23 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.6 mt -105.19 -20.72 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -57.98 85.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.498 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.91 -41.84 1.1 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.117 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.869 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -77.45 159.86 76.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.419 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.81 -168.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.884 2.389 . . . . 0.0 112.687 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.23 -49.94 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.284 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.0 t -52.74 -39.98 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.526 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.869 HG22 HD13 ' A' ' 81' ' ' LEU . 97.6 m -63.15 -49.48 74.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.552 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.2 m -57.84 -48.19 80.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.422 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.1 mt-30 -50.38 -44.16 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.079 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 25.5 m -60.97 -37.41 82.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.534 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 76' ' ' THR . 14.1 mm -58.51 -49.67 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.769 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.8 mt -73.94 -50.52 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.19 -23.98 38.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.796 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -40.12 90.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.208 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.4 pp -93.74 48.19 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 110.92 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.46 -7.07 51.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.555 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -120.2 34.32 5.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.315 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -92.43 155.92 17.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.239 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 t -108.04 -9.71 15.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.126 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.9 tpp85 -154.42 114.31 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.374 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.635 ' CG1' HD21 ' A' ' 101' ' ' LEU . 12.7 t -99.31 104.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.558 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -92.66 97.66 10.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -107.02 154.57 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 111.155 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -124.12 86.85 2.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.0 pt -111.74 169.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.304 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.658 HG22 ' CG ' ' A' ' 18' ' ' PHE . 27.3 t -118.05 111.08 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.909 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.647 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.685 ' HG2' HG21 ' A' ' 34' ' ' VAL . 89.1 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 N-CA-C 112.784 0.263 . . . . 0.0 112.784 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 54.6 99.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.799 0.333 . . . . 0.0 111.426 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 34' ' ' VAL . 49.0 m-85 -90.76 137.99 31.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.9 pp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.78 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.0 tp10 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CD1' HG13 ' A' ' 104' ' ' VAL . 4.0 m-85 -58.25 143.87 42.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 125.63 3.35 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 111.487 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.27 104.65 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.466 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 ' HG ' ' A' ' 64' ' ' LEU . 17.6 t -85.76 141.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.103 0.477 . . . . 0.0 111.435 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -132.28 104.7 6.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.323 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 31' ' ' LEU . 8.8 mm -106.66 99.68 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.353 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -79.54 109.87 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.93 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 4.9 pttm -133.13 -170.4 2.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.968 0.414 . . . . 0.0 111.38 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -121.26 170.32 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.231 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.51 162.07 16.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.937 0.398 . . . . 0.0 110.74 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.52 20.09 50.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.302 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 31' ' ' LEU . 51.3 mt-10 -132.14 31.94 4.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.249 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 14.11 -81.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.307 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 23' ' ' ILE . 20.4 tp 177.75 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.221 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 83.75 59.45 2.1 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.575 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -147.9 156.97 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.471 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 51' ' ' ASN . 39.2 t -125.22 123.75 65.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.109 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.484 HD12 HG11 ' A' ' 47' ' ' VAL . 1.9 pt -114.02 145.66 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.28 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.692 ' HA ' HD11 ' A' ' 83' ' ' LEU . 34.7 m -138.11 166.76 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' HD11 ' A' ' 48' ' ' ILE . 31.6 mt-10 -55.87 133.76 51.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 23.2 p -76.16 83.57 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.463 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -80.34 -7.26 88.71 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.036 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.955 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.36 -162.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.499 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.29 8.24 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.871 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.42 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.68 49.25 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.643 0.735 . . . . 0.0 111.19 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.955 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.5 mt -59.56 -40.6 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.771 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.965 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -150.61 87.87 4.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.004 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.66 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.163 2.575 . . . . 0.0 113.63 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.86 -92.87 0.17 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.953 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.14 167.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.61 129.93 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.052 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.093 HG22 HD13 ' A' ' 66' ' ' ILE . 66.7 mt -68.5 94.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.43 -2.42 54.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.33 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.475 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -169.88 159.94 8.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.6 mtm -158.94 138.61 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.433 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.688 ' CE ' HD11 ' A' ' 30' ' ' ILE . 19.7 mtm -72.95 105.16 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.17 74.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.91 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.53 -33.56 0.17 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.946 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.95 -179.19 32.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.941 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 31.4 Cg_exo -58.93 -16.47 32.3 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.464 2.11 . . . . 0.0 112.601 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.01 53.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 110.813 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -36.98 55.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.497 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -57.73 -46.85 83.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.458 ' CB ' HD13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -63.14 -65.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.33 -23.19 29.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.387 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.754 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -56.88 -35.52 69.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.854 ' HG ' HG11 ' A' ' 21' ' ' VAL . 6.9 mt -97.61 118.06 33.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -129.09 141.06 51.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG22 ' A' ' 49' ' ' ILE . 48.2 mm -47.57 143.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 111.832 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.66 11.38 58.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.592 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.877 ' HB3' HD12 ' A' ' 103' ' ' ILE . 64.9 m-20 -101.59 161.38 13.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.564 ' HB2' HG23 ' A' ' 104' ' ' VAL . 1.9 mm100 -119.99 97.99 5.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 103' ' ' ILE . 3.4 mt -67.6 143.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.574 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.869 ' CE ' HD13 ' A' ' 44' ' ' LEU . 12.3 mmt -111.94 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -125.61 138.35 53.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 111.445 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.869 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.5 mt -112.79 108.32 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.654 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.602 ' ND2' HD22 ' A' ' 93' ' ' LEU . 90.1 m-20 59.69 21.17 9.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.164 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.96 -34.45 4.47 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.596 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -66.69 104.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.747 0.308 . . . . 0.0 111.116 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 p -68.13 146.59 53.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD11 ' CD1' ' A' ' 73' ' ' ILE . 13.9 mt -120.02 -28.41 5.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.308 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.2 p -56.72 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.56 -21.87 2.71 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.305 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -100.86 162.41 20.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.983 0.391 . . . . 0.0 111.543 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 44.9 Cg_endo -66.8 -171.65 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.045 2.496 . . . . 0.0 112.584 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.45 -50.47 11.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.37 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 p -52.99 -36.51 60.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.713 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' ILE . 77.5 m -66.87 -50.81 61.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.56 -49.75 73.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 110.707 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.514 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.4 mt-30 -50.33 -49.48 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.462 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 3.2 t -55.04 -37.95 67.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 76' ' ' THR . 23.5 mm -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.175 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.046 HG21 HD13 ' B' ' 0' ' ' ILE . 22.5 mt -67.68 -50.23 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.462 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.03 -20.0 62.01 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.85 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.46 -19.18 70.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.485 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 73' ' ' ILE . 2.2 pp -116.33 51.83 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 110.948 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.0 tttt -78.48 -30.74 47.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -97.75 32.6 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -95.9 155.88 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.016 0.436 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -104.26 -12.84 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.0 tpp85 -148.5 126.75 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.741 HG12 HD21 ' A' ' 101' ' ' LEU . 18.9 t -110.42 104.79 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -91.28 127.69 36.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.583 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -140.36 154.81 46.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.026 0.441 . . . . 0.0 111.211 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 91.4 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.877 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -114.9 172.61 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.125 0.488 . . . . 0.0 112.309 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -113.23 119.02 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.979 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.456 ' CG ' HG21 ' A' ' 34' ' ' VAL . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.914 0.297 . . . . 0.0 112.282 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.44 HG22 ' O ' ' B' ' -2' ' ' VAL . 10.7 p -99.57 -10.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.46 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.456 ' CD2' ' HG3' ' A' ' 53' ' ' MET . 26.2 m-85 62.78 167.13 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.376 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.046 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.791 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.76 ' CD1' HG22 ' A' ' 104' ' ' VAL . 1.6 m-85 -62.81 153.22 33.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.994 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.69 124.45 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.0 111.517 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.91 102.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.185 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.7 ' HB ' HD12 ' A' ' 101' ' ' LEU . 37.3 t -88.15 112.32 23.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -106.3 113.52 27.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.699 HD13 ' OG ' ' A' ' 61' ' ' SER . 16.0 mm -111.37 99.85 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.468 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.87 124.64 29.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -157.09 -172.07 3.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.255 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -111.47 176.83 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.655 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -72.99 157.03 38.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.742 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.52 11.05 67.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.615 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 31' ' ' LEU . 16.9 mt-10 -124.32 32.84 5.4 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.285 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.752 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 14.4 -80.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.994 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 23' ' ' ILE . 5.1 tp 174.43 -49.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.297 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.37 69.79 1.12 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.79 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.03 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -154.06 155.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 117.01 0.405 . . . . 0.0 111.656 178.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' B' ' -3' ' ' PRO . 55.1 t -118.72 128.94 75.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.505 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.568 ' O ' HD21 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -119.7 141.82 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.34 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 83' ' ' LEU . 32.7 m -136.51 163.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HD11 ' A' ' 48' ' ' ILE . 14.4 mt-10 -50.96 134.81 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.468 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.1 p -78.17 83.66 4.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.596 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.09 -7.65 88.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.946 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.839 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.63 -161.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.429 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.75 -25.98 7.52 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.717 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.76 33.58 0.07 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.839 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.7 mt -47.34 -40.86 6.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.034 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -146.72 97.2 4.29 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.08 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 12.2 Cg_endo -56.11 91.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.551 2.167 . . . . 0.0 113.097 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.796 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.61 -91.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.063 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -160.3 167.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.787 0.327 . . . . 0.0 111.362 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.9 130.52 68.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.789 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.058 HG22 HD13 ' A' ' 66' ' ' ILE . 49.5 mt -69.16 88.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.52 -13.0 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.785 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.59 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -159.83 160.31 33.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.751 0.31 . . . . 0.0 110.888 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 ttp -147.82 134.1 19.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.03 0.443 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.425 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -70.48 83.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.569 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CG ' ' HG2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -56.24 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 163.32 -28.21 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.409 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.74 -165.36 39.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.08 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.1 Cg_endo -69.11 -16.31 40.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.506 2.137 . . . . 0.0 112.477 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -49.39 73.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.727 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' CG ' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -77.76 -37.09 49.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -63.69 -41.37 98.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.23 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.699 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -46.45 -71.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.254 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.05 15.72 10.45 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.802 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.37 -32.1 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.918 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.683 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.5 mt -85.61 126.9 34.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.65 129.92 23.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.058 HD13 HG22 ' A' ' 49' ' ' ILE . 24.9 mm -45.02 143.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.944 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 11.94 55.01 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.736 ' CB ' HD12 ' A' ' 103' ' ' ILE . 3.1 m-20 -107.03 159.83 16.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 1.2 mm100 -113.85 114.55 26.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.901 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -84.9 136.02 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.613 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 30.6 mmt -96.06 -69.12 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 24.3 p -132.39 146.68 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.69 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.79 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -120.17 120.1 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.776 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 61.01 19.42 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.332 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 -27.47 10.85 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.792 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.762 HG21 HD12 ' A' ' 89' ' ' ILE . 3.0 m -71.23 111.6 6.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.943 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.519 ' O ' HD21 ' A' ' 81' ' ' LEU . 22.1 p -76.17 142.48 41.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.311 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HA ' HD21 ' A' ' 81' ' ' LEU . 65.9 mt -111.12 -20.65 12.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.161 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.402 HG22 ' SD ' ' A' ' 71' ' ' MET . 16.7 t -59.98 92.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.409 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.98 -22.15 3.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.469 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.616 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -102.04 161.05 24.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 111.481 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 81' ' ' LEU . 57.8 Cg_endo -69.16 -167.49 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.0 112.572 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -78.1 -50.15 12.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.268 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -52.4 -38.22 58.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 HD13 ' A' ' 81' ' ' LEU . 36.3 m -64.39 -49.16 72.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.519 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.29 -51.6 69.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.771 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' HG11 ' B' ' -2' ' ' VAL . 56.8 mt-30 -49.63 -39.88 37.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 2.8 m -64.96 -37.95 89.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.659 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.762 HD12 HG21 ' A' ' 76' ' ' THR . 23.9 mm -58.65 -49.97 80.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.022 HG21 HD13 ' B' ' 0' ' ' ILE . 38.1 mt -72.94 -49.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -57.4 -22.82 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.452 . . . . 0.0 110.741 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.51 -39.33 61.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.171 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -94.83 46.16 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.752 ' CD ' HG23 ' A' ' 30' ' ' ILE . 21.1 ttpp -76.73 -36.01 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -88.79 51.57 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.123 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -111.24 172.37 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.393 0.616 . . . . 0.0 111.573 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.6 p -113.99 -7.1 13.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.656 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.791 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.2 ttm180 -161.94 150.43 15.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 31' ' ' LEU . 4.0 t -133.09 113.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.65 130.96 38.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 HG23 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -140.06 154.92 47.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.3 90.72 3.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.901 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -113.63 172.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.45 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.76 HG22 ' CD1' ' A' ' 18' ' ' PHE . 24.3 t -111.73 119.93 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.625 ' HB2' HG11 ' A' ' 34' ' ' VAL . 68.0 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 CA-C-O 120.724 0.218 . . . . 0.0 112.385 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.666 HG11 ' OE1' ' A' ' 87' ' ' GLN . 18.4 t -59.55 136.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.575 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -120.31 138.68 53.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.03 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.841 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.637 ' HZ ' HD22 ' A' ' 44' ' ' LEU . 2.2 m-85 -58.94 151.57 21.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.815 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 129.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.95 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.8 122.73 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.744 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.914 HG13 ' CB ' ' A' ' 63' ' ' LYS . 44.3 t -106.68 111.48 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -107.84 114.91 29.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 99' ' ' VAL . 19.9 mm -114.16 99.25 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 112.48 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.949 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.71 -170.81 2.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.336 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -117.46 158.23 24.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.522 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HG3' ' CA ' ' A' ' 95' ' ' ASN . 8.6 mptt -58.38 145.89 36.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.947 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.51 18.45 79.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.382 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -129.19 29.1 5.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.137 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG23 ' CD ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 19.17 -82.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.123 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . 15.3 tp 179.24 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.916 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.447 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.45 62.53 1.63 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.598 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.067 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.22 155.9 7.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.966 0.413 . . . . 0.0 111.433 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' -3' ' ' PRO . 30.7 t -123.67 116.35 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.791 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -104.46 146.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.259 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.852 ' HA ' HD12 ' A' ' 83' ' ' LEU . 30.0 m -135.66 167.3 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 48' ' ' ILE . 2.0 mt-10 -56.08 131.19 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 51.4 p -74.25 84.49 1.89 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.539 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -82.7 -6.7 88.26 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.917 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.11 -163.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.714 0.292 . . . . 0.0 110.287 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.38 -26.38 6.92 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.798 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 p 80.0 51.7 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.801 0.81 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 82.3 mt -61.18 -41.75 90.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.774 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.976 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -149.2 81.53 7.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.103 178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -35.35 90.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.536 2.824 . . . . 0.0 114.136 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.976 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -136.41 -96.43 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.149 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -156.14 167.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-O 120.687 0.279 . . . . 0.0 111.05 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.14 128.68 62.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.035 HG22 HD13 ' A' ' 66' ' ' ILE . 52.4 mt -67.78 90.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.45 -8.88 55.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.158 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.589 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.4 t-20 -162.01 159.81 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.006 0.431 . . . . 0.0 111.405 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 13.4 ttm -152.0 148.11 27.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.7 mtt -56.07 -22.41 27.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 61.09 47.26 7.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.63 -34.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.134 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.63 -171.18 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.11 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 51.0 Cg_exo -54.02 -24.83 34.01 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.428 2.085 . . . . 0.0 112.408 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.71 70.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.001 0.429 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -39.38 44.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.709 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -53.26 -47.23 69.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.44 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -56.32 5.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.06 -16.8 53.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.066 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.914 ' CB ' HG13 ' A' ' 21' ' ' VAL . 25.1 mmmt -57.3 -30.08 64.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.368 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HG11 ' A' ' 21' ' ' VAL . 26.0 mt -103.12 134.68 46.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -144.15 128.19 17.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.035 HD13 HG22 ' A' ' 49' ' ' ILE . 30.5 mm -44.1 142.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.125 0.488 . . . . 0.0 111.891 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.31 18.37 46.22 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.464 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.827 ' HB3' HD12 ' A' ' 103' ' ' ILE . 78.9 m-20 -112.31 164.8 12.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.756 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -118.65 116.49 26.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.176 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.724 HG23 HG22 ' A' ' 103' ' ' ILE . 5.6 mt -85.87 143.99 10.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.219 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.798 ' CE ' HD13 ' A' ' 44' ' ' LEU . 8.3 mmt -112.17 -67.52 0.99 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 132.11 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 111.692 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.876 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.3 mt -115.96 114.18 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 58.51 23.86 11.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.4 -35.5 4.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.672 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.72 HG21 HG23 ' A' ' 89' ' ' ILE . 3.7 m -68.63 117.1 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.356 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.54 154.17 34.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.876 HD11 ' CD1' ' A' ' 73' ' ' ILE . 61.9 mt -121.49 -37.58 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -53.23 91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.303 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.32 -24.84 2.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.117 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -103.6 160.95 24.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 111.406 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.37 -169.6 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.859 2.372 . . . . 0.0 112.726 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.18 -47.74 17.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.816 ' N ' HD23 ' A' ' 83' ' ' LEU . 17.8 m -53.15 -42.06 65.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.451 . . . . 0.0 110.446 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.653 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.9 m -65.05 -49.28 70.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.764 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.418 ' HA ' HD22 ' A' ' 78' ' ' LEU . 90.2 m -55.76 -56.2 23.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.324 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' NE2' HD21 ' A' ' 83' ' ' LEU . 27.9 mt-30 -48.88 -46.11 42.13 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 110.14 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.93 -36.93 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.556 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 HG21 ' A' ' 76' ' ' THR . 24.8 mm -57.99 -49.95 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.973 HG21 HD13 ' B' ' 0' ' ' ILE . 44.0 mt -71.25 -43.71 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.7 ' HG3' HG22 ' B' ' 0' ' ' ILE . 8.7 mttp -54.96 -24.86 25.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.88 -45.43 42.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.337 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -85.95 58.86 5.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.912 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.559 ' CD ' HG23 ' A' ' 30' ' ' ILE . 22.1 ttpp -87.37 -31.34 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.273 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.406 ' CA ' ' HG3' ' A' ' 27' ' ' LYS . 71.1 m-80 -113.8 65.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.337 . . . . 0.0 111.595 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.4 mm100 -118.95 -28.45 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t 75.44 5.87 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.994 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.9 ttm180 -165.07 127.48 2.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.062 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.01 126.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 0.0 111.932 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -108.71 108.87 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -127.37 117.58 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.228 0.537 . . . . 0.0 112.356 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 90.77 8.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.977 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.4 pt -109.02 171.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.068 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.4 p -115.38 131.6 67.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.725 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 73.8 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.755 0.231 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 11.3 t -58.41 150.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.855 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -117.86 138.06 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.327 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.067 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.596 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' C ' HG13 ' A' ' 104' ' ' VAL . 9.3 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.996 0.426 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.8 m-85 -67.73 154.28 41.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.648 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -166.83 126.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.512 . . . . 0.0 112.13 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 106.44 3.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.062 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.2 t -93.29 104.25 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.128 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.87 104.78 15.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.663 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -102.55 99.29 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.29 109.82 9.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -130.36 -177.23 4.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.595 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -113.86 168.88 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.82 155.09 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.923 0.392 . . . . 0.0 110.698 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.6 15.14 73.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.469 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -129.45 32.8 4.6 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.942 0.401 . . . . 0.0 110.248 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.59 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 13.74 -80.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.273 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.953 HD13 HG21 ' A' ' 99' ' ' VAL . 13.6 tp 175.67 -45.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.789 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 53' ' ' MET . . . 85.38 63.63 1.56 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.609 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 HD11 ' B' ' 0' ' ' ILE . 1.0 OUTLIER -153.28 155.81 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 111.323 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.63 HG21 ' HG2' ' B' ' -3' ' ' PRO . 46.5 t -123.5 129.02 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.5 pt -114.53 144.22 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.774 ' HA ' HD22 ' A' ' 83' ' ' LEU . 27.1 m -137.13 165.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' O ' HD11 ' A' ' 48' ' ' ILE . 7.1 mt-10 -54.47 133.83 45.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.448 ' HA ' HG12 ' A' ' 48' ' ' ILE . 52.4 p -76.28 83.08 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.451 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.68 -4.45 90.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.707 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.898 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.75 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.22 -26.66 6.7 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.667 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.436 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.78 44.98 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.501 0.667 . . . . 0.0 111.56 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.898 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 70.1 mt -59.15 -35.02 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.49 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.799 ' O ' HG22 ' A' ' 46' ' ' THR . 85.0 mt -155.65 96.32 2.4 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.029 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.3 91.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.653 2.235 . . . . 0.0 113.497 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.11 -90.15 0.33 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.69 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.66 167.58 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.879 0.371 . . . . 0.0 111.463 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -131.84 129.56 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.629 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.051 HG22 HD13 ' A' ' 66' ' ' ILE . 66.6 mt -68.57 89.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.4 -15.77 45.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.049 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.643 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -154.38 158.99 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.729 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.8 ttp -149.2 137.45 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.534 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -53.42 -24.63 13.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.351 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m80 60.61 46.4 9.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.494 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.63 -38.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.051 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -174.01 2.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.942 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.8 Cg_exo -53.78 -24.07 29.24 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.357 2.038 . . . . 0.0 112.313 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.416 ' HB1' ' SD ' ' A' ' 52' ' ' MET . . . -65.68 -49.12 69.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 110.733 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.2 -39.0 50.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.524 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -55.8 -47.15 77.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 t -65.15 -64.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.783 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.9 -24.34 19.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.5 mtpt -58.15 -25.53 61.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.788 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -103.41 131.61 50.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -144.06 133.93 23.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.419 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.051 HD13 HG22 ' A' ' 49' ' ' ILE . 26.7 mm -44.91 142.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.004 0.431 . . . . 0.0 111.924 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.56 13.53 47.36 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.662 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.844 ' HB3' HD12 ' A' ' 103' ' ' ILE . 66.4 m-20 -102.88 162.43 12.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 2.3 mm100 -119.24 98.11 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.777 HG23 HG22 ' A' ' 103' ' ' ILE . 3.5 mt -71.97 143.84 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.618 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.712 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 15.2 mmt -108.97 -69.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.849 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.84 142.03 51.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.337 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.808 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.7 mt -115.35 106.95 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.78 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 58.15 26.39 13.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.06 -36.43 3.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.997 HG21 HD12 ' A' ' 89' ' ' ILE . 3.2 m -67.78 107.74 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.43 ' O ' HD21 ' A' ' 81' ' ' LEU . 10.9 t -72.71 148.7 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.081 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.808 HD11 ' CD1' ' A' ' 73' ' ' ILE . 62.6 mt -118.49 -12.44 9.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.516 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' SD ' ' A' ' 71' ' ' MET . 14.2 t -69.99 101.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.677 0.275 . . . . 0.0 111.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.28 6.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.29 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -104.4 158.12 32.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.011 0.405 . . . . 0.0 111.421 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.69 -172.07 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.945 2.43 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 36' ' ' VAL . 12.1 tp -78.12 -44.34 26.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -41.1 65.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.083 0.468 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 81' ' ' LEU . 56.6 m -64.26 -52.77 57.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.435 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.2 m -56.58 -50.03 73.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.402 ' NE2' ' HG ' ' A' ' 83' ' ' LEU . 9.9 mt-30 -50.19 -42.87 52.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 109.962 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -61.12 -37.21 81.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.997 HD12 HG21 ' A' ' 76' ' ' THR . 17.6 mm -58.83 -49.84 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.61 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.821 HG21 HD13 ' B' ' 0' ' ' ILE . 22.3 mt -68.98 -50.32 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.51 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -56.4 -25.1 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.996 0.427 . . . . 0.0 110.765 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.83 -46.27 90.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.969 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -88.79 66.92 8.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 110.659 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -40.88 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.357 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -88.87 50.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.292 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.72 150.4 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 111.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 p -92.32 -8.14 45.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.459 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.28 145.49 5.86 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.778 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.953 HG21 HD13 ' A' ' 31' ' ' LEU . 1.4 t -112.48 104.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 0.0 111.915 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HE3' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -85.1 121.14 27.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.886 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.912 HD21 HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -138.91 154.36 48.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 111.128 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.97 89.89 3.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.844 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.5 pt -107.9 171.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 0.0 112.282 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 18' ' ' PHE . 5.1 t -122.82 113.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.409 ' CD ' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.63 ' HG2' HG21 ' A' ' 34' ' ' VAL . 78.6 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 CA-C-O 120.744 0.227 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 18.9 t 69.12 -67.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.143 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.534 ' CE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER 68.14 99.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.308 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.004 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.82 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 104' ' ' VAL . 24.8 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.5 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 9.7 m-85 -62.89 146.79 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.985 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 124.01 2.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.974 0.416 . . . . 0.0 111.48 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.51 131.47 42.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.278 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 29.9 t -112.89 132.81 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.37 106.26 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -110.86 99.3 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.89 109.73 14.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.19 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 6.0 pttm -131.59 -169.01 2.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.211 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.5 177.74 4.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.245 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -79.86 162.16 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.761 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.96 13.92 28.76 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.905 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -123.04 33.69 5.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 109.972 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.707 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.4 OUTLIER 14.51 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.43 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER 174.12 -42.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.005 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 86.91 62.08 1.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.621 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.34 155.83 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.952 0.406 . . . . 0.0 111.299 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' CE1' ' B' ' -1' ' ' TYR . 22.3 t -120.58 131.36 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.157 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.801 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -116.6 156.96 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.495 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.71 169.46 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.975 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' HD11 ' A' ' 48' ' ' ILE . 17.5 mt-10 -62.14 130.62 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.871 0.367 . . . . 0.0 110.984 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.0 p -69.94 84.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.619 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.99 -3.96 88.81 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.896 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.845 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.1 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 110.462 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.74 -26.2 7.72 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.875 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.82 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.426 0.631 . . . . 0.0 111.244 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.845 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 72.9 mt -60.87 -40.17 84.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.567 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -149.38 117.03 3.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.574 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 20.7 Cg_endo -61.21 102.58 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.199 1.933 . . . . 0.0 113.234 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 HG13 ' A' ' 79' ' ' VAL . 1.3 p -153.54 -154.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.123 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -109.32 158.1 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.646 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -119.22 133.34 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.111 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.082 HG22 HD13 ' A' ' 66' ' ' ILE . 54.5 mt -69.74 95.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.67 -1.88 52.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.67 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.454 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.3 m-20 -170.57 159.52 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.71 144.67 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.914 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.707 ' CE ' HD11 ' A' ' 30' ' ' ILE . 5.4 mtt -55.9 -22.6 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 61.95 50.51 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.682 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.53 -36.05 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.054 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 -171.8 1.54 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.111 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 49.3 Cg_exo -55.74 -23.64 42.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.544 2.162 . . . . 0.0 112.493 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.56 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -66.5 -50.11 64.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.06 -38.4 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -57.36 -47.12 82.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -57.24 -74.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 15.18 8.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.444 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 61.5 mtpt -108.56 -24.75 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.816 ' HG ' HG11 ' A' ' 21' ' ' VAL . 69.0 mt -103.0 118.66 37.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -131.62 140.72 49.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.741 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.082 HD13 HG22 ' A' ' 49' ' ' ILE . 47.0 mm -47.33 145.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.554 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.01 7.17 59.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.862 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.4 m-20 -99.85 157.27 16.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 0.268 . . . . 0.0 110.558 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -117.32 112.23 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.881 0.372 . . . . 0.0 110.684 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.824 HG23 HG22 ' A' ' 103' ' ' ILE . 5.8 mt -78.94 138.76 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.83 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.9 mmm -103.57 -67.49 0.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.211 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 p -131.2 133.51 45.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 101' ' ' LEU . 2.7 mp -105.56 117.07 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.809 ' ND2' HD13 ' A' ' 93' ' ' LEU . 66.5 m-20 56.64 27.32 12.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.1 -30.4 9.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.842 HG21 HG23 ' A' ' 89' ' ' ILE . 37.7 m -61.73 100.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 111.124 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.05 114.92 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.745 HD21 HD12 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.34 25.15 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 46' ' ' THR . 22.0 t -72.71 87.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.587 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 45' ' ' PRO . . . 134.74 -17.09 4.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.509 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.49 157.07 73.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.618 0.246 . . . . 0.0 110.775 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -175.05 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.519 2.146 . . . . 0.0 111.972 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 36' ' ' VAL . 23.6 tp -78.11 -46.43 20.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.983 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 52.8 p -53.63 -40.87 66.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 89' ' ' ILE . 69.8 m -66.14 -50.9 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 92.2 m -55.79 -57.02 13.76 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.66 0.267 . . . . 0.0 111.283 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.801 ' HA ' HD11 ' A' ' 35' ' ' ILE . 4.2 pt20 -50.09 -40.22 44.93 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -63.78 -33.82 76.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.252 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.842 HG23 HG21 ' A' ' 76' ' ' THR . 5.8 mm -58.93 -49.4 83.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.037 HG21 HD13 ' B' ' 0' ' ' ILE . 35.5 mt -71.06 -47.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.125 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.689 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -55.64 -23.61 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.05 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -33.91 48.84 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.193 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.809 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.3 pp -104.25 46.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.402 . . . . 0.0 110.704 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.23 -23.55 35.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.245 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -91.95 42.42 1.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.4 135.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.41 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 t -78.53 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.183 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 ttm180 -145.51 127.5 15.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.02 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 31' ' ' LEU . 11.6 t -112.93 104.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -87.73 126.47 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.766 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -137.7 117.83 13.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.273 0.559 . . . . 0.0 112.302 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 71' ' ' MET . 1.1 m120 -89.37 97.69 11.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.7 pt -121.33 172.64 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.131 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 17' ' ' GLU . 22.7 t -115.97 110.76 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.412 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.029 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.44 ' HB2' HG11 ' A' ' 34' ' ' VAL . 58.6 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.79 0.246 . . . . 0.0 112.231 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.413 HG21 ' HE3' ' A' ' 91' ' ' LYS . 11.1 p -57.64 154.06 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 34' ' ' VAL . 3.7 m-85 -127.43 123.38 35.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.037 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.95 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.83 0.347 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' HG22 ' A' ' 104' ' ' VAL . 1.2 m-85 -58.85 144.27 44.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.329 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.591 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -164.85 128.47 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.306 0.574 . . . . 0.0 112.11 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.43 101.64 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.019 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.2 t -82.27 115.84 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -116.53 104.52 11.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.27 99.53 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.0 OUTLIER -77.39 109.89 11.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.78 -170.91 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.36 154.09 25.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -56.67 153.95 9.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.27 12.12 79.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.597 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' LEU . 38.0 mt-10 -124.93 31.68 5.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.204 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.926 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 18.49 -81.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 175.74 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.72 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.51 65.1 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.427 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.043 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.15 156.08 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 111.893 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 77.1 t -117.69 129.7 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.637 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -118.11 150.78 20.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.9 m -147.49 166.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.206 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 48' ' ' ILE . 21.7 mt-10 -56.3 133.48 52.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.474 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 60.5 p -74.37 83.51 1.93 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.435 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.91 -3.87 90.28 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.73 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -54.95 -164.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.629 0.252 . . . . 0.0 110.541 179.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.06 -24.86 7.01 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.823 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.73 54.96 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.578 0.704 . . . . 0.0 111.217 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.73 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 60.3 mt -70.71 -36.33 64.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.624 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.807 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -150.04 110.14 3.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.782 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_endo -56.09 86.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.207 1.938 . . . . 0.0 112.62 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.18 -155.32 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.17 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' N ' ' OG1' ' A' ' 46' ' ' THR . 0.9 OUTLIER -107.71 161.87 6.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.625 0.25 . . . . 0.0 110.745 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -120.33 133.13 68.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.771 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.056 HG22 HD13 ' A' ' 66' ' ' ILE . 61.0 mt -73.62 91.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.73 -13.9 44.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.844 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.65 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -156.59 159.56 38.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 111.144 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.2 ttm -153.36 130.66 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' GLY . 8.2 mtm -64.95 93.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -57.86 80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.29 -28.74 0.27 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.743 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.07 18.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.844 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.9 Cg_endo -69.52 -14.36 36.71 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.808 2.339 . . . . 0.0 113.043 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 -52.32 60.25 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 -40.21 30.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -50.81 -47.22 60.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.447 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.16 -70.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.62 16.72 6.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.345 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.744 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.3 mmmm -101.08 -28.5 12.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.691 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD2' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -103.89 134.71 46.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -142.51 127.34 18.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.255 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.056 HD13 HG22 ' A' ' 49' ' ' ILE . 22.4 mm -43.31 142.56 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 112.078 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.73 17.3 45.29 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.428 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.855 ' HB3' HD12 ' A' ' 103' ' ' ILE . 89.5 m-20 -104.27 178.88 4.43 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.946 0.403 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.447 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 4.0 mm100 -134.33 114.92 13.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.704 HG23 HG22 ' A' ' 103' ' ' ILE . 5.4 mt -87.89 125.07 41.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.056 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.795 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.63 -44.77 10.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.668 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 p -158.51 144.64 17.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.705 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -118.7 126.4 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.015 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.525 ' ND2' HD13 ' A' ' 93' ' ' LEU . 88.7 m-20 53.84 26.92 6.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.358 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.9 -21.78 40.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.768 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 89' ' ' ILE . 3.5 m -67.89 101.36 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 m -65.69 111.27 3.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HD12 ' A' ' 73' ' ' ILE . 48.5 mt -90.99 -20.66 21.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 22.0 t -54.61 88.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.366 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.67 -25.94 4.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.691 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.8 mt -77.52 152.68 81.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.99 -169.51 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 111.95 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.569 HD22 ' NE2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -78.31 -52.25 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.227 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -53.07 -40.72 64.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 89' ' ' ILE . 52.5 m -65.05 -50.2 67.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 78' ' ' LEU . 92.2 m -58.85 -50.44 73.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.682 0.277 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.569 ' NE2' HD22 ' A' ' 83' ' ' LEU . 6.2 mt-30 -49.4 -43.66 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.176 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 35.3 m -61.27 -38.83 88.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.657 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.77 HD12 HG21 ' A' ' 76' ' ' THR . 24.1 mm -58.25 -50.13 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.761 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 0' ' ' ILE . 24.1 mt -67.74 -50.23 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.08 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.63 -21.11 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.93 -39.05 55.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.6 OUTLIER -93.25 45.77 1.18 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.902 0.382 . . . . 0.0 110.989 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.926 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.37 -5.97 58.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -114.8 49.96 1.0 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.688 0.28 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.74 161.41 30.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.675 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 t -93.5 -11.5 31.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.538 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 16.9 mmt85 -141.26 138.88 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.771 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 31' ' ' LEU . 13.5 t -113.03 103.74 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -90.83 118.57 30.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.445 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.03 117.44 12.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.67 95.25 9.73 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -117.64 171.46 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.167 0.508 . . . . 0.0 111.999 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.723 HG23 ' SD ' ' A' ' 71' ' ' MET . 40.5 t -124.62 128.1 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.647 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.503 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 49.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.937 0.307 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.9 m -98.02 -23.26 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.806 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 34' ' ' VAL . 10.8 m-85 63.59 136.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 33' ' ' VAL . 1.8 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.666 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 104' ' ' VAL . 17.6 tp10 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 104' ' ' VAL . 2.4 m-85 -66.28 153.34 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.564 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.95 125.98 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 0.0 111.31 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.71 106.39 7.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.402 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' HD12 ' A' ' 101' ' ' LEU . 21.5 t -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.532 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -129.06 104.33 7.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.035 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 31' ' ' LEU . 11.6 mm -105.9 99.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.451 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 98' ' ' ARG . 1.6 mp0 -82.92 109.29 16.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -132.08 -171.41 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.916 0.388 . . . . 0.0 111.359 -178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.57 156.57 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -59.93 154.43 18.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.011 0.434 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.52 13.13 74.15 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.416 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' LEU . 15.9 mt-10 -124.79 32.26 5.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.391 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.704 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 17.73 -80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.159 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 99' ' ' VAL . 14.7 tp 178.06 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.075 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 85.13 60.51 1.83 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.756 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.066 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -150.7 156.78 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 111.45 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' B' ' -3' ' ' PRO . 20.2 t -123.7 121.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.114 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 47' ' ' VAL . 2.1 pt -111.75 149.21 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.189 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 48' ' ' ILE . 33.0 m -137.2 168.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.06 130.85 48.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.681 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' HD11 ' A' ' 48' ' ' ILE . 49.6 p -71.41 83.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.544 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -5.36 87.14 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.713 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.0 -162.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 110.948 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -53.17 -18.83 6.94 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.765 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.4 m 107.48 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.598 0.759 . . . . 0.0 111.082 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.763 HG22 ' HG ' ' A' ' 44' ' ' LEU . 81.4 mt 57.71 -65.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.353 0.597 . . . . 0.0 111.399 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.957 ' O ' HG22 ' A' ' 46' ' ' THR . 1.3 mt -138.54 81.66 23.83 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.798 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 76.8 Cg_exo -50.57 93.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.641 2.227 . . . . 0.0 113.072 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.957 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -139.77 -87.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.29 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.3 167.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 120.661 0.267 . . . . 0.0 111.059 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.06 126.94 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 66' ' ' ILE . 65.0 mt -66.18 91.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 -8.73 55.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.31 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.619 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.3 m-20 -163.68 162.06 23.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.441 . . . . 0.0 111.316 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.1 ttm -153.8 134.28 13.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.679 ' CE ' HD11 ' A' ' 30' ' ' ILE . 4.9 mtt -50.93 -26.07 5.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.247 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 57.6 56.44 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 110.686 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -35.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.07 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.5 -160.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.911 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 55.4 Cg_endo -69.13 -22.65 34.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 112.212 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.57 77.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.026 0.441 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -38.61 52.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -59.21 -29.96 67.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.241 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -73.42 -68.31 0.51 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.804 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.37 -32.82 5.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.369 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -60.69 -27.15 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.705 0.288 . . . . 0.0 110.983 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' HG11 ' A' ' 21' ' ' VAL . 22.6 mt -97.97 126.6 43.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.02 137.08 27.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 49' ' ' ILE . 24.3 mm -46.0 145.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.13 14.09 58.0 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.428 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.883 ' HB3' HD12 ' A' ' 103' ' ' ILE . 83.6 m-20 -103.7 163.0 12.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.671 0.272 . . . . 0.0 110.899 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.42 106.44 11.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.822 HG23 HG22 ' A' ' 103' ' ' ILE . 3.2 mt -78.72 139.68 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.634 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 mmt -104.38 -68.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.2 t -124.11 140.84 52.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.985 0.421 . . . . 0.0 111.579 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -117.56 109.79 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.603 ' ND2' HD13 ' A' ' 93' ' ' LEU . 62.0 m-80 59.09 25.94 14.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.186 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.8 -34.73 5.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.681 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.73 HG21 HG23 ' A' ' 89' ' ' ILE . 3.9 m -67.85 109.88 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.429 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -74.44 147.46 41.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 73' ' ' ILE . 81.2 mt -115.89 -22.06 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.241 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 71' ' ' MET . 13.1 t -62.88 102.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.411 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.24 -30.53 4.28 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.337 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.469 HD13 ' CG2' ' A' ' 85' ' ' THR . 0.2 OUTLIER -93.98 159.49 34.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.957 0.408 . . . . 0.0 111.387 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.94 -174.33 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.943 2.428 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -77.89 -43.39 30.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -53.32 -41.53 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.156 0.503 . . . . 0.0 110.527 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.612 ' O ' HG12 ' A' ' 89' ' ' ILE . 63.7 m -64.79 -50.49 66.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.73 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.498 ' HA ' HD22 ' A' ' 78' ' ' LEU . 64.0 m -55.53 -57.2 12.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.328 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' SER . 4.0 pt20 -50.14 -39.53 43.61 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.7 t -61.65 -38.06 86.33 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.208 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 76' ' ' THR . 24.3 mm -58.96 -49.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.739 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.066 HG21 HD13 ' B' ' 0' ' ' ILE . 29.0 mt -69.34 -50.42 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.825 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.73 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.9 -42.68 68.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.988 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.603 HD13 ' ND2' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -91.63 52.18 2.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.569 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.704 ' HG3' HG23 ' A' ' 30' ' ' ILE . 1.4 tmmm? -88.0 -20.75 25.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.932 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -99.85 49.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.738 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.565 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.3 pt20 -128.41 -179.14 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.564 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.1 m -123.68 -3.85 8.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.3 134.56 24.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 110.476 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 31' ' ' LEU . 3.9 t -119.38 104.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.39 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -97.4 97.86 9.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.456 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.97 154.99 23.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.57 91.86 3.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.883 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.2 pt -113.62 172.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 18' ' ' PHE . 9.8 t -121.44 124.76 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.658 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.905 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.538 ' CG ' HG21 ' A' ' 34' ' ' VAL . 34.8 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.801 0.251 . . . . 0.0 112.403 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.3 -15.89 7.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.712 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 64.79 170.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.03 0.443 . . . . 0.0 111.321 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 33' ' ' VAL . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.597 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 104' ' ' VAL . 4.7 m-85 -58.63 154.1 15.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.45 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.33 125.93 1.9 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.183 0.516 . . . . 0.0 112.024 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 101.15 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.354 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.833 HG13 ' HB2' ' A' ' 63' ' ' LYS . 22.7 t -82.73 108.23 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.56 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' CE1' ' CG ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.89 104.76 15.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 31' ' ' LEU . 17.2 mm -104.83 99.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 6.6 mp0 -82.31 117.23 22.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.01 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.74 -170.93 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -117.76 -179.54 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.47 161.7 30.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.36 15.17 58.69 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' ILE . 41.6 mt-10 -129.59 33.5 4.47 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 110.269 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 8.25 -78.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.225 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 23' ' ' ILE . 11.2 tp 176.27 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.822 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' H ' HD12 ' A' ' 30' ' ' ILE . . . 87.07 63.67 1.44 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.515 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.079 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.78 156.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.195 179.033 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' -3' ' ' PRO . 45.9 t -126.45 123.95 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -109.51 148.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.649 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.3 m -140.74 167.58 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.501 ' O ' HD11 ' A' ' 48' ' ' ILE . 11.5 mt-10 -54.56 135.16 46.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.377 . . . . 0.0 110.807 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 48' ' ' ILE . 53.1 p -78.54 83.11 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.807 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.28 -4.87 87.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.604 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.925 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -56.09 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 122.338 0.255 . . . . 0.0 110.383 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.41 -26.63 7.22 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.689 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.434 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.75 40.31 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.402 0.62 . . . . 0.0 111.605 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.925 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.9 mt -54.21 -35.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.611 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.806 ' O ' HG22 ' A' ' 46' ' ' THR . 89.2 mt -155.09 96.55 2.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.147 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.2 Cg_endo -55.53 92.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.569 2.18 . . . . 0.0 113.45 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.65 -88.8 0.22 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.785 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.46 167.64 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.501 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.74 131.06 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -68.9 92.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.3 -6.5 55.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.219 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.622 ' C ' HD11 ' A' ' 66' ' ' ILE . 1.5 t-20 -163.53 157.72 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -154.82 133.96 12.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.529 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 30' ' ' ILE . 10.8 mtm -75.07 96.75 3.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.31 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -62.97 78.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 170.71 -33.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.057 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.33 -168.1 18.52 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.927 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.1 -16.33 40.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.456 2.104 . . . . 0.0 112.471 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.15 65.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.191 0.519 . . . . 0.0 110.607 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -77.22 -36.45 54.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.87 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -58.01 -47.27 83.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.85 -7.64 59.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.288 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.833 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmt -72.86 -29.56 63.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 21' ' ' VAL . 92.4 mt -101.45 120.06 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -132.49 133.6 43.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.426 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.029 HD13 HG22 ' A' ' 49' ' ' ILE . 28.1 mm -45.65 143.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.063 0.459 . . . . 0.0 111.7 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.53 57.54 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.564 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.891 ' HB3' HD12 ' A' ' 103' ' ' ILE . 0.9 OUTLIER -105.34 172.01 7.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.46 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -128.37 112.34 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.357 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 HG22 ' A' ' 103' ' ' ILE . 3.3 mt -82.88 142.89 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.659 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.673 ' SD ' HG21 ' A' ' 46' ' ' THR . 14.1 mmt -105.7 -70.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.36 131.8 52.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.435 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.892 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -103.6 111.73 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.605 HD22 HG22 ' A' ' 73' ' ' ILE . 65.6 m-80 60.43 20.11 9.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.84 -33.46 5.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.743 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.537 HG21 HD12 ' A' ' 89' ' ' ILE . 3.6 m -68.71 100.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 110.985 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m -65.94 149.05 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 73' ' ' ILE . 63.0 mt -116.89 -22.82 8.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.367 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG22 ' SD ' ' A' ' 71' ' ' MET . 34.6 t -50.44 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.348 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.606 ' C ' HD23 ' A' ' 81' ' ' LEU . . . 116.33 1.65 20.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.985 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 80' ' ' GLY . 2.2 mt -108.13 151.24 41.28 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.954 0.377 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.91 168.02 25.04 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.59 2.193 . . . . 0.0 111.828 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.2 tp -62.01 -45.24 94.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.969 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -43.06 68.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.462 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.7 m -65.27 -51.31 61.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 78' ' ' LEU . 33.0 m -55.73 -56.24 22.84 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.422 ' HG3' HD12 ' A' ' 83' ' ' LEU . 28.6 mt-30 -49.44 -41.13 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.105 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 44.8 m -61.53 -38.77 88.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.424 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 85' ' ' THR . 19.8 mm -58.26 -49.98 79.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.972 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.988 HG21 HD13 ' B' ' 0' ' ' ILE . 14.5 mt -75.67 -50.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.185 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.492 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -55.77 -23.89 32.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 110.911 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.32 -44.1 76.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.222 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.5 pp -85.82 62.62 7.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.068 0.461 . . . . 0.0 110.942 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.611 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -84.61 -23.54 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.13 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.8 38.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.257 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -96.73 162.2 13.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.191 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.6 p -118.52 -10.7 10.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.532 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 4.1 tpp85 -156.03 116.07 3.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.186 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 101' ' ' LEU . 10.3 t -99.09 117.86 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.901 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.25 97.8 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.144 179.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -109.73 155.3 21.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.451 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.66 91.52 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.909 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -111.51 169.83 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.619 HG22 ' CD1' ' A' ' 18' ' ' PHE . 4.7 t -116.28 124.81 72.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.696 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' A' ' 34' ' ' VAL . 70.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.712 0.213 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' -2' ' ' VAL . 30.9 m -57.27 124.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 34' ' ' VAL . 12.5 m-85 -102.33 113.16 26.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.079 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 104' ' ' VAL . 2.4 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.9 m-85 -58.93 153.11 18.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -166.91 125.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 112.065 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.3 103.37 2.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.99 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.929 HG11 ' HG ' ' A' ' 64' ' ' LEU . 26.2 t -87.16 108.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.491 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -96.83 112.18 24.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.453 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.27 102.62 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.28 114.99 24.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -145.06 -171.54 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.215 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -109.68 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.342 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -55.4 148.57 14.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.46 14.4 82.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.126 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 31' ' ' LEU . 3.2 mt-10 -128.02 31.21 5.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.592 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 14.48 -79.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.348 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 173.57 -47.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.66 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 89.72 67.58 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.651 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.08 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.71 155.97 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.326 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.4 t -116.8 128.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.715 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.2 pt -116.03 149.85 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.609 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' HD22 ' A' ' 83' ' ' LEU . 31.0 m -141.68 167.71 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.032 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.77 129.69 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.516 ' HA ' HD11 ' A' ' 48' ' ' ILE . 70.0 p -70.8 84.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.344 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.47 90.05 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.96 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.777 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.01 -163.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.663 0.268 . . . . 0.0 110.59 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.94 -25.38 7.33 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.788 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 4.7 p 80.43 44.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.694 0.759 . . . . 0.0 111.61 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.777 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 78.4 mt -58.64 -37.68 66.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -148.58 104.73 3.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.884 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' GLY . 51.6 Cg_exo -52.71 94.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.091 1.861 . . . . 0.0 112.612 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -145.02 -153.74 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -109.27 164.6 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.595 0.236 . . . . 0.0 110.634 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.54 129.3 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.041 HG22 HD13 ' A' ' 66' ' ' ILE . 71.2 mt -67.61 93.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.22 -6.15 51.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.287 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -165.59 162.52 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -150.86 144.08 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.259 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.592 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.0 mtm -57.13 -28.56 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 61.47 61.02 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.82 -33.54 0.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.196 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -165.78 6.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.055 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 50.9 Cg_endo -69.13 -16.93 40.56 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.443 2.095 . . . . 0.0 112.407 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.05 70.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.19 -34.21 56.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.748 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -59.62 -47.23 86.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.041 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 m -59.68 -52.19 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.75 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.55 64.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.076 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB2' HG13 ' A' ' 21' ' ' VAL . 2.3 mmmt -72.13 -31.56 66.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.929 ' HG ' HG11 ' A' ' 21' ' ' VAL . 21.0 mt -97.23 99.89 11.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -119.59 144.9 46.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 49' ' ' ILE . 51.7 mm -47.22 142.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.722 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.34 9.28 61.96 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.927 ' HB3' HD12 ' A' ' 103' ' ' ILE . 25.3 m-20 -96.97 154.5 17.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.682 0.277 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 6.2 mm100 -111.08 111.44 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.971 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 103' ' ' ILE . 3.2 mt -86.57 113.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.748 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -77.6 -64.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.256 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.39 148.43 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.836 HD12 HD21 ' A' ' 78' ' ' LEU . 2.7 mp -118.91 114.35 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.776 ' ND2' HD13 ' A' ' 93' ' ' LEU . 29.0 m-80 60.78 29.77 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.32 -20.0 52.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.804 HG21 HG23 ' A' ' 89' ' ' ILE . 2.9 m -69.86 95.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.774 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -71.87 121.06 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 73' ' ' ILE . 1.3 pp -128.91 28.18 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 46' ' ' THR . 22.7 t -75.39 86.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 140.26 -50.26 0.77 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.684 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -51.02 163.82 0.48 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 111.116 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.59 -178.68 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.768 2.312 . . . . 0.0 112.829 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.8 tp -78.26 -45.04 23.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.104 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 9.7 p -53.41 -40.88 65.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.093 0.473 . . . . 0.0 110.69 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.7 m -66.08 -49.25 68.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 74.4 m -55.52 -56.28 22.15 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.286 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.747 ' NE2' HG21 ' B' ' -2' ' ' VAL . 5.8 pt20 -49.18 -46.24 45.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 34.8 t -56.42 -35.18 67.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.345 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 76' ' ' THR . 6.5 mm -59.58 -47.28 91.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.017 HG21 HD13 ' B' ' 0' ' ' ILE . 44.6 mt -69.88 -50.63 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.161 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -63.24 -17.53 62.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.215 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.45 73.61 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.691 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.776 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.3 pp -117.17 42.86 2.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.02 -7.21 57.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.442 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.61 35.01 1.4 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.666 0.27 . . . . 0.0 111.591 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 2.2 pt20 -126.12 134.67 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.836 0.35 . . . . 0.0 110.31 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -8.71 51.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.757 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.779 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 6.4 ttm105 -145.35 150.11 36.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 0.0 110.873 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.641 HG13 HD21 ' A' ' 74' ' ' ASN . 2.8 t -135.67 118.16 21.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.554 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.1 mtpt -97.73 97.84 9.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.708 ' CD1' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -102.13 153.44 19.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.969 0.414 . . . . 0.0 111.074 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.84 94.49 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 68' ' ' ASP . 4.4 pt -120.52 171.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.748 HG23 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -116.45 117.83 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.552 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.602 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.4 Cg_endo . . . . . 0 C--O 1.23 0.123 0 CA-C-O 120.784 0.244 . . . . 0.0 112.291 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.747 HG21 ' NE2' ' A' ' 87' ' ' GLN . 28.5 m -58.41 110.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -100.29 143.05 30.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.113 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.08 HD11 HG22 ' A' ' 33' ' ' VAL . 2.4 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.917 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' C ' HG13 ' A' ' 104' ' ' VAL . 10.1 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CD1' HG22 ' A' ' 104' ' ' VAL . 7.7 m-85 -62.33 154.32 28.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.236 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -167.64 125.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.342 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 101.53 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.862 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.8 t -83.89 116.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.75 104.56 12.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.488 179.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.2 mm -104.25 99.74 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.098 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 50.1 mt-10 -75.53 109.99 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -131.51 -173.95 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.4 . . . . 0.0 111.492 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.49 159.34 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.9 156.96 13.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.17 18.03 62.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.355 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -130.23 31.7 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.891 0.377 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.661 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 14.31 -80.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.311 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 99' ' ' VAL . 11.9 tp 177.8 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.866 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.76 61.48 1.86 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.537 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.06 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -147.43 156.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 111.66 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.47 ' CG2' ' CE1' ' B' ' -1' ' ' TYR . 37.6 t -120.82 126.79 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.01 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.576 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.8 pt -116.74 144.15 25.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.206 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 83' ' ' LEU . 36.0 m -133.97 163.26 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 124.29 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 48' ' ' ILE . 51.8 p -65.48 84.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.386 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.6 -3.97 90.49 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.754 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -56.17 -162.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . -52.94 -18.94 6.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.842 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 44' ' ' LEU . 16.2 m 107.27 -86.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.486 0.714 . . . . 0.0 111.004 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.701 HG22 ' HG ' ' A' ' 44' ' ' LEU . 84.4 mt 57.3 -64.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.387 0.613 . . . . 0.0 111.4 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.971 ' O ' HG22 ' A' ' 46' ' ' THR . 1.4 mt -135.87 73.39 60.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.625 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 87.1 Cg_exo -47.1 90.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.882 2.388 . . . . 0.0 113.359 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.971 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.76 -91.57 0.29 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.372 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -154.04 167.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 111.431 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -135.31 129.59 50.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.775 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.118 HG22 HD13 ' A' ' 66' ' ' ILE . 79.2 mt -66.41 94.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.01 0.91 55.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 m-20 -174.07 161.62 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 111.141 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 mtm -154.96 159.78 40.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.126 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.502 ' CE ' HD11 ' A' ' 30' ' ' ILE . 8.0 mtt -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 60.96 47.11 7.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.614 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -35.31 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.23 -171.97 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.173 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.11 -21.93 45.03 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.549 2.166 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.65 -49.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.961 0.41 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -39.36 41.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -52.8 -47.39 67.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.393 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -68.9 -61.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.78 -1.97 38.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.196 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.795 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.9 mmmm -76.97 -28.75 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.862 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -107.04 113.97 27.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.042 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -130.92 141.41 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.395 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.118 HD13 HG22 ' A' ' 49' ' ' ILE . 42.0 mm -44.87 141.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 111.84 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 17.72 52.37 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.428 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.902 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.5 m-20 -102.83 158.49 16.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.622 0.249 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -117.57 106.99 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.963 HG23 HG22 ' A' ' 103' ' ' ILE . 1.4 mt -85.4 119.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.632 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -80.44 -65.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.66 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -133.64 146.97 51.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 111.473 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.2 mt -113.89 114.37 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.759 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.626 ' ND2' HD22 ' A' ' 93' ' ' LEU . 25.2 m-80 59.12 22.22 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.86 8.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.846 HG21 HD12 ' A' ' 89' ' ' ILE . 3.4 m -68.18 108.27 3.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.528 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.3 t -69.98 138.16 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.967 HD11 ' CD1' ' A' ' 73' ' ' ILE . 57.6 mt -111.07 -23.32 10.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 35.7 t -58.82 98.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.03 -29.47 3.71 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.413 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -96.15 159.8 31.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 111.609 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.74 178.68 2.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.003 2.469 . . . . 0.0 112.517 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.3 tp -72.35 -39.45 68.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.091 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.5 t -53.32 -46.08 69.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.451 . . . . 0.0 110.393 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 89' ' ' ILE . 28.6 m -62.07 -50.5 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.992 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 28.8 m -55.39 -55.77 27.8 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HA ' HD11 ' A' ' 35' ' ' ILE . 27.9 mt-30 -49.28 -40.48 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 110.289 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -63.57 -37.11 86.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.407 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 HG21 ' A' ' 76' ' ' THR . 27.4 mm -58.15 -49.56 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.987 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.01 HG21 HD13 ' B' ' 0' ' ' ILE . 36.6 mt -71.83 -44.27 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' HG3' HG22 ' B' ' 0' ' ' ILE . 0.1 OUTLIER -54.97 -25.36 29.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.828 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.01 -51.05 48.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.091 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.6 pp -79.04 60.96 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 110.953 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.2 ttpm? -87.2 -26.07 23.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.358 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -108.51 51.95 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.33 . . . . 0.0 111.324 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 mt-30 -109.45 163.9 12.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 0.0 111.683 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.0 p -98.47 -10.92 22.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.36 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.69 150.4 10.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.279 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 31' ' ' LEU . 13.1 t -119.91 119.19 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 112.054 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -97.6 117.81 32.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.9 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.37 117.95 13.9 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.994 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.99 96.22 9.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.963 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -120.44 170.46 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.183 0.516 . . . . 0.0 112.229 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.3 t -108.25 113.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.237 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 3.4 ttt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.493 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.443 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.881 0.284 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' VAL . 31.1 m -84.53 161.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.47 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 5.5 m-85 -119.74 160.33 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.06 HD11 HG22 ' A' ' 33' ' ' VAL . 2.0 pp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' C ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.886 0.374 . . . . 0.0 111.062 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 71' ' ' MET . 4.9 m-85 -59.38 154.28 17.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.49 125.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.105 0.478 . . . . 0.0 111.542 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.8 129.93 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.164 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.4 t -110.39 129.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.08 104.64 9.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 ' CD1' ' A' ' 31' ' ' LEU . 18.1 mm -107.48 99.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.01 110.88 21.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -135.16 -167.75 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.0 111.307 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.48 172.81 6.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.489 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.93 158.82 34.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.696 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.68 16.62 56.24 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.389 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 31' ' ' LEU . 8.6 mt-10 -126.32 30.83 5.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.755 HG23 ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 16.46 -80.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.966 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.719 HD23 ' CG1' ' A' ' 33' ' ' VAL . 2.9 tp 177.58 -45.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 90.06 64.71 1.23 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.977 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -151.47 156.35 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.635 HG21 ' HG2' ' B' ' -3' ' ' PRO . 19.6 t -121.18 122.74 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 0.0 111.359 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 HG11 ' A' ' 47' ' ' VAL . 2.4 pt -111.47 142.37 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.0 m -135.18 170.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.645 ' O ' HD11 ' A' ' 48' ' ' ILE . 32.0 mt-10 -60.57 135.22 57.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.461 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.0 p -75.52 83.57 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.432 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.39 -8.47 83.33 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.82 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.994 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.45 -161.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.637 0.256 . . . . 0.0 110.468 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.43 -26.67 7.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.883 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.423 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.98 42.04 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.404 0.621 . . . . 0.0 111.384 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.994 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 89.0 mt -51.49 -42.46 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.887 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.918 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -151.58 89.72 4.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.231 178.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 80' ' ' GLY . 85.4 Cg_exo -45.58 111.34 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.974 2.449 . . . . 0.0 113.841 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -156.54 -89.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.48 167.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.236 . . . . 0.0 111.015 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.645 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -133.68 129.41 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.634 ' CG1' HD11 ' A' ' 70' ' ' ILE . 78.9 mt -70.3 96.2 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.84 0.57 52.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.233 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.912 ' HA ' HD11 ' A' ' 66' ' ' ILE . 1.1 m-20 -169.46 161.2 9.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.451 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 14.4 mtm -155.23 134.93 12.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.42 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.489 ' HE1' HD11 ' A' ' 30' ' ' ILE . 13.9 mtm -70.39 95.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.299 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -60.64 80.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.125 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 165.45 -31.45 0.22 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.59 -167.43 31.96 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.086 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 56.5 Cg_endo -69.28 -16.12 39.37 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.652 2.234 . . . . 0.0 112.529 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -66.89 -49.6 65.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 110.83 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.57 -38.59 48.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.43 -47.21 82.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.193 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -59.34 -68.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.55 38.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.165 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.776 ' HB2' HG13 ' A' ' 21' ' ' VAL . 19.5 mmmt -72.33 -30.01 64.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.51 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.689 ' HG ' HG11 ' A' ' 21' ' ' VAL . 53.6 mt -102.7 129.97 49.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.576 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 73.8 m-80 -142.75 138.12 30.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.726 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.912 HD11 ' HA ' ' A' ' 51' ' ' ASN . 6.2 mt -46.67 140.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.202 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.8 16.62 44.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.58 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.866 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.1 m-20 -111.87 157.22 20.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 110.739 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -112.79 117.75 33.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.873 HG23 HG22 ' A' ' 103' ' ' ILE . 2.3 mt -91.8 108.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.787 ' CE ' HD13 ' A' ' 44' ' ' LEU . 21.6 mmt -66.94 -67.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.425 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 53.5 p -131.57 156.07 46.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.348 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HD11 ' A' ' 93' ' ' LEU . 3.3 mt -124.44 109.8 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.493 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.559 HD22 HG22 ' A' ' 73' ' ' ILE . 71.6 m-80 64.23 29.42 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.879 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.62 50.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.924 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 89' ' ' ILE . 15.0 m -77.75 95.84 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.741 0.305 . . . . 0.0 111.315 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.425 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 56.4 p -77.02 131.63 38.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.247 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.98 19.26 7.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 23.5 t -60.39 88.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.848 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 133.07 -24.66 3.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.779 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.3 mt -70.72 155.42 93.42 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 110.766 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.99 -173.75 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 tp -78.13 -47.21 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.008 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 p -53.37 -43.35 67.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.085 0.469 . . . . 0.0 110.263 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 89' ' ' ILE . 83.1 m -65.04 -52.23 57.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.852 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.461 ' SG ' HD13 ' A' ' 78' ' ' LEU . 85.9 m -56.56 -50.33 72.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.474 ' OE1' HG11 ' B' ' -2' ' ' VAL . 11.5 mt-30 -49.89 -45.1 50.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.386 . . . . 0.0 110.07 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -60.26 -35.95 76.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.519 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' THR . 7.5 mm -58.21 -48.99 83.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.432 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.915 HG21 HD13 ' B' ' 0' ' ' ILE . 57.1 mt -73.08 -42.17 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.158 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -55.18 -25.83 35.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.5 69.21 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.397 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 73' ' ' ILE . 2.2 mt -93.31 45.28 1.16 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.755 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -83.22 -26.68 30.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.193 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.01 35.69 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.74 159.78 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.134 0.493 . . . . 0.0 111.635 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 p -114.24 -9.26 12.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.455 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -150.73 134.9 16.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.368 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.646 ' CG1' HD21 ' A' ' 101' ' ' LEU . 13.1 t -122.59 104.84 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 0.0 111.723 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.99 100.48 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -115.57 123.33 48.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.458 . . . . 0.0 112.089 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.3 93.81 9.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.317 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.873 HG22 HG23 ' A' ' 70' ' ' ILE . 2.0 pt -114.42 170.25 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.045 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 18' ' ' PHE . 21.7 t -115.0 126.51 72.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.822 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.81 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.635 ' HG2' HG21 ' A' ' 34' ' ' VAL . 64.9 Cg_endo . . . . . 0 CA--C 1.528 0.215 0 CA-C-O 120.626 0.178 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.474 HG11 ' OE1' ' A' ' 87' ' ' GLN . 23.0 t -45.11 -56.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.584 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 53' ' ' MET . 1.0 OUTLIER 64.16 149.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.07 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.053 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.946 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.519 ' N ' HG23 ' A' ' 104' ' ' VAL . 5.9 m-85 -58.8 154.06 15.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.809 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.73 125.44 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 111.468 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -73.3 105.89 4.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.648 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 101' ' ' LEU . 26.6 t -82.37 132.17 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -123.99 104.71 9.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.645 HD13 ' OG ' ' A' ' 61' ' ' SER . 10.3 mm -110.3 99.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.337 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.81 109.79 20.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.268 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.77 -172.07 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -106.86 163.36 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.42 155.94 27.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.35 16.13 64.49 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.425 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -126.38 30.51 5.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.916 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 19.36 -82.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.957 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.787 ' CD1' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 175.19 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.624 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.45 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 91.19 67.67 1.17 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.814 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.019 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -150.84 156.53 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.375 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' B' ' -3' ' ' PRO . 36.5 t -124.73 119.81 57.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 47' ' ' VAL . 2.0 pt -110.41 145.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 48' ' ' ILE . 34.7 m -136.4 165.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 131.62 51.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.025 0.441 . . . . 0.0 110.623 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.471 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.0 p -69.85 84.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.653 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.36 -4.31 89.53 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.832 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.73 -163.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.667 0.27 . . . . 0.0 110.302 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.07 -25.68 7.99 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.77 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 8.9 p 82.21 63.04 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.001 0.905 . . . . 0.0 111.517 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' HD23 ' A' ' 44' ' ' LEU . 48.3 mt -78.91 -32.31 15.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.757 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 80.9 mt -156.13 89.74 2.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.286 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 Cg_exo -49.19 86.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.822 2.348 . . . . 0.0 113.515 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.81 -91.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.055 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG12 ' CD2' ' A' ' 83' ' ' LEU . 2.9 m -160.27 167.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 120.684 0.278 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -133.5 127.68 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.93 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.071 HG22 HD13 ' A' ' 66' ' ' ILE . 60.8 mt -67.74 93.39 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.25 55.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.137 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.474 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -165.95 156.82 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.301 . . . . 0.0 110.9 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 ttm -153.38 131.57 11.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.262 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.45 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 6.2 mtm -63.23 100.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.493 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -66.45 73.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.15 -34.13 0.15 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.126 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.3 -168.2 13.85 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.919 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 55.0 Cg_endo -69.32 -16.57 39.51 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.502 2.134 . . . . 0.0 112.424 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.48 71.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -40.39 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -58.12 -29.67 65.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.645 ' OG ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -69.23 -66.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.11 -33.47 5.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.136 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 21' ' ' VAL . 15.4 mt -92.6 119.25 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.814 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -133.07 130.07 38.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.585 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.071 HD13 HG22 ' A' ' 49' ' ' ILE . 42.3 mm -45.74 142.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.87 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.96 12.01 55.85 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.502 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 103' ' ' ILE . 69.6 m-20 -105.88 161.33 14.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.785 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.1 119.85 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.767 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -89.7 97.82 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.708 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -57.81 -64.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.599 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.2 p -137.14 149.9 47.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.26 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 78' ' ' LEU . 3.2 mt -117.59 118.24 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 56.08 29.09 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.28 11.98 56.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.796 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.88 HG21 HD12 ' A' ' 89' ' ' ILE . 3.1 m -100.65 95.91 7.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.762 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.722 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -58.09 126.7 28.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 73' ' ' ILE . 23.5 mt -109.14 -23.62 11.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.3 t -56.03 88.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.464 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.16 -38.79 1.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.362 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -81.21 159.68 67.23 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.436 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.19 -175.04 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.956 2.438 . . . . 0.0 112.659 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -78.25 -46.42 20.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.0 m -53.6 -42.61 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.996 0.427 . . . . 0.0 110.589 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG12 ' A' ' 89' ' ' ILE . 71.0 m -62.01 -49.28 76.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 78.7 m -56.56 -46.5 80.69 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.811 0.339 . . . . 0.0 110.729 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' NE2' ' CD1' ' A' ' 83' ' ' LEU . 10.3 mt-30 -52.69 -43.11 65.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.049 0.452 . . . . 0.0 109.896 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.1 p -60.9 -37.23 81.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.422 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.88 HD12 HG21 ' A' ' 76' ' ' THR . 21.0 mm -58.22 -49.44 81.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.963 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.965 HG21 HD13 ' B' ' 0' ' ' ILE . 52.7 mt -71.46 -45.04 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.224 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -58.48 -20.68 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -20.71 67.85 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.055 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.618 HD21 HG21 ' A' ' 73' ' ' ILE . 2.5 pp -100.53 43.88 1.04 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.001 0.401 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.06 -5.89 58.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.291 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -122.55 54.21 1.22 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.871 0.367 . . . . 0.0 111.208 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.78 ' OE1' HG22 ' A' ' 99' ' ' VAL . 3.3 pt20 -136.27 160.48 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -98.79 -15.84 19.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.828 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -139.68 143.87 37.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.749 0.309 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 31' ' ' LEU . 2.4 t -124.65 104.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -95.92 97.6 9.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.225 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -109.51 154.83 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.927 0.394 . . . . 0.0 111.002 -179.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.6 OUTLIER -118.94 97.58 5.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.789 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.77 170.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 111.681 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.785 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.5 p -121.4 132.61 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.801 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.642 ' HB2' HG11 ' A' ' 34' ' ' VAL . 71.7 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.837 0.265 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.33 119.35 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 34' ' ' VAL . 2.3 m-85 -100.21 132.17 45.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 33' ' ' VAL . 1.6 pp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.01 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.001 0.429 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 13.1 m-85 -60.21 151.94 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.878 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.64 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.35 124.51 2.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.137 0.494 . . . . 0.0 111.18 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 120.54 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.4 t -103.16 147.2 9.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -140.34 104.79 4.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.825 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mm -107.4 99.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -83.99 109.87 17.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.405 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -132.27 -175.32 3.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -104.63 144.27 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.372 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HG2' ' CB ' ' A' ' 95' ' ' ASN . 15.6 mttt -50.24 144.45 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.076 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 10.73 80.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.624 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 31' ' ' LEU . 26.9 mm-40 -124.86 31.05 5.75 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.851 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 25.5 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.089 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 23' ' ' ILE . 56.8 tp 177.56 -41.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.791 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 85.79 63.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.856 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.025 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -151.11 156.12 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 111.216 178.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' B' ' -3' ' ' PRO . 38.6 t -121.61 129.83 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -119.76 140.84 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.434 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.9 m -131.52 168.15 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -58.91 132.57 54.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.914 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 24.4 p -74.1 84.08 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' TRP . . . -79.27 -7.74 88.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.074 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.59 -162.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 110.322 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.02 -26.5 6.01 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.445 -0.884 . . . . 0.0 111.816 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 80.31 45.74 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.544 0.688 . . . . 0.0 111.256 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.893 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 83.6 mt -59.01 -39.28 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.942 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.97 ' O ' HG22 ' A' ' 46' ' ' THR . 2.0 mt -146.22 80.99 9.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.386 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 80' ' ' GLY . 94.8 Cg_exo -42.57 91.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.913 2.408 . . . . 0.0 113.581 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.13 -89.42 0.2 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.354 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.667 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.61 167.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.653 0.264 . . . . 0.0 111.205 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.43 129.44 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.075 HG22 HD13 ' A' ' 66' ' ' ILE . 52.2 mt -68.21 91.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -13.26 41.46 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.764 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -158.13 159.1 35.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.975 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -153.13 129.14 10.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.439 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 3.3 mtm -56.3 102.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.0 70.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.777 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.88 -34.26 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.066 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.09 -167.86 4.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.093 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.5 Cg_endo -69.27 -16.11 39.37 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.813 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.41 -49.69 58.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.856 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -36.87 50.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -56.73 -47.28 80.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -73.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.39 -4.05 23.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.309 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.693 ' HB2' HG13 ' A' ' 21' ' ' VAL . 20.1 mmmt -75.93 -37.49 58.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.539 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.847 HD21 HD13 ' A' ' 101' ' ' LEU . 53.3 mt -91.81 126.53 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -132.15 128.13 37.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.496 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.075 HD13 HG22 ' A' ' 49' ' ' ILE . 43.8 mm -44.18 142.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.5 . . . . 0.0 111.937 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.12 13.33 56.38 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.563 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.908 ' HB3' HD12 ' A' ' 103' ' ' ILE . 87.4 m-20 -102.37 166.93 10.29 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.761 0.315 . . . . 0.0 110.615 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' CH2' ' A' ' 40' ' ' TRP . 3.4 mm100 -120.32 105.71 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.762 HG23 HG22 ' A' ' 103' ' ' ILE . 4.9 mt -78.82 129.48 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.706 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -95.42 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 p -126.56 142.26 51.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.598 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 HD21 ' A' ' 78' ' ' LEU . 2.8 mp -120.08 122.85 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.515 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.524 HD22 HD13 ' A' ' 93' ' ' LEU . 1.2 m-20 59.76 31.23 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.85 14.52 69.71 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.522 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 m -109.14 95.63 5.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -73.56 131.01 41.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.591 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.682 HD21 HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -125.24 16.32 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.136 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -63.04 89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.999 0.428 . . . . 0.0 110.28 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 134.63 -22.04 3.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 78' ' ' LEU . 1.5 mt -74.1 167.71 33.04 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.276 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 85' ' ' THR . 9.7 Cg_exo -68.9 -177.27 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.751 2.301 . . . . 0.0 111.439 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.668 HD11 HE22 ' A' ' 87' ' ' GLN . 0.8 OUTLIER -78.64 -52.9 7.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 179.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 -38.84 65.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.723 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 89' ' ' ILE . 37.2 m -62.4 -43.12 99.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' HA ' HG13 ' A' ' 89' ' ' ILE . 77.3 m -58.79 -51.48 69.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.668 HE22 HD11 ' A' ' 83' ' ' LEU . 21.7 mt-30 -50.99 -44.05 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.276 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.5 m -60.42 -35.19 75.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.371 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 85' ' ' THR . 2.8 mm -58.35 -49.43 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.104 HG21 HD13 ' B' ' 0' ' ' ILE . 59.1 mt -71.45 -43.44 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.769 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.38 -24.44 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.84 -42.28 38.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.627 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.524 HD13 HD22 ' A' ' 74' ' ' ASN . 0.4 OUTLIER -89.19 51.15 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 111.142 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.851 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -87.32 -23.84 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 56.6 m-80 -116.07 63.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 3.3 mm100 -124.19 -29.78 3.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.602 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 3.8 t 82.28 -2.16 1.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.247 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.43 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.1 ttm180 -154.93 134.02 12.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.73 0.3 . . . . 0.0 110.229 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.631 ' CG1' HD21 ' A' ' 101' ' ' LEU . 17.7 t -119.75 104.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.711 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -90.98 100.85 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.71 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.847 HD13 HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -115.84 120.76 40.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -90.45 90.58 8.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.908 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.7 pt -111.94 164.63 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.706 HG23 ' SD ' ' A' ' 71' ' ' MET . 61.6 t -103.05 107.96 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.333 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.6 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.715 ' CG ' HG21 ' A' ' 34' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.823 0.26 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.402 HG23 ' N ' ' B' ' -1' ' ' TYR . 18.2 m -55.96 -42.51 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.365 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 34' ' ' VAL . 1.5 m-85 64.97 90.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.104 HD13 HG21 ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.042 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CA ' HG12 ' A' ' 104' ' ' VAL . 5.4 m-85 -58.68 151.98 19.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.965 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -164.38 125.23 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 111.508 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.09 102.14 4.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.4 t -82.7 136.66 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.153 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -124.95 104.77 8.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 61' ' ' SER . 15.3 mm -105.88 99.78 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -86.87 109.82 19.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -138.04 -171.15 2.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.995 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.54 169.38 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.59 156.99 31.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 18.84 61.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.292 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' C ' ' A' ' 30' ' ' ILE . 2.7 mm-40 -127.7 29.5 5.46 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.582 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 10.29 -78.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.326 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 172.75 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.77 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 89.01 66.65 1.26 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.467 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.045 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -149.39 156.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' B' ' -3' ' ' PRO . 21.9 t -121.23 126.51 75.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.721 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.552 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.3 pt -113.94 151.92 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.77 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 35.2 m -142.61 167.3 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.32 131.1 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 48' ' ' ILE . 25.2 p -70.4 84.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.62 -5.82 89.21 Favored Glycine 0 C--N 1.328 0.135 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.967 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.751 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.24 -163.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.566 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.08 -24.49 6.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.412 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.76 36.52 0.08 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.233 0.54 . . . . 0.0 111.404 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.751 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.5 mt -52.45 -36.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.657 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -147.59 101.06 3.74 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.943 178.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 75.6 Cg_exo -51.76 83.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.398 2.065 . . . . 0.0 112.876 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -133.84 -152.35 0.48 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.214 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 83' ' ' LEU . 15.8 m -111.28 166.1 5.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.634 0.254 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.04 131.33 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.019 HG22 HD13 ' A' ' 66' ' ' ILE . 73.1 mt -68.2 93.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.28 -9.58 44.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.238 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.466 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 1.2 m-20 -162.12 160.22 27.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 111.053 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -152.06 147.65 26.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.582 ' CE ' HD11 ' A' ' 30' ' ' ILE . 3.9 mtt -59.64 -27.86 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 60.61 60.85 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.697 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.96 -30.15 0.16 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.278 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.7 -170.68 29.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.043 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.411 ' CB ' ' HB3' ' A' ' 25' ' ' LYS . 29.7 Cg_endo -63.09 -17.21 59.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.301 2.001 . . . . 0.0 112.343 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.88 -49.02 66.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -38.77 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -56.38 -45.95 80.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.415 ' CB ' HD13 ' A' ' 23' ' ' ILE . 1.6 p -56.04 -56.15 24.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.93 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -29.21 11.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.289 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' CB ' HG13 ' A' ' 21' ' ' VAL . 5.4 mtmt -61.02 -29.3 69.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' A' ' 21' ' ' VAL . 86.8 mt -101.69 125.96 48.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.14 147.75 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.019 HD13 HG22 ' A' ' 49' ' ' ILE . 50.8 mm -50.41 146.5 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.647 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.93 59.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.262 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.62 ' HB3' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -102.55 174.18 6.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.689 0.281 . . . . 0.0 110.658 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.68 ' HB2' HG23 ' A' ' 104' ' ' VAL . 3.5 mm100 -130.35 107.8 9.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.147 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.72 HG23 HG22 ' A' ' 103' ' ' ILE . 7.5 mt -88.71 134.2 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.808 ' HE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -97.02 -69.91 0.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 t -129.62 144.95 51.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.267 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.966 ' CD1' HD11 ' A' ' 78' ' ' LEU . 3.4 mt -113.88 110.95 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.666 ' ND2' HD13 ' A' ' 93' ' ' LEU . 70.8 m-80 57.69 22.77 8.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.94 -34.21 4.71 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.868 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.85 HG21 HD12 ' A' ' 89' ' ' ILE . 3.8 m -65.55 103.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.795 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 p -68.81 135.59 51.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.309 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.966 HD11 ' CD1' ' A' ' 73' ' ' ILE . 29.5 mt -112.58 -20.16 11.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.089 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 46' ' ' THR . 35.9 t -56.28 88.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.649 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.51 -49.69 0.86 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.361 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.795 HD21 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -64.46 159.88 55.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.554 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.67 -177.39 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.037 2.491 . . . . 0.0 112.654 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.587 HD23 HG12 ' A' ' 47' ' ' VAL . 1.9 tm? -78.17 -49.91 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.712 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 m -53.15 -41.14 64.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.991 0.424 . . . . 0.0 110.56 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 89' ' ' ILE . 54.8 m -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.036 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 73.0 m -55.7 -54.1 48.41 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.459 ' NE2' HD13 ' A' ' 83' ' ' LEU . 25.3 mt-30 -49.03 -48.01 44.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.2 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 23.2 t -56.81 -35.26 68.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.556 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.85 HD12 HG21 ' A' ' 76' ' ' THR . 7.0 mm -58.8 -48.58 85.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.88 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.999 HG21 HD13 ' B' ' 0' ' ' ILE . 23.7 mt -67.49 -50.55 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.17 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -61.27 -19.97 62.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.87 -23.22 69.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.583 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.666 HD13 ' ND2' ' A' ' 74' ' ' ASN . 1.4 pp -113.82 44.27 1.66 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -88.33 -12.27 43.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.42 39.15 1.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.775 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.02 147.98 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 110.677 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 7.1 t -83.13 -9.12 59.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 1.9 ttm180 -147.15 141.78 26.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.746 0.308 . . . . 0.0 110.725 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.775 HG22 ' OE1' ' A' ' 96' ' ' GLN . 10.4 t -127.7 104.89 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.36 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -88.68 97.91 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.739 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -102.28 154.55 18.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 111.297 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.4 OUTLIER -124.13 97.65 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.72 HG22 HG23 ' A' ' 70' ' ' ILE . 1.7 pt -121.51 172.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.129 0.49 . . . . 0.0 112.295 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 69' ' ' GLN . 4.3 m -125.9 130.99 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.587 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.527 ' CG ' HG11 ' A' ' 34' ' ' VAL . 68.1 Cg_endo . . . . . 0 N--CA 1.464 -0.243 0 N-CA-C 112.623 0.201 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 33.1 t 54.39 87.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.42 ' CZ ' HG23 ' A' ' 34' ' ' VAL . 1.2 m-85 -81.89 145.77 30.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.045 HD11 HG22 ' A' ' 33' ' ' VAL . 2.2 pp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.775 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.865 0.364 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 44' ' ' LEU . 6.4 m-85 -64.71 154.44 36.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.784 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.59 125.32 2.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.233 0.539 . . . . 0.0 111.559 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.55 100.15 1.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.502 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 101' ' ' LEU . 24.9 t -82.43 112.01 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.131 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -110.92 104.82 13.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' CB ' ' A' ' 61' ' ' SER . 4.1 mm -105.96 104.16 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 98' ' ' ARG . 1.2 mp0 -84.05 110.3 18.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -133.5 -171.3 2.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -112.22 166.72 11.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -65.05 158.49 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 110.724 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.38 17.77 60.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.487 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -126.81 29.73 5.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 22.77 -82.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.097 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 99' ' ' VAL . 16.7 tp 174.95 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' HA2' ' HE1' ' A' ' 53' ' ' MET . . . 88.49 63.5 1.35 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.819 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.046 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -152.7 156.07 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 117.18 0.49 . . . . 0.0 111.795 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 31.1 t -126.35 116.4 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.588 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -103.24 152.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.44 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 48' ' ' ILE . 26.8 m -140.09 168.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 48' ' ' ILE . 28.7 mt-10 -58.46 132.14 52.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.939 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.5 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 54.6 p -74.11 84.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.423 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.84 -9.62 84.22 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.123 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.903 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.23 -161.65 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.723 0.296 . . . . 0.0 110.439 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.73 -26.07 7.55 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.801 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.439 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 9.1 m 80.54 35.87 0.11 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.264 0.554 . . . . 0.0 111.49 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.903 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 74.2 mt -49.25 -39.36 12.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.056 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.906 ' O ' HG22 ' A' ' 46' ' ' THR . 1.5 mt -145.66 87.71 6.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.091 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 6.7 Cg_endo -50.39 90.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.873 2.382 . . . . 0.0 113.308 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.9 -91.58 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.818 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.497 ' H ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -158.67 167.58 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.38 131.11 63.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.091 HG22 HD13 ' A' ' 66' ' ' ILE . 56.0 mt -68.1 93.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.06 -1.89 53.73 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.115 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.492 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.1 t-20 -170.01 152.6 4.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.2 mtm -146.7 121.35 9.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 0.0 111.448 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.482 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -54.48 90.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.607 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -59.25 82.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.05 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 53' ' ' MET . . . 162.76 -29.92 0.27 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.953 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.57 32.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 55.8 Cg_endo -69.52 -16.06 38.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.704 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.25 63.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 -33.38 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.751 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -61.37 -45.58 93.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.417 ' CB ' HD13 ' A' ' 23' ' ' ILE . 6.8 m -63.73 -68.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.22 -25.65 17.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.505 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.567 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.89 -27.07 40.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.643 ' HG ' HG11 ' A' ' 21' ' ' VAL . 71.5 mt -98.76 134.53 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -140.43 134.73 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.711 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.091 HD13 HG22 ' A' ' 49' ' ' ILE . 49.4 mm -46.42 144.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.705 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.22 84.57 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.659 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.922 ' HB3' HD12 ' A' ' 103' ' ' ILE . 74.6 m-20 -85.59 164.0 18.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.678 0.275 . . . . 0.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.737 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -119.45 118.29 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 111.193 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.783 HG23 HG22 ' A' ' 103' ' ' ILE . 4.4 mt -91.62 108.73 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.53 ' CE ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.85 -66.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.876 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.8 p -135.65 148.53 48.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.408 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 3.2 mt -118.22 112.5 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.77 23.85 12.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.78 -30.49 7.43 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.886 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.877 HG21 HG23 ' A' ' 89' ' ' ILE . 3.0 m -67.7 102.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.716 0.293 . . . . 0.0 111.039 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.593 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.9 m -69.04 136.75 52.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.054 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HA ' HD21 ' A' ' 81' ' ' LEU . 40.5 mt -112.24 -13.52 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 21.6 t -67.05 94.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.341 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.91 -22.73 3.8 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.479 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.93 157.61 33.57 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.983 0.391 . . . . 0.0 111.472 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.01 -174.15 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.818 2.346 . . . . 0.0 112.801 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -78.15 -48.43 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.459 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 p -52.99 -42.21 65.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.705 HG22 HD13 ' A' ' 81' ' ' LEU . 99.1 m -61.55 -48.33 81.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.839 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' HD12 ' A' ' 81' ' ' LEU . 78.8 m -56.13 -50.16 71.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.883 0.373 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -50.22 -46.2 54.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.305 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.3 m -59.69 -35.7 75.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.64 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.877 HG23 HG21 ' A' ' 76' ' ' THR . 18.2 mm -58.15 -50.0 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.063 HG21 HD13 ' B' ' 0' ' ' ILE . 58.7 mt -69.54 -45.31 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -55.57 -23.42 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.31 -33.3 32.38 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 93' ' ' LEU . 2.0 pp -95.65 35.12 1.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.915 0.388 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.76 -5.79 58.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -107.65 43.96 1.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.404 ' CD ' ' HB2' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -131.97 176.07 8.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 110.9 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.2 t -102.17 -16.74 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 28.3 mmt85 -131.21 150.49 52.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 101' ' ' LEU . 7.7 t -129.4 104.3 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mmpt? -90.0 120.92 31.62 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.3 117.84 11.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 111.804 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.78 99.41 12.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.574 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.922 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -118.68 167.35 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.153 0.501 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' HB2' ' A' ' 69' ' ' GLN . 4.3 p -112.06 129.09 68.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.247 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 72.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.781 0.242 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.76 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.542 ' CE2' HG23 ' A' ' 34' ' ' VAL . 36.6 m-85 -109.33 131.51 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 90' ' ' ILE . 1.8 pp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.593 ' C ' HG13 ' A' ' 104' ' ' VAL . 2.3 tt0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.83 0.347 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.512 ' CG ' HG22 ' A' ' 104' ' ' VAL . 4.0 m-85 -67.29 151.55 47.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.692 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -163.73 125.9 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.314 0.578 . . . . 0.0 111.616 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.56 105.88 6.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.572 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 63' ' ' LYS . 22.8 t -84.38 141.2 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -132.84 104.53 6.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.217 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 31' ' ' LEU . 14.1 mm -106.57 99.63 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 98' ' ' ARG . 37.2 mt-10 -85.63 109.55 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.023 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -140.54 -172.86 3.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.154 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.8 169.07 8.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.423 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 157.12 30.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.532 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 9.92 65.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.507 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ILE . 4.4 mt-10 -120.13 31.87 6.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.197 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.2 OUTLIER 5.77 -75.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.103 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 99' ' ' VAL . 2.5 tp 171.73 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.844 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' HE2' ' A' ' 53' ' ' MET . . . 83.15 62.73 1.79 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.249 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.036 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -146.03 156.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 111.715 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.553 HG21 ' HG2' ' B' ' -3' ' ' PRO . 38.3 t -119.43 132.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER -117.16 156.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.635 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.749 ' HA ' HD22 ' A' ' 83' ' ' LEU . 32.0 m -148.28 165.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.808 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.19 131.82 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.609 ' HA ' HD11 ' A' ' 48' ' ' ILE . 87.5 p -69.13 84.09 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.403 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.47 -1.19 90.24 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.562 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.8 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.579 0.228 . . . . 0.0 110.475 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.28 -25.5 8.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.833 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 83.05 64.27 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.739 0.78 . . . . 0.0 111.459 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.586 ' O ' HD23 ' A' ' 44' ' ' LEU . 43.5 mt -83.0 -31.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.841 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -156.51 101.39 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.809 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 9.6 Cg_endo -52.11 83.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.58 2.187 . . . . 0.0 113.363 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -133.45 -157.7 0.83 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.041 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.6 m -105.64 153.36 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.933 0.396 . . . . 0.0 111.651 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -115.78 132.79 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.8 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.063 HG22 HD13 ' A' ' 66' ' ' ILE . 48.8 mt -69.31 90.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.44 -11.3 52.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.192 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.626 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -161.8 159.9 27.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 17.1 ttm -149.15 135.64 19.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.935 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 30' ' ' ILE . 2.9 mtm -51.95 -27.19 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 38.6 t60 58.66 54.67 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.676 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.2 -37.14 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.217 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.88 -166.14 2.45 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.951 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 51.0 Cg_endo -68.91 -16.94 41.6 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.292 1.995 . . . . 0.0 112.131 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.53 -44.74 73.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.482 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -39.42 49.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.565 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -58.34 -47.12 84.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -63.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.14 -23.42 27.3 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.287 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.876 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -56.84 -36.59 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 21' ' ' VAL . 23.1 mt -101.08 104.39 15.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.995 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 1.5 p30 -121.54 141.23 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.531 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.063 HD13 HG22 ' A' ' 49' ' ' ILE . 28.5 mm -46.34 145.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 111.809 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.62 4.82 61.9 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.64 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.6 m-20 -106.07 150.96 25.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.29 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -113.08 126.72 55.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 111.157 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.729 HG23 HG22 ' A' ' 103' ' ' ILE . 6.3 mt -88.93 134.87 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.726 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -96.81 -57.82 2.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.241 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.0 p -147.23 145.26 29.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.969 0.414 . . . . 0.0 111.401 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.75 HD12 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -115.23 120.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 73' ' ' ILE . 71.9 m-80 55.87 27.98 11.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.37 -26.01 24.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.795 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.655 HG21 HG23 ' A' ' 89' ' ' ILE . 3.4 m -65.51 102.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD21 ' A' ' 81' ' ' LEU . 4.9 t -68.77 131.48 45.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 73' ' ' ILE . 21.0 mt -109.82 -25.34 10.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.715 HG22 HG22 ' A' ' 46' ' ' THR . 26.0 t -54.99 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.524 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.45 -38.09 1.49 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.242 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.66 159.73 57.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.372 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 -172.14 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.847 2.365 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.8 tp -78.04 -45.01 24.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.018 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 7.6 t -53.34 -43.0 67.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.983 0.421 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.683 HG22 HD13 ' A' ' 81' ' ' LEU . 89.7 m -63.86 -48.63 75.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.646 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 71.9 m -55.97 -57.16 13.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.549 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.681 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.4 pt20 -48.86 -42.09 35.33 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.968 0.413 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -60.94 -35.69 77.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.311 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 85' ' ' THR . 13.9 mm -59.0 -49.4 83.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.013 HG21 HD13 ' B' ' 0' ' ' ILE . 29.1 mt -71.96 -46.09 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.721 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.2 mtpt -55.42 -24.41 30.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -47.25 47.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.209 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.33 55.72 3.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 0.0 110.814 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -87.93 -19.47 27.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.288 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -109.29 54.37 0.66 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.785 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.8 pt20 -126.21 156.15 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.618 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 p -93.98 -12.23 29.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.763 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 3.1 ttm180 -143.58 139.49 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.522 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 ' OE1' ' A' ' 96' ' ' GLN . 2.7 t -120.87 104.43 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.516 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.38 119.45 32.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.826 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -132.0 154.35 49.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.024 0.44 . . . . 0.0 111.118 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.5 OUTLIER -122.29 92.25 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.2 pt -116.05 170.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 112.161 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.726 HG23 ' SD ' ' A' ' 71' ' ' MET . 35.9 t -119.98 113.9 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.889 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttm105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.961 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.553 ' HG2' HG21 ' A' ' 34' ' ' VAL . 88.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.787 0.264 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . . . . . . . . . 21.2 t 61.35 122.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.889 0.375 . . . . 0.0 111.278 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 34' ' ' VAL . 32.9 m-85 -117.84 143.9 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.036 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HE1' HD21 ' A' ' 44' ' ' LEU . 2.5 m-85 -64.2 154.28 35.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.754 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.12 127.57 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 111.834 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.47 102.05 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.524 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 63' ' ' LYS . 24.8 t -82.77 135.3 25.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.022 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -127.28 104.84 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 31' ' ' LEU . 15.0 mm -104.71 99.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -90.07 109.61 20.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.121 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -135.07 -165.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -106.47 162.34 13.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.407 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.81 158.78 15.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.511 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.87 19.48 50.16 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -124.68 29.24 6.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 110.07 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' CE ' ' A' ' 53' ' ' MET . 0.3 OUTLIER 15.73 -80.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.482 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.566 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER 174.13 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.794 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 93.17 67.49 1.08 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.59 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.044 HG22 HD11 ' B' ' 0' ' ' ILE . 0.9 OUTLIER -152.45 156.12 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.707 0.289 . . . . 0.0 111.008 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 47.9 t -120.62 123.64 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.045 0.45 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.565 ' O ' HD11 ' A' ' 83' ' ' LEU . 1.6 pt -110.91 140.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.803 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.635 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.6 m -133.12 168.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.121 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.6 mt-10 -58.47 132.32 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . 44.3 p -72.92 84.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.469 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.05 -8.44 83.94 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.032 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.974 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.39 -161.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.478 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.4 8.61 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.816 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.427 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 81.13 47.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.424 0.63 . . . . 0.0 111.172 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 92.3 mt -55.95 -42.18 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.944 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.943 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -152.63 88.68 3.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.32 178.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.44 108.91 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.123 2.548 . . . . 0.0 114.108 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -154.85 -91.48 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.379 178.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -160.18 167.49 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 110.962 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.513 HD11 ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.67 130.23 59.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.039 HG22 HD13 ' A' ' 66' ' ' ILE . 66.1 mt -69.09 94.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.5 -1.9 49.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.434 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 1.3 m-20 -166.69 159.36 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.0 ttm -154.07 135.19 13.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.654 ' CE ' HD11 ' A' ' 30' ' ' ILE . 9.7 mtm -71.82 99.84 2.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.59 76.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.84 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -35.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -170.13 18.26 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.997 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 56.2 Cg_endo -69.11 -15.68 39.72 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.541 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.52 67.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.898 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.43 -38.99 48.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -57.47 -47.1 82.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.253 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.8 p -56.9 -63.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.53 -9.19 57.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.321 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.794 ' HB2' HG13 ' A' ' 21' ' ' VAL . 8.8 mmmt -72.93 -31.41 64.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.88 0.371 . . . . 0.0 110.548 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 21' ' ' VAL . 87.5 mt -96.85 130.4 44.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -139.44 134.06 31.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.039 HD13 HG22 ' A' ' 49' ' ' ILE . 50.1 mm -46.49 144.32 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 111.798 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.09 13.25 57.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.8 ' HB3' HD12 ' A' ' 103' ' ' ILE . 65.7 m-20 -108.56 160.0 16.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.684 0.278 . . . . 0.0 110.698 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -115.06 119.17 35.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -90.42 113.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.812 ' CE ' HD13 ' A' ' 44' ' ' LEU . 24.3 mmt -72.98 -66.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.709 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 77' ' ' SER . 86.4 p -134.42 160.31 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.719 HD12 HD21 ' A' ' 78' ' ' LEU . 3.3 mt -118.5 111.11 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.73 28.89 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.11 -30.14 5.54 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.222 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 89' ' ' ILE . 11.1 m -78.26 99.98 6.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.465 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 67.3 m -84.8 137.49 33.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.638 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.743 ' HA ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -128.76 24.77 5.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.879 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.6 t -75.64 93.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.005 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.09 -18.78 4.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.143 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.68 163.19 33.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.982 0.391 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.05 -179.28 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.803 2.335 . . . . 0.0 112.417 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 tp -78.13 -44.62 25.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.24 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -53.14 -42.55 66.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 89' ' ' ILE . 99.2 m -63.73 -47.8 79.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.715 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.514 ' SG ' HD13 ' A' ' 78' ' ' LEU . 77.0 m -55.76 -57.48 11.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.358 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.548 ' NE2' HG21 ' B' ' -2' ' ' VAL . 5.8 pt20 -49.77 -39.95 39.7 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.508 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 16.7 t -62.45 -36.61 82.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.26 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 76' ' ' THR . 2.1 mm -58.84 -49.73 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.347 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.041 HG21 HD13 ' B' ' 0' ' ' ILE . 54.6 mt -69.4 -50.45 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.131 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -58.62 -22.01 55.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.881 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.15 -30.31 59.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 89' ' ' ILE . 1.1 pp -104.38 35.32 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 111.062 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.82 -5.92 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.592 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -96.08 35.69 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.682 0.277 . . . . 0.0 111.73 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.53 170.67 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.737 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 t -99.18 -8.74 24.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.855 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.4 ttm180 -139.6 140.03 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.712 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 93' ' ' LEU . 13.9 t -130.51 106.1 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.643 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.483 ' HE3' ' CE1' ' A' ' 22' ' ' PHE . 7.9 tttt -88.13 131.8 34.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.68 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -142.07 117.9 10.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.002 0.43 . . . . 0.0 111.448 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.31 89.66 8.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -111.67 166.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.913 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 69' ' ' GLN . 6.3 p -109.07 122.78 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.638 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 -179.601 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.484 ' CG ' HG11 ' A' ' 34' ' ' VAL . 98.3 Cg_endo . . . . . 0 N--CA 1.464 -0.216 0 CA-C-O 120.789 0.245 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 87' ' ' GLN . 5.0 m -58.17 142.7 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 53' ' ' MET . 0.5 OUTLIER -119.56 115.91 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.044 HD11 HG22 ' A' ' 33' ' ' VAL . 2.3 pp . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.904 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.582 ' C ' HG13 ' A' ' 104' ' ' VAL . 3.2 tp10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.428 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 4.9 m-85 -61.75 148.68 42.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.06 126.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.171 0.51 . . . . 0.0 111.805 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.66 133.01 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.938 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 63' ' ' LYS . 18.9 t -116.29 111.41 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.253 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.749 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -101.37 115.72 31.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.67 HG21 ' CD1' ' A' ' 31' ' ' LEU . 12.5 mm -114.86 99.4 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.862 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -88.81 128.31 35.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.327 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.556 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -157.44 -166.83 2.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.58 167.43 10.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.87 157.64 17.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.0 110.736 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.92 11.1 73.79 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.542 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -123.96 32.51 5.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.258 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.775 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 10.64 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.154 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.67 ' CD1' HG21 ' A' ' 23' ' ' ILE . 59.1 tp 177.35 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.709 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 83.62 63.51 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.702 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG22 HD11 ' B' ' 0' ' ' ILE . 0.7 OUTLIER -152.45 156.46 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' B' ' -3' ' ' PRO . 40.9 t -122.16 117.28 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.56 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.6 pt -106.18 147.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.471 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.8 m -140.38 169.71 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' O ' HD11 ' A' ' 48' ' ' ILE . 6.5 mt-10 -63.18 129.37 40.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.927 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.51 ' HA ' HD11 ' A' ' 48' ' ' ILE . 59.2 p -71.12 83.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.98 -3.56 89.08 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.695 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.876 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.56 -163.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.698 0.285 . . . . 0.0 110.603 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.24 -24.69 7.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.811 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 82.52 35.38 0.07 Allowed 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.182 0.515 . . . . 0.0 111.562 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.876 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 69.2 mt -49.1 -39.34 12.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.765 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -148.31 111.69 3.74 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.019 178.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' GLY . 34.8 Cg_exo -59.71 98.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.096 1.864 . . . . 0.0 112.62 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -152.57 -155.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.009 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -106.25 165.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -125.71 130.53 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.068 HG22 HD13 ' A' ' 66' ' ' ILE . 69.0 mt -71.42 93.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.94 -5.06 53.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.114 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -163.03 164.3 25.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -160.79 132.13 5.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' B' ' -1' ' ' TYR . 8.2 mtm -69.3 101.97 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.343 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.84 78.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.26 -30.69 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.164 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.37 -176.1 38.3 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.099 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 34.4 Cg_exo -59.75 -16.55 38.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.594 2.196 . . . . 0.0 112.712 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.24 -50.26 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -32.7 49.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.349 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.26 -47.15 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.287 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -56.54 -69.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.28 22.97 7.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.126 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.771 ' CB ' HG13 ' A' ' 21' ' ' VAL . 8.7 mtpp -107.88 -33.0 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.753 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.763 ' HG ' HG11 ' A' ' 21' ' ' VAL . 54.0 mt -96.03 123.21 39.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.664 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -127.49 133.32 49.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.593 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.068 HD13 HG22 ' A' ' 49' ' ' ILE . 46.6 mm -45.46 141.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.97 15.07 56.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.214 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.938 ' HB3' HD12 ' A' ' 103' ' ' ILE . 98.1 m-20 -101.42 164.63 11.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.779 0.324 . . . . 0.0 110.695 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.523 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 5.2 mm100 -120.32 115.17 23.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -89.06 117.78 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.56 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.5 -64.28 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.376 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.4 t -132.24 146.17 51.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.821 HG23 HD23 ' A' ' 101' ' ' LEU . 3.4 mt -117.11 111.3 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.559 HD22 HD22 ' A' ' 93' ' ' LEU . 89.1 m-20 60.92 25.93 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.09 -28.59 11.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.618 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 1.054 HG21 HD12 ' A' ' 89' ' ' ILE . 86.4 m -63.9 96.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.076 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -74.41 117.97 16.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.722 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.795 HD21 HD12 ' A' ' 73' ' ' ILE . 1.2 pp -125.03 27.71 6.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 46' ' ' THR . 24.8 t -74.6 80.22 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' PRO . . . 139.23 -13.28 3.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.779 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -83.11 157.8 65.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 110.819 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.1 -174.93 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.577 2.185 . . . . 0.0 111.891 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 36' ' ' VAL . 22.5 tp -78.31 -39.95 38.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.699 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.3 p -53.71 -44.69 70.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.349 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.9 m -63.95 -52.97 57.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.859 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 78' ' ' LEU . 73.5 m -55.74 -52.15 64.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.769 0.318 . . . . 0.0 111.002 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.449 ' OE1' HG11 ' B' ' -2' ' ' VAL . 19.2 mt-30 -49.71 -42.62 46.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.021 0.439 . . . . 0.0 109.896 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 91' ' ' LYS . 1.3 m -60.9 -36.86 80.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.271 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.054 HD12 HG21 ' A' ' 76' ' ' THR . 14.7 mm -58.98 -49.37 83.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.398 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.133 HG21 HD13 ' B' ' 0' ' ' ILE . 34.6 mt -72.59 -49.96 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -59.46 -20.33 54.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.895 0.378 . . . . 0.0 110.956 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.38 -28.49 67.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.362 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 93' ' ' LEU . 1.4 pp -106.92 57.67 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.7 -30.58 29.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.104 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -96.57 37.47 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -100.69 144.05 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.019 0.438 . . . . 0.0 111.353 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.9 p -96.63 -5.77 38.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.576 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.749 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 10.8 ttm180 -157.0 137.79 13.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.245 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.556 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 2.5 t -132.01 123.87 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -100.8 128.48 46.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.627 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.821 HD23 HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -139.37 116.66 11.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 111.931 -179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.05 93.02 9.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.938 HD12 ' HB3' ' A' ' 68' ' ' ASP . 2.6 pt -116.34 168.87 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.984 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.582 HG13 ' C ' ' A' ' 17' ' ' GLU . 37.3 t -115.05 119.44 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.544 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.562 ' HB2' HG11 ' A' ' 34' ' ' VAL . 91.1 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 CA-C-O 120.818 0.258 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.449 HG11 ' OE1' ' A' ' 87' ' ' GLN . 9.1 p -64.17 142.81 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 34' ' ' VAL . 4.7 m-85 -112.31 135.69 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.133 HD13 HG21 ' A' ' 90' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.99 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' C ' HG23 ' A' ' 104' ' ' VAL . 4.3 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.458 ' N ' HG23 ' A' ' 104' ' ' VAL . 7.8 m-85 -65.14 154.52 37.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HD3' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.17 125.15 3.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 111.734 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.87 101.94 4.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.407 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.843 HG11 ' HG ' ' A' ' 64' ' ' LEU . 15.8 t -83.54 139.3 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CE1' ' CE ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -131.91 104.91 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.527 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.627 HG13 HD21 ' A' ' 31' ' ' LEU . 11.1 mm -103.42 99.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.21 109.98 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.319 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 -174.35 4.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -107.52 176.38 5.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.601 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 155.72 39.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.04 13.97 65.16 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.497 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 30' ' ' ILE . 5.5 mt-10 -125.45 31.19 5.6 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.157 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.61 HG23 ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 9.83 -78.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.288 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER 173.39 -43.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.757 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 87.56 60.53 1.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.664 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.02 HG22 HD11 ' B' ' 0' ' ' ILE . 0.8 OUTLIER -144.92 155.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' O ' ' B' ' -2' ' ' VAL . 88.4 t -123.62 129.37 74.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.744 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.1 pt -117.94 153.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.632 ' HA ' HD22 ' A' ' 83' ' ' LEU . 30.6 m -141.93 169.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.838 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' HD11 ' A' ' 48' ' ' ILE . 3.2 mt-10 -61.72 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.491 ' HA ' HD11 ' A' ' 48' ' ' ILE . 88.5 p -68.37 84.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.507 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.21 -3.73 87.02 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.801 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -55.61 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.616 0.246 . . . . 0.0 110.443 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -49.96 -24.28 6.23 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.766 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' NE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER 82.16 38.71 0.05 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.327 0.584 . . . . 0.0 111.277 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.769 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 65.4 mt -54.15 -34.99 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.792 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 46' ' ' THR . 85.2 mt -152.01 104.41 2.82 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.16 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 61.9 Cg_exo -52.14 84.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.516 2.144 . . . . 0.0 113.14 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -133.72 -154.65 0.61 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -108.12 167.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -127.5 125.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.993 HG22 HD13 ' A' ' 66' ' ' ILE . 59.3 mt -65.18 91.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.24 -8.11 55.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.123 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.533 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -166.26 161.02 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 111.344 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -155.65 142.71 19.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.597 ' CE ' HD11 ' A' ' 30' ' ' ILE . 7.2 mtt -52.66 -25.01 9.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.66 47.75 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.802 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.97 -39.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.05 -169.59 1.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.278 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.19 -23.91 56.14 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.644 2.229 . . . . 0.0 112.196 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -62.65 -49.31 75.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -76.99 -39.02 51.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -50.89 -47.1 60.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.43 ' CB ' ' HE3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -60.45 -51.95 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.831 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.08 55.62 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mtmt -69.06 -35.27 76.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.843 ' HG ' HG11 ' A' ' 21' ' ' VAL . 63.4 mt -88.03 113.65 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -127.92 135.23 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 49' ' ' ILE . 26.0 mm -46.27 145.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 0.0 111.752 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.45 64.66 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.876 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.856 ' HB3' HD12 ' A' ' 103' ' ' ILE . 3.0 m-20 -106.38 163.43 12.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.902 0.351 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB2' HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -114.68 121.47 43.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.708 HG23 HG22 ' A' ' 103' ' ' ILE . 7.7 mt -91.17 112.64 25.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.444 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.626 ' HE1' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -77.51 -63.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 t -133.16 154.09 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.935 ' CD1' HD11 ' A' ' 78' ' ' LEU . 4.4 mt -126.18 104.13 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.83 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.526 HD22 HG22 ' A' ' 73' ' ' ILE . 50.9 m-80 60.02 24.13 13.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.74 -33.31 4.99 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.926 HG21 HD12 ' A' ' 89' ' ' ILE . 3.9 m -65.2 98.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.586 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -70.21 106.8 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.935 HD11 ' CD1' ' A' ' 73' ' ' ILE . 25.8 mt -79.89 -31.23 40.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.3 p -52.75 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.78 -27.8 2.18 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.267 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.744 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -98.72 159.73 29.66 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.887 0.375 . . . . 0.0 111.427 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 -172.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.837 2.358 . . . . 0.0 112.537 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 36' ' ' VAL . 10.5 tp -77.27 -46.22 23.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.192 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 39.6 m -53.16 -42.41 66.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 110.506 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.707 HG22 HD13 ' A' ' 81' ' ' LEU . 85.1 m -64.52 -48.72 74.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.637 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 76.2 m -55.63 -57.22 12.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HA ' HD11 ' A' ' 35' ' ' ILE . 5.7 pt20 -48.98 -42.51 37.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -61.15 -35.15 76.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.269 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 76' ' ' THR . 8.6 mm -58.91 -49.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.026 HG21 HD13 ' B' ' 0' ' ' ILE . 31.2 mt -72.1 -46.45 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' B' ' 0' ' ' ILE . 1.4 mttm -55.44 -23.99 28.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -42.49 43.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.037 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 0.8 OUTLIER -92.47 56.35 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.21 -27.52 22.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.511 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -94.93 35.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.485 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 4.3 mt-30 -102.24 150.6 23.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.416 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.0 p -91.87 -13.8 30.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.616 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 2.0 ttm180 -148.65 137.83 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.339 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 31' ' ' LEU . 14.4 t -122.15 104.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.896 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' CE ' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -89.53 126.28 35.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.837 179.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.886 0.374 . . . . 0.0 110.965 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 71' ' ' MET . 1.1 t-20 -123.73 90.43 3.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' A' ' 68' ' ' ASP . 1.1 pt -109.36 170.86 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.623 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.2 p -122.81 127.98 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.292 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.411 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' -3' ' ' PRO . . . . . 0.731 ' HG2' HG21 ' A' ' 34' ' ' VAL . 67.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.782 0.242 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -2' ' ' VAL . . . . . 0.782 ' O ' HG22 ' A' ' 34' ' ' VAL . 30.4 m -57.73 119.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' -1' ' ' TYR . . . . . 0.592 ' CE1' HG23 ' A' ' 34' ' ' VAL . 19.6 m-85 -110.67 142.69 42.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.364 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 1.026 HD13 HG21 ' A' ' 90' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 stop_ save_